var title_f34_22_35168="Oxymetazoline: Pediatric drug information";
var content_f34_22_35168=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"14\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Oxymetazoline: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <div class=\"block inc\" id=\"F12618186\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <p>",
"     Information for this drug is presented separately based upon the following methods of administration:",
"    </p>",
"   </div>",
"   <div class=\"sec_xr rmolist\" id=\"F12645375\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <ul xmlns=\"\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?21/52/22340?source=see_link\">",
"       Oxymetazoline (nasal): Pediatric drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/40/32386?source=see_link\">",
"       Oxymetazoline (ophthalmic): Pediatric drug information",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12670 Version 25.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-6A12EA632A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_22_35168=[""].join("\n");
var outline_f34_22_35168=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   DRUG INFORMATION",
"   <br/>",
"   [by method of administration]",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?21/52/22340?source=related_link\">",
"      Oxymetazoline (nasal): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/40/32386?source=related_link\">",
"      Oxymetazoline (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_22_35169="Thigh foot angle";
var content_f34_22_35169=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F68556&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F68556&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 540px\">",
"   <div class=\"ttl\">",
"    Determination of the thigh-foot angle",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 520px; height: 407px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The thigh-foot angle (TFA) is the angular difference between the axis of the foot and thigh when the patient is in a prone position with the knees flexed 90 degrees and the foot and ankle are in neutral position. The TFA is external (or positive) when the foot points away from the midline (left) and internal (or negative) when the foot points toward the midline (right). The TFA normally ranges from +10 to +15 degrees.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_22_35169=[""].join("\n");
var outline_f34_22_35169=null;
var title_f34_22_35170="Patient information: Transient ischemic attack (The Basics)";
var content_f34_22_35170=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"12\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16581\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?21/2/21542\">",
"         Signs of stroke",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?12/14/12512\">",
"         Patient information: Carotid artery disease (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?35/37/36435\">",
"         Patient information: Medicines after an ischemic stroke (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?23/55/24435\">",
"         Patient information: Stroke (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?7/63/8180\">",
"         Patient information: Hemorrhagic stroke treatment (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?18/53/19286\">",
"         Patient information: Ischemic stroke treatment (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?37/37/38484\">",
"         Patient information: Stroke symptoms and diagnosis (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?20/18/20772\">",
"         Patient information: Transient ischemic attack (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Transient ischemic attack (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/transient-ischemic-attack-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H25943216\">",
"      <span class=\"h1\">",
"       What is a transient ischemic attack?",
"      </span>",
"      &nbsp;&mdash;&nbsp;A transient ischemic attack (TIA) is like a stroke in that it causes the same symptoms as a stroke, but it does not damage the brain. TIAs happen when an artery in the brain gets clogged, or closes off, and then reopens on its own. This can happen if a blood clot forms and then moves away or dissolves.",
"     </p>",
"     <p>",
"      The symptoms of a TIA are the same as the symptoms of a stroke and can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Weakness or numbness of the hand, tongue, cheek, face, arm, or leg",
"       </li>",
"       <li>",
"        Trouble speaking normally or at all",
"       </li>",
"       <li>",
"        Trouble seeing clearly with one or both eyes",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      TIA is sometimes called a &ldquo;mini-stroke.&rdquo; This is because a TIA is just like a stroke, except that a stroke causes long-lasting symptoms, while a TIA goes away quickly.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25943231\">",
"      <span class=\"h1\">",
"       What is the difference between TIA and stroke?",
"      </span>",
"      &nbsp;&mdash;&nbsp;A TIA does not cause permanent damage to the brain like a stroke does. But the symptoms are the same. This can make it hard to tell if a person is having a TIA or a stroke.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25943246\">",
"      <span class=\"h1\">",
"       What causes a TIA?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Just like a stroke, a TIA can happen when the blood supply to part of the brain is cut off for a short time. This can happen if a blood clot blocks the flow of blood through an artery in the brain and then dissolves or moves away. It can also happen if one of the small arteries in the brain begins to close off from the effects of high blood pressure.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25943261\">",
"      <span class=\"h1\">",
"       How can you tell if someone is having a TIA?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The symptoms of a TIA are the same as the symptoms of a stroke. There is an easy way to remember the signs of a stroke. Just think of the word &ldquo;FAST&rdquo; (",
"      <a class=\"graphic graphic_figure graphicRef73487 \" href=\"mobipreview.htm?21/2/21542\">",
"       figure 1",
"      </a>",
"      ). Each letter in the word stands for one of the signs you should watch for:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        <strong>",
"         F",
"        </strong>",
"        ace &mdash; Does the person&rsquo;s face look uneven or droop on one side?",
"       </li>",
"       <li>",
"        <strong>",
"         A",
"        </strong>",
"        rm &mdash; Does the person have weakness or numbness in one or both arms? Does one arm drift down if the person tries to hold both arms out?",
"       </li>",
"       <li>",
"        <strong>",
"         S",
"        </strong>",
"        peech &mdash; Is the person having trouble speaking? Does his or her speech sound strange?",
"       </li>",
"       <li>",
"        <strong>",
"         T",
"        </strong>",
"        ime &mdash; If you notice any of these stroke signs,",
"        <strong>",
"         even if they go away",
"        </strong>",
"        , call 9-1-1. You need to act FAST. The sooner treatment begins, the better the chances of recovery.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      In the hospital, doctors can do tests to look for problems in the brain, blood vessels, and heart. This can help them choose the right treatment.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25943276\">",
"      <span class=\"h1\">",
"       What is the risk of stroke after TIA?",
"      </span>",
"      &nbsp;&mdash;&nbsp;A person who has had a TIA is at high risk of having a stroke. This risk is highest in the first few days to weeks after the TIA. That is why it is so important to get medical attention right away if you think you (or someone else) might have had a TIA.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25943291\">",
"      <span class=\"h1\">",
"       How is a TIA treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;TIAs are not usually treated directly. Instead, treatments are directed at reducing the risk that a person will go on to have a full-blown stroke.",
"     </p>",
"     <p>",
"      To lower your risk of stroke, you should:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Lower your blood pressure, if it is high",
"       </li>",
"       <li>",
"        Keep your blood sugar as close to normal as possible, if you have diabetes",
"       </li>",
"       <li>",
"        Lower your cholesterol, if it is high",
"       </li>",
"       <li>",
"        Stop smoking, if you smoke",
"       </li>",
"       <li>",
"        Do something active for at least 30 minutes a day on most days of the week",
"       </li>",
"       <li>",
"        Lose weight, if you are overweight",
"       </li>",
"       <li>",
"        Eat a diet rich in fruits, vegetables, and low-fat dairy products, and low in meats, sweets, and refined grains (such as white bread or white rice)",
"       </li>",
"       <li>",
"        Eat less salt (sodium)",
"       </li>",
"       <li>",
"        Limit the amount of alcohol you drink",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        If you are a woman, do not drink more than 1 drink a day",
"       </li>",
"       <li>",
"        If you are a man, do not drink more than 2 drinks a day",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Take your medicines exactly as directed. Medicines that are especially important in preventing strokes include:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Blood pressure medicines",
"       </li>",
"       <li>",
"        Medicines to prevent blood clots, such as daily",
"        <a class=\"drug drug_patient\" href=\"mobipreview.htm?6/12/6342?source=see_link\">",
"         aspirin",
"        </a>",
"        ,",
"        <a class=\"drug drug_patient\" href=\"mobipreview.htm?33/2/33830?source=see_link\">",
"         warfarin",
"        </a>",
"        &nbsp;(brand name: Coumadin&reg;), and",
"        <a class=\"drug drug_patient\" href=\"mobipreview.htm?0/58/933?source=see_link\">",
"         dabigatran",
"        </a>",
"        &nbsp;(brand name: Pradaxa&reg;)",
"       </li>",
"       <li>",
"        Medicines called statins, which lower cholesterol",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Another way to prevent strokes is to have surgery to reopen clogged arteries in the neck. This surgery is appropriate for only a small group of people.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25943342\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?23/55/24435?source=see_link\">",
"       Patient information: Stroke (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?35/37/36435?source=see_link\">",
"       Patient information: Medicines after an ischemic stroke (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?12/14/12512?source=see_link\">",
"       Patient information: Carotid artery disease (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?20/18/20772?source=see_link\">",
"       Patient information: Transient ischemic attack (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?37/37/38484?source=see_link\">",
"       Patient information: Stroke symptoms and diagnosis (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?7/63/8180?source=see_link\">",
"       Patient information: Hemorrhagic stroke treatment (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?18/53/19286?source=see_link\">",
"       Patient information: Ischemic stroke treatment (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?34/22/35170?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16581 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-7CC26F0507-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_22_35170=[""].join("\n");
var outline_f34_22_35170=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25943216\">",
"      What is a transient ischemic attack?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25943231\">",
"      What is the difference between TIA and stroke?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25943246\">",
"      What causes a TIA?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25943261\">",
"      How can you tell if someone is having a TIA?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25943276\">",
"      What is the risk of stroke after TIA?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25943291\">",
"      How is a TIA treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25943342\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16581\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?21/2/21542\">",
"      Signs of stroke",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?12/14/12512?source=related_link\">",
"      Patient information: Carotid artery disease (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?7/63/8180?source=related_link\">",
"      Patient information: Hemorrhagic stroke treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?18/53/19286?source=related_link\">",
"      Patient information: Ischemic stroke treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?35/37/36435?source=related_link\">",
"      Patient information: Medicines after an ischemic stroke (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?23/55/24435?source=related_link\">",
"      Patient information: Stroke (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?37/37/38484?source=related_link\">",
"      Patient information: Stroke symptoms and diagnosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?20/18/20772?source=related_link\">",
"      Patient information: Transient ischemic attack (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_22_35171="Thin blood smear 2A with answer";
var content_f34_22_35171=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F61406%7EID%2F72894&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F61406%7EID%2F72894&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Blood smear of falciparum malaria",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 395px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Giemsa stained thin smear of blood (x1000) shows an erythrocyte with multiple ring trophozoites of Plasmodium falciparum (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Maryann Waldron.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Blood smear of falciparum malaria",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 368px; height: 292px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Giemsa- stained thin smear of blood showing the characteristic banana-shaped gametocyte of Plasmodium falciparum (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Stephen B Calderwood, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_22_35171=[""].join("\n");
var outline_f34_22_35171=null;
var title_f34_22_35172="Fundus of septate uterus";
var content_f34_22_35172=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F65245&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F65245&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Smooth broad fundus of septate uterus viewed through a laparoscope",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Laufer MR. Structural abnormalities of the female reproductive tract. In: Pediatric and adolescent gynecology, 6th ed, Emans SJ, Laufer MR, Goldstein DP (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2012. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_22_35172=[""].join("\n");
var outline_f34_22_35172=null;
var title_f34_22_35173="pupillary reflex pathway";
var content_f34_22_35173=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F57842&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F57842&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 568px\">",
"   <div class=\"ttl\">",
"    Parasympathetic innervation and the pupillary reflex pathway",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 548px; height: 387px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGDAiQDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACo7ieK2hea4kWOJBlnY4AFcb4l+IlhpTtDp1neaxch/KItFHlq/8AdMhIXPsMkd64HVZPGfiHVrpdftWhgaEmx0vTZxI0bHo9wSvH1yAKAO8bWtd8SSMPDMcdlpoJX7fcr80v/XNT29yKmfw/rdohuP8AhLJ1kUZbzo1MeffPAH4V5f4b8Iaxd3wX4gRXuhQRFfInhvI5hKw7NJj5PYYH1r1bUfC2nX+nGHVNWvrmzIyRNcJsOOh+7jigCLT/ABY9nIkGvm3MTHYmo2rB4GPo5H3D9a7BGV0DIQykZBByCK8J1jwbrt/rlmngyKwutGgZWkvNVz85B5Rdv31x324967H7FfaBKkmmudKdzj7FPJ5tlK3oj8GMntnFAHo1FYXh3xHDq0stpPC9nqkH+utZeo91PRh7it2gAooooAKKKKACiiigAooooAKD05rJ8Q69aaHbo1xvlnlO2G3iG6SVvRRXIXEWqa9dmPWHmcAbv7IsJNioD08+X19h+RoA1tY8XA3EtnoYglliO2e7ncJb259CxIyfYVXtdF1XVoluT4vkdh/z4hfLB/A8/jXnt14M8SWXi2W51DTtMg8LTEbm01ne4tVA44OB9WCk16DoPhPRrWF59C1y+iimbzHa3uY9rt6n5cE/WgAF/wCJPDcjNrHl6vpS8tcQLiaFfVlA5H0H412FheW9/aR3NnKssEg3K6nINeG+MfCd7Z38tx4Ee/16+kkLTx+fFGsOep87HB/2eaNIt/Gnh/8AssaMix6tg/2hp+qS4hue48qQKQz47g/hQB71RXn2ifEjzjMviDRLvSTCcSyhxPFH7uVwyj3K49TXewTR3EKTQSJJE4DI6HIYHuDQBJRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVxHjfVJLqeXSLSZ4baGLz9RniPzrH2iU9mb17CuyupltraWeT7kaFz9AM15tZ2kl5p2mpcORPrN215cHoSo+6v0AxQBF4d02Yz20sFvFDeypizttv7uwg7ybe7H35Jr0jTNPh062EUAJJO55G5Z27sT3NZ/hqMSC7vcANPJtXHOEThRW3QA2RFkRkkUOjDBVhkEfSsqPw1okcokTSbFXByCIV4PsMVr0UAIBgYAwKZcQRXELxTxrJE4wysMg1JRQB5/4h0Z0voEjkdLyIF9OvN3zccmFz3GOldR4V1f8AtnSEnkCrcITHMg/hcdal8RQ79MklUDzbciZCexXn+WayPD8P2LxBdFHH2XUY1uokz909xQB1VFFFABRRRQAUUUUAFU9Yv49M0y4vJQSsSk7R/Eewq5XMeMbeXU7jTtMi2+W8vnTgtj5F/wDr0AYGiWl/d363Nyzf2xer5jSsuRZQdgo/vHt+dd7p9lBYW4htk2r1YnlmPcse596zfC8Ykiur3HNxKdvsi/Ko/StugArLu/D2j3kpkutLspZM5LNCpJPvxWpRQBHbwRW0KxW8SRRLwERQoH4Co76zgv7V7e6jEkT9Qf5j0PvViigDzjXdLure8VopT/alshe2mOMXkX8Ub9iwH5im+F9RTR5rO5tcp4e1N/LaAnIsbn0HojHt2Ndh4pgZ9M+0RAedausyHGTwef0zXKw6VDPceINHjBFvewi6g74Y8gj6HFAHodFY/hG+fUPDtjPMcz+Xskz13Lwf5VsUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAYnjaRovCmpui7m8kgD1zx/WqUdqw1LRNjBY4bIjZnvtFaPi62+2eGdSgwTugbgHGcDP9KoWlxG9l4f1FBmNo1iZuuAy4/mKANPwyQdEttpU8N93p941p1laG3lSXlm2d0MpYZ7q3INatABRRRQAUUUUAQahn7Bc46+W2PyNYGlGR28PvMCJfJk3ADAHFaHiq7NloN5Ig3SlCqLnG4kdM9q5f4Z65eeKIIr6+0qbSzaxmFYpJN+4Z4fPuBQB31FFFABRRRQAUUUUAFZF0rf28pyv/Hq20H1zWvXNeM7ubR4E1a0smvZ4UeMQKwBkJHCg/WgDS8NqV0S1BIJCnOOnU1p1xnwo1yTXfCsM1zZNYXIYlrVnDGMEnAyAPeuzoAKKKKACiiigCtqeP7Out23b5TZ3dOnesHTraRNcsLg+VtezC8HngdvatPxJIy6Y8UZ/e3DCFB7k8/pmorNI311wi8WcCwg46E8/yoAqeCIzBBqlvuBSK/lCgDGASDiukrm/ApeWwv7pyCLi9ldSBj5c4H8q6SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKiup47W1muJiRFEjSOQCSABk8DrXlen/GWDUfDepa/Y6BdS6Ta2k10kwvLdmPlgnbKiuzRFsHGQfegD1miuM0P4m+EtW0e81CLW7NI7GGOa9DOR5AccckDcM8ArnJ4HWpz8RvCC6SmpS6/ZQ2TTtbeZMxj2yhdxRgwBVsc4IFAHVsAylWGQeCD3rj/AA5DsTVvDNyxV7ZzJbk94XOVI+h4o8LfEbw94n8TapoWkXMkl3YLG5cqBHMroG3RnOSBuAOQOemRzV/xXpFzcNb6po5RNYssmPd92ZD96JvY9j2NAFUXNwjJe7Cb6yHk30Kjl4/76+vqPxrp7WeK6t457d1kikG5WXoRXM2t1D4jt11TRpPs2r2uYpYZhhlPeKUdceh/EV5+vi7xNoPjzVIp9BFr4fCh/KGWLP8AxOuCcL/tBceuKAPa6K5vR/Gug6nbJKmoQQ7u0zhRn2bO0/ga0H8RaKhw2r6eD1x9pTP86ANSmTSxwxPLK4SNBuZicACseXxToyIWW+SVAu4tCrSLj/eUEfrXH+KfEU8xjWODzrtlEkNieUgUn5Zp8dT/AHU7/rQAnjHV31aaGzhDKsoyiY+ZYzwZGHYt91R15Jrt/DWnf2bpkcbIEkYBmUfw8YC/gOKwvBnhd7NjqOrFpdQlbzWMhBYv/fbHGccADhRx712VABRRRQAUUUUAFFFFABVXUrRb6ylt2O0sPlb+63Y/nVqigDy7T7qbQNdIK26PK/lrbLlTI/Vk9Mn7ynvyK9I0+9gv7VLi2fdG3HTBB7gjsR6VmeJNCTU4zNBtS7C7dx43j0J7H0PY1yOl6hfWF/5U2+3uEKxtcXTKEum/55yAEbZPRxnd+lAHpVFYVv4o014Fed5bds7XWSF8Rt3BbGB+dTx+JdDk3bNZ047Tg/6SnB/OgDWpCQASTgDkmsa68UaNBGWXUILhu0ds3nOfwXJrzHxx471rUIrL/hFtLXU7GW5EUttHIN8qg8gsD+i59yOlAHoE+pRXMp1VgXsbYmO0UDmeU8ZHt2H4mo9ZuJNB8Kzvjfql62xFzkvM/AA+n9KsRKltbprHiHybKO2j/dW5cbLYY7noW7cfQVV0S2ufEGsR6/qUUkFpACun2kq4YA9ZnHYnsOwoA3vD2njStFs7EHJhjCsfVupP55rQoooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAI7lHltpY4pTDI6FVkUAlCRwQDxxXjMvwMW7udTu73WbKO9utPnsFk07SEs1YyjBkmVXIlb6bRnmvZL2WSGznlghM8yRsyRA4LsBkLn3PFfOd3481DVPBCXWo6/Yajqkk1o93oh08xnTnN3Gu0nO4EZIw/JIyOAaAPQNd+EcWsTXskusPE0+l2dhGUtxmKS2k8xJTlsMCQAUI6d+4fafCuQavZ6vf64LnVF1pdZupFs/LjmKwmJY0TedgAIOSWJP6cL4Y1Wa18W2sTRrOs3jrWoyXUu6KsbEBOeDxisS2+NHicprk1vqVvdwpo899As9vGsttLHMi7XROF4Y/IxY9DmgD3fRvCVxpXxB8QeIoNTVrPWkgM9i1t8yyRRiNWWXd93aOV29e/autrxHx/4y8b+CbXRZXntNYfXIZLO28iy8lYb5ypgyC7EjBYYzzt7V7RYpPHZW6XkqzXKxqJZFXaHcDlgO2Tk4oAxNe8MRX96upafcyabrMa7Vu4Rnev8AdkQ8Ov159CKyb/VHtY1t/Hemwi3U/LqdqC0APq38cR9+n+1XZXVxDa27z3MixxIMszHAFYhtp/ED7r1Hg0kfdtm4a495PRf9nv39KAOavfhrpt+/2zS9QePzRuWRfm3D13oVZvqxaoYfAniC1H+i+ITG44345x9cZ/Wtu48O3mgTG88HsiQ53TaTI2IJf+uf/PJvp8p7jvWz4e1601uGUwCSG6gbZcWsy7ZYW9GH8iODQBxR0nUrO3vJbbVtXfXtMAlCS3ryQ3Kdf9WeMEZHTIPepNCkg1nVNYiBCnVreK+tZO+VGCP+AsK67Xomt5rfVYVJkt/llA/jiPUfh1rhb/TJ9K1wQ6W373e2oaST0fPM1vn0I5AoA9E0K+a/09HlG24jJjmXuHHB/wAfxrQrk9P1OFxHrtmD9guwEu4/4oJBxkgeh4P511akMAVIIPII70ALRRRQAUUUUAFFFFABRRRQBDe3MdpaS3ExxHGpY1xeqwuNARbmK2l1HVbpJPKuGACgHPqD8qjtW3qsqaje/ZmdVsLM+ddyE8EjkJ/U1zF9NPrt6l3bLZytd5t9NVmKutuf9bN1B5HTA/GgC7M8t8l5q99JdxQxubfT4rS9ZVmB4DkIcEk+ucAVTn8Ga/M1rJ/bf+ryXimZpQ2ezE8tj8K6DTbSCbUobS1jC6dpAEaKOhlx/Qfqa29T1C00uxlvNQnSC2iGXkc8D/E+1AHDWnw2BEX9parJOI3Mi7I+QT7uWH6Vbg1DTbC7lsfCOnHVdUX5JZg58uI/9NJjnH+6uT7U5YdU8ZgPc/adI8Pk5WFSUubxfVz1jQ+g+Y98V1unWNrptnHa2FvFb20YwscahQPwoA56y8Lz3l7DqPiu7XUbuJt8NtGuy2t29VXqzf7TZ9gK6qiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAGyOscbPIQqKCzE9gK5LSfiX4M1e4nh0/xFYTPBbtdyHftVYl+8+4gDA788d66q7h+0Wk0O7b5iMmcZxkYzXk7/BW2udD0HSr3WZJLfTNIudKdorfY03nbSJAdx27SvT5s0AdfbfEnwfcadcXya/aLaW0kcU0ku6Py2k/1e4MAQGwcHocHmpoviB4Uls7m7i1yze3t1heVwxIAmO2I9Odx4GM1w1n8GJI7MRXOt2byi6srgzQ6YY2kW3cuFcmVsls4yMAf3a6Dxf8M7XxJ8QND8TSX7wJYhBdWYi3Le+W5kh3NkY2uSehzwOKALWoav4I1/xnpmm3l9bXWvaXcu9pD5jhUuFT5hx8jOq5+U5K9cCuzuJlghaRwxAHRRkn2FeYaR8I4tK8ZtrFtqUElmdRk1Nbe4st80UjkllSXzAAuSeqFscZr1OgDGt7Ca/uEvNWGNh3QWoOVj/2m/vN+grZoooAK4L4o2dxBZrq2hM9prkakJcxJuMiAEmNhj5gegz0PSu9rK8RyWosPJud7ySnEMcR/eM/bb7j1oA80+FPj298S6Il1f2l3auzMstneMXLoODJG5VTweqmus1TS3vLR9Lik8u+tCLvTJyemOgz+h9jWRqfgnV55YtXguLWDWYss5j34uEPWNlLbASBjcAOa6q2ni1/SIL2wBhvLdvlSQYaJxw0bfyoA5m1v3tg/iC2t2aynPk61p4XLQSDhpQPbuO45rpNNu4tK8iAyiTSrjBs7ndlVz0Qn09D+FZOoSmwnbxNYQubdx5WrWQXnA48zH95e/qKim8nw7AZVC3fg2++Zgo3fYy38Q/6Zn/x00Ad9RXOWd8+jLHHfz+fpb4Nvf5yFB6LIf5N0PeuiVgygqQQeQR3oAWiiigAooooAKy9YvpI2SysNrX8w+XJ4jXu5+n6mk1XVTBMtnYR/adRccRj7sY/vOew/U9q52MzXd1Ppek3CXNwzlNV1Hfgw5H3Ex/F6Dt3oAS5NvcedpkNxNb6Vpp83Ubl4srcHGTHluvqcA+lTWLskMutSRQG4usW+mxxxkFIT90cgHnqeKdDawXcy6TZiW30TSiBc+ZH8lycZ27j1A6sccmtGxaK7mbWLrbFZW6kWwfgKg6yH69vagDn/EmqS6FpcltatL+5Qswt1/fXUxBby0ODj3bFcf8ACK71PxrdQar4ptb6KBGdrTTrpmZYWU480lsFie2Rgdq35PDc3jjVW1u5WJdHB/0Oyu0crIRx57BWXr2U8YrvNE0hNNQs8gmuWUKzhAiqo6Kqj7qj0oA1KKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiuVi+IfhKbUrzT7fxBYT31pHJJNBDJ5jgRgl8BcliADkDJ46UAdVRXPN4y0FZpoftxM0McEskYgkLKk5xESAuef074roaACiiigAoorO1PUhavHbW6effS/6uIHt/eY9lHrQAuramlgI4kRp7ybiGBOrH1PoB3NRaVpbQ3D31+4n1GQYL/wAMS/3EHYe/epNL037Izz3En2i+l/1kxGOP7qjso9K0aACuP1+I+G9XPiG0jc2c2I9SiTnjoJgPUd/auwpksaTRPHKoeNwVZWGQQe1AGFqRFlMurWgEtjOo+1ooyGQjiQfTv6isaxKeGNVXT5NsvhnVWP2VydywSN1iOf4G7du1T+GnOh6vP4YvTutWUy6c7nO+M/ei9yv8ql/s23cXnhnUFaSxuIzLaknlVzyoPYqeRQBUks38FiXyYXu/CsmTJbY3tZZ6lQfvR+q9u3Fa1pazW9vHdeGbmG40+RQ62sjZjIPeNxkr9OR9Kh8Iahch7nQtYIbUbEACTtcQn7sn17H3qrcaTfeF7iS98NRNcabIxe50kHoTyXhJ6H1Toe2DQBsp4gtYyqalHPp0h/5+Uwn4OMr+tXV1TT2UMt9alTyCJl5/WotE1iw1yy+0afMJEB2uhG1427q6nlT7Glm0TSppPMm0yxkk/vNboT+eKAIrnxBpcD+WLtJpunlW+ZX/AO+VyagMuq6oCsETaXanrNLhp2H+ynIX6kn6VqH7Jp1q8h8i1t0G5m4RVHqewrnJJr7xPN5VobjT9HjfEkzIA94uOkfOVT/axz2oArov2sS6T4YaSG3YkXerpIrsH7qpOSz+/QVa1XdbQweH9BT/AEicYnmWQBoIz1lbuWPY45NaGoXNh4X0NVt4ooIkxFbwIMBnP3VAA7mseGG50iwUskMniXVXAkkjXAB9f91BQAlzZTzW8Og+HZYobSy2i6lnDSb++zggknqTmsfU4/EHiXVZdBhu9LGm2e1r10tJArt1WH/WcjucYroNbuf+EZ0G3sNLHm6pdv5NsG5Lyt9529hyTWr4Z0ePQ9Iis0bzJOXmlPWWQ8sx+poArRW3iNEVReaOqqMBVs5AAPQfvKd5PiT/AJ/tIP8A26Sf/HK3KKLAYgi8SZ5vNII/69ZP/jlXtOXUlL/2lNZyf3fs8TJj65Y1dooA8i+MV0kXjTwnD4nurmz8DSJcG8limkhia5CjylmdCCF6lckAn6VxGheONc0LTNBtLrXjpfh3UdW1WKy1TVIfNlGnxRhrd/3hBJ3ZALZyNvUcV9KVm6hoWnahrGlareW/mX+ltK1nLvYeUZE2PwDg5U45Bx2oA8D0jxf4pv8AxJ4Hv/EOstpcOqaNc7rR4GSG8kWbC4QsBvkj2MDjKg8cGn6F491O28O+D7e41my8J6RcaE16NQay86Oa5EpX7OoY4GFAbA+Y5wK+i6KAPPPiJruuWmq+DNL0HUILKTWrmSCa5ktfN2hYS+VQkYOR3P1z0ry69+KfjJfDPh8yXtjZPO99BcavJAiRSTQSlI0O/wCSPcBuI6nGFxX0pRQB4z4M8UeNfGGta1a22q6VZiw0yxnCpZmVZZ7i2dsq5YbU8xQ3KsSOOOp56z+KvjLU/Auu+ILOySJNOFnp0ga2LGK64+1zbepVNwAHQdTkDn6HooA8++C/iTU/Emg6hNq+oWGpNBeNFDdWbKweLarAPs+TeMkHbx04Br0GiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAr6hbtdWFzbpK0LzRNGJF6oSCNw9x1rxLw1oHjLSvhjdeCm8HwRXFrp19Bb6vBfwhZZXikEbxrw6uzMAS23HJJ7V7fe3MVnZz3VwxWGCNpHIGcKBk/oK8v0n4wLeokt1oMthBc6TPrNnJcXsSiWCMgLvPSMtkdTgZ5NAHKah4E8Zsb6a2sphczWOhQ+Yt3GGZ7d83AJ39hnP97tmpv8AhD/GTfGSDXRpT21nHrDs91bXcYilsShALBpDIzdMrgKP4QetbVh8b4LjT9Skfw/d/bbK8s7T7PFOpE32osI2R3C8fKeoA6c4q5afFyS5uItKTwzdjxNJqkumDTWuo9oMUYleQzD5doQg9M5496AOG1Hw3qvgP4F2HiC8lu7Xxjpdzb3c63N/JcLOyzuiwYDsu1klPCYycZ5GR7P8M9EuvD3gbSNP1OaWfUhD5t5LI+5mnc7359AzED2ArzZ/ixe6oYdSsRLYaXJ4b1TUWtykckqTW0pjDBiMH7pIB4ORmtY/F+G0tw76VeXdhYW+ntquoGSNDA92qGMiMff++pbGMZ4zQB6XqtzdQxpHp9uZrmU4Vm4jj/2mPp7Dk0mk6atirvJIZ7yY7pp26sfQegHYV58/xZ2eIfsR8O3h01dfHh2TUBcR7VuTjbiPO4g7hk8Y9zxXqNABRRRQAUUUUAYfi3Rm1fTlNqwi1G1cT2kv9yQdvoeh+tZKawur2Wi6kqiOeG7EFzH3ifoy/nXZV5/4y0u507Wba/0pd0OoXMUd3Apwd4PyygeuODQBqePITZrZa/bcXWnSANzjfCxAZT+ea6tGDIGXoRkVy3jt1vF07RIypmvrhSyntEh3Mf5V0V7d2+n2rT3UqQwoMZYgD2FAGHrvhuGa7bVtNu20nVVHzXUYGyRR2lQ8OPryOxFcz/wsLVraC4VvDk+q+QBjUdLO+zfPfJ+YY77Q+K3obO98TulzrEctlpK7lXTH2k3Azw8vt/sfnWydU0fT9lo19p9qUAVYTMibR2AXNAGFpOnxeKIYdT1XUYNTtWUFLK3Ia0RwevI3Mw/2unoK68AKAFwAOMCuV1Pw+yXT6x4UmitdRb5pYgf9HvPZwOjejjke9aPhvX4dZSWJ4ntNSt8C5s5SN8R/qp7MODQBThddW8Z3CmdXg0pFX7OY+krjO/J7gdMVK0ir4tup7llWC1sgQzH7mTkn8qaZRpvjIrPMFh1OICFNgA8xOvzY6keprD8Rafdat4wk0hFkSwu4Y5rybOMxoceUvux6+1AF/wAJwvrmqzeJ7xCsbqYNOjbI2Q55fHqx/SuwpsUaQxJHEoWNAFVR0AHQU6gAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAzpdXtheC2h33EwkEcghG/ySRkF/QU06soRm+xX3yz+RjyTk/wC1/u+9PsnlbUL4PNaPGGXYkI/eJx/Hz19K0KRbstLGZPqyxLdN9ivn8iQRkLCSXz3X1HvSz6qsLXYNnev9mVWJSEnzM9k9T61pUUxXXYzpNUVHlX7JeMY4RNkQkhv9kere1CaorSRJ9kvB5kBnyYThcfwn0b2rRxRSsF49jOg1RZTaAWl6n2hWYb4SPLx2f0PpTYdWWVLVhZXyfaJDGA0JBjx3b0HvWnRTC67GYNWUxq/2K+G6fyMGE5H+0f8AZ96JNXVEnf7FfN5MwhwsJJfP8S+q+9adFKw7x7GbPqqxC8zZ3r/ZtudkJPmZ/ueuO9LLqgje5X7Het5EQlJWEkPn+FfVvatGimK67GeNTUyBfsl5zB5+fKOP93/e9qSHVFle2UWd6vnxmUFoSAmP4W9G9q0aKVgvHsZcepx3Udsr2N4EutyFZIOEA67x2BryLwd8J9M0y+kudZFzqVpd20ukLYpZSwxRRu4ZmIaaQqMrxtKqM5AB5r3GigLrseb2vgbwfYw3Rh8Pam2+9tjIZJ7iV5JLckwyZaQkqu498HuDgVV8beANJ1qO8/slG07URqH9oXFy9rcTM8pj2FoyksZXI252Nt45FepUlAXj2PNPD3w68M6F4cj0u8s73UGsdNuLCW5ZZFM0Fw7PMiqhxyWPT5h2NXYfB3gzUp7PUBoVwXtIIRHvWdFdIeIhJGSBIV7bwxrv6KYXXY4t/C/hszrH/Yt23n6kPEJcNKFF4uMSH5uD8o+T7vtXRw6osptALS9X7SGILQkeXj+/6e1aNFILx7GZDq6yJbN9ivl8+UxANCQUx/E3ovvQNWXyw/2K+5n8jHknP+9/u+9aeKMUBePYzJdXWNLlvsV83kSiLCw5L5/iX1X3pZ9VWH7ZmzvX+zBSdkJPmZ/ueuO9aVFAJx7GdLqixvcKbS8PkwiYkRcMD/Cp7t7VhW+rR3+of2jdW91Fp9tA00DvHhD/AHmYno3YCtPU5H1O7bTLZysK4N1KvYf3AfU9/auc8Q3trqsktl58cHhnTMf2hKM4lcdIFx1HTP5UWYXjbRDNI1NTqE/ifWba6RLiIrZAR7xDAOecZ+dzzgZpPtjajqdnqOrWt1ceb82naSbcBoCP+WsmTkE+p4FOIutX1O3maCJrmL57C1+YR2kZGBLKOMv6Ljj9a0fCMkthqt5pes7X1dz5wuwpAu4+xGehXoVHSjUd49h0bz6lHFLrUN+Y5ZzCLOGJkRP9pz1Zffp7VeSXT7W3mEOiypHFMIdkdoBuP94DuvvW/VTVEEmnXKG3NyGQjyQ20ye2e1GoXi3sUp9AtC5lsN2n3J5821wmT/tL91vxFc5r9rci5gmvXjstZhBWz1eJMRP/ANM5R2B9Dx6HNdlpyCOwt0EBtwqAeUW3FOOme+KzvFupxabpLB4Fu57g+RBannznPRcenc+1Ml6MxrbUH8U6bPp827SvEdkVZ0IBMbjo6H+JG9R64q5Dctremx6hZJImqWMjRvG6bCWHDoRnoeo/CuYudA1PSbGwmv74Pdwcw6giY+yMT/qmA+9CenPIq7batPNeyarbwSrq1mqw6npitnenaWPPUdwR1HBoEdzp93He2qTwnhuoPVT3B9xVisAyR2cg1aybzNPuQGuFVshf+mg/rWut7asqsLmAqwyD5g5FAFiiqxv7Net1APrIKadSsR1vbYf9tV/xoAt0VVGo2R6Xlsf+2q/41NDPDNnyZY5MddjA4oAkorifGvi6/wBO8UaL4Y8O2Nrda1qcctwHvJWjggijHLMVBYkk4AA9z742gfF2yurOGDVNMvY9eN/eaW9hYobndc2yhpAh4yCpBBOOvPTNAHp9FeYWnxf07UvEGi2Gkabf3VlqmnyXsd6ImxEUk8sq6Y6KwIZs/KR3zmrGl/FPT5tH0R2t73VdU1CxOoG30mydykAbaZCrHKrngDJJPQGgD0eiuJ+IHj1PCFz4bj/si+1FdZujbj7OjFogE3Z27TuY9l4zhjniki+JWj3Da4tnZ6zcjR5Jobp4rF/L8yKRY2RZDhC2Wzjd90FjgDNAHb0V53YfF7wzqGjrfWY1CeZ786bHYxQb7iSfbv2qFJUjbzu3bcd6f4e+JcetfECTwwugava7bRbn7RcwMhUndlXXHyj5cBtxBbgetAHoNFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFBoqC+u7extZLm8lSGCMZeRzgKPU0AlfRFaxjkTUL5ntrSJWZdskRy8nHV+Ov51oVxul+LPDf9rXhivdKied0CypcqzXBxjkdj2rsqiE4yV4u5rVhKD95NeoUUUVZkFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAYXjjxRYeC/C17r+sLO1jabPMECBn+d1QYBI7sO9U7XxzpQ0J9W11Lnw3arP9nA1tFtWdsAgqCeQcn/AL5b0qD4ueE5/HPw91Xw7aXMVrNeeVtmlUsq7JkkOQOeiY/GuOsPhfq9jZ6BPYt4Z0/UtF1Ga7ggtbOb7HIksIjJdGkLeYCMhg2OBx3oA6fwp8StJ8RWFhfxqtnY3Vrc3hmuruBPKjglaN2Zd+7b8pbeAVA6kHitqz8aeF72G/ms/EWkXENggkupIryNlgU/xMQcAe9eZaV8G9Rs9ChsZdWtHlTQtU0hnWJgC93M8iuBnou7BHWq3jb4RTtpMlzaOkjQeH7LTBb2lqHaaeC4WXeULKGUgAEZzgd8AEA9Ui8ceFZtIn1WHxHo8mmwELLcpeRlI2PRWIPBPoeakPjHwyLS0um8Q6OttdoXt5GvYwsqggEqSeQCQDjoTivGtK+HPiXxfbazq2t/8SPVJdcg1SzjYSRK/lQeVhhFL5kYOTghwwxnAziur8M/Cj+zdc8P316NLe305b0yWsaTSqzzshDBpndiQVJJJ6ngCgD1iisbQ/DOlaFdXdxplvJFNdnMxe4kkDHJPAZiB1PTFXtT1Gz0u0a51G6htbdeskrhR+ZobtuOMXJ2irst5rJ1e/cTLp+nkNqEoznqIU7u39B3NcZffFBLy9Fh4P0m51q5clUlz5UGR1+ZuuPwrlNXsPGQdbXUdajtNR1BzILbTztfaOryy/woo9PpWPtk9IK56KyydOzxMlTXnv8A+Aq7+9I7XxRr9noqx+H7PUbe0vJV33N5PIF8hD1ck9XbsK4aPxpoiGKLSl1CaCxJjtrWKIyo7k/6+XA+Zj2BJHerWg+D9AJg1X7M2pxyfurcXe5nvJ+8mGOBH1+or1jw9o8OkWpVUj+0ScytGgUZ7AAdFHQClatLsvxKcsvpaJSqP1UV93vP8UcJpfifxDHbumieBdTkL/NJc6hOsDu5/iII5H0NQeI4viDf20N1Npmh2s1ixuY54pmZ1wOQAeuRxivWKRlDKVYAgjBHrT9lJ7yf4f5E/XqUX7lCPz5n+crfhY800+H4ha1pdtcRa/otvb3KB/NitWMiA+gPGasT+DvGU8LxSfECbY42nbpsanH1DAj8K2vhyzLoU1sxP+i3c0Iz2AbI/nXVUewXVv72L+06q+GMF/25D9UzzyHwf4yhiSOPx/NsQbV3aZGxx9S2T+NYlpp3jfVtfnu7bWdJuDpTtaQzXFsyq5wNzBVyA3bNetXD+VBJIP4FLfkK5z4cRGPwnayNgyTvJM5Hcs5p+xj3f3v/ADF/adVu8owf/bkP0SMJpviRFFJBLp/h6/UAgyGR08wf7tchqeo+IdJaG9uPCOoWd1b8Ws9vMtwuD96KTH/LM9s8jtXudRXVvFdW8kE6B4pBtZT3FL2Ukvdk/wAGP69Sk/3lCL9OZfk7fhY8e8N/EjQ7DVRbSB9N066XfPa3MTg287HnaeQUPpgYrsNHn0KKcLZPpt7pMzny5Yij+Q5P3SRngnofwrL17Q50udkSQT6lEhEBuVDJqFv/ABQSZH3gOh+lcppXg/wtqUqolrf29rdM6reRz7GtZs828q9AQfuk5zS/fR7P8P8AMq+X1dLSpv5SX/tr/M9mfRtLcEPptkwPrAp/pUR8PaKTk6Rp2f8Ar2T/AArzprLxv4V1NbLSNWg1Syfm1h1Qne+BynmADDDsMita3+JH9n3CW3jPRrvQpW4E7fvYGPs60e3S0mrf13E8sqT/AN3kqi8nr/4C7P7kzsV0HSFOV0qwB9Rbp/hVu2s7a1LG2t4YS3Xy0C5/KmadqFpqVqtzp9zFcwN92SJgwP5VarZWeqPOlFxdpKzOZ8XeDLHxLe6bfvd3+m6rpxf7Nf2EipKiuMOvzKyspwOCp9sVxuo/CQRaj4SHh3UrrTrXTLi+ub29E4N7NLcRbTIGZGVnLfeJAwOnavWKKYjgbP4V6Jp8mgvpd1qdk2kW0tonlTKftEcj75BLuU53NliV2nJNQ2/wn0qxtNKTSNX13TLrT7A6at5aXEazTW+8vsfMZXhiSCFBGeDXolFAHNeMPB9p4ottLjuL3ULK40y5W7trq0kUSo4UryXVgchjnIrLvPhlot34Y17QpbjUPsusalJqsziRA8czyLJ8ny42hlGAwb3zXc0UAeb2nwg0W1tpBFqetLfnUP7Tj1ASxLPDP5YjOzbGE2lRgqVI56dK19I8BWumeJ7XX01nWp9QjtPsc5uJkdbxNzsDL8mcguSNhUDAGMDFdjRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRketc94paSKB3WcRgrjk4xXk661CuoyD7ZHMST8qAnGOvPSgD3nNQ3lvFd2stvOoeKVSjKecg14Fe+PtLjBW2try5l/2FChfzNb/AIX+KuhWMkUGqxXliZcL50kRMYPoW/r0oavoCdtUVvAfgKW0+IF4b2Mmy01t8TEcSE/d/IV7bkCud8QzQGxF8bmIWuzer7sKR67q87PiTSrzzvKv7WQRHa4E69foetYYfDww8XGHVnZjcdVxs1OrukkezZHrRmvAp7+OOcTW8yhdwbaXUlv8K67SvEljpkDXk04gLtmXcwwx6AcVucZ6fRUNlcLd2kVxHwsihhU1ABRRRQAUUUUAFFFFABRRRQAUUUUAcF8cpdWs/hpqupeH7u4ttQ03ZfKYXK70jYGRWx1UpuyPavFD468V63rltZW2o6hBaeNNTgn0l42KPaWUdxMkoH90mOOJiB/ePvX03rN9p2nafJPrV1aWticRySXcipGd3AUluOc4x3zWPpWu+ENRjsJ9L1LQ7hEma0s3hmiOJduTHGQfvbedo6jnpQB5dYfFnxFc+O76ya10iHTLXUbmwktrm4hgmRYw2yXLT+YxYgEgQ425wTjNclqfxb8W6n4Z1Dbqum2GoWk1lPO1vahoYopJwmFuI7iRHXlclgpI3YHce+6n4i8H2Cf2zqOqaHEFka1F5JNFnzF4aMNnO4c5XqOc1k6b4u8IPL4nsymnWel6X9me5u5PKW1uFniEiMrA4YEEDJ68YzQBwPiv4sa/pGo63Ba33hq4bSotMkggSFzJq5uVHmLAfNOBzuXAbAIyT1qDRfF3ijRfEeqzR3Vnd6JdePG0WSC6WR54xKIwDG+7aqrwQu3qTXo+kWvhBtYl17w9daPeaprkSC0zdIUk+zIV/cgAkbQ2G2g44ziuWtrrRpNUsdU8Y+M9BgS5l+0WVnpl+Iradw23zi2QZDkY3ccjGamUmmklc6KNGM4ylOail979F+rsjjJvi9rOu2viOyiurOXT7vQNUurWeCIW1xbPDG204WeRgOuN6xtxkAV6NpnhvSNQ8O+HfEHiL7Tqdy2mWixW00hdGk8peQvdmPJJrvbjT9Is4bi5ns7KNNrmWRoV+YMPmycc57+tZP2i2s7M69rCpb28CbbSADHlp0AC/wB9uAB+FEoKatJEUa9Sg3KlJpvTQglaHwvp32yW3ifVLjENtaQKFAJ+7EgHQDqT+Nc3YWD3Yur7Vrp5EkZXvL21kBFywPy2sWOding4xk1PZR3mva7PdXbCC4RMTF0JWzt2H+qU9DKw+8ewrqtHsIJRBP8AZ0tdMteLO22hQP8ApoR6+n51S0M229yzodhKZG1DUE23Ug2xxdrePso9/U1tVnPrmkxuUk1SxVwcFWuEBz+dX45EkUNGysp6FTkGgQ6qGrapb6ZHEZxK8krbIookLvI3oB/kVfrntalVfENizNxb280+3HtjOe1AHO/D7xBGtrdfa7G+tYrrUZhHPKimPcTjBKsdp474HvXodefWFuf+Fe6crSZkuLhZQW6ktITj8q9BoAxvEGqpaI1nFbXF3eTRMVhgAyBjG5ixAA+prlvA/i2ytfDWl2mpwXVndsjCKJot/nkMc7Nmcn2rqCceLdrIu17PhieT83SuS0G3W2gtYsIZNO1eSHO3BVXJOBj60Ad1pd1c3kbyXFk9mhP7tZWBcj1YDIX6Zq7RRQBT1PT4dRtxFOvKsHjcEgow6EEc155r+ltLNf3f2AT3wULqenx8LexD7s0fPEi9j17V6Fdarp1o226v7SBj2kmVT+pqtqFtFqKR3enzRfbYOYZlYEEd1JH8JoA5zQNRttW0+LStSuo51uF32NwisrOi9M56Sr3Gc8VuWbi58zR9dhinlVflMqBkuU/vYPGfUVyOr2pijutS08TwW7v/AMTC3gP72ymH/LeMf+hDoRzW7p14viGzNtJI0Op2uHguRjEwxxKmOqnuPwoBNp3Rman8OltLptQ8F6hLod8eWiQ7reX2ZO34flWH4l8Z+MtIttG0e5sdNstd1bU006C/fMluEKlmlCAgluMBSRyfwr0jS9WSe3nW92293a8XCMeF/wBoH+6eoNYXiKDQPFulx2fiq2s/7HurhI7L7XMYpJ5+dpiOQwbG7G07iM9qzjSUXeOnl0O2rjqtenyVrSfRv4l8+vzv5GRf+Ldd8JvYaJqcUHibxBd/aJ4ms1Fkn2eJFZmcMzAPlsADIPHSm6P8VR4g1KztPDfh3UNRNxp0Opl/PhiEUchZcPvYcgrj5c0zxV8ONJtvD0Fvonh2G/W1lknWKS+ninJkULIROH3ncqgFSSCAB2rpfB+gadaGDVotC/sfUmsYrFofMyEhjyUQKrFQASecA+tVza2Od0WqaqXVtt1f7t/nsefeCvinqms2PgW+8QW39nDWDftJ9lVGhnSCFn3YJZ0A2njOSR6GtqP4q3P/AAjEPiC48LXkWmX/AJS6Y32qJnunlkCRqyj/AFZO7dnJAAPfg7OjeCPBOja1YWmm20EWpad519a2hvZHaBJgYndYmc4jblcY2g5wAc0+D4XeDobW6tY9HH2W5Ty2ga5maONd4fESl8RfMA3yBeQPSqMjmNW+M8Wl6XJLd6DcxX9vqUmmXcck4FvbSIgfc04BG1lYbfl5OemM0aj8ZUtbW9uYfD893b6fY2uo3kkF7C6xwzZ+4QcSEY7cHnkd+qf4aeFG0yOwGnTxwJLJPuivriOV3kADs8iuHcsFUHcTnA9KxR8HPDcniW6v7yBJtLa2tba30td8cMQgJI3hXxKCSDtdSMjvmgCm3xQNjPqQSzvdXd/EUeiWkCmKHDPB5i4Y4+Xjq3PNQXfxoFvoAvDoDrqMV5d2Nzp73qeZHJb437NqsZByOQMDuRxnuZPA3h2S8N02nZnOpprBbz5P+PtU2LJjdjhTjb932qhffC/whfPI9xpLeZJc3F27x3c8bNJPjzssrg7WwMp932oAyfA3jm58VeO3igZk0WfQLTVIIJEUOjyu4OWHXgAYzjivSq5/w/4O0Lw9dR3Oj2P2eaOyj09W86R8QRklEwzEcEnnqe5roKACiiigAooooAKKKKACiiigAooooAKzde1zTtBsXu9Wu4raFBnLnk/QdTXKfE34m6P4GtGSctdam6nyrWHBYHsW/uivkvW/F+p+IdSk1HWpCbmRjjJyqDsFHYD6UAfRniL48aXZl49F024vXCZDzMIkz9OSa81vfj34zadjFFpUUYbIRYSePQktXmsSXFxFLsfdxkfNzisycP5RZgeuMnpmgD6W0D4nW3xA09tMurY2OswpvEYbctwMc7P54NcH4hgu5Pm2vGUlchT8oCgenSvLIL250+eGeMPFPEQ6sCVIxXrqa/ZatDHcwR7Z5Ew6MR83HIx/WgDA0eyMmPMILg5JGP8AH+dbV5Zo1lNG3zKEOYyvTjtUUNu/2wTW4JjI2soX5lPpirkFw0rS4Q4RWR0I74oATX7S4vtN8JaTcXl0bSLTfOaNWKhjv4yM9qy9S0RYl2RhY14+TArqdTnt3udCmVlZRpK9DxgOc0mpCO7aGSMqqyAbST1/CgDz2KG5VN9vLJgFgqsOAB1wfStKO+sNRubKK7mlgtLbE15NJ0GOmBWtpVxHp6SpcW7XHlrIgIIAUk8c9q4HxTfyJpUVjHGI455TLIQc+Zg8CgD2Zf2h9C0iKOy0zRtSvbeIbfOmlSMt+HNeg/D74ueG/GXlW8c4sdUkJAsp2+Y4/unoa+KrpNsrsR8oP0qOJ2U7o2KMOQV4I+h7UAfo7RXyL8OPjZqvhe0is9Wjl1izHyoHk2yRL7Mc7vofzr6O8BePtC8bWhl0i4K3CDMlrN8ssf1Hce4oA6yiiigAooooAKKKKACo55o4InlnkWOJBlnY4AHqTUlclq3iCfUbubSPC6w3V0BtuLpmzFa59f7zf7P51M5qK1NKVKVR2Xz8jlvinq2geLtGh8OWerQyXU99bOBFE06nZKrkHaMHIXFVtW+FOpN4gvtZ0PU9Ps7s63Bq9rHLbM8QCQGJkcKVPOS2Qf55Gv4c+GkeieL49TW6M9rHGWCuMN5p6njjHevSKyoSqyTdVWd/wOjGww0JRWGk5K2t+543pPwr1zRpNM1S01jS5tbsL3ULnFzaubaRbogt8ofcjDHUE9cGqOo/DFtb1DWkTxLpiaw91pmoRw2m6MRSWtt5JDJHIrojEkjawK8YORXd+MvEV5Lf/wDCN+GIxNrE6/vpmGY7SM/xN7+gp/hzQYfAlkwjD3UEx33VyVHmhu7HA5X27VanzStHYcsKqVH2lZ2lL4V1t3fZdur9DkbL4Wa1plx4f1HRtR0ix1TTbu9ndWhubmGQXSIrsTJMZGf93uzuAJPT1xLT4Ia3ZadoVtYeILSwubK1W1nv7VZ1mdBO0hXaJBHIpDYw69c9RgD3qGVJolkidXjcZVlOQRWNqckmqXZ0y0YrAv8Ax9zKSNq/3AR3P6CtDiI2ZdYunuJzs0izYsN+Aszr1Y/7I/nXG3V/ceL9eh+yxhrSNs2gPBhXvdOD+SDHvU/jfUxfXcXhbSSqwDEcwUNiRsZWHK8gd2PYcd6uaDpwuIntbZo0s1x/aV9ENgunUY8tPRAOMjsMetAEgtL69S10vw8IV0W3z599dFpGncHoqjG/nkkkD61PqsGg6c2dfup9Vuhg+VLmUL9Il+VR7kfjVS68RTarNNpXhaOWG3tY8m4SPAcD+GMngD/a/Kooba3SS2hjt3unvI8TW0L74Ub++7HknPrSbsG+hZh160kWdbTwjcfZYRl3kjgiUqB1UFvmFR6W/h7VWifSWu9Av5fmiCjyPN+i8xyD6ZpEaRoonJ/tDULGYxNDbtsijB7Png8VXvLaLUYr/TLuOPUrqAfaLeNlMUMHoA645HtUp9wutTqLHVbuyvI9P8QCISyHEF5ENsc5/ukH7r+2cHtWV4juWZfEd3FIQLe1FouOfmbr14zzUHhm8h1CKTw9rt5b6gxiWSNxIMkZxtDA5JU9GHNT+OLaz0fwYbWCAm3kuIo2VnLFizjksSST9TVJ31G1Z2Lktvsg8M6eMDaUdhx/Anp9T2rqawZtjeMLSIEgxWjMBxjk4repiMTVsQa/pE4VPnLwsTjOCMj9a527t2XVfFNsgBYrDfRjnqBz/Kui8Vq32W0ljUs8V1Gw5xjnBqhK6QfEmFP3u+605sj+D5X/AJ0AaF3r8EOm2s8KPdXF0oMFvF96Q45+gHcnpWTqUKpCLrxhqxiif7ljbO0cf+78vzyn9ParN9baP4TtLzU4IoobhwQvmzEgknhVDH5Rk9FxXEW9ubme8uNRkXWPElpKJDIMwwwoeQqnuo7461MnYaXc3tP1rQTarNp3hiRbAkgXEltFChI4/jIbP1FEF/4UvppWm0+40a5VtjXDQNa4btiZPlP/AH1WfNHDd6n5Ds2ptdxeZDGBiyhdffuc96LO6jupbe5u5Dqc6MbS4CALax/7wPBxUuTWvQfKbN/puu6Xcwajo9wmsQDCzwT4WaWL2dflcjtkZPrXJa39l0COPXtFdRpPmM0MjhidOnP3kZBz5bHgr/CTnFWI9YuPCcl2LC4N80coZtNHyxbD0WFuzew4Pt1qzaWsPicTeKLNI7qNsx3Oin7pAGDvH/PYDoen86pNMnUt6ZLdeNIY9cEQtbixbZ/Zjnl2HJE3t3UfQ1S+L3h+bxtovhi90nS5dTfTdXiubizS5FvIYQrCVAWZVDZ29SDwcHnmpZXz+FNQtLiwnnutEuAfKxGHeRR1hbofMT+HJ5AxXoEhW2ZdZ01d1rOokuYgCCy4++B/eHcd6oDzFvA3iFPD3j+8TTpbjXrzUZxpVtdak5hazfyTgIsoQH5XxuwcgAkKa5/SPAHjS20C9s5NOvm0ka3BenSJNQhje7tfKIkjBjcovz4JQkKcde5+ireaO4hSaFw8bgMrDoRUlAHhvhbwfJpnxa0bWR4al0+yk0t7cW7auksljMJ5WBceZl1MZUBU3KpOO2a9yFc74y8LWviWyVXZre+gO+1u4+HhfsQfT1FZngvxLdvfSeHvE8Yg123XKuB8l2g/5aIf5is3O0rSOtYZVKPtKTu18S6pd13Xft6ana0UUVocgUUUUAFFFFABRRRQAUUUUAFFFFABRRUV3cRWltLcXMixQxKXd2OAoHU0AOmljhiaSV1jjUZZmOAB6k14P8VfjWlvFJp3g+VWk5SS+xwh9E9T79K4X4v/ABRuPFN7JY2DvFocbfKg+VpiP4m9vQV5FPLub7xU5zxQBav9RmvLqWW5mkmmkbc8jsWZj7mqjLlCdxxn5TUYUsp6tIx4wK19P0ua7dI0VQHGQMhiffFAG14asElmRoctGQq7eBuPfHr9a6K28Po0i2zWhltJJN5ljGXXHYZPH41s+HNMsNK02GO6xNufoB87cfw55X+VderW8luq2cbQMCDsKg9e2RwaAPIPE2htPrLRabGuXKqgA/WtyXQYLVf7PV5lvVgV4WZAsZI6+4NdHqNo2iwyS2dsPtGSVMY4x1Oe9c/pc8t3Ld6lei4kAURKxTCAnnknvQAxJZxah4pkjmBHmqV3biO9aVq1zqRFvYW4E8hOSj9ePQDJ/KspmL3w+yxOCwPDcBgOp969X+BptbnWbqaA7Zo4sOijjk/SgDg9T8Pa7py2JubKdYLa3MKq0eCUzuyPU1npr1pBbhUDz3Kf6uMc/N7+lfUniOyS+0e5idFZghZCR90juK+ftXu9JhvJ5NRVYxDD+6VIuTJnrz/OgDi9SBYW6XLD7TdODLsAOPasLxpprm+EsUcxg2+WVIOYyK05ZFv9U+0CX5lO9VP9TXQrBNMsF0oZ0k5kXBPH0oA8k1JPLkELREzBRlwTzn2qK1tTM5QY35OB34rtNb0aFZZEt4QS8mVZRgAHtWNPYm2mmCBl+Q9elJgc9IXllJkJZj/EeTV/QtZvdH1KK90u5nt7mM/u5ImKke30rO2vgqHyByRngH1pqplZHDJhRyGOCc+g70XA+4/hb4/07xro8flTqNVgjUXVueCreo9QfUV3Ffnr4a17UPDus22p6VK8N1A2QwOAw7qfUH0r7L+FvxN0nx3ZiOJhbatGgM1o5592Q9xTA7+iiigAqOeaK3heWeRI4kGWdzgAe5qnrer2mi2DXd85WMEKqqMs7HoqjuTXO2+l3/iiZLzxEjW2mK++HSiBlsdGmPc/7PSs5Ts+WOrN6dHmj7SbtH8/Jd/y7iSXOoeL38rTJJtP0HJD3q4EtyOmIwfur/tEfSun0rTrXSrGK0sIVigjGAqjr7n1NWkVY1CIoVVGAAMACnUQp2fNLViqVuZckVaK6f593/SCuX8feJv+Ef01I7VPO1W8bybSEEZLn+L6CukuJkt7eSaVgscal2J7ADmvOvAdvN4q1+48X6kreQpMGmRMThEB5cc9TSqTatCO7OrA0YWliKyvCHTu3tH57vyTOh8CeGf7AsHnvW+0a1d/vLy5Y7i7egP90eldORkEEZBpao6zqCaZYSXDKXfhY0HV3PRRVxioqyOSvXnXqOpUer/r7uxzWuT3Ph+dbfQYxMlwS8tsBn7Mn8Uqj0H93v2pdd1m30DwzCmjOLi8vMrbkfMXYjLSH6dfrgVuaRatp1nLdajKHu5B5txKeAuBnaPQAV4jc/aNX8Vza3Z2AnspJQttaLJ3BzvCj/vthxniqMjrPCulvDFMsk1xbCWPzb+WVgDbIeSmenmP1J6gcVoaneW2qW1tabZrfw6SIY7e2BEs57F8cpH+pqjdSDU4I9O0e98rS7b99d3zruF1PnJjx3IPUfhS292sAaTT0jsdGvyVuL+YlZVl6cKelJ36EuS2ZZuLi5t44leTyJbFiG0+xk3ySxdBmmXaCCM6e0f2SGfE9na2jskzt1IkbtzTLa6ubKKaa0tmthbMFurq4UPLdQ/31I5pY3kW3/4kx+zWLDz7fU5pA7SFjkxgEZ5qdloJyX9f1p39bomvSY4hNqWYbe8VbeXT7ZdzLIehdxzVTV761sILSDVJSl9ZuPK0mxly06HgAg8t9Kp2+uQi4eHT7ee3S83fao1Rnu2fpuVADtB9TgV2XhDRJ7aebU9TRftssaxRqfmeONegZu7HqcUJf1/X9XNLq9/6/r9CDw34Ss5ra6vNW0yBJ7s5jhKANbJ/CoI+63ckHrWX4mkuEsDodzMZ5Le8tnimfktGW4DepGMZ713OpalFp1sJLgMSx2xxoNzyN2Cjua4vWLKZ9W0Y6iALzUtQSVolP+riiUkLnv7+9WhHS6oyWHiiwvpyFgnjNqXPRWJyuT2z0roagvbWC9tpLe7iSaBxhkcZBrIXQr23XyrHXb2G2PGyRElZB6KzDI/HdQA3xPMLi507S4GzczTLKwH8Ma8lj7dqzfEl2th420+4ILFbCcqvYkc4rodJ0e20zzHiMk1zL/rbidt8kn1Pp7DArnvHEKnXPDryZEU00lo5B7OmB+ooAmh8M22pWMs+txx3l/dxndK65EQI4WMH7oHtXG314+jzxQa88wmjxaC0ii2x3kZ4Vw/rjqM59q7vR797GSPSdXbZcoNsEp4S5UdMH+9jqOtXNf06DWdKurC5JWKZNu5eGQ9iD2INTJXQJ6nASwlIjpVzKguLYieysbIFW2DkByB09abe3AcLb3yuy6imItItVUbZRyd8g/qRWewv9DgWw1BzpIsuY9SRTMt6ndWbB2E+hNRwSWs+mzTW3l6Fo12SfPfd5/neq57H1FZK62/r/hvyLvpZ/wBf8P8AmiSG1k+1wal4ieaTU7bNuuk2GGREPAB98dWq/Cl1o+uSR6cbaDVDD51pZQx7VliHWOU45Po2cioUnK2MlwUbTYrdTHdmRd015Hj7685/E0ltNtsbWGzuH0nTHIazvHIe4uG6mMg9M0ap/wBf15P5Cv8A1/X3r5mrdPp+s6feXIieKFyo1OyyPMs5RyJlx3B7jqKb4B1aXSdYuNC1B3lWRvNW4eTKEtypX/Zcc9TzkcVzz38ulofEljYR6fZo7LdQ3CHz7vnDDHcHqOlWPE9jDeWFtc6f++hCfa9PPILRdXh47qfmXvwa2TuSejsw8P3eTn+yrh+w4t5Cf0U/oa3xzXMeCtYTxP4YQ3ogefb5dzErbh7E+mRzzVnRZpLC/k0a6kLhV8y0djy8f90+6/ypgbxrk/H3hh9bs47zS3+z67ZfPZ3Abbg/3Se6n0rrKKmcVNcrNqFeeHqKpT3X9Wfk+pzXgTxMniPSS8qGHULZvJu4GIykg4J+h7V0tea+NYJfCPia38V2Ab7FcMtvqUIJwQeBJ16ivR4ZFliSSM7kdQyn1BqKcn8Mt0dOOowXLXor3J7eTW8fl08mh9FFFanAFFFFABRRRQAUUUUAFFFc3418ZaT4Qsln1WVy7/6uCIbnf6D/ABoA6N2VFLMQFAySegFfOfx1+J1vqkJ0Lw7dpNYn/j7uIm+8QfuD29a574t/EC+8QXjx6brDLokigLFCWjz6rIOpI/KvIbhCR8rL9BQA+5cuxKkDArPJDFwnLDr7VbWFy6KgBkY9M8UscTzTRQQKCzHBBA5P160AN0+xupwspjdoAcbs4AP1Feq+GrZdPtgl1axSsMMnGGb296foOlppulIkybTuDB4xksfoTzWnNBbyXMc115kEpydyDlhn0AA/LNAFnU0t3kt5pbRkUDlVAGwn+HpxWvpcYeMFJI1Ur8qHLH6H0/lSWbMIHmZlEe3jeclh+H+FZWqeIreztmkgOFLDcq8fhQBL4hvzZWsjzFVycdsH6e9ee393c3kzJBlIMgsiSZVvcik1TXP7VvpZ76UpDnCxgHj/AGj/AJzWXJJ5pZ7eKW1hDDE5Y5HH07/WgCxc39xLp8KeY7wQSFIl/hUnkjP9K674P+KR4c8V2j3jOtrcZglPGBk8E+wNcTDptrLbgGY7mJIZs5JqpJbTWtvJtYN5bDchHT0P0PSgD7p1K+ig0u5uVkjISJnU7hg4Ga+QPGN/9o1pZkUSxTDhGyclv93mpLNUNik+qXF2lsyMYI8OE4HLA9D9BXBz6tcNdxkSyJOrbhIh5X0xQBsJfSiQKo2ugEZwuOn9a7/QNSivbERicCfp5eefxFeYw292YJZJVjnWY7iWf94D69e9NsL+4sLpWgLJKrcZGAT7igD1a4iikglV4wMjovtVSbS0u7Ezwp5iodrl2BK/j1rO0bXodSKidhHP0kUnr/8AWrfgP2SUxW7IIHAyx/l6UAefeIvD2IzNaQkADnIGCe+K5O82QSIkrIzMM8LjFe33cMU9pHt4G4pwvyE9hkev0rh/HfhM7o3srcyztyyx5Zge4I/rSYHn8wQkFCNuMgL2q5oeqT6RqkF9ZyOl1bsGjdWIwfw7e1VIAYmYrkOjbSvpSTKI5MBlYeqnimgPsH4LfFZPGUZ07Wjbwa1GMqEJC3C+oB6H2zXeeIvEcWlutnaxSXurTLmG1hBJ/wB5j/Cvua+HdJll0mWHUJZnt5EIkgET7ZSex9hX0Z8BPiFo+qySabfQJaa/MdxuHfe17/wI85Hp+VY87m7Q+/8AyOr2MaKUq272XX1fZfi/I9N0Tw3Ib8av4iljvdX/AOWe1SIrYf3YwT+bdTXT0UVpGKirIwqVJVHeQUUUGqIOA+Kt5cXcWn+GdPOLnV5dkjZI2Qj7xrtNKsYNM062srVQsECCNQPQVwXhFf8AhIPiRr2tyLvt7ECxtcj7pH3iOf6V6RWNL325/wBWR6eP/cQp4VdFd/4pa/grL7wrBs0/tfWDfPzZ2pKWy9mf+KT+gqfxNefZrBYkljikuHEQd2wFB+8fwFW9Lls2tUj0+eCWKIBf3ThgPyrY8w434tapJHpcOjWciLdagcNucKBGOoyfU4H51h6In9geG59TtLNft0x+y2MMeTukPDuMnOM/oKg12Q6z4xv5hHbzCFhaw7ny6EHG5Vz/AHieea0/FC20WoRWt1O8Wi6fbC3dYQTI0jjqCOnHU0A3Y5h9Dm0S8uYdOcapqaYvDYSZ8tj3cHPDg59M1t2F5a6jdwXcLS6lNqUflSwpzDauP7w7EHt1pQXtbVbeQNYm1wYra3YST30PbJ61gavo/wDZ8ouLBjptlfbWisEyrXD90c8kP6N+dS9rt/1/X4EXd/6/q7/NG1JOUuFkZo9Z1jT32vBCTHDEh9c8U2+NpBcXEWpTR38yqLu1SUhbeA+gPc57D8qhj1O1ubAahdj7FYAGC+0xBm4LDjMmMYrW8A2KX99NfzWVsNPtgIdPO3fgdSwJ/LNJO7v/AF/XQLdO39f8E2vh9BePbXmr6jGIrnUXVwmwqVRRgZB6Z61sanq4tZksrSI3WpyjMcKjhR/fc/wr79+1RXWoSz3R0/SAJLvGZJWHyW49W9T6LWlo2kwaXCwRnluJDumuJOXlb1J/p0FWlYog0fR2t5zfalKt3qjrtaXbhYx/dQdh+p71luDffEiMEfu9Osi3/A5Dj+Qq/r3inTNFnjtbiSSa/kUtFZ20ZlmkA7hR29zgVwOl+P4bLxtqx1PTtSiS7EPlKqJK0YwR8yoxI/WgZ63RVbT7621C2W4spkmhboynofQjsfY1ZoAK5n4iws/hmW5iOJbORLpT/utz+ma6YkYya81+InxE0ez0bV7KyS51O5SFkkFmgZYyRjliQPyzQB3V1aWmt6UqXUQkgmRXHOCuRkEHsR6isZbq68PskGrSPPp5IWK/OMr6LL/8V0Pesnw5460+1s9I07XIbrS7uW1jaM3KqUcbR/GhIH44ru3WO4gKuElikHIOCrA0AZ15ALuxntyAEmjZcnnOR1rynR7XGuyaTcRSy6wsHzJc4EMez7joO+eOa9Ae2ufDc7vE8txojnJjY7ntPcdyntyR9Kj8V6XBr2gSmGCG5lCebbSZ5DdQVbtSltoBxVtI9xJa6hEV1bV7eT7NdXbHbHbr67T0pzwpNc3dpZyS6nqtqTdW91c4EMI/2T0OKz5LqHUbdZ715FhuCIJ9Isx8yS9MykDPX1q7d/aAlva30ey+sctFpViTskj7b/Xj0rLRWt5f1+gnpr/X9dfvLli8c+tfabZn1Ce9h2S3hfNtBIPQEfyqt4by0l3oX9oNeXiubu3uTEUWO4U5MY9QRSz2kJWLTr4DyLj9/Y6ZaKVKuOSHI96Zq0t5BbWmp3KPDf2sgP8AZ1mAwVwfvMR0496cU+n9f8OtfkNabsXwhfLoHjHZGLeLTtSG8lyVKEnG0fR8jHoa9Q16wa9tlktiFvbdvNgc9mHY+x6V5l41ttsq3tokY2sl5ErqCm2T5WBHs2016doV+L3RLW6mlhZjGPMdD8m4cNgnHGc1qBNpN8uoWMc6jax+V07ow6irlc7ZXdrF4ikSyubeaC7XcyxSK2yUew9RXRUAUdb02DV9KurC7QNDPGUYHtnvXIfCi/uEsb3w9qLbr3R5TDu/vx/wn8q7015v4jX/AIR/4o6PqyDZbaohs7jHALjlSef6VhV92SmvR+h6mB/f0qmFfVc0f8Uf81dfcekUUCitzywooooAKKKKACiiqesTSwaXdy243TJGzIB64oA858ceNNT8N+NILW3iSaC7Cqqvnjg5xj3rw34seJbzxJr5nlQKbeMQtFkjnqSBU3iDVby8vfPuZriS5gmEmXfpz8wHpXM+LIEtNbuvLfzYpD5qNnJwwz1oA5a6nAQYY56Zx3qNXkSFWyjK5znuPxp87+ap2KA2OQT2qnHCZpN0KHg4VW5+vNAFp2EgCBlfHGdvWvQvhvoTXVpPqN63kwxkLCNuN3qwrzmFWUHavJyuGUHn/GvovwuZLHw1p6Tud6wYGOSuR6EgfhxQBg6xexzXa2mmPKxOMMISAPx/qBWulhGGEd7ue6xv+RvlVfftXI2B1P8Ath3nlcKrEqTEQCPUdfyrp/Fsy6Vokr4EskoALRqflz2YjpQBha3rp0+VreznG3GfMVgSfYY6CuM1i7knl3s2S2CM5x+VWbW3eU+UUXzbthEpK7tgJ7en1FL4rhxq1yqAiK2YRKowcbRgn60AZBjikIIDbl6oSTz61NNLL5ZUSK6kAlVyFB9x61UkniS6MMEILKuRKCWMnuQePwxUckwZ0X5gw5+9/nFAE8hmf94oVEB5CnhT/SmXaiW0ZpARMh3ZzkOR2Ip0uzdtLbQOR3yf6VDdyySKxYoQwx8i4z+AoA7bXNft734WaFab4xfpczK6oMeXGR6dvwrz+ztkiQSyKWLZI+nv6U7UVIsI3HnM2dknmYypxxj1GKb5ieWqsOCBn1P07UATTqSFZXXanVQe3tUU0heX5wMZyHznH+NJBLGgYlfMUjAwcGnxGE4GzIIOcryPxBoAtxS75mmtlZHjALEdPr9K7HRNSguljiuSu9BnB5A/rXGW0NvIh81mBwcbSCafZLK0YnJdXQ7FfgZHpQB61LbSfZ4YSwljOSpDHO30GOlR3wvJ4ylpbTLatGElnZSOR2LcdemP51neDNbS4uIbe4aT7R0QnnPt7V0Xi7UJY9NWFWjkRiQDu+ZPoD0+oGaUpKK5mVGDnJRjq2eJa5psyzslojsrNzEoyc+9QIYtKiIlWOe+YZCEBli/Hufauy1NQdMlisikMwT5/JRs/izck/mK84a3njBkaNlVcHfg9T05rn1rLtH8X/wDrvDDfDaU/vS/zf4LzFuZXndp5phJMx+ZeSR/T8Kl0zVrzSruK7064ktrmM5SWM4Zfoe1V2Vc/K5kJ9Fx/Oo8KV75HUEYrdWSstjjbcndu7Po34S/HS+nvrbSPFiC5jkIjjvox84PbeO/1FfSEMqTIHjYMp7ivzqsJVhuC8hKKT95Rk/h716zo3xf1XTGsLuGVhDabIJbVm3C4j/vHPRvpVCPr+qWtXaWOkXl1IyqsULPljgcDvVfwxrdr4i0O11Sxz5Fwu4Buo9qzfibPHb+BNZaZtqmAqOM5J6CoqPli2b4Wn7WvCm+rS+9md8HLUweB7WdgPMu5HuW+XGNzZx713FYngmJ4fCWkRyqUdbZAVIwRxWxO/lQySHoilvyopR5YJGmPq+2xVSp3k/zOda1t9f8Qu93DHPZ6adkaOAymY/ebHsOKn1vRLYWst5psMdpqMKF45YVCFiBna2PvA9MGp/CsXl6LC7HMkxaZznOSxz/AIVe1TP9mXe373kvj/vk1ZyHlXgKGaS80uW9toYbidhK7L87s3LEMewHbgVbtmQ3t7qNhAhF9cSR3d/NNhbcqcDap61F8Pt8d7YM1r5YkwpnMmfN/dnoD0x04qzZiC5YZikv98r200G7/R7chjhmXuelKTtv/X9biewxPNjieaAo+oaecSapdx53Qnk7PX8Kjtbe2kSZLGZEt71fPh1S4fLGT0jH/wBer0rmSZmITUNa0wYIUGKBUP1ODgVi+IVg1Fo9EljuNUn1IiS2KKPJtQCN2Mdh60uWwbv+v68yrZaJD4l1xdZ0e2jneyUx3U15DlL6UcbeeMD+8M4Nd5b6u2sD+ztIX7NdxALdB0/49PbHQt6D8at3rmyjtdG0aONbpkCgIAFt4xwXI/kO5qZfDsdnBFJpkhiv4uTM3PnnuJPXP6dqaVtBmnpen2+mWogtlOCdzMxyzserMe5qv4m1aLRNDur+d1RYl4LHjceB+pqXS9SS9MkMiNBeQ8SwP1HuPVT2Iqh41gM2gynYkixMsjK4yCoPP+P4UwOJsFliV5rYLBfI/nTahPCGku0PLbO5AHHFYM8UGn+MI7vR5msdN1yB4f7QmY7hcA7gADyPStqISsA1tJFqepae+5by4UxwRxN6djgVmeMNNk1K3ulsmm1G5bF/a3Tr/o8EichV9c8isruN/wCv6/yBdEbOnXsulala6lZW8iWDOLbU5bolHlc8LKEPfPfuK9SFeQQ6gmqaTperWwfVL+/2W0rHcsURzyNmMZGD+VevIMKB3Aq4P3UFrM4/4hXoMFtpBv8A+z0vsiW5BwyJ6KexJ4rzPxhMmnaNBZ28A0+O5mSxuriaLE0sY53qB2wOor0jxjZNPr1qphjcXFs8UUkwDRxSKdwJU9a87sLm41fxodXXyNQi0eP7DcXkxMUKu332UHH3RxUy1f8AX9eg12NqK2EGltbWUqWWnYBttSnw8s6nqiqfyrp/h7dGBpdOjiuU04r5tobgbXA6Ou08gA8j2rmLpLgWV9DawSaxqFm/2mC5vDtijTqNh74HarXge8tNb8aQajpt5Pd/6Kz3bElUic8bAp6VMN/6sU9tT1UjIweRXJ3trN4buHvLFXk0iQ5ntlGTbk9ZEA/h9V/EV1lBAIwRkGtiDiPFujwatpsepackRvYysqXECjzHTuA2MnjtXLadcJLAz6RL9ma0JDXVyRJc3cf8SqOqkHjFdvLC/hu982HP9izt86D/AJdnP8Q/2D39K5rxjZ2+keKLDXLSxtPMnHlPdTHbHGc5LNjgkjgE1MloNXM+2iSGzMemSf2Vpd8S8d/cSMbrzSeVVTyM+1Toy29rLe+S1hbKTDqElyv7+4QDAYenrTvLjudRvIrOKS+kkX7TBfXS5t4mHZPpUtvcx319Y6hBGmoyOpgubyQ7YLcjr8h71l71rf1/XUb/AK/yK0q/afBdk1tmRY0ntd0meVHzLkn6da0/AunnV4Z4dTt4hptpIBBbRsDFKWUNvYDr16H8qosJG8HYuLt7svez/vyu3eu1ucDjGK1/hM6Gyvo4wQqeSD82cnyxzWyJ+Vja1/w/aG2jvNPs7aHULI+bBJHEFPHVeOxHGK29Ou0vrGC6i+5KgYe3tVisPwxiFtRs1JKW9y20egbnFMDcrg/jPbl/Bxu1xvsriO4GVz91v0rvK574hQyXHgnWookLu1s2FAyTWdZc0GvI7ctqezxdKX95fmbGm3K3mn21yjIwljV8ocjkdqs1z3w+uIrnwXo8kDbkNuoBwR04roaqEuaKZhiKfsqsodm19wUUUVRiFFFFABSMAQQeQaWigD5h+LekJpHjG6McAjhn+deeCD6Vz2paDc6j4Thv4EeVrPMToV6x9VI7nFfRnxM8Kt4j0qM2iBr2BsoC2Aw7jniuX8E28eh6FqQ14eXIsuEtSjbwe23HJz7CgD5OuYSJSUI9x3qBQNxCsU+gPP619W+IvB1l4meGa98PpbwONrXMcixzL77VHP4815t4n+DjW0ZutC1A3luMlkdcMuO3+RQB5LYeVFPHvDEEg7SM457V7dpTl4Nnmyx5QKqOMhR6jPevKxpVzpt3umhklCDIRD1I/wA+ldn4T1fUdQTyI7K4JQ/LFhmD/h60AdQlk9hNHcTmGSONsb8kbh6HPQfSuJ8Wao2r664EpWBOCsZO04/n+NdDqzapqAlihUpFHGWl2gIFHT+Igk+wriHuYdKBiXyixOWl2kv9B2oA35orvRNV0Ge7jDG4InZN247SeAcd+9c9rdx9onnlkVhI8jsWGB1PcUalqz6pb72dcKFGCcsQOBxTL1lmulMMCRIyKVVMlSccnmgDOVoo1hDB3DHt6+1RSIRuMIYup6dsVaFuVfKK7PnJBGPrihoSQhKBRnhvU/nxQBBBG7bzJgk4Py9qdeTvYqz27FWJATJ5J9xVyztUSY73IUdg2QT7VT1Odr90WOJVii6Hnc3uaAKOZE0tZ0by38xl3DuT1qPyjJHGRICT/Ex616bN4Ogf4TSarIdl0lwo2bwdqn1GOtedWMcflNEH2snOSeDQBQCshwUwxPDAVet4wwPmfKw6KM5NRyAxzuygFeygfyqSCWNon80FX/vKQcGgCdQnmgKm/bxtPDE/h1ratNTS00i9tpoWdbkKvy43pIvRvbjiuftw4LOrs4I/hP8Anmtj7UbO2El4hYlSVg6k57n2+tROoob79jajQlVemiW7ey/r8ehNB5MMsF5HlFjByZOg9Pqa7/T7yzutO+33s0s0oXCtJyB7AY4H615bNffarZSflOCFjUcfhW34R12JLCTTr+PcpOUcNg/hxWcabm+ep8l2/wCCayrxpxcKGz3fV/5L+mT3WsGfWXisLe3eB2US5JJ2/Wua8d2RjukeCBYIc4AjJ2ZPpkk11FpaeZcy3NuFzzgZ7Vyni7e0sZlYPk4bbztNbM5DCh8qVXM0pWYgbQBncf6VHLJJG+UcKQMHHB/HFOCbiAwyyg/KDzjtVZ3JwD24zUgOBLOWJLMepJ61Idw6cBjim2sM1zMsMEckkjdkUn8au3iLFOIUAHkrtbg/O3eqQH2H8A9RsW8E2VjFeRzXigvIi5JX6+lbXxj/AOSfan9F/wDQhXn37LugT2mjXOqzMfKn+SNCoGOeSK9U+IQJ8Ea1t5P2ZqiqrwkvI7MulyYulLtJfma2jf8AIIsf+uCf+gipr5DJZXCAZLRsP0rH8BzC48HaPIJPMzbJlt27PHrW9VQd4pmOIi4VZRfRv8zJ8KSLJ4dsGVWUeXjDdRgkf0rVdQylWGQRgiuS0nU7bQtZutDvphEjOZ7WV8hCrH7hY8Bgeg711hkQJvLKE9c8VRieMaF/xKNVu4/ssvmWFwDJJuym1XxgDHB2tmtvVEhs/Ed5pt00jWGpHz7e3gjOZWPU7x0AOKy9RP27x5qslhbtdQ+Ut1abZNqXMiDbMgPOQVNbsaQyaXaW19NdRWBw1hqUTYe1Y/8ALKQ9sdMng9DSYepXvXkSymuLtGFzbI0cmm2Lh8rj5TKa1vDcWneHvC1peWtmFvryNQFLF5JXPRdxycfoKytY0vxJbXUECpbXOkXSmO6bTrbE8gxxks2BnoTnFdbomkyCaK8v4kieGMRW1qpytsmMde7HuaEhW1uy1oOmvZRST3ZWTUbk77iUDqeyj2HQVq0UUxmZrGlC9MdxbSfZ9Qh5hnA6f7LD+JT3FM03UVvTLYahEIb5FxLCeVdTxuX1U/p3rWqhq2mRahGhJMVzEd0M6fejPt7eo70AcTrWlaloTwvbWl3q2kwZEdtbOAyqTyroeHA7Ec+1Z0t1Ncxyoltql8YnEtnZ2lnJAkR/uSOwUfWvQdM1GQzix1NViv1GRj7swH8Sf1HUVq0aPcVtLI8o+GmkX1j4qvrfXgts6L9sstOjYNFCJD85z/EwPHtXq9ef/EnVoPD2t+HdURGluzMbYwxsAzxPwc54ABxyeK6/SdVi1GKZvLlt5YG2TRTYDRnrzgkEe4NJK2g27md49t7SbwxeS3pZPs6+fFIv3lkX7pH44H415voGl3+iaTGPEem6leLd5kmitIRLAzvyXYqdwxxkEfTNb/jHxNbalqGh6TLbzxabe3QdrtyoR1Q+gO4AtgZIAr0oD0pOKY7s8pRb3WPJt0sLy7mtW/cBUe2s1XsJGbBbHoAa7Tw74WttKc3jkHU5W3zzQjy1fj7u0cbR2Bro6KailsDbYUUUUxDJoknieKZFeNxtZWGQR6GuYt4Y7SeTQNVijn0+cEWhlAZXTvER6jt7V1VUtX06HVLJ7ebcufmSReGjYdGB9RQB5zHZ2Vnr97o9qk85sAtxYWJlbYpxyMnPy56DtTdZ1G2tbV59UBuYrsBP7NtRviim7ZYY6ntVjxBp/iIaxaT2NvIb8Mkc0qYEF1GO7MMtGR3GOau/2auj3cfnrBc3buZLXSrGPbGH/wCejk8nH944A9M1FmUmkZHiJBo/hrT9NXiaC2eWVATgNJ8qqR9WPHtXRfCa0MHhlpniEbTzMRg5yq4UfyNcj4ihvLyXUliRtRnsQZrvyyQJrojEUC+gQHNdloeprafD2GazZPtFpAqSRtyY5AQGVh65JqydzsaxNBmMuqa1lCqpcBAT3wtS6xr1lo2mi6v5lDFMpGvLyHHRVHJpvhW1kt9LEtwQbi6c3EmOxbkD8BigDYqh4g/5AWo/9e8n/oJq/XNfEmb7P4F1qTzfKP2dgG3beT71FR2i2b4WHtK8ILq0vxKnwj/5J3ov/XH+prsKw/BAx4Q0gYx/oycfhW5SpK0EvIvHT9piak+8n+YUUUVocoUUUUAFFFFABXJ+M7WSG8sNWggEzW7bHTjkHv8AhXWUyaJJonjkUMjjDA9xQByBvZZYWjkjxk5OcD8KhukuZLeSOEw7XOSrpzj2Oabd6XdaFJuTdc2O7IlY/NEPRvUD1q7dSxi3TzX+Z13L5Z3A/iKAPIvFeiTQSyXM0G9AOSqdB+H9a48a1b2kStBEVZMjevXHv619B3bu9oREkG0LjDKST+FeS+M/D8FrG19C0c1sx2yRlWzGfX6D0oA4bU/F7Q3AubJzHdrysgABB9cc1xt9eyX1w01xI0k0hJYtyTV3xPpkunzRyKG8mT5lDAgY/HmqWmsjOytjPY0AEFsyxeYsigt/DnBx/Wr8SskMqTyHYEygZTkn8On8qSOKOTCnbuzkNuPA9hUtsrNL8smQBjGdufbNADrERPblGn8udnBXeMIV+vX/AD2qK+jto2eF73zHUZ3Rc5PYCrzRJs2tCiknrjO38ax7rTZEZ5hKjDP3BySP6CgBuni3jnMl7HLMm3aVWTYQT3+lXrG3bUdYEFsJFt/Nzlznao9+9Z1tmR/LCM38WOeK9Q8BaXbJA81yFWcYwikfKO31zUTdlbqB1F/qKt4dksmtdtpgK4HQj1I9a8J1S2/s/UZYSodlPC8gMp6HP+FfRuqRBNAeM26vHsAxuG8n2Gc5rxnXbJbsCR+JogeTySP/AK1cuGnHVxd0m0ypKxyYuRGxaWAbyuM8g0zeiyECF5CxGFA61pQrdCRraLdtZMZOMAfX0pr3C226CAOJFAVpSOT6gdwK3lUalyR1ZtToXj7So7R/Fvsu/wCS7jC1pYOxUZnx/qwSVQ+/qaS1YzoGZnklkcl94ATA7Z6015fMUxI2F3bio4DfU9TR5qYdYk288fMSAPQVUKfLrLV9xVq3OuSKtFdP8+7M67ujH5kcYUQBs7QvAPbBPNNgkeSfcqgSIQRgUl3alWDjkZ5xzUFuxjlDKhLKc+taGB297qGpRraXRhiYXSld0ZjUrjj7i9PxArkdTkuZG2SCRpA3zAKfm/Cti0v47hAZ1ZgMD5Rz7CrN5dx3sg8m2hjfGzZGpXn1NAHN2Gi3V9MsS+XCp/jk4A/Lmuim8APaaZDeXmo2hMp/1ETlpAPfg4PtXW6Fol3b2fnFAHkHKsvY1pXFpcMqo6IkoP8ACPl/LoKVgMLw1qOleH7W9s7rS7nzDCTHPFdBSBjuCPmBPbj6VH8MPh3cePNWEoV7bSI5N0868E8/dXjrW7beF5Ne1ux02yCveyOHLyJkQKP4z/hX074e0mHRdJgsoNp8sfM4ULvbuxA9aYD9D0m00PSrfTtOj8u1gXagzk/Unuanv4Bc2FxAc4kjZOOvIxViihq+g07O6OD+DNxu8IfYnP72wuJLcqVKsAG4z74rvK830g/8I58VdQsnUpZ61GLiAhfl81fvDjgV6QKxoP3eXtoejmsU8Q60dqiUl89/ud0YMdvDN4k1KC6jWaOaCNjHIgKkDjvUw8MaIAFGl2mwfw+WNv5dKNXzaahZ6h/yzXMMxx0Vuh+gNbA56Vseacv4z05o7Cz1HTYVFzpMnnxxoMBo+joMe38qp2clpp91HLEtsPDesjedzcLO/bBOMN6DHNdoQCMHpXEW9pDpuqXPhu+AbTdQ3T2DOuRG3Vo+e4PzAUAadqr+HdRisy7PpFydtvvOTbv/AHM/3T2z06Vf165njS1trR/KmupRGJMZ2DqSPese036ppt54e1S6STWLRQxkVSu4ZykgH4DOKkkvDfaNBeuv+m6bMDPH3Vl4b8xzQBoDRGjG+21PUknH8ck5lUn3Rsr+QFPtdSmhuls9WjWKZuIp0/1U3sP7rex/DNakTrLGkkZ3IwDA+oNRXtpDe2zwXKb42/MH1B7GgCeisnSLqWO5l029cvcQrujkPWWPsfqOhrWoAoazY219Zst2fLEf7xZgcNER/ED2xXnbeJ9b1KFohcmwsR8tvexRjzdSOcfu94Kxj1JBJ6iuo8Y79UvtP8PRlljuyZbtlOD5C9V/4EeKytcuLrXlm0/SJ10vSbOVYPtyQiWVph0WFT8oA7k5+lAHlPxk8Cy2FnZm98XXwuNWlEc0t1H9pkiCjdtiKgNtz2HB61638MNKmi8J/wCk3NzcfaIViSe4UrJIirtDspOQTnpS6P8ADuG31I6hrerXutXZ48y6wOPTA4A9hgeoq5r89/d38P8AYbN5Olv5twsfSY4/1Q7dOaAPBfEvhaL/AIWXZC/1u+t7i4ZdPktZ7UvCoOcNG7HaR0IHUHmvWtO8PeIPDN0mn6V4lvbw7C9smqMJo5gvWNjgMh9GBx7V1WsaJpPjLSkeYNh14kXhh/ssDwcHsehrl4fC2teHr+3ms/Es2pzRq/2Wx1GEGMjHKrJneGx0JJHtQB2nhzXI9YhlSSI22o2x2XVq5y0Tf1U9j3rYrz6/1BJf7L8YafGYnjcWuowk4Plk4Ib1Kt0r0BSCAQcg85oAWqep38On2/mShndjtjijGXkb0UdzU93PHa20k8xxGi7jWbo9pNJK2o6gd1zL/qo8cQJ2Ue/qaAIEstT1RfM1K6ksITytraPhgP8Abk65/wB3H1NMeOTRNQsxHd3U9pdSeS0dxIZSjEcFWPP4ZroaxtQK3eu2VsFDC3BuJDx8vZfxoAm13UXsYIo7ZPNvbh/KgQ9C3qfYdTWHqjHw9YCK0YXfiLUm8qOR/vO/dj6Io5x0FWba6t7q/vNduZQun2SNFC5Py4H33/oKyLK7YLP4r1BB9quh9n0u1kO0qh+6OejOeT7UAOsdEhF/p+hpC81pYH7bd3IlH7y5PQMOpJOTzjtWl450DS7/AEO/lubGF5igzIFw55HUjk1peGdL/s2wZpkUX1y3n3TKSd0h68nsOgqxrw3aRcj1X+tAGUNG0vStCnuLSwhSY22C4TLkbem481taSpXS7QMMN5S5H4VmawxnisdMjJ33G0yY7RryT/StxQFACjAHAFAC1wHxlmLeG7XTozmXULuKEKFJYrnLY+grvzXm92P+Ek+LNvCqF7LQ4i8jFePOboOeuKxrv3eXvoellS5a/tntTTl9233uyPQ7WIQW0MIJIjQICe+BipaKK2Wh5zd3dhRRRQIKKKKACiiigAooooARgGBDAEEYIPeucudGbTZXn0i2SaF+ZLMvtH1TPyg+1dJRQBwl14lsLUKmrWd7o6SPtje6j2xlh23A4/OqeoS6ZPazF5bS4RlyrB1cN9e35132o2Fpqdo9rqFvFcW7/ejkUMDXn2ofBnwxcLJ9jN9YlyD+4nOB7YbPFAHjXiC1ivo5oI0+RScor7gjf7IA4H0Fec6hYf2dMsjF0DNtwR3/AKV9L3vwTsxifT9ZvlulHHnBWU+g4AIrz7xF4MvTFdW93GA0ZxIVI3N36d/rQB5WmDMJFKupGMg5waEdoGL5xjse9WNR0OWzWQ2obyh1LdfoT6/SsmJmJxK2GHY0AdLDqUTxpHcqdyjC7ucD2HpRIsEm1owAH6A9TXNbgbmJTIwUkDk5rrrG1a2dfNj3K2CMmgDZ8O6Rb28b3F1AwPChF+bJ9D6V3NlpltBCt/N5nmsMRIfl3e5AHT61yWnTv5AiJMa79ykjcD7HvXe6dpMOp/6UJJtwIzEhLD8CQP8A61cdSbUrSWn9aFFLUpJU0FDIxZhccMB1461zNyILuPy9PtvMvpJC+1Ey445xgcqfT9K91fw7FJoSRvExAXOw8tXlmt+G0069a4spZVnBzGGJTB9TtBz9K5Y05U07pptu1tdH09fyNac4Rleavbp/XQ8q8Rac1lBA7K0FuXxJEw8sM2enr0rntUjhmvpJLWIJDJ9xGOdntnv9a9Tm1rXLaEwPqEx+Yhnnbco7YAfOPriuL1nRZ4UNxFJFM0kmMLIHYuexXrXoUIqELf1/w5FWrKrLml/l8l5HNqgQYYq30bOaUjawAIUemQce1M1C1vLFzFewT28hzhZIjH+hFQ28oRtx7fjWxmWNgYY4IHUjvWRdQSrKQEZdw3DnGR65rXa6jALSYDEcADiorSxDyb3jwT8wGM0AO06JxCsZVE44CZPmH1bmvW/APh+2sEim1CLfcSDO3cMKe3FcvoHhHxDq6w3tlpF5c2g4XyQFK47gng/SvVvDGnzxmMXVpfRSKQBHJbyGQH8Bj9aAOsXSo2iRTAFLLnjnFcfqWnXOoamdM0K1Nxen77liqQj1civWbPR5ZrYC4LwsQRuUjdj6cgVr6bp9tp1usNpGEUdT1LH1J7mgDlPhz4Eh8KRS3V1N9r1i4GJ5+QoH91R6Cu2oooAKDRRQBw/xV0ia60iDV9NX/iZ6TILmIgZLKPvL+VdJ4a1eDXtDtNStWDRzoG47HuPzrSdQ6lWAKkYIPevNNDkbwL4yfQ7lz/YeqOZrGRiMRSk/MhPbPasJfu583R/0j1KP+14Z0ft07tecftL5br5npU8STwvFKoZHBVgfSsrTZ3sbgaZeOzH/AJd5m6SL/dz/AHhWwKgvLWO7gMUufVWHBU9iD61ueWT1k+JtHTWtLe33mG4QiW3nXhopB91hTLLUZLS7TT9WYCZ+IJ8YWcens/t37Vs0AcJb3VxrFol8vmweIdGcpd20X/LYAcrg4yrDlTV+SdXih8Q6dBI1vcxhb22K4Yp/eK/3l5B9qk8UaZd297Hr+hIG1GBdk8GcC6h7r/vDqD+FUtP1C2tZV1rSyJNE1BybwvIFFpIOCxB6c8MPWgDX0S5W0kSz3h7OUb7OYHIZTzs+o/lW9XJ6lax6ajEx+doM53uI/vWrHkSJj+Hvx061ft7u/sI089DqViRlLq3AMgXtuT+L6r+VAEviEeQbS/UhWglAY46o3BFbFc/eaompQfZ7BJipYebNLE0aRKDk5LAZPsKlk8QQSlo9Jgn1OZR/ywGI/wAZDhfyJPtQBlyyJD4w1y5MuJYdOXarNwo5Ofzqr4YSP+xfCxicPDIzyswPDOcnPPfOawfFFlqsXjTTNV1fStOvLG7T7ELcz/JE55UuSnPPGcVN4N0aTQ1vvDV6Utbtpjfae8RIiIznYvTlTwR6c0Aeh67PLbaNezW4JmSFmT64rH8OT3NjottCNFuR+7D5jljYOzDJJJYHOT3Faen6lDeIbe7CRXijbLbuefcgHqp9agj8OadCoWA3UMQO5Y47qRUU+wDYH06UAUfDs0y+JdUt3thao6JcGLzA5DHgnjgZrS18LnT2yBKLpNnHPfNPtbTTNDimlVo7cOd8s00pLMfUsxzWPfapD82uXjMmmWin7MhHzTueMgdTnoPXrQBl3FtBt8cWbOpt2AmIB+4zJk/Q5ANdhoBLaHp5ZixNvHknqflFcJd215F4daK7TZrHiO8XfHkZjQ/w/wDAVHP1r0aCJYII4YxhI1CqPQAYoAzNZC3N/p9iXADOZnXPJVeg+ma16xtXE1rqFrqMcUs0MatHLHENzAHowHU49KP7cF0u3SrO5upT3eNoUX/eZwPyAJoAu6rqEWnWpllyzMdkca/ekY9FArlytzcTSaVE5/tC7/e6hcJnEEZ6ID/exwB9TU90blNQWNGivPEEicEA+TZof4sf48n6VFqcraRFFoehHztcvyXkmZvmjB+9O/07D14oAhvEg1zU10S2xHoGk7WvWxhZHHKxZ7gdWq/obf8ACQ6iNWIibSoMrp6mIhiw4aXkdD0GO1Z1ppyzxxeHdGluItNtSHvb5CM3D5y0e71J5Yjp0ruI0WKNUjUKijAUDgCgB1Zfie6itNDupZmAG3AGQCxzwB7mrOpX8GnwebO3LHaiKMs7dlUdzWLf2UtxaTahqgHmqn7m3HKwgnr7t7/lQBf0KykjVr28/wCPy4VcrnIjUDhB/X3rWqO3/wBRH/uj+VSUAZHivWofD+gXmpT9IUJVf7zdh+dYXwt0WXT9CfUNQAOqam5urhiMEZ+6v4CsbU3Pj7xommwNnw/o8gkuZFORNOPuqOxAr0xQAAAMAcCsI/vJ8/RaL9T1K98Jhlh/tTtKXkvsr9X8haKKK3PLCiiigAooooAKKKKACiiigAooooAKKKKACuX+IOktqPh+4e1G28iUsjjrjuK6ikYBlKkZBGDQB8d6tLNA7Qyh8LwVPB/KuR1C1WSf9wzeYTyuP5V758V/B0iTNc6evz8l1X+IdjXiN9ZN5jKR5bKcHIIINAHMXKMMqw/Ouh8P61lY7W5ZjMvCsf4xWdcwSxfIwBUnkkf5xVcwcKSCGJ+ViOlAHpun3b5XcuY89CORXr3w4mjnlEcjDauHCkHn1r588L6z8y2t8f3h4V26N9a9P8LanLpl/HIuflPsaAPozqPauE8f6fFFAJkJjBP4ZrWsPFOntbJJJdqI9pLb1IKn09K818f+LBq0pgtiVt06ZP6mgDhtVuY2uWilcmPPOK5fV/syZmmYrEgzk9vpWxq2pW1hCZbsgBgQoGNzH6V5xqd5dajPvmLCEH5Is8fjQBVvb97q4kd3laPOEV2JwPam2ocTIynJ7bhkfrxUoiBU4B3fTpV+xsgY97nAHTHegCW3s0E4aURLnnbtwor1/wCEvwyTxFs1TVfNTTVbKxjjzv8A61ee+GtNOs6zZWOyQ+ZIqkqBlefevs7T7SKxsYLWBQscSBAAMdKAH2ltDaW0dvbRpFDGoVEUYCipaKKACiiigAooooAinuYLfb9omji3dN7hc/nUteMfHTwvqfibx38P4tO0i11GBE1NJ2v7d5LOEvAgQylQdvIJXOMsBijwp4U8T6H4r0Pw2Nc1n+w9J8PwSmeJAtvdXa3LkxOzI2F2bQVUhtgHIoA9nNYni7w/b+JNFlsrjKP9+GVSQYpB91gR718/6ZafEPWtE8R6fr0/iI313o17Fc2ctpIInuNpMflSlfKAb7m2MnKtzg807UB44g0DwraaTN4ts9ITRwhlFlM1xDfq2CskaJv8tQAEDDaRnk8GlKKkrM0pVZ0pqpB2aPc/At1rLacbHxHaSx39p+7NzkGO5HZ1I/UGumrxOKTxNeeMGi8T3HjG2SUWK6c+jWxW2w0a+e02FKoQ5bcJPugfLniuR8GWXifRPAHhLTZovGlnp1vcXcesxWdq4uYZApMAgAXcYSxJLLuXJ5OM4UVyqw61RVZuaVr9FsfSd7aQXtu0FzGHjPOD2PYj0PvWRbXtxpN1HZau5kgkbbbXh/iPZH9G9D3+tc/4FXx9N4e8My65daVDL9mT+0obm0d7ln3HOHWRUVimzgocNu+g7LVZLFLKT+1HgS1YYczsAv61RkXK5DWPD09hf3Oq+H4o5RcjF9pjkCK7H94dlkx36Hv61Uh8RXenSC3srS41DTHYLBf3BMMcWf4XdgSw9GCn0rdTStQvedX1NvLPP2eyBhTHoWyXP4EfSgDjrHxtZaTI1rbebfRs4jTRkjVL6zOOU8skb19x+ZrF1LxP4isNamtvDOnXKaemJbm0EK3Vxbg8llUOETP9xnz6CvTrrwroN1bC3udIsZol5AkhDEH1yec1RvtPtdJtLDRdCtobCO7mwy26BMIOXPHfHegDzuzv76eA6rrmoatJZXEg8qe/063mtbbnoVhlOOeMsMjua6XVvFniDRnu/wDQtPu9MtAhkvbZZCY0YZy0Q5wBySpPHatzU9BOmJLNoVnHJayqUvNOGAs6kYLL2D4/Pv6159p/i3TvBX2r+2Ji2lEGEOy4Lxj7q4/vrnay9eh6UAb8vieDxZ4WveILuzABF9pzO4hcfMrMjqrKOByN1dHpiWnjbwZp9zeBt0kYdJo22vHION6MOQcjNeeeOviZovhLwTaaV4eu1stW1C2L6ekpEyRZP8T5KjrxycVQ+FHis+GfCmmRX80uoXcjt9sttPtpJwjMchwwGwHJ5AOKAPRLme60ZFTxdYx6vp8X3NUitxI8Y9ZYwCR/vLkeoFPtYvA120RtY9NnEwyrRjegz0yRwp9jirR1jxNqJxpfh9LGJhxcapcBSPfyo9xP0LLXGeKPhRc6uLq/uNUaTULiJo54LAGwhm9MhNxYg/3y2fagDpJ7rw5YXRsfDujW+q6qp/1VrGrLCfWSU8IPxz7GtPSvD1zPqEereJZ0ub+PmC2iz9ntf9wH7zf7R59MVh+FLfxDo/h+1TRRpGqWMaBfs7R/YplYcFSVDITn1VaNf8eXNlFDZ3uiavpV5cttM32f7THEo+84aItnA9QKAEn1dbn4hXzx2k97PpMQghgjwApcZeR2Jwoxx6+gNZ7fErUry/ez8O2Fjrd5HkzW1pJIBAPV5XVVH4Ak15f4Z+IqeBPiRrEmq6rDL4V1GXMKwgyTNJwA7KcOD/ezx6V6nrPi/wAO6TrN7YWcsdvq+rxpMLmSTcJFIxwMkggHhMDOeKAJ59e8RzW1vIL6EXNwgdbHStP+0yxAnG52kkUYHTJAFYN54q8UWct5DBqtwZLdwk0uqaOqW8IPffCzHP1HHetvwpbX88M1lYpHa3Dti+v4gSYkH3YkJ6vjkkcDPrXST6dbeGpLGfTY/KgeUQXKg/6zd/G3q2e9AGNaa3f6ZowMehG3u58NLqF5eQi2Zj/y0Mgbcw9BtHpxSaHZXV4txHpc8xlnkH9oaxcwlTcDukA/ujoDwB1GTXUw+FdChneaPSbPzHfzCTGD8394A8A+4raAwMCgCnpGmWekafFZadAsFtGPlRf1JJ5J9zTNX1OLTYFZleWeQ7IYIxl5G9B/j2o1XUVslSOJDNeS8QwKeWPqfQDuah0nS3gle8v5BcajKMM/8MY/uoOw/nQAmnabI1wt/qhWS+wQiKcpAD/Cvv6t1NO8Tts0G8b0T+orUqjrdm+oaVc2kcgjeVdoYjgUAWbY5toj/sD+VcX4/wBfu/tEPhrw6c65fqf3gYAW0fdz/SrnirX7rR7S10zRrV7/AFudRHEqqTHHxje56Ad8VN4L8LJoMU11eSm71q7O+7u35LH+6voo7CsZSc3yR+Z6WGpww8Fiqyv/ACx7vu/7q/F6bXL/AIU0G28OaLDp9oCdvzSSMcmRz95ifc1sUUVqkoqyOCpUlVm6k3dvVhRRRTICiiigAooooAKKKKACiiigAooooAKKKKACiiigCpqVjHfQFJAu4D5WIzj/AOtXgvxA8FLFdOyRmCZzkAD5X91Pf6da+har39lb39u0F5CssR7MOnuPQ0AfF1/pklvJ5dxuVs857isy5spFxgblHI254r6V8afDZrgNLp0a3KAcISFkU+x6N+hrym+8OyWdyI5IpLcKcN5qFG+g3f8A16AOCa1LkK+4DAG5uorb0nWrm0QW91l4+gc9QK159KMcbNND8o5EgOePeqcmiy3LZsLc3HAysQJI/KgDoP7bt/sQQXigj+Et/TrmuY1jW5JJGj0+MM3TcRkflW3L4N16LTY764sLqO1X5A7phgPpjOPc1zYtJVZm2bCvXd1NAGJfxy3Dme5fzZgMFicfh6VRETKSDGWz+H610bWjSufkyOpA/pSx2zk7YlJPYBaAMe2h3HfKoz0HqP8AGtO0tTLIsEJLF+lbemeHbm/kVZIykZ6+p+meM16t4I+GsoaOWVDDD1Z5U+ZvZQf5mgC58F/CaWf+mzxAunIYj+L2r2GqmmWEGm2aW1qm2Ne/cn1PvVugAooooAKKKKACiiigDlvGPjjTPCtzb215DfXd5PDJci3soDK6wx43yMMjCjI9z2Bql/wsvQ57+3tdJh1LVzJbQ3kkmn2jSpbwzcxtIeNuRk4wSACSKteM/Ath4qu7a8mvdR06+hgltftNhKqO8EmN8bblYFTgdsg8giqEXwx0mxvobnQdQ1fRAttb2k0Wn3CqlzFAMRiTcrHIGRuUhsE880AFz8TdEOjW15ZNM73sl3bWivEQGmt1cuG9B8h571k6f8X9Li8NaLe61BdG9utKi1W9Wwt2ljs4XOPMc5yFznpk8E4qSH4NaFDqEdwmqa75ENzc3MFmblDBC06ssm1SmcfOTySc9+oMlz8HdAm0+ys0vtYt4YNNTSJ/InRTe2qHISb5PXPK7TgkZxQBZ8QfFnw3oerXFhdLqcxt2thPPa2bzQxCcZiZmXs3QAZJPQHmuf8AEXjPQPEOm297pza/aeIVvptOtrW3t2F0LiJd7o0RO0qFIY5PQjvxXS6r8LtD1K41iV5r+Eao9g0scLoFj+xn90EBQ4B75z7Ypk/wt0hp7i6tr/VrPUZNWn1iO9t5YxLbyzRrHIqZQrsKqBhgx96UoqSszSlVnRmpwdmijpfxX06/8TeH9I02zv7+x1Wwa7XUvLI2FZPLYOm0AbSDubICkdOaVPin4Pv0lvp4LxYbazm1C1uLizIFzBGcPJATycHHBwcHOMVoad8L9E0u58PT6XPqNodGgktkVJVZbmOR98izblO7c2SSNp5Ncn4i+Hfhvwzo9wl1F4ov9Laxm06EwyRTDTIJTlxGCA3p8zByAMZxQ2oq7ClTnWmoQWrPTvDus2finSGu7a1vEs5CUC3tq8BkXAO4K4BKkHg9DVYvL4bYCUvNoxOA55a19j6p79qm8HanpOpaBZnQrwXVpDEsSkn5wFAGGGBg8elbZAYEMAQeCDQmmromcJU5OE1ZroxEdZEV0YMjDIIOQRXP+IkuJtb0dNPlhjuo2kdjIhcBNuDkAjr0zVxNEjt5S+nXFxZKTkxREGPPsrAgfhirVjp8dpJJKXea4k+/NJgsR2HHQewpkkGn6k0tw1nfRfZ71RkLnKSj+8h7j26iqWtaCZpnvNMECXTczQzIGhuQOzjsfRhz9a1dSsIdQt/Lm3KwO5JEOGjb1U9jWdbalLp00Vlrci73O2G7xtSX2PZW9uh7UAcBf6D4cTUYLyWxsdJ1OzLTR2GoW6vBuPVoSMck/wB0/wDAa6nTLHxDq9sv9vvYwWksizeTBuZlUchOQMepPNXr21t/E1+1vd28NxpNm/zLIgdZZR2wey/zqYeFNMUr5DX1ui8iOC+mRP8AvkNgUAWNb1b7CEt7OL7VqU3EUCn/AMeY/wAKj1NVLfwzBOhl1uWXUL1x8zs7Kie0ag4UD16+9amm6XZaaH+xW6xtIcu5JZ3PuxyT+JqGfXLGKeSJXlneP/WC3heXZ9SoOKAOYRLrwZrcs09w03hm7xueViz2cvQFmPLIfU9O9dFq9jPeS2moaVcQrdQA7DIN0cisOQSOR9RVoPY61p0qK0VzazKUdeoIPUEH+RrmdH8P6dDcz6ZIlzayxAGP7NeSwrNF2IVWAyOhwKAKXjHRE1u1i/4TNPDtvawuHSQqZ5Aw/uFwoB/BvpT9I8O21xkaRp66bp7ndLfSRbby6PsSNyj3PPoBXT2HhzSbCfz4LNGuf+e8zNNIP+BuSf1q5qN/b6fEHuXILHaiKMs7eijuaAGollounBVEdtaQjgdh/iT+Zrntcm1C+tYbuSJLfS4545DG6EzOoP3jzhR04wT9K1rSxmvblb3VlAKHdBbZysX+0fVv5dq1pI1ljaORQyMMEHoRQAqkMAQQQeQRWbq2qfZXS2tI/tOoS/chB+6P7znsv+RUP9iSpF5Ntqt9b2+eEUoSo9AzKSBVzTtNttPDm3QmWTmSVyWeQ/7THk0AQaPpX2NpLm6lNzqE/wDrZiMD/dUdlHp+dalFZXiLxBpnh2xa71e7S3iHQHlmPoqjkmk5KKuy6dOdWShBXb6I1TXjXijxnYeFf2h4x4i1r+z9Hk8LDak0rCEzm7ODt6btqtzjOBW9FP4g8eMrQrNoXhzcCHbi5ugD2H8Cmuj8SeOfDXhq9Sz1zV7e0uWiM/lsGYrGDje2Adq54ycZNTCfPqtjbE4Z4e0ZyXN1S1t6va/l06nkdr8S9fvfi5HoNlqka2FzqF3pzW1zbRrNbFI3KOEHzbQVGC7fOM8L25rw/wDETxVpvwz8KgeIBNLc3Nzb6lqN5GHk0505SCV5CRuYknL9gAMcGvoC48deGbfXoNFm1m2XUpnjjSHJPzuMohbG0Mw5CkgnjAqlF8TPCN1fSafYa7ZXGpBJmW3DldxiBLruxgEYJI645xirOY4jwf4y8W+IvFWiae+paXDANCi1a9NtaG4Fyy3ckTrE25du9UGDhgM8A8GvPLj4na74i0jxZp9xqSXWnXHh69ukVoo4ri2kjYLtYR/cOGPyEsRwc17z/wALJ8N2mkaTd6zqdpZy6hardpDG7T4jP8eVX7gPG8gCteHxZoU32fytTt2+0Xj6fFgn57hM7ox7jafyoAn8KEt4X0ckkk2cJJP+4K1a870L4t+HLvwjo+uazP8A2QNSiaZYZA8vlqJCmWdVwBkdTgVftvib4Ym8S63or3wt59IhSeeeYqsLoyliVfPRQOc46jGaAO1orF8MeKdF8URXEmhX8d2LdgkyhWRoyRkblYAjI5Bxz2raoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACo5oYp02TRpIno6gj9akooAoDRtMHTTrIfSBf8KtQ28MAIghjj/3FA/lUtFACMAwIYAg9Qe9chrHw78P6pc+e9u9vIc58lgA31BBFdhRQB5v/AMKm0xZP3V5Ksec7TEpP5/8A1qv2vwx0OBcbrpiTknco/pXc0UAY+leGtJ0tle1s080D/WOS7fmen4VsUUUAFFFFABRRRQAUUUUAFFFFAHk/xQ0i9l+K3w81eJdbawtjdQXEmnRGQQMwTZuAUlVc5VmPGFHI61zMX/CbQfCe01O/n8W3etX1/wCRcWyq0b2ECzzASiOOPzmBUISASSCuCFFe/UUAfO2kXnjp9A8PR+JG8XLpEd3fxXs1haSC/ZVI+zFlCmXYctyAeg3HHNdD8KNKv9O+Kfii6vx4o8nUbSynt5tQgwk4FugfzmVdgmRvl25BHPBHNe0UUAFFFFABQeRVLWdVsNE02bUdYvILKxhx5k87hETLBRkn1JA/GofD+v6R4is2u9B1Oz1G2VijSWsyyBW9Dg8HocH1FAHNa/8ADyyur59T0G6n0TWCdxntThJD/tp0IrNHi7xF4TYReNtMN1Yjgarpy7lA9XTqK9KNVbG/s9QE5sbu3uhBM1vN5Miv5cqnDI2DwwPUHkVi6KTvB2/L7j0IZhKUVTxMfaRW1916S3+TuvIp+H/EWk+Ibbz9HvobpB1CnDL9VPI/GtauM1/4ceH9XuzerDLp+odRc2MhhcH144P5VN4HtLrTbzVtOvPE6a41sYh5LbfPtMqTiTBz8ylSM9hkdacZTvaS+a/r/MmtSwrg6lGo7/yyWvya0fz5fQ63NY3iNluYBpSIkk94CpDDIRO7Efy96s6vrOn6O1gNSuVgN/dJZW2QT5kzAlUGBwSFPXjigQW2ny3eoXVwql8b5ZWCrGo6AHsK1OFJt2RlWWk6l4fto4NGmS8sYxgWt2xV1/3ZAD+TA/Wrf9t3CEJPoeqJJj+ARuv4MHx+eK14pY5VDROrqe6nIp9AGM8F/qq7bsPp9pnmJJAZZB6Mw4UewOfetS3gitoVigjWONRgKowBUtFAGVqGk+ZMbvT5fsd/3kVcrIPR17j9RWHrN5qipFLJod0dRtm3Ry2ZSWOQd15ZWAI7EfnXXSyRwxl5XVEHVmOAPxoiljmjDwuroejKcg/jQBztlrWq61axy6Vpq2kT8Ga+kGUPceWhJJ+pFaWmaSlrMbm5me8vmGGnlA4HooHCj2H60yG0msdZd7ZN1ldZaVQR+7k/vD2Pf3rWoAKKp6tqNvpWnzXt65SCIZYhSxPYAAckk8YrzyX4oXepSz23hTwtqd9dQbRMLkCER7uVyMk8jnnFRKpGO51YfBVsQuamtF1bSX3uyPT6x/EfiXSPDlt5+sX0Vup+6p5dvoo5Ncd/Y/jrxKd2sarF4fsz/wAutgN8pHvJ/hWx4d+HXh/RLn7WtvJe3/U3V6/nOT688A+4FRzzl8Kt6/5f8MdP1XC0P49XmfaGv/kz0XquYxv+Ep8S+Lsx+DdNNhYNkHVNRXbkesad/rz+Fafh74eWFjfLqetXM+t6wCG+03ZyEP8AsL0ArtxRQqKvzTd3/XQmpmElF08NH2cX23frLd+mi8gHFeF/GfwN4o1jX9YbwjavJFr2mw2N9JL5HkqUkbHzNIJEwMZ2o+c9jXuleLfFHxf4r07xF4ottA1S1sbXRNDj1YJJZCZpm3uCm4kbQQvoT9K2PONCb4Ox/wDCWPq9vqkHkT3MF5PbXVkZiJYwoLRP5ihc7R95Wx2qSL4RbNL0Wz/tvJ029v7vf9k/1n2lZBtxv42+Z15zjoM1ymr/ABh1WxfWrOae3t9VF5phsLdrZjutp1iMjZ6EZZgCTxwKZ4l8aanqWn+PLLVfEEGnXcMGrWsPh77FiV4I7aUxzCX73O0Pv+4RwOSKAOw034W6hof9lz+HfEy2V/baPFo1xNNpyzpNHGSVdULjY+SepZfUGo7H4S3dn4hs7pfExfSbPW5dbhsGsF3K8gbchlD5Iyxwcfge3Ay/EbxVpF7oumW11YafZ22m6Y9tHfKFXUleJDKQ5+YkElQE5BHOc1vT/FnUoda/saS5gTVl8ZPpj272zAjTiH8tunU4XDDk84FAEt78B7i48L6Voi+Kybaz02XT2SawMkZZ5Wfz0TzQEkG7aSd2QBjFb2ofCMXz+IIZdbddO1zTbWxu4FtRvD26bY5EfdwO5Uqc+tZPwO8fa74q8SajY65ex3hhtfPLWUMTWiEyYAWRTvVsZ/dyDdjJ4xz7VQBxHw38Dy+D5dTmub6zvbi9EKtJb2RtyRGGALkyOWPz+wHYCu3oooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOA+Pfh7VPFXwn13RtBtftepXPkeVD5ix7ts8bt8zEAfKpPJ7Vyuu/C3U4ns5rbULzU73U/Eltf61cW8gscWqRSIQoRwQBuGdpLEnPbj0b4geKY/B3hx9Wms5r0CeGAQQsqszSSBBgsQOrdzXK6X8Vln1eLSdT0G60/VDrC6RJCZ0lEbNCZVfcvBBUdB0oA47xD8PPE6fEP7VYR6lcaTBJZ/2XcW18m6ziiRVaN/NkDYJBJIDl85PNULj4aeKLTR/FNho2lzQGfxGb/euoLt1HTyzEQAF+GGQW3hQ2MEmvQIvisNQubWw0PQri+1e5vL22jtmuEiQLasFkkZznAJIwME/SsW5+LF5oWt+KhrtlKyw3WmWdhpwKK0U1xa+a6PIMggEPlvm6cZoAxbbwJ4lg0rQIr7R9U1bQ7O5vGn0KfUYY5cSBPJYFZPLZEbfhC+VzkZ6CEfD/wARabdeNbjSPCm6fVdOs/sP2jVfMjjZY41ngc+YGd8hirH5Tt5YAkV6F4X+KFvrmoeHrCTSLyzu9WkvYispG2JrZUZiDgb1YOMMAK53/he9k9toM8eiTRRatb/aElvbpLeIfvWj2LIw2s/y5IJUAEc0Ac54Z+H/AIvtRpsM+m3Udja+LbPVIobi6gJhtlgdZWCo5UfOw+VefTPWvatN8P3S2uo2uva3d67a3i7PKuoIIxEvzbgPKRCc5HXP3RjHNdBRQ1cabi7rc8+l+FHh+MudKm1TS9w+7aXjhd394g5yfxpG8C6/bhX07x1rCzoRt+0qs0f4qetehUVj7Cn0VvTT8jv/ALVxbVpz5v8AElL/ANKTPPH8P/EGJd8PjO0uJF5Ec2nIiN7EqCR+FL9l+J//AEEPC3/fqavQqKPYro397K/tOb+KnB/9uRX5JHiXxi0jxvqXwb8V2WqpZ6pdzC1+yW2j28ryMRcxl8rjJwBngdATVKfwZ4l8F6Vcz2DPb2era5DPqNj4Xhf/AEO0EZU+QuN2WYIWKLnHQYzXsfivxFp/hbRZdU1Z5Ft0ZY1WJC8kjswVURRyzEkDH9K5m/8AihpWnxRC70rXo76RZZDYmyPnpFEFLykZxsAYcgnPQZIIrSMeVWOGtU9rNzsl5LRHlviG7+IyeD9BcP4jaZZbxvs0dtMtxcQh/wDRxNLCjNHJt7MApz8xyKcNM8Z6Z4h8b6hpVv4ii17UNFsZbHzVE0LyrCRMkkoTyzJGSQo4ySeCDXpGufGHwrpHlvI2oXNu9nBqDXFraPJHFbzNtSV2/hGeoPPPQ1L/AMLY8PCwuLmaDV4ZINSj0p7WSxcXHnSDdGBH97DDp39qozPMtJbx7Pb2VtDqPitLe412xR5JrCVZ7WBopxP88yHcoYRkkgopI5OcVsa3B4z07UPGEGmnXJrGK90eL7ZHADdT2YgUXMkLBR5kuRztHBJwB0rsdD+Lega3f2ljawarbXN2tysRvLJ40E0AJkhJ/vqBkgZHbOeKp6X8YNHktdDhnW6vtU1GzS8Men2rbRGzlAwV23clT8o3Nx06UActo8fjvUr3w3YTX3ifT9GudU1NBeGEC6SxWEG3M5dGCMXDAFwG5HfFe7xrsjVSzNtAG5up9zXBR/Ffw9Le61BBHqMsOkLctd3SW+Yk8hS0g67uNpAJABOACcipdZ+KXhvR4DNey3QT+zLfVvkgLHyJ5hEhwO+5hkUAd1RXnWu/GDw1oiwf2hFq8UjwtdSQyWLxy28IkaMSSI+1lBKkgYLEc4xXoVvNHcQRzQOHikUOjL0YEZBFAD6KKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAzfEOhad4i077DrFv8AaLXzY5tm9k+dGDKcqQeGANYmsfDnwrrL3r6jpQmkvLuO+mcXEqMZ402K6lWBUhePlwD3rraKAOMHww8ILpltYR6SYoLaeW4gaK6mjlieT/WFZVcOobAyA2DjpUj/AA28JPaXls+joYrv7N5oM0mc28YjhZW3ZRlUABlIPqSa6+igDjbr4ZeEru0sre70yW4Szme4gea9neVXcAMTIX3kEKoIJIOBxUC/CjwYtpZ2g0hzZ2qLGlsbycxMquXAkQvtkwxJ+cNXc0UAFFFFABRRRQAUUUUAYvi7w3YeK9FfTNT85YjIk0csEmyWGRGDI6N2YEA1zOo/C+z1FYZLvxD4jfUo0mhOofaYhO8MoUPCcR7AnyjACgg5IOSTXoFFAHneq/CHw5f2N9ZCS/tbW70u30gxwSpiOCF96FSyk7s9Sc5+vNXb34aaPeatcahLc6gJp9YtdbZVkTaJ7dQqKPkzsIHIzn0Irt6KAOEsfhfotnf6fdxXWomSyvL69jDSJgvdqVkB+ToAx24wR3JrIvPgj4cvdM0jTbu+1abT9NhSCOB3hO9Vctkt5e9CScExsmRXqVFAHnE3wf8AD114hvdY1G41G9ubqG5gKyvGoRJ0KSDciK7fKxA3s23PFUv+FI6E9pPb3Ws+IrsS2MGnB7i5jdkhhnWdFU+XxhkA9MZ7nNeqUUAcT4v+G+k+Jtej1mS6v7DUlt/sry2hiPmxBiwVlkR1yCThgA3PWuxtYVtrWGBCzLEgQFjkkAY596looAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigD//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Martin, TJ, Corbett, JJ. The Pupil. In: Neuro-ophthalmology: the requisites in ophthalmology, Krachmer, JH (Ed), Mosby, St. Louis 2000. Copyright &copy;2000 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_22_35173=[""].join("\n");
var outline_f34_22_35173=null;
var title_f34_22_35174="Treatment of adult Still's disease";
var content_f34_22_35174=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment of adult Still's disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/22/35174/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/22/35174/contributors\">",
"     Lisa A Mandl, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/22/35174/contributors\">",
"     John M Esdaile, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/22/35174/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/22/35174/contributors\">",
"     Don L Goldenberg, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/22/35174/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/22/35174/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?34/22/35174/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 19, 2010.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adult Still's disease (ASD) is an inflammatory disorder characterized by quotidian fevers, arthritis, and an evanescent rash. Following its initial description in children by George Still in 1896, \"Still's disease\" became the eponymous term for juvenile inflammatory arthritis (JIA), now called systemic onset JIA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35174/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/35/21046?source=see_link\">",
"     \"Systemic onset juvenile idiopathic arthritis: Clinical manifestations and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In 1971, the term \"adult Still's disease\" was used to describe a series of adult patients who did not fulfill criteria for classic rheumatoid arthritis (RA) but had features similar to the children with systemic onset juvenile idiopathic arthritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35174/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The treatment and prognosis of ASD will be reviewed here. The clinical manifestations and diagnosis of ASD are presented separately (",
"    <a class=\"graphic graphic_table graphicRef79051 \" href=\"mobipreview.htm?6/35/6715\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/3/11320?source=see_link\">",
"     \"Clinical manifestations and diagnosis of adult Still's disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     COURSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical course of ASD can be divided into three main patterns [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35174/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Approximately one-third of patients fall into each pattern [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35174/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Monophasic pattern &mdash; Patients with monophasic ASD have a disease course that usually lasts less than one year, with complete resolution of symptoms.",
"     </li>",
"     <li>",
"      Intermittent pattern &mdash; Patients with intermittent ASD have one or more disease flares with complete remissions between episodes. Although subsequent flares cannot be predicted, they tend to be less severe and of shorter duration than the initial disease episode.",
"     </li>",
"     <li>",
"      Chronic pattern &mdash; Patients with chronic ASD have persistently active disease, usually associated with a destructive arthritis. Some patients require total joint arthroplasty.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Predictors of chronic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several predictors of chronic disease and an unfavorable outcome in ASD have been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35174/abstract/3-6\">",
"     3-6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The development of a polyarthritis early in the course of ASD",
"     </li>",
"     <li>",
"      Involvement of the shoulders or hips",
"     </li>",
"     <li>",
"      The need for more than two years of systemic glucocorticoid therapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Functional outcomes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The functional status of patients with ASD is generally good, even in the setting of a chronic disease pattern. In one series of 62 patients with ASD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35174/abstract/3\">",
"     3",
"    </a>",
"    ], 36 percent had chronic disease courses but 90 percent were judged to be in American College of Rheumatology Functional Class 1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35174/abstract/7\">",
"     7",
"    </a>",
"    ]. Joint arthroplasty has significantly improved the functional status of many ASD patients with chronic destructive arthritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35174/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Chronic active inflammation can lead to secondary (AA) amyloidosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35174/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/14/33000?source=see_link\">",
"     \"Causes and diagnosis of secondary (AA) amyloidosis and relation to rheumatic diseases\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     TREATMENT OPTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapeutic decisions should be based upon the extent and severity of organ system involvement. The principal options for treatment are nonsteroidal antiinflammatory drug (NSAIDs), glucocorticoids, biologic agents, and disease-modifying antirheumatic drugs (DMARDs). Salicylates, once a mainstay of juvenile idiopathic arthritis therapy, are now seldom used to treat either Still's disease or ASD because their therapeutic index is narrower than that of most NSAIDs.",
"   </p>",
"   <p>",
"    As a general approach, we suggest starting treatment with an NSAID but moving quickly to glucocorticoids followed by biologic agents if ASD does not come under control. Patients who are on the sicker end of the ASD disease spectrum should be treated with glucocorticoids from the outset of therapy, followed by biologic agents if the disease proves refractory. DMARDs now generally play an adjunctive role in the treatment of ASD.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     Methotrexate",
"    </a>",
"    is often used in conjunction with biologic therapies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     NSAIDs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with relatively mild disease may respond to an NSAID [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35174/abstract/3,8\">",
"     3,8",
"    </a>",
"    ]. No randomized trials have compared different NSAIDs according to their efficacies and side effect profiles in ASD.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/38/15978?source=see_link\">",
"     Ibuprofen",
"    </a>",
"    (800 mg four times daily) or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/43/43705?source=see_link\">",
"     naproxen",
"    </a>",
"    (500 mg twice daily) are reasonable selections for initial therapy. If patients do not demonstrate a response of their symptoms within several days of starting an NSAID, the addition of a glucocorticoid should be considered.",
"   </p>",
"   <p>",
"    There is some concern about the potential for NSAID use to trigger the macrophage activation syndrome (reactive hemophagocytic syndrome) in patients with ASD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35174/abstract/3,11\">",
"     3,11",
"    </a>",
"    ]. This syndrome can be difficult to distinguish from the underlying ASD and can be catastrophic if not treated. Close monitoring of the patient's complete blood count and alanine and aspartate aminotransferase concentrations is recommended, particularly early in the course of the disease and its treatment. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/3/11320?source=see_link&amp;anchor=H16#H16\">",
"     \"Clinical manifestations and diagnosis of adult Still's disease\", section on 'Reactive hemophagocytic syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     GLUCOCORTICOIDS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of patients eventually require treatment with glucocorticoids, and those with high fevers, debilitating joint symptoms, or internal organ involvement should be treated with glucocorticoids from the outset of therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35174/abstract/4\">",
"     4",
"    </a>",
"    ]. The usual",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    dose is 0.5 to 1.0",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day. Pulse",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?30/25/31129?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    (eg, 1000",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    times three) can be used for life-threatening disease due to severe hepatic involvement, cardiac tamponade, disseminated intravascular coagulation, or other complications. Approximately 70 percent of patients respond to glucocorticoids alone or glucocorticoids used after a trial of NSAIDs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35174/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     BIOLOGIC AGENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Biologic agents that have been used in the treatment of ASD include inhibitors of tumor necrosis factor-alpha (TNF),",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/18/294?source=see_link\">",
"     anakinra",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     TNF inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Experience with TNF inhibitors in ASD remains limited to case reports and small cases series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35174/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]. Promising results have been reported with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/31/28151?source=see_link\">",
"     etanercept",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/6/28776?source=see_link\">",
"     infliximab",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/24/39303?source=see_link\">",
"     adalimumab",
"    </a>",
"    , but treatment failures and apparent loss of efficacy over time have also been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35174/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following data illustrate the range of findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among 12 patients treated with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/31/28151?source=see_link\">",
"       etanercept",
"      </a>",
"      , 7 had improvement after six months of treatment [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35174/abstract/17\">",
"       17",
"      </a>",
"      ]. The mean disease duration in this study was 10.7 years at the time of enrollment. Most patients had arthritis as their primary disease manifestation at entry. The following observations were made:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Seven patients achieved ACR20 responses (",
"      <a class=\"graphic graphic_table graphicRef64036 \" href=\"mobipreview.htm?25/30/26091\">",
"       table 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Four achieved ACR50 responses",
"     </li>",
"     <li>",
"      Two achieved ACR70 responses",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, among the three patients with fever and rash at disease entry, only one demonstrated improvement in these disease manifestations.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Six patients treated with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?28/6/28776?source=see_link\">",
"       infliximab",
"      </a>",
"      experienced resolution of their fever, rash, hepatosplenomegaly, arthralgia, and myalgia after the first series of infusions [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35174/abstract/18\">",
"       18",
"      </a>",
"      ]. Glucocorticoid doses were reduced during the follow-up period of 5 to 28 months, suggesting that infliximab had been effective.",
"     </li>",
"     <li>",
"      Four patients not responsive to glucocorticoids or glucocorticoids and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      had complete remission of their disease after receiving",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?28/6/28776?source=see_link\">",
"       infliximab",
"      </a>",
"      &nbsp;[",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35174/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As noted, some data call into question the long-term efficacy of TNF inhibition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35174/abstract/16\">",
"     16",
"    </a>",
"    ]. This was illustrated in a series of 20 patients with disease refractory to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    who were treated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/31/28151?source=see_link\">",
"     etanercept",
"    </a>",
"    (10 patients),",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/6/28776?source=see_link\">",
"     infliximab",
"    </a>",
"    (15 patients), or both agents sequentially (5 patients) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35174/abstract/20\">",
"     20",
"    </a>",
"    ]. The following results were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Complete remissions were observed in five patients (1 with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/31/28151?source=see_link\">",
"       etanercept",
"      </a>",
"      , 4 with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?28/6/28776?source=see_link\">",
"       infliximab",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Partial responses were observed in 11 patients (6 with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/31/28151?source=see_link\">",
"       etanercept",
"      </a>",
"      , 5 with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?28/6/28776?source=see_link\">",
"       infliximab",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35174/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Despite these initial benefits, 17 of the patients (85 percent) ultimately discontinued treatment with targeted TNF inhibition because of either the loss of efficacy or the occurrence of adverse effects.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Anakinra",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/18/294?source=see_link\">",
"     Anakinra",
"    </a>",
"    is a recombinant human interleukin-1 receptor antagonist. Data from small case series indicate that anakinra can control disease activity in patients with ASD that is refractory to treatment with other medications, eg, glucocorticoids,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/31/28151?source=see_link\">",
"     etanercept",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35174/abstract/21-25\">",
"     21-25",
"    </a>",
"    ]. Some of the anecdotal reports of success with anakinra are striking, but require confirmation.",
"   </p>",
"   <p>",
"    Data from a case series of four patients, for whom",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/18/294?source=see_link\">",
"     anakinra",
"    </a>",
"    (100",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    was added to either existing therapies or as one of several new treatments started simultaneously, are illustrative of other reports in the literature [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35174/abstract/23\">",
"     23",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      All patients responded to treatment within three days.",
"     </li>",
"     <li>",
"      Acute phase reactants such as the erythrocyte sedimentation rate, C-reactive protein, and serum ferritin returned to normal.",
"     </li>",
"     <li>",
"      Other laboratory hallmarks of active ASD, including leukocytosis and elevated serum aminotransferases, also normalized.",
"     </li>",
"     <li>",
"      Serum cytokine measurements indicated that interleukin (IL)-18 was highly elevated and IL-1beta was moderately elevated at baseline. &nbsp;Both of these cytokine levels normalized after the institution of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/18/294?source=see_link\">",
"       anakinra",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      Substantial reductions in glucocorticoid doses were possible in all patients.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Rituximab",
"    </span>",
"    &nbsp;&mdash;&nbsp;Limited data suggest that",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    , a chimeric monoclonal antibody that leads to the depletion of peripheral B cells for periods of six to 12 months or longer, may be promising for the treatment of ASD that is refractory to other biologic agents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35174/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     DMARDs",
"    </span>",
"    &nbsp;&mdash;&nbsp;DMARDs can be employed when patients have either not responded sufficiently to NSAIDs, glucocorticoids, or biologic agents, or have developed side effects from these medications. Only limited data exist to support the use of any particular DMARD, and no controlled trials have assessed the efficacy of these agents in ASD.",
"   </p>",
"   <p>",
"    DMARDs that have been tried in ASD include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/26/2471?source=see_link\">",
"     hydroxychloroquine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/36/19015?source=see_link\">",
"     leflunomide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/28/8647?source=see_link\">",
"     sulfasalazine",
"    </a>",
"    , gold,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/29/4569?source=see_link\">",
"     mycophenolate",
"    </a>",
"    mofetil, and intravenous immune globulin&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35174/abstract/3,21,27-40\">",
"     3,21,27-40",
"    </a>",
"    ]. Most reports of DMARD use in the treatment of ASD involve combination therapy with NSAIDs, glucocorticoids,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    biologic agents. Thus, the attribution of a good clinical response to the specific effects of a DMARD is usually difficult.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Methotrexate",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     Methotrexate",
"    </a>",
"    , a cornerstone of therapy for RA, is used frequently for the treatment of ASD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35174/abstract/27-30\">",
"     27-30",
"    </a>",
"    ]. Its most common role is as a glucocorticoid-sparing agent. In one series of 13 patients, methotrexate was administered as a first-line agent in a dose of up to 20 mg per week [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35174/abstract/29\">",
"     29",
"    </a>",
"    ]. Improvement was noted in eight patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Cyclosporine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Limited evidence suggests that",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    is effective in treating ASD, particularly if complicated by reactive hemophagocytic syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35174/abstract/31-33\">",
"     31-33",
"    </a>",
"    ]. The typical cyclosporine regimen for this indication is 3-5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day, split into two doses. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/3/11320?source=see_link&amp;anchor=H16#H16\">",
"     \"Clinical manifestations and diagnosis of adult Still's disease\", section on 'Reactive hemophagocytic syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The clinical course of ASD can be divided into three main patterns: monophasic, intermittent, and chronic. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Course'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Therapeutic decisions should be based upon the extent and severity of organ system involvement. The principal options for treatment are nonsteroidal antiinflammatory drug (NSAIDs), glucocorticoids, biologic agents, and disease-modifying antirheumatic drugs (DMARDs).",
"     </li>",
"     <li>",
"      We suggest initial therapy with an NSAID in patients with relatively mild disease (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/38/15978?source=see_link\">",
"       Ibuprofen",
"      </a>",
"      (800 mg four times daily) or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?42/43/43705?source=see_link\">",
"       naproxen",
"      </a>",
"      (500 mg twice daily) are both reasonable selections for initial therapy. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'NSAIDs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The majority of patients eventually require treatment with glucocorticoids. We suggest treating patients with high fevers, debilitating joint symptoms, or internal organ involvement with glucocorticoids from the outset of therapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      If treatment with glucocorticoids is required, we suggest beginning with a dose in the range of 0.5 to 1.0",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day. Pulse glucocorticoids may be employed initially in patients with life-threatening manifestations such as severe hepatic involvement, cardiac tamponade, disseminated intravascular coagulation. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Glucocorticoids'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Biologic agents used in the treatment of ASD include tumor necrosis factor-alpha (TNF) inhibitors,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/18/294?source=see_link\">",
"       anakinra",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?40/12/41161?source=see_link\">",
"       rituximab",
"      </a>",
"      . The data available on all of these agents in ASD are limited. We suggest using a TNF inhibitor as the initial biologic agent in ASD not controlled with NSAIDs and glucocorticoids, and moving to anakinra if a response is not evident within two to four weeks (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Biologic agents'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Many DMARDs have been used in the treatment of ASD, but only cases series are available to assess their effects. The most data have been accumulated with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H12\">",
"       'DMARDs'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/1\">",
"      Still, GF. On a form of chronic joint disease in children. Med Chir Trans 1897; 80:47. (Reprinted in: Arch Dis Child 1941;16:156).",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/2\">",
"      Bywaters EG. Still's disease in the adult. Ann Rheum Dis 1971; 30:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/3\">",
"      Pouchot J, Sampalis JS, Beaudet F, et al. Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) 1991; 70:118.",
"     </a>",
"    </li>",
"    <li>",
"     Klippel, JH, Dieppe, PA. Adult Still's disease. In: Rheumatology, Mosby, London 1998. p.5.22.1.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/5\">",
"      Wouters JM, van der Veen J, van de Putte LB, de Rooij DJ. Adult onset Still's disease and viral infections. Ann Rheum Dis 1988; 47:764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/6\">",
"      Calabro JJ, Marchesano JM. Fever associated with juvenile rheumatoid arthritis. N Engl J Med 1967; 276:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/7\">",
"      Hochberg MC, Chang RW, Dwosh I, et al. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 1992; 35:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/8\">",
"      Cush JJ, Medsger TA Jr, Christy WC, et al. Adult-onset Still's disease. Clinical course and outcome. Arthritis Rheum 1987; 30:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/9\">",
"      Wendling D, Humbert PG, Billerey C, et al. Adult onset Still's disease and related renal amyloidosis. Ann Rheum Dis 1991; 50:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/10\">",
"      Rivera F, Gil CM, Gil MT, et al. Vascular renal AA amyloidosis in adult Still's disease. Nephrol Dial Transplant 1997; 12:1714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/11\">",
"      Dino O, Provenzano G, Giannuoli G, et al. Fulminant hepatic failure in adult onset Still's disease. J Rheumatol 1996; 23:784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/12\">",
"      Wouters JM, van de Putte LB. Adult-onset Still's disease; clinical and laboratory features, treatment and progress of 45 cases. Q J Med 1986; 61:1055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/13\">",
"      Cavagna L, Caporali R, Epis O, et al. Infliximab in the treatment of adult Still's disease refractory to conventional therapy. Clin Exp Rheumatol 2001; 19:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/14\">",
"      Caramaschi P, Biasi D, Carletto A, Bambara LM. A case of adult onset Still's disease treated with infliximab. Clin Exp Rheumatol 2002; 20:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/15\">",
"      Benucci M, Li GF, Del Rosso A, Manfredi M. Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still's disease: the first case report. Clin Exp Rheumatol 2005; 23:733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/16\">",
"      Aarntzen EH, van Riel PL, Barrera P. Refractory adult onset Still's disease and hypersensitivity to non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors: are biological agents the solution? Ann Rheum Dis 2005; 64:1523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/17\">",
"      Husni ME, Maier AL, Mease PJ, et al. Etanercept in the treatment of adult patients with Still's disease. Arthritis Rheum 2002; 46:1171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/18\">",
"      Kraetsch HG, Antoni C, Kalden JR, Manger B. Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences. Ann Rheum Dis 2001; 60 Suppl 3:iii55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/19\">",
"      Kokkinos A, Iliopoulos A, Greka P, et al. Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients. Clin Rheumatol 2004; 23:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/20\">",
"      Fautrel B, Sibilia J, Mariette X, et al. Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases. Ann Rheum Dis 2005; 64:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/21\">",
"      Fitzgerald AA, Leclercq SA, Yan A, et al. Rapid responses to anakinra in patients with refractory adult-onset Still's disease. Arthritis Rheum 2005; 52:1794.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/22\">",
"      Kalliolias GD, Georgiou PE, Antonopoulos IA, et al. Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial. Ann Rheum Dis 2007; 66:842.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/23\">",
"      K&ouml;tter I, Wacker A, Koch S, et al. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature. Semin Arthritis Rheum 2007; 37:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/24\">",
"      Vasques Godinho FM, Parreira Santos MJ, Canas da Silva J. Refractory adult onset Still's disease successfully treated with anakinra. Ann Rheum Dis 2005; 64:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/25\">",
"      Lequerr&eacute; T, Quartier P, Rosellini D, et al. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Ann Rheum Dis 2008; 67:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/26\">",
"      Ahmadi-Simab K, Lamprecht P, Jankowiak C, Gross WL. Successful treatment of refractory adult onset Still's disease with rituximab. Ann Rheum Dis 2006; 65:1117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/27\">",
"      Fautrel B, Borget C, Rozenberg S, et al. Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease. J Rheumatol 1999; 26:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/28\">",
"      Kraus A, Alarc&oacute;n-Segovia D. Fever in adult onset Still's disease. Response to methotrexate. J Rheumatol 1991; 18:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/29\">",
"      Fujii T, Akizuki M, Kameda H, et al. Methotrexate treatment in patients with adult onset Still's disease--retrospective study of 13 Japanese cases. Ann Rheum Dis 1997; 56:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/30\">",
"      Masson C, Le Lo&euml;t X, Liot&eacute; F, et al. Adult Still's disease. Part II. Management, outcome, and prognostic factors. Rev Rhum Engl Ed 1995; 62:758.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/31\">",
"      Shojania K, Chalmers A, Rangno K. Cyclosporin A in the treatment of adult Still's disease. J Rheumatol 1995; 22:1391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/32\">",
"      Omagari K, Matsunaga Y, Yamashita H, et al. Successful treatment with cyclosporin in adult-onset Still disease manifesting as acute hepatitis with marked hyperferritinemia. Am J Med Sci 2003; 326:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/33\">",
"      Marchesoni A, Ceravolo GP, Battafarano N, et al. Cyclosporin A in the treatment of adult onset Still's disease. J Rheumatol 1997; 24:1582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/34\">",
"      Larson EB. Adult Still's disease. Evolution of a clinical syndrome and diagnosis, treatment, and follow-up of 17 patients. Medicine (Baltimore) 1984; 63:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/35\">",
"      Mahmud T, Hughes GR. Intravenous immunoglobulin in the treatment of refractory adult Still's disease. J Rheumatol 1999; 26:2067.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/36\">",
"      Irigoyen, PI, Olson, J, Hom, C, et al. Treatment of systemic onset juvenile rheumatoid arthritis with anakinra (abstract). Arthritis Rheum 2004; 50:S437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/37\">",
"      Henrickson, M. Efficacy of anakinra in refractory systemic arthritis (abstract). Arthritis Rheum 2004; 50:S438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/38\">",
"      Jung JH, Jun JB, Yoo DH, et al. High toxicity of sulfasalazine in adult-onset Still's disease. Clin Exp Rheumatol 2000; 18:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/39\">",
"      Bennett AN, Peterson P, Sangle S, et al. Adult onset Still's disease and collapsing glomerulopathy: successful treatment with intravenous immunoglobulins and mycophenolate mofetil. Rheumatology (Oxford) 2004; 43:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35174/abstract/40\">",
"      Vignes S, Wechsler B, Amoura Z, et al. Intravenous immunoglobulin in adult Still's disease refractory to non-steroidal anti-inflammatory drugs. Clin Exp Rheumatol 1998; 16:295.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5595 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-183.166.191.243-0970125B04-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_22_35174=[""].join("\n");
var outline_f34_22_35174=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      COURSE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Predictors of chronic disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Functional outcomes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      TREATMENT OPTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      NSAIDs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      GLUCOCORTICOIDS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      BIOLOGIC AGENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      TNF inhibitors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Anakinra",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Rituximab",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      DMARDs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Methotrexate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Cyclosporine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/5595\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/5595|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?6/35/6715\" title=\"table 1\">",
"      Manifestations of adult Stills",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?25/30/26091\" title=\"table 2\">",
"      ACR RA response criteria",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/14/33000?source=related_link\">",
"      Causes and diagnosis of secondary (AA) amyloidosis and relation to rheumatic diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/3/11320?source=related_link\">",
"      Clinical manifestations and diagnosis of adult Still's disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/35/21046?source=related_link\">",
"      Systemic onset juvenile idiopathic arthritis: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_22_35175="Convergence insufficiency";
var content_f34_22_35175=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F72919&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F72919&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Convergence insufficiency",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 376px; height: 520px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) The patient is fixing on a near target with both eyes and single vision. B) When the target is moved a bit closer (too close for the patient to converge on the target), the left eye drifts, with resultant diplopia. The patient has a remote near point of convergence.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Tasman W, Jaeger E. The Wills Eye Hospital Atlas of Clinical Ophthalmology, 2e. Lippincott Williams &amp; Wilkins, 2001. Copyright &copy;2001 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_22_35175=[""].join("\n");
var outline_f34_22_35175=null;
var title_f34_22_35176="Tonsillectomy in adults: Indications";
var content_f34_22_35176=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Tonsillectomy in adults: Indications",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/22/35176/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/22/35176/contributors\">",
"     Jose W Ruiz, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/22/35176/contributors\">",
"     Shira Doron, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/22/35176/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/22/35176/contributors\">",
"     Mark D Aronson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/22/35176/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/22/35176/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?34/22/35176/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 31, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The number of tonsillectomies performed in the United States peaked around 1959 with 1.4 million operations, the majority being performed in children. The rate decreased to 500,000 in 1979 and to 380,000 in 1996 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Approximately 130,000 of the tonsillectomies performed in 1996 were for individuals over 15 years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The literature regarding indications for tonsillectomy is largely focused on children. The extent to which pediatric data can be reliably extrapolated to older patients is unclear.",
"   </p>",
"   <p>",
"    This topic will review indications for performing tonsillectomy in adults. Tonsillectomy procedural techniques and complications in adults, evaluation of the adult with pharyngitis, and tonsillectomy in children are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/38/6761?source=see_link\">",
"     \"Tonsillectomy in adults: Surgery\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/38/5738?source=see_link\">",
"     \"Evaluation of acute pharyngitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/22/35178?source=see_link\">",
"     \"Tonsillectomy and adenoidectomy in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PHARYNGEAL ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tonsils are lymphoid tissue. The lymphoid contents are covered by respiratory epithelium that can invaginate and cause crypts. The common term \"tonsils\" refers specifically to the palatine tonsils. Waldeyer's ring, a ring of lymphoid tissue in the pharynx, is formed by the palatine tonsils, as well as the pharyngeal tonsils (adenoids), tubal tonsils, and lingual tonsils (",
"    <a class=\"graphic graphic_figure graphicRef75111 \" href=\"mobipreview.htm?12/5/12368\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef72358 \" href=\"mobipreview.htm?41/4/42053\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Tonsillar crypts can harbor bacteria. Solidified \"plugs\" may form within the crypts, and are termed tonsilloliths (\"tonsil stones\"). These often have a foul smell and can contribute to bad breath.",
"   </p>",
"   <p>",
"    Tonsil size is based on a grading scale between 0 to 4:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Grade 0: Tonsils absent or atrophied",
"     </li>",
"     <li>",
"      Grade 1+: Tonsils fill 0 to 25 percent of the oropharyngeal diameter",
"     </li>",
"     <li>",
"      Grade 2+: Tonsils fill 25 to 50 percent",
"     </li>",
"     <li>",
"      Grade 3+: Tonsils fill 50 to 75 percent",
"     </li>",
"     <li>",
"      Grade 4+: Tonsils fill 75 to 100 percent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    \"Kissing tonsils\" fill 100 percent of the oropharyngeal diameter and are touching each other.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     POSSIBLE INDICATIONS FOR TONSILLECTOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a retrospective review of 361 tonsillectomy procedures performed in adults in one US academic institution between 2001 and 2007, the following indications accounted for the surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Chronic or recurrent infection - 57 percent",
"     </li>",
"     <li>",
"      Upper airway obstruction due to tonsillar hypertrophy - 27 percent",
"     </li>",
"     <li>",
"      Suspected neoplasm - 16 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Recurrent acute pharyngitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most episodes of acute pharyngitis are caused by viral infection and are benign and self-limited [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/5\">",
"     5",
"    </a>",
"    ]. One group of investigators has reported Mycoplasma pneumoniae to be a significant pathogen leading to severe recurrent acute tonsillopharyngitis and tonsillectomy in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/6\">",
"     6",
"    </a>",
"    ], but these observations require confirmation, and the issue has not been studied in adults. German investigators cultured tonsillar tissues from 130 children and adults undergoing tonsillectomy for recurrent tonsillitis (at least three episodes in the prior year) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/7\">",
"     7",
"    </a>",
"    ]. They found intracellularly persisting Staphylococcus aureus to be the predominant pathogen isolated and believe these organisms to be the most common cause of recurrent tonsillitis in their patients. A role for Fusobacterium necrophorum in recurrent or persistent sore throat has been suggested, particularly in adolescents and young adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/38/5738?source=see_link&amp;anchor=H7#H7\">",
"     \"Evaluation of acute pharyngitis in adults\", section on 'Fusobacterium necrophorum'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The proportion of adult cases of acute pharyngitis due to group A streptococci (GAS) is variable, but on average is approximately 10 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/10-14\">",
"     10-14",
"    </a>",
"    ]. This proportion may be higher among adults with repetitive episodes of tonsillitis, but detailed information on this issue is lacking. In one study in 285 children and adults who underwent tonsillectomy for recurrent tonsillitis, cultures of deep tonsillar tissue were negative for GAS, although GAS DNA was present in 20 percent and GAS RNA in 16.5 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/15\">",
"     15",
"    </a>",
"    ]. The authors concluded that factors other than GAS infection were likely responsible for most of the episodes of recurrent tonsillitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/38/5738?source=see_link&amp;anchor=H2#H2\">",
"     \"Evaluation of acute pharyngitis in adults\", section on 'Microbiology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Management is challenging in patients who experience multiple episodes of GAS acute pharyngitis within a period of months to years, confirmed by culture or rapid antigen test [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/16\">",
"     16",
"    </a>",
"    ]. There are several possible explanations for apparent recurrent GAS infection:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Repeated new infections with GAS acquired from family, classroom, or community contacts. As yet unidentified host factors may play a role in the propensity of presumed immunologically normal individuals to experience such repetitive illness.",
"     </li>",
"     <li>",
"      Persistence of an asymptomatic carrier state for GAS, and symptomatic pharyngitis due to unrelated intercurrent viral infection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/17\">",
"       17",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Noncompliance with the prescribed antimicrobial regimen [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/18\">",
"       18",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      A second episode of pharyngitis during convalescence with the original infecting group A streptococcal strain (ie, treatment failure), which is a rare event [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    True repeated streptococcal infections place the patient at risk for both suppurative and nonsuppurative (eg, acute rheumatic fever) GAS complications. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/30/27110?source=see_link\">",
"     \"Complications of streptococcal tonsillopharyngitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Criteria for surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Almost all studies of tonsillectomy for recurrent pharyngitis were performed in children. Based largely upon these data, the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) suggests that tonsillectomy be considered in patients who meet the &ldquo;Paradise&rdquo; criteria (below) with documentation in the medical record for each episode of sore throat and one or more of the following: temperature &gt;38.3&deg;C, cervical adenopathy, tonsillar exudate, or positive test for group A beta-hemolytic streptococcus. However, guidelines from the Infectious Disease Society of America (IDSA) advise that frequent GAS is not an appropriate sole indication for tonsillectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Recommendations from specialty societies'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    A frequently cited recommendation in children is the \"Paradise\" criteria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/21\">",
"     21",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Three or more episodes in each of three years; or",
"     </li>",
"     <li>",
"      Five or more episodes in each of two years; or",
"     </li>",
"     <li>",
"      Seven or more episodes in one year",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Stringent criteria define each qualifying episode [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For adults, there is no evidence from studies, nor is there expert opinion consensus, to support recommendations for a specified frequency of episodes that should prompt consideration of tonsillectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/22\">",
"     22",
"    </a>",
"    ]. Thus, each case should be evaluated individually with consideration of the frequency and duration of the problem, the severity of individual attacks, and their impact on the patient's quality of life. While evidence suggests that some adults experience substantial benefit from surgery, guidelines from the IDSA, updated in 2012, recommend that tonsillectomy not be performed for the sole indication of reducing the frequency of GAS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Efficacy of tonsillectomy for recurrent or chronic pharyngitis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Streptococcal carriage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment with oral antibiotics for asymptomatic patients is not advised on a routine basis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/20\">",
"     20",
"    </a>",
"    ]. Patients and families should be advised that carriers are unlikely to spread streptococci to close contacts and their own risk of streptococcal-related complications (eg, acute rheumatic fever) is minimal. &nbsp;Furthermore, there is no indication to perform tonsillectomy in asymptomatic group A streptococcal carrier.",
"   </p>",
"   <p>",
"    Treatment for streptococcal carriage is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/38/2666?source=see_link&amp;anchor=H18#H18\">",
"     \"Treatment and prevention of streptococcal tonsillopharyngitis\", section on 'Carriers'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Chronic tonsillitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic low-grade infection of the tonsils is a common indication for tonsillectomy in adults. Chronic tonsillitis is defined as the presence of a sore throat for at least three months' duration, accompanied by tonsillar inflammation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/23\">",
"     23",
"    </a>",
"    ]. The typical history in these patients is that their sore throat gets better during antibiotic treatment, but symptoms recur as soon as the antibiotic is discontinued.",
"   </p>",
"   <p>",
"    There is only one prospective study, and no randomized trials, of tonsillectomy for chronic tonsillitis in adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. Some have proposed that tonsillectomy should be considered for chronic tonsillitis that is unresponsive to aggressive medical therapy, and associated with persistent sore throat or tender cervical adenitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/23,26,27\">",
"     23,26,27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Halitosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic halitosis (bad breath) may be related to debris in the tonsillar crypts and the presence of tonsilloliths [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/27\">",
"     27",
"    </a>",
"    ]. Affected patients often have large crypts or spaces within the tonsils that collect bacteria, food, and debris (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/32/43527?source=see_link\">",
"     \"Bad breath\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Although the AAO-HNS and others have cited chronic halitosis as an indication for tonsillectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/26,27\">",
"     26,27",
"    </a>",
"    ], there are limited data to support this practice. In one study, after ruling out other possible causes (dental, periodontal, sinonasal, pulmonary, and esophageal), halitosis resolved in 35 of 44 (79.5 percent) patients eight weeks after tonsillectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/28\">",
"     28",
"    </a>",
"    ]. It has been suggested that tonsillectomy be considered in the management of halitosis only if a patient has malodorous stones in tonsillar crypts and halitosis persists despite optimal management of all other causes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Obstructive sleep apnea",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common indication for tonsillectomy and adenoidectomy in children is obstructive sleep apnea (OSA) due to adenotonsillar hypertrophy, while in adults it is chronic or recurrent tonsillitis. Large tonsils can obstruct the airway during sleep and children present with snoring, mouth breathing, witnessed apneic events, and daytime sleepiness. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/17/40217?source=see_link\">",
"     \"Management of obstructive sleep apnea in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For most adults, first-line treatment for OSA is weight loss (if appropriate), continuous positive airway pressure (CPAP),",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    dental appliance. Tonsillectomy may be part of a surgical treatment protocol, usually combined with uvulopalatopharyngoplasty. Surgery should only be considered when medical treatment is not tolerated or ineffective. Observational studies suggest that multilevel surgery (addressing nasal, oropharyngeal, and hypopharyngeal obstruction) is associated with improved outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/29\">",
"     29",
"    </a>",
"    ]. Future research should focus on prospective and controlled studies. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/48/2826?source=see_link&amp;anchor=H15#H15\">",
"     \"Management of obstructive sleep apnea in adults\", section on 'Surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Asymmetric tonsils",
"    </span>",
"    &nbsp;&mdash;&nbsp;Asymmetric tonsils are most often due to benign factors such as unequal scarring from infections, unbalanced lymphoid hyperplasia, or an illusion created by a difference in the depth of the tonsillar fossa. Unilateral tonsillar enlargement, in the absence of other signs or symptoms, carries a low risk for malignancy. In a retrospective review of 53 patients who underwent tonsillectomy for unilateral tonsillar enlargement in one institution, malignancy was identified in 9 of 20 patients with symptoms or additional findings, and 0 of 33 patients without such findings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/30\">",
"     30",
"    </a>",
"    ]. In another series of 98 cases, all 23 of the cancers detected occurred among the 37 cases for which preoperative clinical suspicion was high, based upon associated symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Malignancy should be suspected if unilateral enlargement is associated with any of the following signs or symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/23,30-32\">",
"     23,30-32",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Chronic pain",
"     </li>",
"     <li>",
"      Dysphagia",
"     </li>",
"     <li>",
"      Mucosal abnormality or ulceration",
"     </li>",
"     <li>",
"      Persistent cervical lymphadenopathy",
"     </li>",
"     <li>",
"      Progressive tonsillar enlargement",
"     </li>",
"     <li>",
"      Systemic symptoms suggestive of lymphoma (eg, night sweats, fever, weight loss)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients with these findings may have malignancies such as lymphoma or squamous cell carcinoma. Tonsillectomy may be required to obtain tissue for pathologic examination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Peritonsillar abscess",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peritonsillar abscess (PTA) is an infection in the space between the tonsil and pharyngeal constrictor muscle. It occurs more frequently in young adults than in children. The classic presentation is a history of sore throat for a few days, which significantly worsens, with severe dysphagia, odynophagia, and a \"hot potato\" voice. Treatment is with antimicrobial medication and drainage. Appropriate antibiotics should provide coverage for anaerobic bacteria as well as GAS. Drainage may involve needle aspiration or incisional drainage. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/45/36569?source=see_link&amp;anchor=H990950053#H990950053\">",
"     \"Deep neck space infections\", section on 'Peritonsillar abscess (quinsy)'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Immediate tonsillectomy (quinsy tonsillectomy) is occasionally needed for patients with PTA who fail to respond to medical treatment and drainage.",
"   </p>",
"   <p>",
"    Recurrence rate for PTA is reported from 10 to 15 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/33\">",
"     33",
"    </a>",
"    ], and recurrence is more likely if two or three episodes of acute tonsillitis have preceded the occurrence of PTA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/34\">",
"     34",
"    </a>",
"    ]. There are no prospective controlled trials comparing tonsillectomy with close monitoring for preventing recurrent PTA. Elective tonsillectomy is usually advocated if a patient has had two PTA episodes. Patients with only one episode of PTA, but a prior history of recurrent tonsillitis, are more likely to develop a second PTA and may benefit from elective tonsillectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Infectious mononucleosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tonsillectomy is not generally performed for infectious mononucleosis. Management of tonsillitis related to infectious mononucleosis involves symptomatic care with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    or non-steroidal anti-inflammatory drugs (NSAIDs). Corticosteroids are not routinely recommended, but may be needed if there is risk of airway obstruction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/35\">",
"     35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/18/31018?source=see_link\">",
"     \"Infectious mononucleosis in adults and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rarely, tonsillectomy may be indicated if there is upper airway obstruction from tonsillar hypertrophy that does not respond to corticosteroids [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/36\">",
"     36",
"    </a>",
"    ]. The risk of post-operative hemorrhage is increased in this subset of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Post-transplant",
"    </span>",
"    &nbsp;&mdash;&nbsp;Posttransplantation lymphoproliferative disease (PTLD) is a complication of solid organ and bone marrow transplantation. It is caused by Epstein-Barr virus and related to the intensity of immunosuppression and underlying recipient disease (such as hepatitis C or cytomegalovirus co-infection). PTLD has a high mortality and is difficult to diagnose. One study showed tonsillar hypertrophy, male gender, young age at transplantation, and liver transplantation were associated with higher rates of PTLD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/38\">",
"     38",
"    </a>",
"    ]. Early detection is critical; tonsillectomy is recommended for pathological diagnosis if there is tonsil enlargement of unknown cause and PTLD is suspected in a transplant recipient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/39\">",
"     39",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/50/23338?source=see_link\">",
"     \"Treatment and prevention of post-transplant lymphoproliferative disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Unknown (occult) primary",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cervical metastatic cancer from an unknown primary source accounts for 5 to 10 percent of head and neck cancers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/40\">",
"     40",
"    </a>",
"    ]. Tonsillar carcinoma is the source in 18 to 47 percent of these unknown primaries. The work-up for unknown primary may include imaging (CT, MRI,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    FDG-PET scan) followed by panendoscopy with biopsies and tonsillectomy for the potential primary sites. If there is no source identified, even clinically normal-looking tonsils might be removed to reveal an occult primary (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/44/30407?source=see_link\">",
"     \"Overview of head and neck cancer\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     EFFICACY OF TONSILLECTOMY FOR RECURRENT OR CHRONIC PHARYNGITIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Retrospective studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several groups have retrospectively studied the outcome of tonsillectomy in adults.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A 2003 study in Singapore reported one year follow-up of 121 adult patients (aged 18 to 52 years) with recurrent pharyngitis who underwent tonsillectomy without adenoidectomy for recurrent pharyngitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/41\">",
"       41",
"      </a>",
"      ]. Patients reported a decrease in the number of episodes of sore throat post-tonsillectomy, from an average of 8.4 in the year preceding surgery to 1.4 during the subsequent year. Similar improvements were reported for duration of episodes and number of work days missed.",
"     </li>",
"     <li>",
"      In another study, 114 adults scheduled for tonsillectomy in 2004 at a hospital in Germany completed a preoperative questionnaire developed by the investigators, as well as the Glasgow Benefit Inventory (GBI) designed to measure the quality of life (QOL) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/42\">",
"       42",
"      </a>",
"      ]. All subjects had suffered at least three episodes of acute tonsillitis in the year prior to surgery. Ninety-seven (85 percent) again completed the questionnaire one year later. Subjects ranged from 18 to 62 years of age with a median of 26 years. The GBI revealed improvement in the overall score as well as in the categories of general well-being and physical health. There were significant decreases in physician visits, antibiotic consumption, days off from work and episodes of sore throat.",
"     </li>",
"     <li>",
"      A mailed survey was conducted in the United States for adult patients (aged 16 to 60 years) who had undergone tonsillectomy without adenoidectomy for \"chronic infectious tonsillitis\" [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/43\">",
"       43",
"      </a>",
"      ]. Responders reported significant improvement in total GBI score as well as in general health, social functioning and physical functioning, comparing the 12 month period prior to tonsillectomy with extended follow-up post surgery. Patients reported decreases in mean weeks of antibiotics, clinician visits, and workdays missed. There was no correlation between GBI scores and duration of follow-up (mean 43 months), suggesting the durable value of tonsillectomy.",
"     </li>",
"     <li>",
"      In a subsequent analysis of data from the above study [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/43\">",
"       43",
"      </a>",
"      ], the direct medical costs of adult tonsillectomy were recovered by net cost savings at 12.7 years after operation and the overall economic costs (medical and work-related) were recovered at 2.3 years [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Three other studies reported similar improvements in QOL in adult patients operated for chronic or recurrent tonsillitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/45-47\">",
"       45-47",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The foregoing studies, although consistent in demonstrating a benefit of tonsillectomy in adults with recurrent or chronic tonsillitis, have serious limitations. They were retrospective and depended heavily on patient recall. Follow-up was often incomplete, short-term, and only one study included microbiologic data.",
"     </li>",
"     <li>",
"      Largely verifiable data and results of GAS throat cultures were incorporated in another retrospective study, involving 147 adult patients (16 years of age or older) who had tonsillectomy without adenoidectomy for chronic or recurrent tonsillitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/48\">",
"       48",
"      </a>",
"      ]. Data were analyzed for the two years before and after tonsillectomy. The mean number of clinic visits per patient declined from 3.9 prior to the operation to 0.4. Prescriptions for oral antibiotics declined after surgery as well. Patients with preoperative cultures positive for group A streptococci had significantly more preoperative clinic visits and more antibiotic prescriptions than subjects without positive cultures. Patients reported fewer and milder sore throats and fewer missed days from school or work at postoperative telephone survey.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The lack of a control group (patients with recurrent or chronic tonsillitis who did not undergo surgery) in all of the above studies raises concern about the reliability of the findings. Patient-reported history of recurrent infection may be unreliable, as found in a study in which histories of recurrent infection for children with sore throat did not correlate with findings of subsequent monitoring [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/49\">",
"     49",
"    </a>",
"    ]. Studies in children found that mean rates of severe or moderate infections tended to decrease over time in controls as well as surgical patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/21,50\">",
"     21,50",
"    </a>",
"    ]. However, the children who were randomly assigned to surgical management were less likely to record episodes of sore throat than those assigned to medical management [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/51\">",
"     51",
"    </a>",
"    ]. Two pediatric studies of children on the waiting list for approximately eight to nine months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/52,53\">",
"     52,53",
"    </a>",
"    ] found that 18 to 27 percent no longer warranted tonsillectomy when re-evaluated.",
"   </p>",
"   <p>",
"    The natural history of recurrent tonsillitis in children, however, may be different than in adults. One study in adults, although limited by a low follow-up rate, found that only half of 55 subjects on the waiting list for 18 months or more ultimately required surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/54\">",
"     54",
"    </a>",
"    ]. In contrast, however, a study in the UK found that symptoms of chronic tonsillitis abated in only 8 percent of 100 subjects aged 13 years or older who were on the tonsillectomy waiting list for two years, despite frequent courses of antibiotics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Prospective studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;A multicenter prospective study involved 72 adults (mean age 28 years) undergoing tonsillectomy for chronic or recurrent tonsillitis in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/25\">",
"     25",
"    </a>",
"    ]. Throat cultures for streptococci were positive in 42 percent of the thirty patients who had cultures performed. Participants completed a health status instrument and a health survey. Follow-up was available by questionnaire for 40 subjects (56 percent) at one year. Subjects were contacted repeatedly during the one-year study period to assure completion of questionnaires. They reported significant improvements in multiple parameters (airway and breathing, eating and swallowing, infection, overall physical functioning, health care utilization, and cost of care). An attempt to accrue and evaluate a comparison group of unoperated patients was unsuccessful, because almost all enrolled subjects underwent tonsillectomy.",
"   </p>",
"   <p>",
"    We are aware of only one randomized trial of tonsillectomy for streptococcal pharyngitis in adults (mean age 26 years) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/56\">",
"     56",
"    </a>",
"    ]. Consecutive Finnish patients with recurrent streptococcal pharyngitis (n = 70) were randomly assigned to receive either immediate surgery, or placed on a surgical waiting list. Entry criteria were three or more episodes of typical acute pharyngitis in 6 months or four episodes in 12 months, at least one of which was associated with a positive culture or rapid test for GAS. Waiting time in the control group ranged from 90 to 210 days and patients did not receive prophylactic treatment. During a 90 day follow-up period, streptococcal pharyngitis recurred in 24 percent of the controls and 3 percent of the tonsillectomy subjects. The number needed to undergo tonsillectomy to prevent one recurrence was 5 (95% CI 3-16). In addition, the time to first pharyngitis episode was significantly shorter and severity of symptoms was lower in the control than in the tonsillectomy group. The most common morbidity related to tonsillectomy was postoperative throat pain for a mean of 13&plusmn;4 days. The brief follow-up period precludes firm conclusions about the true benefit of the procedure.",
"   </p>",
"   <p>",
"    These Finish investigators subsequently published a prospective cohort study of 70 adult patients (presumably the same group mentioned above) who were asked to complete the GBI six months after tonsillectomy for recurrent tonsillitis and to maintain symptom diaries for six months before surgery (half the subjects) or six months post-operatively (the remaining subjects) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/57\">",
"     57",
"    </a>",
"    ]. Data from the 62 subjects completing the GBI indicated improvements in general health and physical functioning following surgery; additionally, patients who had a greater number of symptoms prior to surgery reported the greatest improvement in quality of life.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     RECOMMENDATIONS FROM SPECIALTY SOCIETIES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3303903\">",
"    <span class=\"h2\">",
"     AAO-HNS guidelines",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) Clinical Indicators Compendium in 2000 published guidelines for tonsillectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/26\">",
"     26",
"    </a>",
"    ]. These guidelines do not distinguish pediatric and adult populations, and support performing a tonsillectomy for patients with a history of one of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Three or more tonsil",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      adenoid infections per year despite adequate medical therapy. Information about dates of last two infections, description of fever, severity of discomfort, throat cultures, use of antibiotics and history of otitis media management should be obtained.",
"     </li>",
"     <li>",
"      Tonsillar hypertrophy causing dental malocclusion or adversely affecting orofacial growth documented by orthodontist.",
"     </li>",
"     <li>",
"      Tonsillar hypertrophy causing upper airway obstruction, severe dysphagia, sleep disorders, or cardiopulmonary complications.",
"     </li>",
"     <li>",
"      Peritonsillar abscess unresponsive to medical management and drainage documented by surgeon, unless surgery performed during acute stage.",
"     </li>",
"     <li>",
"      Persistent foul taste or breath due to tonsillar crypt stones.",
"     </li>",
"     <li>",
"      Chronic or recurrent tonsillitis associated with the streptococcal carrier state and not responding to beta-lactamase-resistant antibiotics.",
"     </li>",
"     <li>",
"      Unilateral tonsil hypertrophy presumed neoplastic.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The AAO-HNS published subsequent guidelines in 2011 but these specifically only address indications for tonsillectomy in children 00up to age 18 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/58\">",
"     58",
"    </a>",
"    ]. These guidelines advise the Paradise criteria (three episodes yearly for three years; five episodes yearly for two years; or seven episodes in one year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/21\">",
"     21",
"    </a>",
"    ]) as guidance for the frequency of recurrence.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3303915\">",
"    <span class=\"h2\">",
"     IDSA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Guidelines from the Infectious Disease Society of America (IDSA), updated in 2012, recommend against tonsillectomy &ldquo;solely to reduce the frequency of GAS pharyngitis&rdquo; [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/20\">",
"     20",
"    </a>",
"    ]. They do note that tonsillectomy may be considered in the rare patient with recurrent symptoms of GAS pharyngitis that do not diminish over time and for which there is no alternative explanation.",
"   </p>",
"   <p>",
"    As discussed previously, consensus is lacking on the specific frequency of recurrent tonsillitis (GAS or non-GAS) episodes that should generate consideration of tonsillectomy. While the Paradise criteria (three episodes yearly for three years; five episodes yearly for two years; or seven episodes in one year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35176/abstract/21\">",
"     21",
"    </a>",
"    ]) have been proposed in children, they have not been studied in adults. However, they reflect a conservative approach that we support. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Criteria for surgery'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Additionally, we do not advise tonsillectomy for the streptococcal carrier state. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Streptococcal carriage'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Findings suggesting neoplasia as a cause of tonsillar asymmetry include chronic pain, dysphagia, mucosal lesions, persistent lymphadenopathy, progressive tonsil enlargement, and constitutional symptoms. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Asymmetric tonsils'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tonsils are lymphoid tissue covered by respiratory epithelium. The common term \"tonsils\" refers specifically to the palatine tonsils. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pharyngeal anatomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most episodes of acute pharyngitis are caused by viral infection, with group A streptococcal (GAS) infection in adults accounting for approximately 10 percent. Recurrent cultures positive for GAS may represent repeated infection, a carrier state, inadequate treatment, or treatment failure. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Recurrent acute pharyngitis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Streptococcal carriage'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Tonsillectomy appears to be effective in decreasing the frequency of episodes of recurrent pharyngitis and in improving the quality of life of adults who suffer from the symptoms of chronic tonsillitis. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Recurrent acute pharyngitis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There is a paucity of data from randomized trials supporting indications for tonsillectomy in adults. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Possible indications for tonsillectomy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      We suggest tonsillectomy for patients with documented recurrent tonsillitis whose quality of life is adversely affected (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Supportive data are lacking on specific criteria for frequency of recurrence. Although they were not developed for adults, we suggest applying the Paradise criteria: three episodes yearly for three years; five episodes yearly for two years; or seven episodes in one year (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Recurrent acute pharyngitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest not performing tonsillectomy for elimination of the streptococcal carrier state (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Streptococcal carriage'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest tonsillectomy for chronic tonsillitis only when unresponsive to aggressive medical therapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      We suggest tonsillectomy for halitosis be performed only in patients with malodorous tonsillar crypt stones and persistent symptoms despite optimal medical management (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      We suggest tonsillectomy in patients with marked tonsillar asymmetry only for patients who have concurrent signs or symptoms suggesting possible malignancy (chronic pain, dysphagia, mucosal abnormality, persistent cervical adenopathy, progressive tonsil enlargement, systemic symptoms) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      We suggest tonsillectomy for patients with a second episode of peritonsillar abscess (PTA) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). We also suggest tonsillectomy for patients with a first episode of PTA preceded by three episodes of acute tonsillitis in the previous year (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      We recommend not performing tonsillectomy for most patients with tonsillitis related to infectious mononucleosis (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). However, tonsillectomy may be indicated for these patients if there is upper airway obstruction from tonsillar hypertrophy that does not respond to corticosteroids.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/1\">",
"      Rosenfeld RM, Green RP. Tonsillectomy and adenoidectomy: changing trends. Ann Otol Rhinol Laryngol 1990; 99:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/2\">",
"      Hall MJ, Lawrence L. Ambulatory surgery in the United States, 1996. Adv Data 1998; :1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/3\">",
"      Owings MF, Kozak LJ. Ambulatory and inpatient procedures in the United States, 1996. National Center for Health Statistics. Vital Health Stat 1998; 13:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/4\">",
"      Hoddeson EK, Gourin CG. Adult tonsillectomy: current indications and outcomes. Otolaryngol Head Neck Surg 2009; 140:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/5\">",
"      Bisno AL. Acute pharyngitis. N Engl J Med 2001; 344:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/6\">",
"      Esposito S, Marchisio P, Capaccio P, et al. Role of atypical bacteria in children undergoing tonsillectomy because of severely recurrent acute tonsillopharyngitis. Eur J Clin Microbiol Infect Dis 2008; 27:1233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/7\">",
"      Zautner AE, Krause M, Stropahl G, et al. Intracellular persisting Staphylococcus aureus is the major pathogen in recurrent tonsillitis. PLoS One 2010; 5:e9452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/8\">",
"      Batty A, Wren MW, Gal M. Fusobacterium necrophorum as the cause of recurrent sore throat: comparison of isolates from persistent sore throat syndrome and Lemierre's disease. J Infect 2005; 51:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/9\">",
"      Jensen A, Hagelskjaer Kristensen L, Prag J. Detection of Fusobacterium necrophorum subsp. funduliforme in tonsillitis in young adults by real-time PCR. Clin Microbiol Infect 2007; 13:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/10\">",
"      Walsh BT, Bookheim WW, Johnson RC, Tompkins RK. Recognition of streptococcal pharyngitis in adults. Arch Intern Med 1975; 135:1493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/11\">",
"      Komaroff AL, Pass TM, Aronson MD, et al. The prediction of streptococcal pharyngitis in adults. J Gen Intern Med 1986; 1:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/12\">",
"      Centor RM, Witherspoon JM, Dalton HP, et al. The diagnosis of strep throat in adults in the emergency room. Med Decis Making 1981; 1:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/13\">",
"      McIsaac WJ, Goel V, To T, Low DE. The validity of a sore throat score in family practice. CMAJ 2000; 163:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/14\">",
"      McIsaac WJ, Kellner JD, Aufricht P, et al. Empirical validation of guidelines for the management of pharyngitis in children and adults. JAMA 2004; 291:1587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/15\">",
"      Skoulakis Ch, Tigiroglou E, Gkarelis K, et al. Level of Streptococcus pyogenes in patients with recurrent tonsillitis and tonsillar hypertrophy. Scand J Infect Dis 2008; 40:899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/16\">",
"      Bisno AL, Gerber MA, Gwaltney JM Jr, et al. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis 2002; 35:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/17\">",
"      Kaplan EL, Gastanaduy AS, Huwe BB. The role of the carrier in treatment failures after antibiotic for group A streptococci in the upper respiratory tract. J Lab Clin Med 1981; 98:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/18\">",
"      Schwartz RH, Wientzen RL Jr, Pedreira F, et al. Penicillin V for group A streptococcal pharyngotonsillitis. A randomized trial of seven vs ten days' therapy. JAMA 1981; 246:1790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/19\">",
"      Gerber MA, Randolph MF, Chanatry J, et al. Once daily therapy for streptococcal pharyngitis with cefadroxil. J Pediatr 1986; 109:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/20\">",
"      Shulman ST, Bisno AL, Clegg HW, et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis 2012; 55:1279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/21\">",
"      Paradise JL, Bluestone CD, Bachman RZ, et al. Efficacy of tonsillectomy for recurrent throat infection in severely affected children. Results of parallel randomized and nonrandomized clinical trials. N Engl J Med 1984; 310:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/22\">",
"      Katzenell U, Bakshi E, Ashkenazi I, et al. A retrospective study of the eligibility for tonsillectomy. Isr Med Assoc J 2010; 12:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/23\">",
"      Darrow DH, Siemens C. Indications for tonsillectomy and adenoidectomy. Laryngoscope 2002; 112:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/24\">",
"      Burton MJ, Towler B, Glasziou P. Tonsillectomy versus non-surgical treatment for chronic / recurrent acute tonsillitis. Cochrane Database Syst Rev 2000; :CD001802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/25\">",
"      Witsell DL, Orvidas LJ, Stewart MG, et al. Quality of life after tonsillectomy in adults with recurrent or chronic tonsillitis. Otolaryngol Head Neck Surg 2008; 138:S1.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Otolaryngology-Head and Neck Surgery. Clinical indicators: tonsillectomy, adenoidectomy, adenotonsillectomy. 2000 Available at www.entnet.org/practice/products/indicators/tonsillectomy.html. (Accessed December 21, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/27\">",
"      Rio AC, Franchi-Teixeira AR, Nicola EM. Relationship between the presence of tonsilloliths and halitosis in patients with chronic caseous tonsillitis. Br Dent J 2008; 204:E4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/28\">",
"      Al-Abbasi AM. Tonsillectomy for the treatment of halitosis. Niger J Med 2009; 18:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/29\">",
"      Lin HC, Friedman M, Chang HW, Gurpinar B. The efficacy of multilevel surgery of the upper airway in adults with obstructive sleep apnea/hypopnea syndrome. Laryngoscope 2008; 118:902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/30\">",
"      Sunkaraneni VS, Jones SE, Prasai A, Fish BM. Is unilateral tonsillar enlargement alone an indication for tonsillectomy? J Laryngol Otol 2006; 120:E21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/31\">",
"      Spinou C, Kubba H, Konstantinidis I, Johnston A. Role of tonsillectomy in histology for adults with unilateral tonsillar enlargement. Br J Oral Maxillofac Surg 2005; 43:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/32\">",
"      Cinar F. Significance of asymptomatic tonsil asymmetry. Otolaryngol Head Neck Surg 2004; 131:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/33\">",
"      Johnson RF, Stewart MG, Wright CC. An evidence-based review of the treatment of peritonsillar abscess. Otolaryngol Head Neck Surg 2003; 128:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/34\">",
"      Herzon FS. Harris P. Mosher Award thesis. Peritonsillar abscess: incidence, current management practices, and a proposal for treatment guidelines. Laryngoscope 1995; 105:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/35\">",
"      Candy B, Hotopf M. Steroids for symptom control in infectious mononucleosis. Cochrane Database Syst Rev 2006; :CD004402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/36\">",
"      Chan SC, Dawes PJ. The management of severe infectious mononucleosis tonsillitis and upper airway obstruction. J Laryngol Otol 2001; 115:973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/37\">",
"      Windfuhr JP, Chen YS, Remmert S. Hemorrhage following tonsillectomy and adenoidectomy in 15,218 patients. Otolaryngol Head Neck Surg 2005; 132:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/38\">",
"      Sturm-O'Brien AK, Hicks MJ, Giannoni CM, et al. Tonsillectomy in post-transplant lymphoproliferative disease in children. Laryngoscope 2010; 120:608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/39\">",
"      Mucha K, Foroncewicz B, Niemczyk K, et al. Tonsil enlargement after liver transplantation in adults--reason enough for tonsillectomy? Two cases of tonsillar posttransplantation lymphoproliferative disease. Liver Transpl 2007; 13:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/40\">",
"      Kothari P, Randhawa PS, Farrell R. Role of tonsillectomy in the search for a squamous cell carcinoma from an unknown primary in the head and neck. Br J Oral Maxillofac Surg 2008; 46:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/41\">",
"      Hsu AP, Tan KL, Tan YB, et al. Benefits and efficacy of tonsillectomy for recurrent tonsillitis in adults. Acta Otolaryngol 2007; 127:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/42\">",
"      Senska G, Ellermann S, Ernst S, et al. Recurrent tonsillitis in adults: quality of life after tonsillectomy. Dtsch Arztebl Int 2010; 107:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/43\">",
"      Bhattacharyya N, Kepnes LJ, Shapiro J. Efficacy and quality-of-life impact of adult tonsillectomy. Arch Otolaryngol Head Neck Surg 2001; 127:1347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/44\">",
"      Bhattacharyya N, Kepnes LJ. Economic benefit of tonsillectomy in adults with chronic tonsillitis. Ann Otol Rhinol Laryngol 2002; 111:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/45\">",
"      Baumann I, Kucheida H, Blumenstock G, et al. Benefit from tonsillectomy in adult patients with chronic tonsillitis. Eur Arch Otorhinolaryngol 2006; 263:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/46\">",
"      Richards AL, Bailey M, Hooper R, Thomson P. Quality-of-life effect of tonsillectomy in a young adult group. ANZ J Surg 2007; 77:988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/47\">",
"      Schwentner I, H&ouml;fer S, Schmutzhard J, et al. Impact of tonsillectomy on quality of life in adults with chronic tonsillitis. Swiss Med Wkly 2007; 137:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/48\">",
"      Mui S, Rasgon BM, Hilsinger RL Jr. Efficacy of tonsillectomy for recurrent throat infection in adults. Laryngoscope 1998; 108:1325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/49\">",
"      Paradise JL, Bluestone CD, Bachman RZ, et al. History of recurrent sore throat as an indication for tonsillectomy. Predictive limitations of histories that are undocumented. N Engl J Med 1978; 298:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/50\">",
"      Paradise JL, Bluestone CD, Colborn DK, et al. Tonsillectomy and adenotonsillectomy for recurrent throat infection in moderately affected children. Pediatrics 2002; 110:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/51\">",
"      Lock C, Wilson J, Steen N, et al. North of England and Scotland Study of Tonsillectomy and Adeno-tonsillectomy in Children(NESSTAC): a pragmatic randomised controlled trial with a parallel non-randomised preference study. Health Technol Assess 2010; 14:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/52\">",
"      Prim MP, de Diego JI, Larrauri M, et al. Spontaneous resolution of recurrent tonsillitis in pediatric patients on the surgical waiting list. Int J Pediatr Otorhinolaryngol 2002; 65:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/53\">",
"      Woolford TJ, Ahmed A, Willatt DJ, Rothera MP. Spontaneous resolution of tonsillitis in children on the waiting list for tonsillectomy. Clin Otolaryngol Allied Sci 2000; 25:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/54\">",
"      Mulwafu W, Fagan JJ, Isaacs S. Adult tonsillectomy--are long waiting lists putting patients at risk? S Afr J Surg 2006; 44:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/55\">",
"      Laing MR, McKerrow WS. Adult tonsillectomy. Clin Otolaryngol Allied Sci 1991; 16:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/56\">",
"      Alho OP, Koivunen P, Penna T, et al. Tonsillectomy versus watchful waiting in recurrent streptococcal pharyngitis in adults: randomised controlled trial. BMJ 2007; 334:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35176/abstract/57\">",
"      Koskenkorva T, Koivunen P, Penna T, et al. Factors affecting quality-of-life impact of adult tonsillectomy. J Laryngol Otol 2009; 123:1010.",
"     </a>",
"    </li>",
"    <li>",
"     Baugh RF, Archer SM, Mitchell RB, et al. Clinical Practice Guideline: Tonsillectomy in children. On behalf of American Academy of Otolaryngology-head and Neck Surgery. 2011 file://m.oto.sagepub.com/content/144/1_suppl/S1.full.pdf (Accessed on October 29, 2012).",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6869 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-A392849A5D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_22_35176=[""].join("\n");
var outline_f34_22_35176=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PHARYNGEAL ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      POSSIBLE INDICATIONS FOR TONSILLECTOMY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Recurrent acute pharyngitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Causes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Criteria for surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Streptococcal carriage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Chronic tonsillitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Halitosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Obstructive sleep apnea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Asymmetric tonsils",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Peritonsillar abscess",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Infectious mononucleosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Post-transplant",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Unknown (occult) primary",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      EFFICACY OF TONSILLECTOMY FOR RECURRENT OR CHRONIC PHARYNGITIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Retrospective studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Prospective studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      RECOMMENDATIONS FROM SPECIALTY SOCIETIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3303903\">",
"      AAO-HNS guidelines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3303915\">",
"      IDSA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/6869\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/6869|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?12/5/12368\" title=\"figure 1\">",
"      Waldeyers ring",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?41/4/42053\" title=\"figure 2\">",
"      Peritonsillar space anatomy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/32/43527?source=related_link\">",
"      Bad breath",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/30/27110?source=related_link\">",
"      Complications of streptococcal tonsillopharyngitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/45/36569?source=related_link\">",
"      Deep neck space infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/38/5738?source=related_link\">",
"      Evaluation of acute pharyngitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/18/31018?source=related_link\">",
"      Infectious mononucleosis in adults and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/48/2826?source=related_link\">",
"      Management of obstructive sleep apnea in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/17/40217?source=related_link\">",
"      Management of obstructive sleep apnea in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/44/30407?source=related_link\">",
"      Overview of head and neck cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/22/35178?source=related_link\">",
"      Tonsillectomy and adenoidectomy in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/38/6761?source=related_link\">",
"      Tonsillectomy in adults: Surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/50/23338?source=related_link\">",
"      Treatment and prevention of post-transplant lymphoproliferative disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/38/2666?source=related_link\">",
"      Treatment and prevention of streptococcal tonsillopharyngitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_22_35177="Bacillary angiomatosis";
var content_f34_22_35177=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F78497%7EID%2F76323&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F78497%7EID%2F76323&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Cutaneous lesion of bacillary angiomatosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF6AfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDJtHSwhEjzBwflUkE8H0qZ5VljWaZ3WTH3T0C+lU/OSO4ZrhCqL0XHRSeoFXdRjkh02V9gdpMbDnOwfX3rnZ6KIrJ3SRZCR9mjGQCfvexrNnkiin3bRgPs2gkAjqOPatvTILWxliW+DPbKpZgOTI2OMfjVa7jtSy3N7tiMowMf8sgD8p+vajRoGtbskWV4rB0KFVPQ45xj9KyDE9xdtJbIwKKM8nGKvPO1+hj3ZRRyM4DY7mm6E8iym9kkj4JRY9vGAOvuO1G+4paIlS3RbX55VWZzl23fdWorOzl1aMhZM28L5Bz8z+1MupI4pP3SYMrZSNugz3P41eeVrRI7WBN68F/L+Ub8cHPeqW4PVGdJ5n22O1uvM8iI8ADk+g+n8qm1DT2tGjN2+25kO4qpz5S9QAe+a05ref8AdxSqrMyF4yWweepY+tULaYGINMkm5T5cUz87VzySPT0qtFqZ2b0Iv7Qe5gEYV2mh/dtGB1HvUWnaGzxXE1wPMwpdgX27R2yfSrt/NBaeW1r9y4TEszffY9yPap7mxur3yorVGK7MqIxvL49cdqnmcmXypIo2s0+oMtvcspZUIEYHTHRs+tMmsGmjaWWfabfMb7V4AHQnn6VPEYrVQnmNvEmREqlS2exzzU93bqUmTy2hDtvZU+btxu+lEpX3CMepQ05UPmPImF2EiVySc4z09fSrOn281/DucAtuyrucADpjjrVSKMyXJtbeU+XGSzMeMHsT/KtdZ0tbVLYCWNACJZCecZ4xWaZpylcaPNHMrzy+ZFkqqvgsB3YAdB6E1Ev2u1vJIrOKYeY+8qxBLgjjbnv+lWvNluV/0FJHjh4aTIVcDr9aS2a5mv5bl2QuuMFjwMjHGfT0oTXQOXTUo3+owI0aW0MyXMRK4kPKH8PTmnwBb4Kpie8nDfvGAK/Lj7oI+6AatyW8ccjW4nikmAb5vKxkY4x75PepY/s9s6WsLMs8iBZgegHVmOOnpQ9XcS7FLRtLmmnmWO8lhmjAAhRc+YM8gnouBTWt5Z7trW1d5TISAgXPHfcf61rW7m10+WEsdrIdhjX5iMnrVGwtHMMEKtGsjjdw2367m6ClJK2hSKzWl+LTy1aKRI2wUdceX7buhFEAuJleO8uZIlJDSq+Eyo7eh59KvpPeyXawmRCIlzGSw2rg9eRzTLTEzym4YXLNGVYyKCE56jP6VG4+WxTCNe7NyiK23kRxtyeT0Jqw9mqTC3ikeOeXosecOvrzzx6d6S4ivrMWkAkkEe4SRxSjPJ747VYaYNKEuIDEXfJdG4ZhwOeoHt3oTuPyRNb29zBBM0TxvbwrsDTjYMnuB61Qje4mi3p5k6ldryO+AD0HP9K0DqiP5sEMyPH90yCMEHnI4IyMevU1Np0fm20gklieeQFgvlsdp9MAYB4zmq3dg1sVLEC0tLlp4Z/tEIATfIqKCT97HVqoiSS/YIJVdYW83aXO6Rs9Fx/Kr8s8ly5hkmQ4XLyP96UDGDz0H+FWdOglkx9kuGW4nQyFIvl2gcE+xAA/Ole70G9ivDdeRYStC0D3UjH5RJloh0wff3qhdXkiBWkKKRCQoj+YnPVjz0q/NpxjtTPJKI137TGEyzLxlie9Ndo2jZUQI0xwpUDAUY79unSht7CdilZWs0tmZbhn8lM+Wj4UMM5J65OfTtVJgDPIkVsUgZRJGEbJY9CcHqM1cuLbzFR2y5UliVyDnHPXqaV5HTVrZbMRF2t2idUJOzHzcE9eh6UJpoVhdOM0cSpcSRmJlbYkoLgg/wAXsQelVFtPKAR3aS2B+eY9Fz0yPf1Fa1k0F0otIXMSqN/m4/1pzwoHYDJ71HqN49vHEFCiQfIseAxDeox2FJ+Y7IqCF47GZ4ZHeMYaSNGIx6c9Gx6ValUSxxx2rIjyY+ZFPz46Kw7evNLFpUkFu7Tby8gBCqw8tT/efsSeeKmuRNaRJOUtZrhwERUm8wjgg/J6YPWqirkt2MSeVL27kjlPl3gOHYthVP4dsVXtBLDei2t2mdj94AZY46hOxB9KsTpCjbJLeRJSA+GOTz0B/wBk9fapL67ZbYrFCyOhBZHYcEf3cDKilawNkms6klwIl3PDgYc7WADA/L78dPxp6Nbx2Qe5vkVmOwQ8sT3OT2OazUeaWFYY44p2J3MSC0jD0z6c1LE8MFyXvLeY5HDPgBVzgf7xFNa7k6rY1LEq8El1tjYgAIrPkqD97joT7VbjUSBJ38xZk3IMrgDPQnsfpVCyhtrxgkSIFGVTjALe/vVryIXjRYwwKSbpIx83Y8Zx+lNOyshq7K9xvfyY7udWBBfgZwQewHTPvUKWkv8Ax8Wyutt/GZWwv4DqKteZHFJMLS1iZ4wJGjPIYDkk+vvSNeS3bbvJjTaVRVXAVu53ewPShWa1E+xSVYw2JJJUI+VYpWztJHXb3Apk+n2+pRm4bMLIPmlXJDdh8o/rU8lkt3JIsw8vYN21CCcnjj1pfN+y2gW5Hmxg8RxfIysOhY9D9KEhszvtGqW8H3TeW6n5jENpP1HqKktdStHjdI9kM78Cadtmw56Ed+O9WLG8Vl865iiJI3YxhUBPJAzxUc6xaiFRY4t8nymR48B2z2aiyuTfsXb1YFiMa3Nuw/uxjzN3vuHas2SK0mKB5wirnOAVYn2pbXSolknSe6nFyqkKIhwX6bQem2oZrWaOCJZoy2TjYOq9ecnr+FGgakb25SV/JLGTH7uSLgFffPBqJ7uRyiTE5B+ZofvoB6E9K2lliGnyW0luzPJx5vmMgi46BehrJe1kW1RVaYpnOTBwremc9abFcL64MEBBJlaRd8UkZB4x91gO/wBKcJpbixjbOdyZVRgiQegH9ar2j3MNwkj21tcqpz+/UhTj+E4Ix9api68onfF9mjeQuuxuV9Bu7il5i5uhvRO1uRiKRNwDyIzAED196ZfFzfwo6lVZDtDjaGB6ZPeqdlKYUZ5PKuSxGCp3MR6Een0qw0sck0U4b95u2YDbiuB2B7UIfMQ3Wl/aHdvICJGxBZJDn6Z/rTPsggA88/KVGyVuPl6AEDv79Kt3EiJFHFBE+RKJHlJIyByVPrU0pEs5mi2iE+o+XPqB3+lU7Cs73MmCIi4VBPEiAkNI3IK+pq0FzatEZ2CBMFWwA5HQg9TTp7WU3D3EbxCfaG8tBlWB7hRVYSSRebBckxqVJGF3FT9fSp2GS2dlCI45JTKpYZbCk8+n/wBeirqO8awGTbOrJhY3J2k+q/T3oo9BmneRWx1u1XfvByGdsgNntj2q/FKIEFrhd0TbkY/dwOhPvVG/Pljkb3Q7gmcke9F5LKILNt29ZzsIxgnHv6VpfV2BRe5pWoSW1ubt9jIrFWcAZ/AfWs2000Xl5LJOAlsgJJbvnp+NTQo6y+XCDtlJ2E/KqmrcjBYHt3fcwO6QcdfXNHuhZsyLi1SJWSycRKgPmO3/AC1Xtkdse1RbjBZyxGLb5sYBZBuyO59s1eRA94jybdmclSex44qLJiDMWCrKxiLAchexpOXUfLdiW2lLLbC6kMXkJjymd8iTB/nWjpzLOXkVVZj3IxgDsPU1TktYUs+XSKMcArkMx+lUVu5rNlSMlgTuSN+Sme44quZXViWmjobsvKqGAKISjb1xl2Oep9MdKz9QnjszGh2yzSKAu0ZEWf649apjUFhtp0mkVbhzg4jKk/UntWnLDNDpCTSTxn7r7QuFz/eY9yOwFU3fUS7EEhhS0nSyiQptCPLneynOflHvUNnI8IE2ntIUhGZUjYo6AHohHX1xViKe3hsVXzN+AG4whwTzz160xtNuplZkAQIxdnQ7Sy9vqaTfVBa5C0NvBeyyXkkssGFk3SMWcE9VA9c1NNDmFmnhlRJBvjKjAdcjqao6tps8E1vdRTlpmjMmyQffAPT9O9TteJcC2F9czXu3cFjdyFjHXaFHAGam66j12GWRjS9Z7eJIZ8gL5nI/EGpdfU3BihkmW5libEkcS/u0U+/dic1OqG3MsFq6yLIwlkLoBk9gO9TpKmyKKRVa7LYlVoyCD9B7VDatYuz3Dzra1tjEkX+kEAIv8Ke5Pf6Uk7pbu7zxi6cxJtBXjcRwBjp61qaWsESFJ43dGUkSAA45wcH1P6VTmaKEy2ojhaTedz7slR2yehotaNxvUjNu8KebIAmyPGGcYbdySO4NR2mli4nwbiCGAoZJATnA6jnruPpT9gkjtg/zmQ8v947R0GOoH9Kuaj5os5Y4YDE90VjeVFCqRnn3UdqFruBTuLjZaiDYU2ElH2gOR1G7/wCtVLSluLiSZ43jbzP3JjLfeLf3s/T60u2JRH5ULSnPyvKCVLDOQuOcVXhwssdw6s8C8egUDuR3NS+4zVswIhLatJGXiO6U53Kx6bQOvFMgJlumjsgj72KEg9B361Lo5S0kuI7a3AmfLIsw3Zjbo34UlndxQMguoj9kSc5YL88j84jAHUE09NF3ArNMIrKREjjN1cEASSPkx+49gPWi3EQtmjb7Q7vgqWPLL6j0JPetRli1A3GoXzhpHOBb4EYiCjC4IHOPTvUWnosd6m+cFYwWTzR8pPXOfYDpSadyo2sVbSyt4Lq8tryJo2k2sJvNAEa45JGPmPtS2ayLI8dncPExDbyGKgL756HHepY78QyXLPFG12ZF8uExthyVP7xjnjGc4+lFnpg0yNkkmk+0MvzsfmMo6n65zQ0tEhJu5mzQTRaksbBZTLBtDMMjAIwR6DFXrK1E1rLHDNbRTxhh5275XPpn27UheWHU7TzAjmaF02KQfLRsADHY8UyK+SC2kgCRnMmN20ZPPQnsO2KSsnYbTtcp6EPtd066g892sThZIUB3ZVeme31qzc291Z3TvdAPKUVo1QAKMdPbgkVWaxkLyxTLPFcy4eJo8oUXPXj8etN23YcSSg3doHKqjMVLdeTjrTTVvMjW5sxPqY0iSO8mhYyzZBCnLv02Lj69Pas+8geQvKkEzbJAI0ZAMMvJBH4HikvZZ3lTz4pYBFHugEch+Xp0zzj0/Sr/APbTRqsccETFI/LZ7hSx5H3sDgEdu9U7PcNSvbXosbiWWCWFY7lQpQjcsisCdh9B6gc1T8pXu7aWYlG3nYEIwFHG3bTNOhS0t5rmTfLCZGaJyCMuB931+g6GtNrZ7g+arAQIoYByBIM4zj1+grO2hSLE0myyu3jES24cIsL8qrY+8B3JByO1ZllFc2mmTCBjAk4DSTMBlkzwF9vWrEsCy24mt43lkZiDIc7Y1AwQc/zq3awiP95JLHFCVypJ+THOVUevrVNvqDRVhiaGSGVCJZ1B8qRDuwSufx96xoXnvvOlvLjzLgEvtbP70Z9R3Hua0b+Roo1XdiIFfKjEe0vnqfXpViK8sRE0cqD7QvywAIAIx13Fe4+tNWIaM9Lg2z+ZCWQyAxsm3Awe+fUj0p9ylrHZRrJ+8EgyqIMqP6g57dKq3b79PKwT+dIgy0ZU4wTndGf5j0qSzi+Tzrt2khjXIdEyA3ow/HtmhruIpWkLwXLKLh7WJiUM68HHpjoD2rctR5cUmycEDCIxGN/ucGkiaBbVofMt5AwUooAbk+v49qjdGWUf6yVl++AvMWOxx/D7UkiloLIssMDLhACpwmOh9qr2s8TWpdhunaRnKgn5h2ApL9mWylnjmXG1gM8Er9D2zRabraGMRukgeIB1ij5Hrii9hWTZLvUebHIJoo9uMxAEs3XHTIzSbophKLQJeSkExB23GFB/f5wKtRieFXuZYmgiIwoBBk69c/wnHc1Scxu3lOkcKeWT5YA3Djq2KbegNESQpeC1MVu8hMaqxlO1Ez12j+RNEtoVlkW3jMghyd5fDEdgT0ODRbvbrpljGkzpkYkG/eGB7D0HtVmK5eYuEUR24GwSugI+nrQKxWEyiVYbo+S0fJbGTIR3J9aWdmMknnhcyH5GU7Sv17fhTriNbVfKkXdI2SrKwODkYOe1OmlgtwIJLX7TNg5eRwyR9wVxS33GItvaIrq8xlYcb15CgdTjucflUU6O5W3Eh8nO9k3EKF7Mf8ao2hu523327y3B8tg3Ax0z6VJeykwq6xmGSReW8wgkZ6gY6Y4+tCsJli6JgDQwmFlZR5gXnKkg8VkyrAJ0iDRizb5cYK9eufTPtWozNHFGLlP3PATaemR1Y9Qfam37wCHyAAAVDLKwU7uevFUhdLmO1m9jNFLbxk20qFowXyQM4496uJF+7ga0aIXBcAZXa6sfRj1/lT4o1jmWC480xxylWlKbmH91h+B6VanCtHClxGPK3hdyjJPP3h3XPpS6k2uVlF3HB5gCzMJG3Oz4OQOn1/Cq0d7HbTu08YVXy6Q8lVbpwf1q5cpMk7SWkW5w4AEny8eh9frVG+kjZlaQuLlSTsYYUc8bR3ouVYsW5jN1IkXmHI3bk4AGPbrzTZp4FWOOK4w6PvIkPX/az0NWTC1xBCwlLGdtxEI24HYFvr2qEWsCyKkIdkO4Lu52j6/XtTJuyGeUxXkUYmtyGGORuCg/pn6UVZe3jgdbdElGzLsODtPfI7Y9R1oosI6RMG9uZSA8iKQN46cdKyk2i+2zv5kRQ4Vj93nt71fv4FtUZoikrggMFbO3PeqMNuEkV5oyWUFdrk7j6iqbZo9DRSNZ7SRYJG3thQMcZzgfTiq8k4iiSyjjLSudpYrkkD0+tT6XfNJablg23Mb/ACED7g9z60y2Xy2nu5GycFQG4JGc4z60na6sUie9jZZW3SLI0YXChcBT7j2qg5eC0iQyu8qMJJIgBt68KT1zV21t573UIp3DGHJYgNwPqfWnW7STXl0kCMnmybgzjoM9c+tPXoBJCkFzbWwmtZWZMsCq9fx7DpzWbfSStqELKqLMRujI6lgMY9PwrWaZF05INx80ylAzv/D6kCmalbWlyII4kNvdQJ+6C8+a2c59gaqxFjO+ywSu63skj3D/ADMhGBu9KrX+kQQRi5iMqyMceWrZC+5B4/Ctd7n7VbWaLbrbzwP+8ct8+/PJPtUt1qUgvHW4BuMKpiZQEUHPcd/rSsle4+U5mfTtQWReVMLKGUOMZABxnFaGn3WyZIZY2hTG7zuSPcc/zro7hxNC0l5MwkuANmBiNAvPNUZZ0uZjArg25IV2iTLhepB9s0rcuzC1yt9qsp7djFbFx5uIj5n38DOT7VhaNaX1tLLq6JE5hdzPA5IBwTxj0xW2tnFb6iRpTbG35QMeSfT/AGar6lqEnnM2zybWeQC4jIA+cdA35c02+shcti3Y3k8k8WovEjXM0eVG0EKvQHHargtnjkhVDJFNPGzSTXAyrZPXjoPeqtjYGTUgbOWFZZFJSVjiM4H+rz7DPP4VPGZXcr5nlwgEOsjY4HJGD0+nekvMqxNc6cptbItdMUfckiY2hfUnByR+FRItro/ltAsc93Im+SN8mMAngD1bFRQRLJDNLcCRUQbQX6u3Uc9s1YgsAALnekUs/wAioFyy5HXBo2+FD3ZWVZRdQXjyStcPlT5Ax5S9D9eDgVf1RbGC3LyFWYf6iPczBX/vEjqSccGoWtzbS7LdHltCQkbS/LxjliPc5qYl5MWVtEX2qcIg+dz3Y+goT5VYGrmTG08ke6SdY3k4JBBK84KqByO+TXQGEz2JhSZJhFHsRtuNidz/AJ5NZMSR2yfa7JN14WICRRAqgH8WT1NFqZHtzcWrSt53yTFiMIQCTkVK00DZFKFPKMyXLD7fCq+UkoyHX/D61YtLdNQVWJcMj5MhGME8kKD0HbNNvIVtYNMv3jkEDyeSzFgHkLdDjr9TV3ULdUli+xo73b/ebJEZAH3TjrScXbXYFa5NfAx3EEZuGbyVEi7ODGOpC/7Wf51XtWljHlmIRyOPusu4nd/WqcMqSGdLpXaaTqVywY5/hx29uKvGSOwWO8aOaUyEqSyZAXBBwOzUmm3coq2CST6g0wABmbaoY4XP8XHfsOa1daP7+Ca7WVUDLsAGAMD7qDP+c1kWrtb3Vx9kVJHbCtkF2XdzwP73OOaneNpLuMTmR7sAvuk+bAxzkDgn0A44prRCHRWb3L6jfkssySgjPzlV7+xwO9RRTR6ZdMLd0luNvmB2j3Kcjup7+9Pa8eWI23mzCblGCcHbjIDDp74qpci81e4ys5LkguoG2Rj/ALI6cDvSdlqPR6CQvD/bZ89rm6Z1PmohCkuR1z2X9a15ytsgtzCuydiPlyREvop7HI/HNVIlS2tBuchN5kVlX5mYnqT1zn1reWSygZpdouXMe7aPlUSHPGOxx601djSsVIYtREiXEcavdAghWHysqjqc8kAelZzLcXOq6hMxtmxKu4wqSI8AYAPc+pq2xnu1luLiQSyW8RITnC464/Cq2iiOHSUuTEBeu2cupA2Nn7vYYPejR7CejImtjcw/Y7xIxbybrky5+6c8EenPWrkFtNDEn2gyXDCICGTbuwvfvz1zn9KfNNA40+0uTPMyg4gi4YBuSSfr2qVbp7eyWF7aRtxZEUk/JzgyEZ4PTHrRZBcy/PmMy2Nq0MUt22yYOdqeWvXcD07VHbyPAs6bfMhBI3BsJGe+AfUfpTBpguby5lvSfuj94vzS8dCfr6VLpumRte+UUL7hu8ufLH6Z6LQrXEVdQltYZWtrWTznbb/pDxEAkjkdeQM0wBrafZPHulMwDPcLhyP7uB27+1bNrFZyTt9qW5A2+WHjAYI/+z7cCse3t4Xe53zKHY/u2Zip4/nQ7XEWjZtbsUt4lluIjvLDlthHHTovPNXEsIiWjnZY3hw6lRhgMfwj2561zdzJfW915seSxQqwJIby/wAPStO4ktprd3gluYrwRcs8HysccjdnOD9KasxPYlvI4rqJJ7iBYWfnzxjc69h7Zxnms+R7lm+xWF1MA2fPfOQCeoHqe2atraxraRSNE9xMY+rtkJ06Afl3NC3JsInSQlY7nKsnk8oPUZ/nQ7IS1KwsjZ2k8oQBVIjAfDNk9W9e/SlmgRIpJJrwrbIfkWHq+eu0n09DVlLW1yqllbMgDs8pwCemfQ44rL1gWTyQTowEUbqr4fAZ8/yApeqH6F9YEh+e2tmkjYAp5r5YN0BYH+VMNjOt3NKbgSyBuZl4Uce/X0q5YXtpaz7EdHuH/jPzqPrx1qNbxEmitUtxKiyFiSuCoz6+madkxlOytUZriMKCEYkuTjB/vEdAOaXT40F60TSKsUybjIOdrDtz14NXJYs63I1zMi+YoKqfuZ7Aj+tUruf7TBK1oql4VDZ+6FYHnGOuRmp2YdCeKOS5nCRlVTbtRiuRH2OR3+tQeVDIqWW2IAEuztwP8mnW6SyTRSpchvJTKxD5cZ5zuotpGlvxNC377cXx5XyrjtjvQALODageUg6IwPAYZ7j29aksLZpxi4cTw252goPm+b+EdyO2KNhe3uDEBIZGYvK45J7kCrRiELxPF5iFgCxH3n9AfTpT8xW6FKRGuTJJMIwq/J85BZMew6n3NVP7HSe3M0CMkMJAaSQgKCf4VHfr1qYQTxXEZNz5d5IpJckBZlJ4U+h7VN50qItrdxqjN0Dr8rHPOD3NPQHoYxsfsupOjkJEMLIoyRz0b2qW5mMVim6GRbhXBmJbIkA7cVfu5YTdmJMANGA5kBDLtP5Y5ov7iKJY0lizKF43DIVc/wB0dc0J20RLSKNpuujJNEjeSsakuTycjJC+lPt7cTu3lx7II8urygHgDt71DdGK1eKaRWE8QDPGTs+VvT0xwcVDf3L3Ubbkd2By+Vxx2APYU3YlX2HRqkJeN42+xbg+8khtvGVx3OTmrV0yTzMFwIFO4rEBzkDv6EU20uYZS73LS+dgYhcHBIHUHoeO1IkWxt8DoI2+fafl2t1/KgdyIysksJZGSNUOxcZ3fN39qK0o5Wt755t4eRwPMG0bGz2x2NFMXyGWVqk9lJMwiLHJJB9+nHvTbidkiklkkKyTKCNhyi84J+tOjtFjnzGDEhDNj+Fl9vpU+mXKzx5mt0BBwM9iOh9KldjSxNp0qKX82IqJDtJPCnA6n6mtWZE+0R288ivEkas8YXtntWT5bSMr3YRzPkYjbhOe47VNYsbG1lW5LrLHuWNuDvJPHXqKu/QNbEto+ZXihiItxuGc8AHuTT48QtHbbSTLuQENuAPqKqG7TT/Kijgd5Mje3ZR6kVce5dppEt1RYyN249c9gDUp9xsLm1a2kFuWjmlXBLqQdnqPrURAPnXCyOgiAcOWyzNnjPoKbpgW3llF0zS3ZOVc9D6596khwy3CIqyOwIVCuQDT3AyhBdfbH1GVlkI+a4AP3hnqPU1fW787dNG3mWy8Rl8EgHoT71bSO1vGdljNtGdpkG/5gAOQPxzUFnaxf2ptgIiDtlGkUeWBgcuPSkk+4XEuTLdWSQiVQsjhPL6tx1x6D3q/YJ5c0gWNPJByXweQvRM9OTWdcAGWebdt2cRyI+ExnGRjsfSnWsbXM/2O0lxEF3OZDtyRyT7e3rT2YEltFm8uJpESKQMzhNvyr35/pUb2a3ELSzL+5GULq3zBzz09Klhmmvb37LEjC13FmJPLYHX6deKtXcRS3a1tyCgXfjHTPoaAMPRmaG3uUuZWeONjsRCQHYfeA9OvWr1rp8sqzXNr5bIo+dGcZPtk9cDpVC6s2iuXtohEwLKz8YAIGByD3Gc/Sr9lNLFewiRcoAd1v94MMcfTp3pR13EJAUvVjMCOllEwLxyHDCTtkdcnrVjUr54TIkWY7mZtiEYYcDls9faoRbI95Nc2Xy3hOfIB3K4/ug9yM9atW1pDcW80sTgtaxiPyc5y/O8g9sfrSs3sUmkDL51qIYLqZZSDJtb7pHdvSkmWT7KNjyhZjsSQAKdn8XNb1jpcWoW5uJyzBFIMaYbgLiMfiTn8K5+7YtLbWo3DAYMp5UEjgD8epqnHS7BPXQs2NokenmK4UeXdIRGwJMmM/dA9yOSe1U5bGO5aCGWZvNQbMI+NsY6qSOwH51ahxDsyhkmXnchxtXGDg+tPskgtyzXMeX3FvNXjKkcLU3TVgsZuo2m60MP2lTIR+4S4HKDHDcdM9qitDfT6ZbphYYgMeYJvlJ98/jxXUX9mj2qXvmo0YZVUsB164/lmsN3isruS2KR3MnmFm4xGCwyNo7896pprRi06FOHVrhZ3eV1ASPZH5G0MMZGen5/Wkvtfu57eKHS7aSJEfKswAGR+HPPc1qWCRnzxeNwhz5ccICsM5O4/jRb2DXNwkB2J5hMoiVMvFEBncfTJxx7VOr0XULW3MW0FzCsEdyJEEzZ+0LyeuTgZAY5zV68EIWaSNrgvFgxLINu49CzegrWudw8pVdZLlTtDbRthTrwtU5LGNHeGSSS4DuGYRtjPPPXoOB+dS29mUoom8Pwf2ZHFO+1XjO6QupPJ54JGDmopJUndxGku2QsrkH5kH884/CrWo3E8rEJO0wdkQblwI8Z2qxPUCo5fOhhuLYeROrDzDIMjORjAPce1U+wIbp0M90jQBdqyN8rRplmx0DH/ACKrlCs0dqVElynG+RtyhvpVtrq+ksPsMkiKy/Mzxx42R4wOevPoKu+XHGls8cf2olV2MrgBQOBvHrnuefSk4p9Rp2IL2L7Rpy2a+ZJcSNtkVl2kluBgevU+nFUSRGqQ3qv5MaqkYIA3DJyR6VoGG4i1tBabklSIvNcSrhFDDAVc+gzz1qmJRbJ+6Ej4Yq8znIWL0z9aJNBa5LbSbbd0S3IuZWMQlHDbegA7AdiaZc28T2ZInMs3mGOWADlcADJb6Vet5Wt0e6jRJUOIljkw4IYk4b0Pqao3waWH7OYxaI7qrOD6dc/Wh2tqOzIrKMCOLbE7IHy7INpyemT6YxV65ZY9Mv47OVkk3eWzzI25gSM4B4p+nSThFs4JvKxzI8xGJB/PHoKS5Bgns4hJK8fnk/dzg8evPemloJlWdJnTyGTy41BbavBHQAnFPmktraOJWt4zLuBi3puZR9D0HfNaErFpMzyxvYh8lNxHrjkcnFYtwE1DWoyiuIY4H8oN1UZ6++elNrl2Jvcs3qRosPkys4dSXV/vc8EEjsapXETiwnaacRqvyqi/MxPZT3x79qujbeC0gtpCVj+c71+YNjGB6iqt1NcJE9pLJIzK37veABtI7j/Gk9wJLDTkiRbyAFkjH3mO1S5Gev8AeHXms6BXubcOLiWX7O7nfKufmycgD05q/YSRy2JSUyzQK21mjQ4Y9gT+dVbeV7OW8W3k8gSH5k3iT5sfMTnoSO1CstAG3cF3BZEI8iTylZjJJjJUdTjvx0NVDEGu7aCFhJEs29mXDh+D0H9a1xb3N5AImiJzDvbOSypjAP074rMRUtWt7gkHLpgEY5JOcY7e1K3VCLcFkkPnS3Dz+U3MeOT9XI4C0CKeIPcwlI/lIMoYHAB/lkjmp571J7yCEhYtzOHKZBORwMHtVK+tBDYyR2skczb2QJuG1T6/pnHTmjRoCndAeWgVgwdyUdgN27+I5HuK1rW1hZlLjNu+QAgG7dj7rY7Y71hyanb7GhUrEEZHCzgBgRjcB685qxY3b2zSyW7yeWg3fvPlBJ/XkUlvqGlrD7SNEspiy7o4ZCHLfdA/hyO9OjlEKQKJCCx3KUb7hx71nRxC81GFLsPJHcAFYYW2qGGcD6nmrUVgyyBsq6sWWMSkbhwCc/TmnvsIufa7ZIhGhRXGTOUyQee3aoZmt0mibE8z3A3L8hVtx68flg/Wm3Omt5IikeQxsrAMnyq/5/Wn6eqbbd5UkceXtV9x+XA5/Gm30GOS2aX7RNIwZH/dMhIIbjpgVm6voy20lvg3KFXDbQ/zAH0z0q/MiMm35pvm379+Bz2HoR3qORr4ROskSyxQkSZGGYdgAe/0pOy2E9dzGngMV0CbtzFIpBOwkv7Ef1qw9rcWCR3EB8x2+XLZLg/T2q+0i3ccBiEaMiszKBksemCD0OKJLZY4bghkADYAAO6McE5zwD2oXdkpalJo2vbt7m6Wee7mX96WTcT2yM0thaJJFIt1NiUcdcM/59hVqZEiZ5o1IXYC0a55HXB/nVNLEST21w7APIuXLNnHpwKdw5bCanJCQIpkzMmGkR8/MoOPlI71FBIlq0+9FnhfKJz88QB7+1OaELcrb3OQzxuCoOcZI70tokMiKs/yGNgu0DJJ9RRcEh1vMtxJOF/eGMAg7v4s+nfPSioorSaHyry0YRiNvnUdSM5/MdaKN+g72NfX7d4GjFsV2wqFJVCA2f4v6Uy0n3RLGYSl2uGCgjaw6ZFXXjleMRyGRfLBbB6FQf8AGq9tp8897FEyBoYzneflCsecZqpb37jWuhZnjkiURNHPFM75J2Y7Uht4Y5Y0vZzJHb/cKcBCexz3zUC3U7Xs8kpNzEhKBmOSo9/X60i3cVxcTWoIKkYbZ8wJ7nNJbDFt7hZ9RnaXaDcHG3nOF6fmas2to90HedhEMnYMZ6dhVe1tVF4sMDpJb7gryF8+WCc5yf61oQyLZXMlwZI/JT5ACMM6A/eHbNCiPmY6W2KWcXlO6M+QWddoUYzjJ703T5DdLDaJGkcjtkuzbd/PAz29/Wqlz52o3cZUmO3kIZw7feA6H2zWmypcWpSLYYSgTftwxI7Lj/0Kq0etiGzN1S0jt5rmaN1lTd5boDjB+vpV63ltY9EvA0Ej3UkIigMx+VDwC34e9QRxm1tzblWuGkG6R2U5QDoMd6y2nC3FxE8jJaMpJLcMOc7Tn3pNqI1c3l0wPY2nyGR5TtCp/AR13Ht61mtFJFdyt9p/0gN8zgncMHH5YrZsZZIoLSaNnkaSEkRdSvq3vmoLSDztXjnUK0n3mLHHzDlc/Wm/IYt4Jo2ubj7Q1xNcFdq7AgXaMA4HQe/eo7VppGLJGGlZdilcN8ueTzU02Lzzp23M0gzIwOBj09+eKGhYRKImZFkBUqrAKpXk9PajdgZkM8UVxezEubXdtEbKT8inlvzNMiK+X58Cq0kwI3kYUrz1/wBo+napyhjtrWKQb0mBcuBg7WbAG2qh86+vmUACKJyigAKuRxnHqccmob11BLqXI3iW2EVogmlYbi4wML7H16ioL6zjXLRzfOyjPljjOcbenXp1pyl5Z2meXyrwFG8lU2qVUdR9BSxagJr6aN05ducqQUbggfjnJoTSHa5Z+1zpFaWigrCCwzG20yHH8X4dvantOTLYQjznhtip8xxs8wbskk9FHOKjvGSc28METFY2ZWCjDA+ufXrTtSmjiilAhQXO8RFi2MdM/wAqNRjrO5tpb6dtjXECO0paPKqR1wMdgasQXLCQCMCTzclI0GQMdQc/Xqak0W3H2i1EQ+SZ9qxFscd3J9M84q8mk2Vn55t7mKecFtoHJKA4JJ7ZqoptXQr9DL8V3cupiBYIB5FmVLIByeRliPxx6c1XeC0ttUizOzO8aksvSNs8r74HFP1i68mxmhRY0wFDbMncc569+3FW7m1t4Gtxd3CzFIdsaRqAUYrnLH27+9LVtgRX9nCd1xvCqrFFR+MqB97Pc54qPToJEle6dHRmOzLuSwQDv6jPQVKLpGsZWmjc28IJjlcdWz1x+PWrOhvblZHlYozBR8xz65HuD+lKy5tBk9pZXEqXVzHLbQ8EnzBufaR1x7Vi+UyXtnJdyOYRL82wb2HHRvQ4xx71f1S/SGGa1Z1BkIZYofuspPf1HGce1R2hiiCXFxNbjezTIHzvd8cMRngfX0ouug9SQF7u7WKxtVZhGXAf5iSeN2B3x+VQ3fnxQSeZETcKQwZR8y88HHpV218zSNPkupbhi92N22HALEnCqx7A9cCnWlwxgMyy4lV8tg/6zP8AdPtzVWvvuC02MtGLTBoUIdSwAbly+Opz26ir8d3FKLfbaGK5kALM3O7OBnHHHoKakkcDvJaBvNkJaQIQy88A+/vUlnC8cgv7lsnBjS2deSOgyuOF71MRkG90vp4Jpi8EEez94wwqhstj1Y5qDUXtyLpHbzLZpPlJGxsFd27b0IGMY9TRq1nMRDLFKLiaLEm/OQRnsvoBVTVrma5vY5GjUqmEBAB2dzx054/Kk3YRY+0zT29uUiRYTGAYwMuD3x7D9aJSsssJnBEdu/ytsyS3IG73PvVmy8lI2nuQVnkb5W5LNxwF7D3qvYxBjMl5MYgCGYd256HH86VrsLluNZLGFJdrxyzkgSEgYxySc9scVHcZEpRP3NySAwf3BOR9OOetOlia4MYn81YFUCPDggY6HHccYqS1MVxfRXa3DNL5zhYynoOC3uKpLohNkd2/nWsduJFeQfKmcKRjqzH29KpWRluLicyeVCoj2wb32EKPRvfk4NP1G6GpXflbd10co0YUBAQeT+HUnuat6TbK1ldwDCR4C26AbiWU8nJ6VW7sRrchgmthZKEeOaTblW5G0njP4elZusM6hHhSRZky8S7Mkkjk89j6Vp3tubbyZ4hG0kcgjkBYBCvcc+/8VUNU/cPIkoeJ1B3fxZPbDDjGMVEnoVuzO02eae3hsZ2a3ZWJjC8b1PJGegOe/atS9tYm08kqmYW+QAAMZM8EHv7+tPWOEvDLL5bIYgrRsMK3H6GoLSQPKyxyPiM5AlHER/h/GhAVLW7uL5jCC0UvCsvdcDv6j2p3ktNZSM25rw5mz0EaA8E/l0pbiFrMGRg0byqeX5VWzzyOo96dDqEUcbSMXMyZww+6xB4PuKq1yb2NNtPN0humdSZEEsYHJVgOmPTsao2EVlPbXVwmUkRQoiPcn7230xU8M8BdYZpiwD+YGQYwhzuQfjUE8i/a2nhmiEbKA42lSgzjketFkhp3G6rpdvdTFokxIUBfB3IcDGTnqaxbfTmtJgLuNo4SwEZA3K5xkcnpjrzXVXFxDOI/LUSSqT5sijKqOnP86hnksrq3lQCSW1Rv3bOcNx1Pr1pWSdwMe7W68sRJKoRyZVUclX6Dkd6mVrjzNt0iq7LsZD2Y9SPQ8UxIfs18jwOwK4kZWXIRs9F9RUjSbk/fbwkshZ2k4XeOgBqQ2NG1U5lhkfzCBhsfdGB29ap6bCBJcNyVSTKxjqidSQfc8VRglSETKGVYZJysAycxjOC2e+ausTBEkjghVTyiR+hNW2tBEWpPCs7yxELCrLhFPBPTGfrVue3d5lS4UW4Vd2I2yiNnIJ7nNVmt4rdoWvIfMiE4LqDtOB2I7Z9asyTyGSV1YYZCCqfwrnIG49vektNWPczbqBVvYpNOdYXnjYyBv4zwTn0+tV4pwLi5WdghkbhsfKBjv7mp7lYzfRwxEbo4yXUn7vPOD3FTX0aG4KkgsqpkKODn3+nejcVtR008141rYsp29PlO1mX1/kKpR2kapI5l2S8qCOQOelLcSE3bJtZS5zHIgyE2jOM/rSRm58rzAVCkEqwXlx2bmnrcV0yC1aIXEglIBl/d5PBVQO/pnmidpYSWAC2xYIrcA59fpVfS/NleN59m6QkFhjCkk8n/AArTvjBLC9sNzvGPkRckHHUk+mKGJO6Ea5F0y+Rtj3YySwIPOM47Cis3SpMXV3biIFiirlOflznH0oqd9Rmw/wBqjXCu08asFBPVEz0Pqa055pZAsdnA0aygYUnl8dSafbPBbLJmMz3TqTkHCqx7n1p9hpk/2nfI7wrs37gcYXH9a0SeyH5mLbu0cU0CB0AywAOAeeo9aba6aI8y2+UlHLBDgOp7Vs38cpmTzQscNuQshj+YtnkDHfj+dUn1BJrjZFsUtJj5eBgeg96XKlqFxt/Zm3YSTr5MTfK6qw2n6Huc1Ynk+0XCx3cUXlqoygGQBgjIpmoQtLBIGiDhmLGNSd3oee1ZEB8lwk0zrNuGJU4wuew9fUUtmNtj7O736rNbuZDGAq7hkkL7CtEa3fJcwokSxfZjttyFB2kcBj69e9YfmS2+qgmFJQp/eZGN2ehI/wAK6a0jRbCO6EYkhLrI0IBxnPTNO7toyUrFeV7lI1aSVGnkfc8kbHcfQfTvVi8ZJgIBAptHYZeRcs79Sx9hTLySM3Dzw4jeYFlhxlEHQfTirVtE0IiBjxHKuFVSCxYjsKTbb0LVilp0scGoXTpLJb3K/NGUbHGeWA7Y9KWWOS5uJofNKzsN77VyOBnjv/8ArpbqCHUWbyCY5w3Jk4LFeS2ew7AdzUcEyQM8UyPJclCQ6sBu3e/sOop2skIQ3EIuIre2J+zRkBi3HbkfnWjO7XTMPMLRQLswBt//AF+9ZLwspWSOUBkY7AfXjB+tbawmdFhFvvufvyqD8ir/AHvz60JvYLIy5JR+6EMJEfl5BQ5Ygenp0pdEeWa2XZCqypBgSM5XbknI92OetX7nTtyF1mXzIywKkYGzuxP8hVQAQuYoQ6xq2A7fddscj6d6SXK7gx8Kxs1wn2cMtuMI7SkMhPGfcA5471StoLqDz7m7QbvO37mOC3YcdwMZrWtNPEU0EkkTeTK7YV8Zbb6+nPNV9Qv1m1H7RdrvgDY2YG0huG246HIFDSsMsRwTrCLq4GMpvLhss2DgAjtk9c9aoz6c0wRkkLE75JH27V45wo9M96uQ3MtzM9skheF2z5b8MNvTJ7tjmmakkkF1Z2cgGDDvWNedyEsev4A0O2wMnQCyCsmIrokCQuBiNeh/Hmn3TLaB3ikDZyUZAF3qDwcD37VGbx7uz8raxtig3E4Ubh0Oeua1miUWtuz2QSEguvILsvTn3zzmmohzWOewYzc3EhDXADlRIAxL4649RxitBbOGz02OWfy5ZHkA2k4dWPLMw/GqOpwMllJ5cTKuDl25GepJPUk+lW7tmWK2kM4XEitKpT5sd+vTHpSjGyYX1I5wsth5Ub5YlWCADHLD/vrjnHar8cNtO6wYwFyok/hA9c9T3rM1CGGTTxOt15ABZoYQuGkI6HPvnGKsRXMt1p+2OFS5xEdxAMYIzgds4HWgaYyOSCSS5u3hSJiyQrH1IUY5x2OP50/VIgGW6aJY4lfywNhzlv73+Aqz4e0yJ5oWu/Ljco5jkOcGTbn8RVa7nRSJpnmnbPmhZO7joT6jrTtaOobki6dcXVrbiWLcs04QysOnJwVUn+daMd1DYs1haKkfy7JG5bJHUg4z+HSs+5je6tZruCKULFtkdhlhGOpGRx3q0jpFPCzQvHHEhkkeNSdmfXPfvRe2oeRZmtzYaQjsuYZXK/ZwuGUnncG+g6dqgWZzcSwmVUleNZF2v8zLzlfoB69akkv7LUb+Wdnkt0Me6EBDtMnTGOnPfFYskg+3y3cro8ke2NUflQBkkjHucDNNySegWua7CWae4gN08lnFEqssaBXIxlQo/PJrN/eW9zNH+6EYDCJJyMKF6bsd+vHfNLBE66feSkyQCQFQxPzDJ5PHr2+lUDCEumllJmjQgbzzk9MkdxyKlu6WgNWNu1t5mhSQKcqD58QbBUdSFHbpk4qxpojmtvt8MYEYj8wzEbgnXA/HGM1mwS+comnKuvlOrxSrySBgMMenapo5CbIxPvTdCgLk/KeOhHeqTEVobiRbtUkbMSqX3bdu8Hn8/emWiSW7llKJYBWknC/MyE4yR9addgRQmVopJAmVdZMAZPQY/D8Kn01Df3McjLJHaINwR+Bnuf0/KoS1B6Fe3W5tUutQto7d/tWPkY5wpPy4I5DHqansFuEgWKNUkaQ48kJvwecsTnhqlt1tbWf7c37i1f5EiUfPk/8ALRO1S2l8sVyLq0hj8wgsozjIHHI9atJLcDKvmlnZoz5JEY2bPKIG0DkmqtvestudOulVfLQthR/rge/5da2LomeNkkVDdKnmPJu2sQTyvv2pJnN7bRxJJmYgR+cDn5uikegAOKlJ3uhFGMxQWsb70l2N91SSEB6b/qOlZ8ojuAJyRGHblUY/Jz1b1+hqf7WI9Va3ltVSCKPypRGcrIw67f8Aa/8Ar0+ezaeGOW3jNupkIWdRy4z3Ht6U2tNCVuPc2q6XIkgMmHMZLIc8jOB6YrPiijgEcE5T7KfniGMEdup74q7a28lo8trfYgBf5CwxvbGcex+tS39rFLbGKKPKAgkOdx3Z6Clduw7FDVopZCt15ETxW/7wlF5Y9MY9MVNp08V7YGWF0bzpPnXdl9vuKrym7WOQWsskTwtyHGdwxxt7gdajbTxN5jbQoXDNPZny2xjnr3+tK1wbsSNAY1KxyL5TsMKDwVzwc+lIk1qnnR3EgEavlQGznd6AdcVRJvI5bjMTyn5doeNSAo6MccA/zqNL2FI5prgNb3KurIgUBCoOTjHIPpQkg5mtzaluo7YTSQRBpAv7t2G1Rz79Qax7p2ZZGnJCt83lrwIz7D6+tWNMv7e5LSSiW4dgzRkISMntmnXlx9plWCC0k2rJiQuQFz3GeoFT5D03J9HiDWca3Tj7TG6liT/D1z9R6VYv7SKRW3+dNCZGVXHG5uvTvjr7VXt7kr9qMixvIQC/opHG78KsI26R1hfzZowNxAyrZ64HvVWQK5UtlkCGNyXd+HYc7+fvD0GKluYlCYiVzuz5gK4IIJ5A/ujFNmt2SSG6i3RsOAhb7wHJA9x6VKb+K9hnKb0WD5nLDaxB5II/Ki2mor2djP1BjLtuYHDSghAV4MiYz92ojC1yiNanzBKA0oQ4Ixnt2NX0hEu0gZlZh8ynAI9KfKiTE7UFuysR9ohGGbr1PpSjqNuxhKwk1qXY4iKwrlRxk9Dz2OBWoTJc2c8UcA8lQSsmc7B6jFYltbXCzySqI5RJuUllx8ikYOOh5q3cvcravlNnmKBJsJAH1xVRdtzMz2aW3x5SkwKoyQMYLdDj8/zrXtXiSMXUcmJXwU2n5TnqCexrKSVVum2zLChwOhYk44AFReSSZHWQhomDIE4BPYkfSkloLyJZ7xbHV2u7NgiS7o2A5HYHFFUvtkhitkNsF+ctuAxnPrRSuM7mK0ikvfkLlS37wx9h7DtU+kl5Li8Fw7SRbnRFY5OAMgn2qK/c2tuiwMAq4YOpOGz0Bqne30qWSi3kZnPU44JA/lWy90d7jdNmmEZ24wmSZDyWye309aCYmjuRp0QadVxIzDjry9U5mAiUruYKAzluy/3QBx71Nb2++zkm80bHXAKnB2k9MVCDfY0IrzzbVreGXHzBXOOhzyc+g/Wob5F1NVCiJJkk2RzAbc45D+/vTCIZ0jEEUayKw8uPHUkd/wAaeLe5gWVGiWXClsY+ZSDk7aHqVqKbGQ2ttei3jcrcmK4ZXy27rnHUAjkdqllk+yi4MEyosse/ykbIBBqpE/2uSOaB2imjU4dW+bH909iPanxFYriVNQRI2CgIEPyhmHykjrj1o3+ES03JNJWe6XaoJlUjIK5OT/Fire/zJzAZN7lsRsoxknjAPb61nWcz2l08YnCiL92HJILeuPWtBYtqzWpARp/L/eJyVU/1oWiBMrNaOusRW1nIXZBmTb0ZwemfQHvUtzA1yrruAmErFmAyAQP0P+FTIiQPINk0SB1GBjcqAY5xVt7aa109pw0bQG4Cq3VjweRj2pW0sUZpnRLG6jnKtd7kmVgeOBjA9zmrOk2tyltJfLOLcMcZzy4PbHeqa2LiAz7cjJY7sjC+v1qXZOwSOQuA+51Q8bc8hsfSktNwWhPcNbvZ4kd/NkuFeQ7sKsYGc49+BUEUsMduo+eRGLOCF+6x7D14/lVe8kVZbSNYlFup+YdfMbHUj2znFSpFIIhCGZz5haN8bQvHXjvRdrQfS5dkuGuJookieVAoIZ8jGegP171X1eNf7Vilk3vaK6xMgGCz4+YD0AqykUttaulxNIkxBQMOARwSD9arzwzGHeEEscW91Vm+96kim1dai5iwnkmICFGQSPsBzhlP97P04qEyR/29ZTzJJc3EsIVV3HPUhfYcY4qSOMzab5Tg7ygUIGGY14OST74/CotbjmjEBs8vcxFC5PZu/wBO2Kp3W5Jpm38pokuYX2SSqwEfPHPJPbkUjPd31zdzHa6K4VBnGQDhQT3HtUlk8kqeXaNHuQbVQ5yA2SefYnHNW9K00+fciOUzJbnC54AfHTHcDpV22Hcr63JafYBZ2mHhhO13z1J5OO5JwR9KkmhCqqxoGZUR2jJ3Jk+/f+dQsq3l6YbXY0MceFldwAGA+c57+n1oeeRdPi+wTs8qS/JhApLnqfyH4Zob7iH6lZW9vd2PlBZZFwWQ7THE27JBP94jtVOdma5WytiA7ybfKx8wzxn0yRx+dILGeTzFhZGhdzIqpxhsDL469O5p+pMluUmsPOFyjGIEAZGANv15zx2qH6FLQ1da1C1uJILHS4mFvb26iZ2TOyRCcj8ehql5L2kKXEyYa4QOGJ3BQOoHoe9Sw6Y3kEmVTM5V8Bick/fGfWrcgka0JYbIvKUtuUjjkcfUVVr6sFpsLdyOf7N0+SWe0s2jk85+BGY2+4zn1JyKzNHuZbaeSG63TwKBCyE/61QflyfQg1SS2uNYmlyZBYwsEXJ5KgdCDx7irEgIjN4/nOHcQyOG6cYUZ7E4wfalKTkPZliGzaaS2g2qke8xxqzfU7vcc4qvZW0p+13lwof94yL0AEg4+7/KtOO2aO8iacsZliVQm3Aibt3+7jrWNHPBFbTbZpJC0jbCoIyT0c+lS4pahdi6ms96bP7VJHFMCF2kkAJ3YjvzxWnPAjPLZpbeV5gIwT8sa7QSwB9Rnis+WaLyIvMaKWbf+8uGU7mU4wAOwBqM6hcavOloZJpYwqYcnBAXIOfrn9Kq6Qalqzltsu8JSR2wuzZgMR1YHt9O9TaV5bxSxzuPK52kHl8HGSO1V1sLa3v1s3bYyENJIejtn5f8MU6G+KanLLHOlrt+YlFyXkU8ID6nr6cUkrSE3oWvEljJFp8M10B/pRMqLtySq8Df6Z//AF1R0iQ+SPtUhNvJEBGIzjac/dI6+3vV/VLhbqIbbiV4ZW4ldRuzyGAPYd6ybC22RyrEH2jmJufn+b+nUEUpfFdDjotS1qKsZRPNm4t3T90HyAzKwyE75APXpxUEojZpnWINJuztUfKF9Tz1FS+aLSF3mAYQSBC2CcRsPmwe3XPuaekZiM/2eNgqLvBLdRkZH6g0tVqPTYos115gjulQWkR3LMiAMSe7DuParC3CmQsW8ougCgDov09TRYvi+kklVTCW2sr5ZQR0Gf1pt68EtyVjmb5DtXA9PQeueh9KL6XEx6QwWli0cZjmZWMjsrBuex29SetVbVkadtjRGzRzIwfoPTC/r7U+2t5Ibw+XCgmU7gHGNox3z19acyqrw+ThGQEOGHGD61SZLRNqcf2lJ5BIZ7kFcFwMOmOd2OjDtWfDJJBcBZJy0MkTLHuXJB6gfnxmkldNPu72O3nZrZ1R3tyclwOevr/Sm39vFfh5IMxuMeQCdrKRz06YzxzSn3QRvsW7PLQJJ5iiUKZFZhn5x1U+oqtHdoJraBYjM8uTISeBzwfcj0p+lyz27P5sQUEkPgAFWAH3QepxniqWoTpD9muIbhfJJZS2DlAf5njp2ovpcXkyW5jjit7qG33K7McgnBYdj/jVO9sIRp7iWQKIgHRxyH6Z5PWpY2RFik2tKUBJDjhs8Y/I1PdzObG5hWOOWOQqCzLkKnYKeuOtRpYpmdqEES3DtaRsrKihViJG447Y6etVZTcWdg/2idWWQ7DGpBZs46nvWvZXUdvpm+8G0Wa+W21Dudw3Ab3OetVY4RqN1cvNbrGxwyL1UM3QH8ulNpfMnYqRQR3UrTL5sdtsIHynKtjuOmD+lbwkCwRi1iVHJ+Yd2x/ED6c0yBEiRx5ksSk4eQuBweq4+opgulvX8hdkLkiL7R0j2Zxkgep9KajYV9RxaSNz8hfa48wD72T2Ge/0rF1KRkv0uvNYDA80xtnZg4XcO+O5rbFvPZ3QhM1s8wdijwtuC8feH+zUIslcvHJEMMvLcnd6/hU67FaPUrXXmiydbSUyTbAAVc4Unrj1OKr3VxcW8kdtFJMePJb5g3ynqR+NNMb2DyWsoV0cBYZRzjPY/QVNZzC8jEL53W7FXkBwCwPJ9xgACnHQGFpPbQXMkczXe9YGVDHGCF/3ge361SuXGZI7iRnRCD5icMx7ECta1MZknudsgEsrR/7ygDAH41RuCFjlZ1aW1RwSqgBgx6Y9V9qHqTaxlvDBH9v/ANILziMSwsvOGHYD6VI8iXNoZVLAECPJXGOg/PHWodRgWVVmQCNmXLKpO/GepHb6VHFLPZCHLCeAsHaE43A9c59KfkT5s0bl2EsUbom2KMhSB97p+dFNyPPTyZo2knG05GDHk5OM9OKKfKF7llrYz3QgtbiXLLtVW6burD6elWp7c2tt86bz9xVDZJI9j2qwIh9ga6QrtEnMmfU9DU0mFaJGlDlVPDA7VJ6An9aGi0rGdeWwnt2SJmeV2A8sN8yoOvHQ896jkhS32sjS/OobIGR/kHtWndSW7Iq2gDXMTbmcrwo7j3yapafeSPfLceVuEK58uQfLnsc9zRYbLunRy/aE3fM8i78x8heakt5Jbq5ny4E0W4t1XIxgnPp/OodO1G2OoyXEp8m3IJZXGfmPYe2aW3u1kthJARFI7sJNxzvjJ7U7qyDULSzltH3xyGC4jBd9qg4z3I6c1TFhdS75L1gJRE7RhR/rM9Qc+vH0rTaxNzBPdI7RXMY/eKjZAj4xn1+lF680gTzIiYmOd4OMeoAP60uVIDKt5TJawiaZfKiPzl1x3459fpW/bFgrTyrvhiK7ztIJ7KB+NYWoPbm4t42gmXAaVoyNu5R90/nWlHdzPZR3cnmSJbH5wOOevPrxmlGVtGFi60TSWM7qAHlAVSCBuUN2HardnDFEsltKIyQ3zkH5QBzhfT61jW939sukli8tPIYFAvGY/wCpz+dWL26+037TDDPu2HZxubkmqTSXMgH6ndNLfRqoZ3dAxifqFAyXPYZ6YqCAK0VxJJzJt+QMeB+PXAHSmtG6F5zKFkdQrsw+VFPQE+pH8qkleOK6DBHljwu35eXb/Ck273Y/JEM0JM8UMcLuYwHYqcEFhxyPrVyylU/aJp0HzR+WqA8rj+6P606wszLdzLOvkxzEycH7uemcds02wMFsHXytzLny9x9+mD69qEmncL6E3nLdxXU0rudqhTGMDbgYBOenOMis55PtIkjULG0R2xMWzuHckd84/lWiwt2gnt8P58xaR2/gGBkD8Kz4pkutPie4cl1UoOzKRzn6dqryEyWB3sbuQqrEyY2u4yRkc/z6VPHeZtLgOQWc+RsC4O0dCc9z7VnNbuLZYryThNs2Scu5bkKce1WI2t3jBkkEXlyBGDHk55JxSu2w6FrR9RgsN1rcxOWZTJvdMNjPy8/WrVxczwGRbd4zLcZWS5zlQuADt9W7D3rnNRuDfas12jNNtyn2ZRtMqDoF9AOufrWtpyG9KF5DcRcbjGCAAOmPpnH55qlskT1NWWxeKK3FwpyiGK3VmGEjA4Vj3POTWPZhZdVWK4lEaAbjjO1uSSR7cVqSte3pAldI7bc8MByCFA5yT6kDqarW1vGb0WkOOm5XYZIRVZmz+Yqmk3oBab94u22jkj28mQ/Ku0+3vxVBbhodStntmZJljJkkfG3JOOB/KrP2lINFuo3l3yyoc7Ryxbp9AKo6jqCW+sJA5jH2e3VSVXaEYjOCe54ptJpNiTZ0WmyiO+WZDvW3ZmuldgBIuDtwTx2JJp2r39pf2t1Pbum3yRsCZ+/2X2wP51zolhuZ/wDSI5IdOdBsjcFWmOBzg/w/zxUgSyYyrHI0GwfNI38WM9B3ocnay6lLUfYW019ISZ2+y+Z86k4xjgEj6cVZ1PTw1w0kUDSWuGSS2jUg5Xq/Xr0ptvG0NqHvI4kFxGWSXJIC9hj1+tVlnuJZPKjkZSTsAjxgr6k1FrKz3KuRPO6Wt6TMXkROVDYJGPlwOp46+lS2JimuktJpRBbw42Ki5YAryc+nH61NriQW+jt5PlJdzR7Q7HJQE4PPuODn61NpkVtcahmYCGD/AFLORjaev4nI4x60uV3sLmGXbxPBv2KFTiJBwSoPK/U1LBC32SI3CRBk3rheCM8gHHcdamGnebKFAMSzAzc9GXkcehOOlZE5upTLDbgKuQrkdPl4yPfFNq2rQbjme8vY3t44MiPLSyL8zZ64yemQOvaokQ/YWmCAR7ipkXg7uoXP9a29PhV9Pi89wpWIsm1truCcYb1qtqCvv3KIxFG6iRVHEvYMoHXHNDi7JsLlWMzi1AQDAIV8E8qerAeh71Ygkkjvo/ICuxUlYXHyEngt7AZqLU1eN3kUPDCpAxuyUJ7/AI1nT34a0iimhCSLJ/rUXrng8jkADjb0zU2s9QuaouWsxdRSRwyl49j+ZyAT0PocdqraZGi2cdneSMspkHlMFz5gPBP1x/Kn2rxQ3axyxsYnH7l25C+59QB3pmtQo9pIDNGxiG8yqcNuJwR+I647GkvMbsRqdstxZ26l4mYsJOQCw4OR6c1aAKlIlgjhmCbfMc/cBGMnt64+tZwnWBYxb7BbtKP3xPRCOD9M1oTW0qPI+87JE3fOc8Dq3+FJX1H6DDO3lQCZRJccFFzkAc85/OoLYtdTTOQy5YF5GORtAwcDv/Sq7lba9WzdyIZF3QuR83zdVPoe4NawcwQ5jQM+0rgYbJPc+hp+YrmXJFjU5Z4IituRsBCkrGoPAB96lTCzLKNiQM2SH6SexPbnnNQXd5P5cVmkhW0+0KdqDG5+QBzVpbhYG8y5iSbbwIQehPJz7/yqU09gZS1GYNZJcwxJ5pcFl3bhtBwCffvVe9tLfbI1vMnmBjmPOAy9zns2RVyJFvbgRQBUkgDKFPKN12q30B61RWWOaKSdypaPhlT1GBs9OtDYCaXJGZBFKrYwCFPJwDnA/wBqtG/jmlldUUpcnDP8uFUdAP5Vla7bSyRpNNEI7kBMlH25zwpz04qxb36XcBG7aFIWSNnO6TPX8zxSS7ibI9XhJluXdmYjCMG4+YDg59e1PljVIoPL3I20ERjq5J7+n+FTXERa1ZlB2Z3uG+VcjkDJ646VmXupTahppiRQIdwIlCfO3POG7AU33BdjRvLi4vVvreZbcx2gCxNuyT2JHbr/ACrP83zXNnkrGCC8i8/KOy4681blVp/LJ2MsQGxuipgdz/FUkCiKObAKzFAWYKO/t2GPShzuCVhjQFwSVYDoJFBGalluLiLzFQhH/wCWUwxtU46N6UzZMbKEu5JZQ8cRJ5z6Y9aliQo8jXACxFNxUcgE5x9alaaoe5mXczXZUhluJnXerdFDDr0/Gq8EzaRp7XccPmsi7GRvuqW5zn607UtOaFBc20ilnBZ9v3T7egNQSXQDNE4m7IoZcrg9cmqT1uTLYt7dlmip95iDI5JG8kc4HYClSKWM7XnVsfvducsUA4/CqEitE5fzgI422AbhmMf1+tStOyQlQftAmwd6jIVegz6d6NBEFzamVhMCd4I+YnDHHp6ioVEtjewPbyxXaPGA+5NwTd1FaksSoCkkxkAXjZzkHgBaiiCPbR2q7o5lIbzMZCg9z7U0hMpWlwVupo52jUZ8tJHIJTPOD+FFNubONZZvL2bIzg85ViO+fc0UcwJNGzLDLFBILUny2cyeRxtkIPJ9qs21751tdPeuwuJtqpC6fLzxkfQdKiit5JWYhPk2kIxB25J6Z7GrF7ZSX9okKmJTECwkLfOMe9Cuy9h2nqtnbukERN4oZS0g+92/Qc1VUSvaI0TP5pcRs7D0HYenvUlorW0qBneSBcEyjB5Pc/41NJc8XHl5dZJC0aqeg6E/lQtRmeLSFlaNoGjOA5O7jr0/GtK9gtree3Q3XmWywBo3dTGy7jyGB449R1pNKsY557dIp3aYvtXjGAByKXU0ZZp/PP2m3iGD8uVI7DP1o2WwktSS1WNmhS1k8tZJNrXBGQq56n8RV2+j33Jto7kOiEFpI+RtPBPPqRWDFnTWFxaEzxgAi3Ix8x649h6HrUkcsEMcssDzZfkoTgsp6LjqDT5ujGLGXmZridkKMxj3MeCo4C+3eoNRle1s8WjkWt1JseMjJRR6GrrRQT6YVidQYNrBOf3hbr27dKpP5hFpIqKAoLSY9RwOOw5pXtcTRoWMCNZ5XOfLHQfdGeMDv2OadYRx3N1Db20c7PE2TIxwrdyR+Haqry3UEYjiXKPww3fe3DIx6fT2rQjX7Q1pAsyq5BGfu4J45P4daa3BMQxyyKySoCrGRwgb06Mc+np71TttSubcI8SMJVV0ErnIUHjA+narqN5Nwba1KHejIZCMknp8vucdaqXxFvHDGQxdTvkx0PPy5+maUtHdFI2IYpWtYmt9hI+WTzBjYccqCeuetZ0ET2eoCW5kfyGJG9UzuPfHsKtNqFxMLmeJhF83zBeh/hIx24qwDHI9vBOAkLqSvzfKqA8578mr0bJKxlkFtIqLiVnKLGp42nJz7ECormyjhjt4ot32tcs82T8obOFPqO9IpJZZ5VaMtJuCt/Cvr+WKR7y0UzGdpGzG772yu3Azz69gKV3sDRLbsG0+aG7hd42LN5sS5yw9B2rIu33RozbHktx5ZjIzuXH+ea3blbiIW0ESloIo1LsrA7QwGeR3/lms+/gj1Mu8yxKWyieWcbABwSe5NU1dEkGhSmHEsQEiJJsD5wxHB2jvir9xZlb4zQGW3luVJVIiMPn+LHYcY4pmhW8UcIuoJ3EEQbar4dUPYj3J9+lST3Fyb2RkSC6gXCedB8iAgZwM+5/ShK0RXC0ulF866jIIbgEGSFwFwfp/F6Zqtd3UlvcPEkQ+1ySKd6nkDGNox14Gac17Y3Auf7UD+YCXtgVw+eBuLHoOvNUIRLaSszy/aVdFkWUAqVw2Oc9Rg8AdaGgNC8aQ6bCYJoDLIxGc8j5sjA7D1zViLQ4p3ka+ZZUixJKxl2M5x0Hvk1DoEdu1xKu+KWa3K+QkmGV5G6A45JHr61vWPh0K+69M5XzN7wRrhgAOSSffiqjFys7BddSpOnmzQQSQzXplh8wrgl4ccKAepAHNWFt7F3EcdvPlMDc33t3dmOPXtVvTrdbbVwI5Y7dbh2VjE2WEbD7obtgDrVSea4n1R4NNdfsUJaNlZsRttUncT+HWr5UldiuTQXctw0enxRRIApJuGH+t2nDE54x/Op7SztopbiRyqWSruEbna02Rn8uO1Y9ta3c2mvIzhoN/lrGhHmTHtt/2fSi/voz9gRIZ7q9tLgl3ZSDgqQN34+vamn1l0BtdCzq+o2l6zM8awxzDzSp/u7flGfXHrWTcGNLRGt3KmCVVikx8rK+eGPbjFW9OEAKyy+bLIFKzb0wCwOAox6Ut1pVvqlsLaC5QbCHJXIwxPPHTAHJP5VnK7dxrYnW9KIsdtK+wtsmkPzbG/iEYzyenPQZqOSNlkSPzAixtlircKP8A6/ek0+xd0MscAS5jGwpjnZ0zj+vpV3U7Vbdwwlj8sKRJIX3dOSCP0ocXa7GminZWryeILqS3YO0UAXymyQd3UD8PT1rTeeK4uLGOaVQhVgGBxsPTB9PesWxvDbi4lCBfPLGIbsbSec+uB/8AWqDUI5JLaBeAk7rGw34YZPLH0z61F7aIpG5LaWd356rOYhENsRwSJNoyzZ6YOPlPWsi7CC3RLCNwpYMqv3Hb8+9WXe5ZLUXKs6IjAqV+RI/4Cf73A4NNtmwsLMpnYDMaHrj+6fYDn8acnzBHQpvOlxCLa5AS6UnMZG0pkYyD6egqNtPEdth55DGPmZQeuOMkHqatapaRPqSG5iZLpAXdkyWJ/hB/pVS3vxbWzC9gZyzb1nBzhD2PpWb31DcpaFdf2bqCR3syG22M6F14U91x+orUmuGu5/3hfzIzuEZAwI+oORxk+grLvbZdSsWa2dWbkAqMspUZBH0q9o039t6eDJExuEAMjJwVYfw4HrihN7Boi7cK1xDcvcL5kTRs2VwGbHRQeo9M1kmSe08qUS4hZMOyDJTjG0j19+1OMs8MrCAskqnDMD9wDOS3sT2qSwuIw0JMUkiZ8yFN338DkH8c9fWk5AtdSpMsjW3n3DhSymSPyzuGe2734qSzuEkSOWMg3LhjIrHAQYPHuT6068mtZlhdA1tcu26QB85yTkFfTHGRVAQRR2l4820SbAU8wkiRScDHoR6mjS9kGprTKtnP50pJTAW4iTO4qfQ+o/lWOBGkEklnG4Cjem1CQ6sTt/DI5q/p19ZnzZLRDHMMhkL7XCkbeh498isO9jnMOYBLEEB+UyEhhnt7d6TsBeUy6ibf7O4ijAzI0rfKpHUfWo5IYp72Mh9kqARr5K8MQeCzHoDUtiIoIB5cPmgoN6ucbWOM8nuOfrU8huoblLiIx+XKDt2/NhcnkflRYT1H3EN0LY3Evl3EXmY4bcsL9PnX37HpTI7ZI7G5/wBIAcONik8up7AfnSLvw8UG2QSxhCinjGc5P1NULq3ljkgk+eSGb5FAU7gc8D6delN2a0QtYmvJdQpHJMxJWNQNifd+g/Gi3lY/vLgskZjywIwEyeOaq2bRzwtGGQLGhBz0BAPUeoqB7wPAfMmYHJ3pnAHvj0NK5RaLXkktkufKgm3vDjBMag9TT/NV181s7hndzjHbP+fWqOntcNIJJh5olUhUA6L6DParDyveBRKXiiVSiog2nAPU/nSuNIWW4t7xI49ynyAPMkB+TGeAPU9zmq88kcsyoFDP5u1w3HynnAA/nUTSxCzMXkhIC3mbNx+UdOfXmpLS3WQ2guEYNnzXbd94HjjtRe4mQTQxoQqJl35DsBtxnjJqI20lruEILKW3NGgwCMfe685NX5WSKd1RmkQEgRgZyQfumq948ikbRzt8xiOCin29O1MT3KMcrNCktqfIMTDaABlieSSfanafLP51y+5j5pA8vH3vQYHPWm6fpj6lqkMI2xPIyqgP3Rk/xD6da1dIgil1lrWO6CrHK7W10iZ8x+i5A5Vc96erJslqZUcssaMs0aj95tZB6/Q0VdvbeaO8Fu48yZSXl54355yT1Oc0Uco+Y0kmZYpLZ2ZI953Ic/yqxH5lzI6x/MFYIvHUegPr1qAsjiSaaMqsjYOOC2ev51Jaz+cQ8cbxRAncdvtjr60katkcHlS6n5Uj+XCocE9c8cA+1Vof9FvHSDYctsUZyOOp/GrFsXcoFDQxhsFz/Fnp+gpbG3tJZ4gxMLAtuYjABzlcD3qld6EM0Vg82E3in7Ojt5aAMC3I5OPb1qGSJprGCBWV1gJZsHC49/U1CdxkNyrhUc+VEMAlcc4x9c1CgWeHc4ePdJtLZ557KOlEml0GkOETZjIA37mzu6EYP+FSppxmsPttwjJJcMFhcfeYjqfpU0VlL5MKsxELNjLDDHBzgehIpxkVdSMVqZpIoF2qrnJViOmfaktN0PcA7Rqgd1BQKF2/LkAZx9agngPkK0jsFkdiI84xjnB7mpkP2m4ZZ1yVyAF4XPHX3xVe/lzKljERczpu35OPLbnO498D0ppdQYOkCRRxwq6kMGjGc5J6j2FTWpaFLi/8l9u3ajcY3e47r14rPguICYXcbyyAGNTtGcYGfTBq/FBcatBBCBHHLEd0SuQqkKCTuPqegoeuokTRMDBHOuBcKSqleVXu34mmtLvtJZTG0rTkKrHjHc4/KpRKY4o/s8iESHcm9c7XwM8e3NWLVI/OzfzEyRbsAcA4HGPb2p7jSsUNnk+XDIVSIjfuPHBPJPril1T5tQnkSRZLeBFRN6cyZxknH4VplobzY92jxhyzBo1AKk9z7f8A16ybfznupoZEZm3kbFbaB2H64otYV7MbqUst1BE8XySx/KqAkjHUgk+uPyFZ6yMbV1lhefeMyBThj0wuewJxxV6Sxbe1vA8jq/3N7YCtwGY/yzVsxCCM3Mu0RRu4ligPLFRgY7kc5zT5bu5FxlgTb27wOIhdiABFQc4bkk+/ajygIQuTmQhdqc5Zvr/OrNrEllHbJOgDOplMzHcoU4HPrUOpMYw9yFMUWSVyn3h0yvv6VbjoLYh1Dyo4rXSoFYNb3PmzuW+Xb6HtyQce1TancyR2DxQF/scwG4MMFec78dqpaNAHn33DbpbpzDEHYAAZx16ZBJ5rbjQXlhe3F3IIjBGNzYzuI+VU/wDrd80JXVkK6uYV5JZ2MSvNI805i5cLuBJGFTPYCprsPqdys6QEnzAkTFtoPy/Kp+gBzV+USTWTW+nWyLBGx3Ocbd4QsRz0yM4rQsmTzHe8Z3W32QwQKvzzyuoBC+vYZ+tXCHM7dCZTRneHo7O5WG0lsXCIFLSg88n5mHsQOKmmvntxO9jNIEu3URFn3NszwvX73GfStNNHuLm9vNKTyp9SGDKwkCw2/rhh1C5xj1rMgttJs3a2tb03MkfBk2FTwMHDHgKTWyg7WRn7RbsI7m1sI5pJ5XmmgX5Ttwhc9iT29qu6XbXGyC/12B20+6O8RhfmlIHBbHRR7D606bUNOu9ce/vUs/JR0K2EDAiQgDGW6ema3I9Zln+1tcXFihliCiWRwY4IxyURF5JJ/lVwoyInWTMvUNVitpnksIoZFDGWBxgjefugepA7VFd2eqLYT2cL+dqtxiVkQfcOM7iT+VT6Yum2OsSpNBLI5fMDK20zMehA7g+3FbOlXluNUkkvpWlnuflmMK5RGB4U4+g6Vbpt6sSqo5fR7HUdTQWkCpE20TDYOM8jOf1/OrmlWsyw28JlWeNVMECJgtIATnpzgcnJ7U7xHq40u+86OXFuZtsrW6HayNnKL2G1sfg2KmtbKNLNbeaF7a9nuXDtFncI+CRgfd4I9utZ+zV7GiqHMapf3lrBKdPlEN8g2K74G4E8DJ+vHtS2bwNpqCD7Q9wuFuyy4Bdjyo9RgE5710F1ps934sFvcRiR47cTbnUDaB8q/X5SOKqa3ZH7fM1hKLYImyCZP4mkbBH4Ln8Kz9lIvnVzO02ymudNN1HB55jBCnk7AOcjtxmq+q2e4W4a+Y3EsYmzu4K9Np7gg5q9pV01qsto37qcHlcYjcfwgen1NZlteW8uuNfX0uYzJsaXAKhuN3A6jHSs5U1ZFcxp3kRNnKLdvKeYJFH5hJBI65z29+1MmWRLaOG1khZmUecHG14gBknIPOelUbjUJrhpVgVEhDMkWRkBQeuO3GOtWNL/AHsgiO8y4y/y5IccfguOeazdr2RSZbhUfZ5LppQWGURedw7Bm9c9Kz98EcBmubZmt4HKsVOQ7Y4/Afzq/qLiK0czssFxFPyAOMZ6+4rOvZzHf2kKThYiSz/KJFwDkN75JpPTcq9xdQkaKVhYlY96ckqE2r6gDuelYAuL/RtWgvrYJH5xKsW4VmzjLDp7VssGlk2JOB5jB0cjHOefxOafqWnJLYTK6B90io244YD0/rmsne9x2VirY3ouDKrwSLcSS/KDgArnPOOvOanYreysskaR8b3IwGz2CkdM9fpVSCF7fcZlFxCSCCvVcrgZ79utaMc0cOkW1xYvHPcPuJhK5JXdtJPoB0ppOQm7FXTRG8mXjBlSIxoS2Sc87j9KdLcWqRNGyiZZGVZNp3d8/Lnp0/Ws/wA/7PIZTC/mqS6iPlSuPTrxTrWWC6xLK6lUJLiNwFJP8PHp1oVhsdfxW91vNxFtRizBx+QA9Kp3Ns1rNBaxyORJkZJ3bRjoT3FbLSeZMkQcw26ou5lUBmYdBjsM/iawLu4lkmuJVKZRTuYDgNg9PzpWS0Bktkt3BfLLOYDyojMWHSRRnkHNT2Mc895KyyCMOpwrHAQdBj2Peq90sCNblGKAwpkggHOMHAHSrMVzbrHCsjSOu1ioZSWU9trDoTjvVLVk2siaeNbKSYwLKFZQruv8DHjcPXnipL+OWFbeO5uUAhdWjXoBhcjcR61lXd7cPdwrK6qX++2cAgdASOvPOazb64nKFprhJ0J/eAHH0574obS2Doad5KjwnyoNk0rlS2clgcHPHeqUsF08hZ51Dr8wXjoODnHf+VSaesXnMd8ksq/OGj/1YGOAo/nir8UykOkUC4jPzsT8q/7P0qHroNMRb7en3mLKFHlk7MY7D2p26Xy2U8KOpxnceuAKgNuL2cyP0j+ff0IxwAKbC9xDc/ZwHdD80YwNwPqT25pcpV+g+6up1iXco2uf4V5PotR2plZhGZyjFc5JwEb0+mKbcSBHDSKRK4J8xuWTtx2A70y1t5MKAiidj99m+6uOvt9aewnqSII4d6W/mMZDhec545J9OagYSPcrIkjSsvyk52qcdgT27fhU3zBI47eVQ0pOSeqjoefercEUY095pQVt0bYo6Dd2BHfvT3E0QafcTWV/FdADzAwZBkNvbOMYHr0rpbHTJE338Hhu4t7wMWjga4BQN6leuPY1g6TKsGuWd35tukUco+ZxhVHQHP8Anmp5dIikSR18R2bxvI3MjMCee+O+aZLVzMZ5ld5JNwnklwwLc78/Nj8c0VLdGCCcBpGkkT5FyuAh6Bwe+etFO6FyvoaCSCZmld2BMm0HH8Xt6VcuxDbSW0BncRMSTgZBIPJpL0LbQW8C/wCqn3ff4OamjtzK6M06nygchhjGOcUctzW9tBk0PnRTRlitkJAy7sBtwHGPrVy4+z22n2sUIxcSBi7SD7pxwooieFpis5Iidtw4zk9age4efVUXyQygGQZO4hgDk/jxVWW4m7bGRbJE4LSNsBIwobueo/rWtcQxWV6YY/NkjUKSHPMZPT6nFY6S/ZrO42BST36sTurRt7WRt0kieX9oOFkdiSG9SPxqVZbbhfUuvK0flyGUXAkkDKqjG0g/dP4Vnw3EbXRiUmJZJGcHPIOec/pV0Rm0mTLEoxKEZxv9xn3FZkceNWdgQw3428ADKjJzTkCRoP5kSiQJghSC2SdzZ6ntUUdtDJPLLGi+YF8zcCW9O35mm285uDOoLtBE3yIeS2OSMe1DTO7JBApjwA03GBt7AURsEmQ6ZFbsrbicAPukxkAZ4A75PrWzZyLeWUkcRbzHjC/c4jXv9Rj9ayLKNbeWf7OxCk/MXO373Gf6VsRzS226GIHyvLEhTg57Y496aYIoagFtJYoFLIksXnA8euORWhp89lAlxcsBcuqkRqc/KAOtUbq0ZUkaZ4DLuA2Z5HsD360kVsYrW4lQMCAEIIxweQT9aSvfYbdh9pK89rAGyVgjXhjhTzkLx7nvUNzlZxNc+WpZi5RMqSBgFfxyPyrSicWQj02ZxFIYg6grliw5GeeAazdUtZJlaQwv80ilW689TjPb2ptaC8yxp7WplEcRaOaQF2LnIB5AX6CnySI9nHaR2w+0HBDr/EOnQ+tY2mzTXE6xoywQwZjDHG5+emP0rZuVcmO+24jYkJKDncR1wOoAxVJ+7ckraaj2N0i3KNNgCNRIcKCc8D6H+VXNTjubq2kGVaKJlVXByC3XaKoqs8+krJ8rQiRnjIH8ROD/APqpJUFtdMLfMtud6qhJyXCjJx/vNiiPYJIntLOKKJDPKoit40aT5d2+QknHtmiKWeOzt/nAkluCFRgCQ7eox2z3q/bMJJFtFZBJ5khlnlB8uPCYA9CccD0NZckEUWtW+oyFV04ygRo2cv8AKwQ46k/KTWiitDJysbevq+nWV9ptkiMl3ePBK/oQgG0D171z+k+K5VtHltLMvqUTC3spCwK25A+d8HqzfpXP6h4iuLmyjjtmZ5PMWUALucPzuOfUnFdBY6EukXRgba7RTozOD8mWUbh+Ab9K7adPmkrHnVq9jR8SXc+kaIkMDRQG3hUEBdsk4f5pHYnk57fpTbbTJ7jRLj7LdPBbwmMJKi5e4kPAjX0XJJJrooII7q/AkEc5Ef7ssdyKqDI49cetR+GLxrKF9Pktlk07fI0DRsPlZzn5s8/T06V1uklscntW9yAaTJbyx6ZdRNYwQWnmZeNWLkHG0EnHqc1kyxzXOmNJBaSLHLM0bXO3YZOgZFx2x3o8X6hHrXhu4lN5JDPazbWtniIaQA4Khj7c1fufGCf8IpY2OmRKgDuTI3Tk8Y/r7iqWjsJvrcn0jSNcudXR5Lg2lkkRsrd5ow9x5Od21CR19xW/dx6laWv2LSLiNBA48kShIpFU/KWb1JPfrUdn4juJdP00PptwkcERmzIpJYjGCP8AH3p6eJf+J0mkzQxra3JaSSYrkgFl27SOM5zn6Vm4tK9i4z8zIvF0rUrW5hvXFr5PyMJVdkmOMuSwGN55wR0wKm8B6+kjT2N03n6pcXAiiuy2POQrw2f7oUAepIr0jT7O2e7llhW3+zXJDHGOSp9OnNeaWwGjaiZPkuIgzWRSbhApYtHtPf8AiHscVi0pSfKbRqSW5FYXU0f9pXjyCaWe5FoszRsSqIxJ47cc1lPqdzFBeyXFzIfs0RlhjWIfPkevouBx1wa2NWe50KNNNVpLm0y90roB5nzNlw3r0xn0rAOrPeabJOHSJrlZTGE42lvl/PGBWigrXQe3dyHUryWa1trWS3uJbmWLYoc8rIQC5XHXjHJyBxWVHpbrOhtm2WMQCyRqnzGUD+Ieo9afDOllbzXke6KWRQkLOxJTGBhfXLfyq9qV6liLO0gcyahCnllF/wBXM7Yy+4c46lvpXJWgt2dlCbaHoTZQXMEcbNFIgf51A5zlm5/Ae9WIbpYbiWR4JRACPP8AL9jxj60+WBreW6F9NHNcSxuTIfmI2jrgds9PSsqS8jtWspI5ZGRCJHDdHHUZHf8AGuKbs9Drjsa99cxQWkV8sLSXFyC5hkOWAB4ZvTpWPZ2s+2e6ntifObzQvQkdgPYdeKl3tPHPeXAZROxkDu3LHsNo7Y6dq041kgtZZ3jk8ySMhFk58tD0z6EnmiXvsqOhWEW/SV2hfmdpfNQfdbGMA/096ozSrb3VxGly5kKbASScn+LA9B71LqFwLJPssMZafIySM+Xno2OgqO4tiIpHDbQqsIzt5ZjjLDvyelZtrZF2GXN5FDJBNAcRSKIn+YbuOQB25NUb+9EaLHaj7Pc+d5c0lvnGxuMemfp1NXZ7KKWGcvDHHcQIuYyORx69zU1na3N7L8kEEUzQmUIDlECDqfc5yaSTuJ2KJN1JdsbgyhCeCi/MRjAAFWr+zjRHeGGNIkT9yGILHJ5Ujv7+lS6bIxu2Waf/AI90BWdjgFOm5c9R1GKqajMZFRkd2uCSU2gA7D7/AK4pbXuFrmdJHPFCFjaOBDtxJnccg9ee1QIzRwlri3QFiFRlOM5OScfStCG3ha6ia5Hmoufox/wFVp7r7ZqMk0SAW4GwNnjHT5fx5pX0uJroQzy5Xy8Kzu4UZOCRjB+n1rShSRtNZ5keXIViA+F5GAB3P9Kjvba1VpTCVkuRtZ3jO5CM8KT3PrR5seAJJMogAVQ2T07fnVDI2iZrT51SFMGJcrkkD+6T+tUtTy0SWYb5A4Xy14BPfmtIQtKUtki3IHG5Ackd8g1FMsck6zo0ZmRvlVB74y3pU3uJoz5bSSxmknjjKLFgJGGyyk+39atCWc70aNWlhwGRDwDjOW9cZqS8MdvDsMeAsgkZed5yeOew9qpxQTICy3CCOTMsgjbPB7E/0p9BFlbgq5EXltcccj+Ed/wqsb2WEyGd3LSHDoAMMR29hnsKmESyWaz+cscrtjZ/EE6/KvYUCGOOUEvIXw2UVcnjpS2RS1GRW7uyNJKBGFBbsT7VaRrb5oysr9/LPRh656/Ws10uIVMz7VhbGEwQ3XrippZXnJhdwsjRqvmHoFJ56etNCsy2mzEk8MoQv8iDA5zwcf400kxAqvzsybPLHOCTzknjOKeuwOiEExxjJEh4wO1RlwYkKzMWkboUyB7ZqbjNKK+WztBAllpzqBk+cpfHoPf60Sa+YokiOiadjjnydo9+9UpRNOSqRDKrjeTsCj0qEDKIHdUQSEPn5vLHc471WorIbKwuLpw0ccIDBmwchSf6UU6VbWJB9lu8hd2zfFsYjPJ980Ug5jUZ4pEK3UhWIZ/gyRjkY9s1ZsdTuLfSXRCx8xt+1gGJX/PFWPtCW8t3btHGzNGUyOVY+oNZdjAzTcOBFwwEhIyR1QYrXYNyxE0kohRYzGh42v6nv/Snw2jqJI4G3OI/M3bsbQOv481ZlIkEzoQkkYI8tuVx35rHDfaroREvHtA44HHsO9CsmDJ3SMPGrxYVgfMEa89fvVq28CXMZZJzGrKSgZ/uqP4fbNY1wzPqMBLFos7XCHJ46g+oq/E8htA7SR+QJCuwdSD2x7UJpOwMcJ4rm1m3F1mX5QpH5c+lV0igjgjyB54Yq2QeV6cn2qeX/Q7WObYCrNjAz37fQ4pTNMRBDLhECncwUZUdCD70mr7gmPuLW5trG4ezYsltH5m8AEhSck+5/lVWxS5uVafBLJDkq3erV35gT91KVib93hhyD3rNV5oA9sSVMoUFpFwuMdQaHZO/QfkJaC3uZo4pWJYOUZC/zdOD+dXQoin8keYCWVQwODn0IqgTDCIjCu6VV+YPznB4A9sc1oR+YYrktKz3JcMMAZU9CD+FKy6BdrctiOGW6htImZVfJfPL8dSKS8xIjRNyrlTy3Py9xUMlzCmrie2LpHFCMEdWJHb1FVpLg3cwlUnfAMbM/LjAx06+9HMtUV5kkESXTxXMzFgCSwQgHAzjB9cimeVcXlnFb7y77ycDk4PcGrdoElgWW4AYxKyMEYLuOc7jn8KiuSyeVNCUS44Y+U3LZ9PQimlYm9zOithpusFrdY3UuYSVf5fMPRsnsf5itTUZGjkt5Fk8y1QbdhPDeuB9TWbcSLIGhPzuhLqJMcnPU578mribkhtoysckMSbmG7vndgn070JKzQi1GbiRPsUMSbd6xqqrjHdcj171madaXF1qdpbFRDJJiIsr5DljlTn+EnHetuGGe4kikkmeNp5CyBE+47KNo9SMVl2dwbWe0V5G+a9i80IcEgNwf1OK15NdSJSNC/McOlQWsSFtjTRSQ45EoORuPQnGK5zxRqEs6WIjkDILeAq4PVkJ3BT25rd1Am01G3sIXjZpbuWJivGGEhVfzBrgdfkWN1tkyUtd0ciZ6NuOcfjW8V2OOtOyJ9FtXe5E8MnlENguFyASePqa7QM2maIJ5mZZ4z5Qab5lkXkoSPzGetcvpsUQSFFMgVwInkQblByMcDkD3rvPCniSzsNLmt720N/P5hiu41iLoYucE7uAR049a9CHurTc8q/M9S3caTPd6BFfW8TxN5OZBApZcMDhjz0zwfwrO8P2wkltWu4wyXMDJLGGODg84HY8f4Vdm18aTp9h9ne5TR5n8yGFXDPDzjyjk9P4sdRVCXX1WcvqNvFc4ILm3Uqz5OVYg9CBVqdviNFTDyri0v7mzsbObUtOvAFEU+HkiPrjv9etUY9HXU9PddPWxXVrV8T2bymEykdyG43Y9Kv3V1PBJHdaREzImZInziRB/tYPNZrRXl6ssuphLe9MPmwblw0jhvlDemev4VMpLa4/Zmro/iKWyjhgjvY9PS2LRSW99KzYAHIGeG56AetQRzAw+fcR28SmfzAC4JRSMAMAeuP51lwadfak8ct9eG/mlfbhOBG+McjHUetWtI8ESXkkkFv9ogukHzAY2ydeQSOn1pxk97aClDodRaa7BpkLOlw11LtJgiU5UbsA59D15rn/ABN4u1W80+GJoLL/AEUAxB85VlIwxH8WMAAj1q+fClxZ6eWkvLiG5jO0W5GTuXqBwc8c+lcs+j3U8judRlubFCEWVYsmJ8gAMDj5RnPuaqbclzW1MruJqWWuf2rLawQvK16JViW8kUBix++WGcbcEgfWqPiS+eyur6GC5DQo7RyIijaw9sdDXKXct01xNe3cxf8A5YmM/KU7Arn+HI/XrWXFM7CVp55UgiGRGi7ct3I+n51jKdopNaglfqdhpurfaree/vVieS1VbO0hmACxjnkD+JgOcngVDZTs159q84x+Uh8ouhL4IyxX+7n+8e1czYRCFYbsx/a2myYY8j74I+ZweqDqe3Suxnn+0WstufIVjEJbiSElUZV5OSeWJPHHGK46subc9GhGxNo4IlkWS0uJZLlPOaISEeRGM4DHuMc1Sju0m3yTDeqHdhlP7zH3QB2UdakSW8uc7mdmnCAxE48znAH0HpWjqVm+jvcWkspN/IgDRpGuI8kcE+mK4mrnpoprds+2F3It3VXcYALEZKjPYZP6Vpaebm9nZQz3l28IWIK/zFiec54IHTNUDNE6o6oYoRlFUgNgjv8An2qLSoTEsUk8j52ney5JVSeFAHvSTsOxpSaNd2Nx5V5FJBNyX8xCM47575pXu1knTyYGkmiB3PnIiGOAP5028uPLhIuLr5fNXy42YlwCOST7dxWc6tcSiG3aZVEYZwXwFIblm9sEcVOkdhk2ob5Jf3c+JIQGGDvyzdAPXnr6U66kbTYmhLzob21aGdMj5WJzkEdAQBUlrGSzC0laMHIWVk5JH3iMfkKpajcSC72C9AUR7HzgnJ4I/U8ULTUUlckaFNTtrCSzRlkjQJF5zgqu3kg/7JPSn/al8tiAinOy42j50ZsjaAKy45/7Lu3itGUW7HMe0EsvoPf6Ut35Mc26G5a3n+8rONvyjkhz3yenpRbqJsW7lMYMUjbyp8mNAchO+fU1Y0+BIoHNzGXmb/VFnHbtj6Vn+YJ7jdOTC8RCSjOAUPOc9+2PWtS5e3a2MigLE3yqpA6H+vvSaHFlG4vo/wCz7azW3CyuSzyq5JbBzjHoM8UyF2WWJliUNF9xFXABA/WqUtwiyid3iQ25CIsPU9uPp1q6moNcuscAWFMEGSQbmYnk/wCTS33C/YsXcyh4d0pDOmCGf5j6nA6Dk1LHcW8XyxgwwjGGIy8mOenXFZGweaSkbDcMB5PnkwO+emfSr9ukaJMVbJP3njYn5fQe5PFFw9SpqdzJcspm8w7s7VJOW9z7egqebMSqbNFRYgCrlsrnpjB61Lfzoscb+QzshyyA8yewPYVFJK8l4q3CobiM4YMcKCeefoKLD8h0yCdEJRDIuEWR2LYx1xTUgmhfzAy7QxEbSHdk+ox3qSWRpSy7/wBwOuEwz8chfQe9MCWzyAWRcQ7cqJDnyzjGcds80C8iu93cPiN28sMMF8HpjPTpTbWSQSiaJibkKVHyn5gasSO8vloX3KjDcSfkz9aluLkpcOGO5BwFAG4+vPahCIPt8G9olkZJVyWWWMEMcdB6055wscXmMysQcqBxjtjFNvp7S4gt7WKJIruAN+95JIPP19uaqR5R3hlIGccg54x6+lVJWFHXc2dFs7fU9UtIbrzDGzg+UTtBHoT710FpatDHbRDS4BPf3L+dC0efLt14IGeRz3rktOsWvtQtLFpdhmYb3Xovfr649K3tQXTnk02WM6isV7LJamUXGXKjCg49MkHHpQhS30OYne0i1meO2Zp7dJGELE5C4PH1AxRRPaG1v5YZjFG9tKY1bp0OD+dFFm9gTOklX7ZbxSRO5kVS0jEY3jPRfwptvNEyxfZVUqcGQdMsD0z+tOuL1mt3ij8syyIUBzjZnFV4oPsIm4LBVyQpyQ/+Bp9dDTZGtGzbMXMoQIN7sgy2w81kAtfxP5XELFmWd8BvyqCZLiTTg9+22VTtIC42jGRxViESPFbJGSzBM+ZgIGTHIGe4p31FdMbozm3kmCEsCuFDjLBWHzcD0PetaNLaBEjtZGcGPG9hhQ3U1iSXstheyfZYyolAX5SG3DPHuKvTao0jQ2kTKgGTO7pgnjoPahbBsJq9yVWN7d2bcA8mRgZ6YxWtFGrW3mMxaeZ8rJnPy9xj2qjfQRW6w+XGZSy7WcH9PbmpJLh7gNEzozwod4HQdOv04ppNXuK66FGOZTesm5m8tlKbeh9QfWrN00145hQOHcgLk5CKfr6HtVXTnjgmlZQhbeQi84Jz1z6GrM08j3CQho42diSyjLAdCPpStZalblO4Ri8glJZYn8tZV5244IHtVmCZnEYkHmFWxlTtJK8DJpiwQwQMq3BaKV2Vt38Zx8pAqLTlN2JP3gihBDOpOecfmKVrD3LISIMXaMtFKxCkNgoe/T+VX1sAZo3t0LSKCrBeqkeuKjvTtt443ELFpThgckL61JLcLBcZRZNhhPUZ35x6evNNJCTINVvPLWS2toVCTYEjNzjA+alKpd3MkkAiiWMqYwvyrnhf/r1SSIT3m07QRCZAOuwtxz+FWIET7QIYI3+UFpFY4wMdfy5od29QsKY7ePVGeR/MQxtkkbtsh/oPWs6NpZr94mc7CR5ZPG8dgfwB/OkWWOKO5cMMBHQs7feJzjjuD0qLTrT7PLC0skjLG4Qop+8pHIDexAIoXvNNEt20N2+3R6lbESmNsg742LBV2ZHPqtYsskJ1YrIjLDPbKgc8HcSNrD6HH4ZrXnS2/sYXEpf7Wtw8cseeQp4DD3H6g1h6yk8k7RMq7XhS3gOPveWQflPY810pWdzCctBz3bRnWo75GjuIUkMQU/6qZXUk/XGa4xmlM87SMeQWLYz3Gf51reJ9Uk1G/nvCy+fLIHkCLhc7ApyOx45qC3guBE0MknlCdNwGNwYY4Ix0reEbuyPNrzJLbUDZTJdQ7kkjAK7c7XHfI/GvWdDsrjUUjl0O2ju4Z4VF3BG4URuR9457Ecj0IryPT3DTQxSscb1TaDjIJwQfTFdV4QfT7a+f7WZAk8zLazo5SNJEY4yc9McYrrTaWhy0zodf1OyVF0630/etoiwSzNiQOcnI3ccgnGaqzXulvYRpHZyJcwgBo2X/AFo9iP61g38KC/ljNyHWOQgljndnnr3PvT7QSG4jEtzHb27qw8yQ4zgZAP16D61Epa3OqOxYmI0+6SS1dyrhWTZIHGAclCAB0966WddG1mzl3X8qATfaEmIzKrlQMTJ6DHGDXJ3MUjhIbVSJSQFyRnnt/wDXqjJcS2l9tuowkgcK5dsE84P4VKlbc1cdDTuZJNDvYr7TtWWWVJCGaHhtvryOmKuX3i6b+xZTOZZfMPyyEtsbcOcEd/Y9Kdc2VmJzZ2d7byXErt8kwwANvAGeWzWDrnha78NLGz3sV1MRujtYXEgUjnLY4ArRSlDVHPLXc14/HEColtdlpQnynEh5UjlVYdPc+2K5+O8kkspZ0uriVIpBhMYyM/Kx9eBzVG8s7X7PcGW3+zyO26MFwZGbPzYUcY5NU4phZwypsEgByVDnjA449eTQpyerMJ22LGoakJtNhBEZJjKnnLEE5/Ss3UL4m2t7XYiJGpU7W/1hz94+5pLby4gpvFYyH5Vjx09yf6VkKYvtaNcu0QU4IVdzbfYetYVamlzSlTu/Q3dEe0sr6O6vwZlOQtknSTj5VYjkA966lGkeGRbyDykkk3LbrhWKnlfwHKgdhya5zw3aFZG1mVJUsEfyowhVpWfGRgHqPU9s1r2CvqFy884Zy2WlO7aI1HYN6/8A6q5JTPSpQsdDLIS4mk8oNswrQ5Cx5/hU9zjvVJ5IxDG8bSLGrFiUTcVXoCSepNBna4t2aFXa3gQhGYYyOgOBwMngCkujbW0EJndRjaVhVsknGSW/HGAOlc89TsiOtSbZjM8TyOuCFAwAT0z6Cle7aGL7M5RlhkLmOJvlwepJ9T0/CnR3ZlhkErbYixdsfxHHGTVK4QMIZiN7KV82OI43KOcL2yKhPsUTs5lsJTHCGdXAJJO92POB7DrxVqeeAxLEZMM+D5nXgjp7jIrPdk+1Wt8juocNti3fdAGBjvk1LLJPFPHcMYVlXKosa5C9/pk5o6AmXriRoiHhYqFYRxtuyBjrj8aznljW5WWSIOso4Yj5mZck4B/2j+lSXLyW8cccRztyw3HJUeufXOaqEsY3JEjI7L/D2XvnrnrQDZqRBn09UuXjWDaTEx+XDE9Vxz14xWNdGWIM1y7yOFKq0i87s8cHsKsJLFIyyiByir8i57r1bHbtUdy6regXG2QNwykli59vTFDdxFG5s1ZIJVnDP5fkvuU8Dr19R2pbe3ZNgRz5EuFhdmHAPr6HrVuyZLi/t7FWKxuSGnkbgEDp6Ads+9QWZje3lidAYonJAY4GO23vkc0WFfoNitHREUF8sx8obRg5OCfc1dtovs8EkTJ577/kA4PHXP41USUtc7hNmSHAiaQYDL3x71OjMJpCcTCQeYWZcZB7H0GaBjCCGR5LiAbTubB+Y/4VPZzKkW5GkSMj7rKCXP19KgkJkR3gVJFJ4ZgAc9SQPQetWLkwNMFmZZCuQDHwo98d/SiwyG9JaLyvOUvKexyuTx9adpi4s4jD+7kGd7y8FvfPpU9tiC6hlI2uEYIgTPPdj6VDcTRCCbchaM/dXgFT6579aEhNkl1ujldrhy+DyR1Y9sntTrGJd7CVUALkGR/48DpVWeQyOFQo20h5CDk+gA/SpLeZSfIUEmXHmFiNv69D70IAubhpojDOxS3xxEvGQM8n8ai82KSSM2q7YtgACjLu3c1b2RpA7zOYw/GwjOVB4+lZt07W8jGAOsRO7b3T8fegCuYFXV2RJMHDEueSTgA5rQn2tFIX/dhFxtCc/QfWsqK6hkvGkkJKA+u1ucnmtA3IURyTXCykHdhjyTnrn0oJTJ9HvZp9QtodPtwkyODEe6t1HU49q6+SHVhDCw8O2iXsEjPEftAxGzfeYJnHviuK8LXa2+ppeXI3QRy72CLl2GSeB/npW/HDYW99FqEuuW7RRv5oI3+cwznYF9T0NNbCZj6rp13bzf6dAyyXLl1dmHlsM5LFhx17UVbvrm3n0S2tkmHmzXUl0Yv4bVG6K/8APFFFg5iSMfapc71ijVflA6sc+lW5bgx7RKhiIGcyDG4jHGKqaa5t5i8ZYB24IO48dfpTrmaXUdReeaaNMfLGH53e5NUlZXLbJ5fNmuZbl/lQnazgc9Ow/rSmKQSRqYyE3nG5ugI4IpZju3RR5EgAdju5Aqk1zJNNmOXdCkg8vHUcfrmlYd0TzlFeJrkMxCcPGOmD0xVi2t4bh/MdREMA8jOBnGff3pbJ90tw0rGNXO05QAHPT6fWrF2iR7rcgREYPnOcArihagVp9PWeIi02CQAkndgbge3tVCGHyo59ksgYH5w3JGP6VoW1zax2iYUzSFsZUcbfX68dKqMIx5kpmHls2AyDqPRh260Nj0W5BcxvJKscUwKDEnzNjBPDA1ZkBkWKGAAT5IcA8bcZyD2FRXbPLLMUjBSJVReBnPqfzq3H5YW2jbCK0ZXzMj5fXP8AhRa+4rpD7kvfQLEZWYnDeVEnQ/7OOmMVJpKKs058sb4uozzxx+NQh1tL9UV1kKjAMfO8diPamrMltcXccihfNClU3ZLN3GfT2otbUadyVkWbc6OWZnEkatwyLu5zT7tozJJHJJvECEKyHCnce3rkmmMzRNC8hU5Bwv8ACuO34VSuxviwr4jOHztGT1Ix+PGaPUC9pqNFZI1z8skhYyO5BDADGOORipbZnSGO534b7jtkZHHH6cVSVyYYVZSJFXy2w3BJGc1D5sKgGYEp5jJgcY4FHMFhkVsLm6ggCKT88mwj5mC9B7mlFw8t9FFEzs4UMCB8xHTp65ptm5+0G4T/AFkbKifh1I+uaovcka5Bcz4d4Zcbc7cgnkZHTPrVRfQzm+pe/tB41SFYwJY2xng4YMDz65rN16+xeQyu/kwh3mIQcodw3D25Gce9SarMy3bRSr5EquBLvGOM5Un9ORXMavctPczy7ifMkZsH1zjNdMDirS0sWL6N31R22xlbk+ahP3ZAe/saZbzzWrpJ5yxohMAJw5A7gD1FTSKIFjUn5oiHFq3DKW6Mueo9R2qkLqfz5FmhWUyOTjj5m9Pr9K6VaOp58ryexasr+yjurkI0pdnzFKj7XCn2PGa6jw3fre3Men3EDi3lVo2gaMGN22nbIgxlXyPXmueGi3moQ2beVskKs8bvH8s4z0BHfgjFdB4Yvo7eS3sEtZY5vMQMY5f3gmBzkevsOlaQb6isk9BzeGNUsYGXUoHt4vlMchGN4JweKu2XhGe9sZ5fMZ44wWVo5Fzu7fKTk/8A1q1brx81vN5TQOfPRpI5bpvN3+qsDxtyDjHSsCTxrczOWjtIIpVU+UYYhH5Z7kdjml7mzZtG72O48MeDJpgsWozx26JBuV2A6YHX6+1VNRm8J6LdMFuodRngXbvC71RuwUkgHB61w8Xi3UvPQrJ/qiMIxycY459smsi/0tRuaCb7QCpJJGNnf8Kl1Fa8TTV6M6q8u9Jtre51aXVjd3s8RRXMahgx6qB/7NXOLcxXNokFwk1q0jeZDLICRIOm3I7e9Z1vFMF4KyRHEhiZdwYitJ765v2WytbZFjMaqtrglI1U53dcjnP50vaOW2hm4WRmXPmWBBRSM5YEAkYz2J7VSutQkl86ZpAjDDJhgNnY/WpNefF35QdSIztxGxIHfANZEiiRQiqsee57ColJ7IFFNXYx7iefe4ZnAxlycc++e1S2kRmnUlxuzwf4V96ruCZMAfIB2HP41q6KBbsJtqvInKBxlR/tEH+VYSZtBdjo9Nu2WI21ukSRkFolkIwHPWVieT7ds1JBG/lGNWP2YsPMc8Ej+8fQHnipLWGGa0S41AyM0hHz8KZB2RB2X1Y/hVn7c0hiikhhit7c7I4h90nrlj1bHQZrOdjrpomQsJ4ZGje2gckwxuPlZQOGHtnvVC6Zp7hFYK7zEINwyxQdOe2TnmtBpXvrVWKyXH2htruW5IGfkQdlH61nTRhJY5WZQIcEgDhOeMn174rF7m99DTlFxD/Cq+Um89GGewA9KdfL5VpGhMQuJBlmJH7r8uCT6dapI3nGQvvbJwZGYfIvrjuT2FSSSC2RFaJCjIEiBGVUnqxHc+9Tp1GmyjPBJC8c0chkinG4O2WkUA4MgUduvHpUi3IktVWGSNV3MEHVQMHJP5cVcieQSXDRwgh18vsMJ3we3SsrVoYZYppYEFuSo2RxA7mH+eTQ+42bcphuZ7eKNM5BM0pXJLY52+uOlJAkkPmyuj7BujyDkqCPbjOKxdO+2f2ezktMi/IADjH4elPkuVMkUbSyFMDzFGQCf7vv9aFq7ivoOa7Lyosc8n2dMoCRgbeMce9Nh3TsxD7mbKjrnA7j3qsjvcCe2dViSPOImzgAngk+1Ptd9wuI4lZyuC6R4bJPRcdfrVNExk3oy9pMu2/S38uNIoo5Az8fMSpyeetVoS1tdiZiY4S3lqS3IU8/nmqNzBdNdwxpayliuRG/XYOT/jUto63DSJGVIPDbuhx/h1qWCNRlWe3WMTgSFi29xjYfaoI7lZbiG1kxBKobe7Dcrntx2FCyBNNwNo3Pgu4yz464qHUlZ12QxpCyxgks/wA7DH3ePXrTQpF1UzBIY0CsxKoEyxwv64zVkr8pUuk0qgHLKADxls+/pWNbahIunkxSlGIw8qLj5e6k9j/OrclyscEqw28u1lBUMMk8feJB4pWK5iUszTLuOxRGQsAPUE9z26U3UDusRCqhSyh/mxiMA9T+PSqqXMlzGIY41iUthySA+e5z2Hv1qzawpK8sLyCMJHmN2XIJyOgPU4z1p2Yr6FS2ctJIrmQpN80bDqOxJ9utX59rRxhGiQAYOAMke+e/tQgE1mSJUK5CgquOAMYFQW6hT/pyqNvzRozjBHr71I1sWVAS38q3l3FgCxcnCjqOO5qsbgxozeW0rNltjng8dcVJHEMRmRwyuDgqPlA7/p61XeMz/PDCfIJKrvJA/wA4qguZsDo7K0jbGEYUjGSzZP61N9nEj4VVdiQCJI+Bj19KQQiG5Z7UPIqv+8jU9B6gmrBmkmlYyTosA/jGSPZfUn3p2Iv0Lfhu2hl8SWAmhV4GlChOQpx2+ma66LWbuRLUvpsMs5vjaXMawAGMHG3jHGMn64riNCt2vtXtbMsyI1xs3k8jPIwPXjit221TTbO4uZorvX0lk5nYyIGkA4+Ydf601cTMLVVEN/dwEmZ/PYO4b7+GPOB0z6UVUe9iNxNKjOSWZgoGGVf4dx9aKNQbNueK5t8nYyo7ZO7g5z2q7aR52tOqLEyYHfd+NWnjuYLm3liMbxSPn5/nGfp6dqzbtneV4LUxwEMQFXIAPcflRZJGl9SzNM8Ft5Qi8uWQ/I4+bOPeobwF5LcW/lpKhyVPAx25pgnUxweRIT93cVHRuw5qR5IpJWCIjGTIZgCOaGxxZNbRytGrvKAXY7ecBT6H1q0EzA0Eil5H+VCT0PcfSsy1jEUcqZeSF8LGWPO73q4JJJpI1iU/L8uUHI9SfWpVkMmadITFaqV8vJY7hjDYxkY61aREigVIo40kPO5hxz2HrWYYil9GjHuWO0ZAIHX247VckwWVd6Nuwwwehxwaa7juVRbQLPJbRkmQHcrNxz0P606S3kS/hi1VY4VuCsazdlIx8x+nepbaYzTnAibsV6A+vPaqMkjf2icbmfOzcTu2jpgD0pruKRamhu49WexnRI595U7ADkdcqR/C3qOtM1UwvcQCMFWjJeU4AyPUZ7+1RXRZ4Fli3b7fhTk5VO232HpUCubibzJYk80R/KwXO/Hfn1zUyetkEfMuRXKyXE4fLROuxXA6ep/GopyuyVckhY12FexJ5P04p0ESbfLmyibBmUHduBHy9Pfiqs6SJAR8zHzNhKtkcAY5/Gp16lLUsxXBK+bK5lWM7Nu307fjVVpftSoUB3SEs390c9B+lWrFPPBSV1h3ssJZx2JAOce3OadJaRi9uLazlL2kcrrBKf4gO+DVNaAnqVYmVLKCJAyybw6yAYDc8hie47Vj30vn3NwOrFQUxyc55BraUTCDaqJsY4EeciTB7ehrn/MWMvJHhXMjEIx55zxTM3sPkuje2U0Egkk1DC+Q4OScclCO/HT6VzqSZjfGSA2MDjcMZ496nvHMN0squyspyMEqQfr65rOv5UllZoSUjJ3FB/CT1A9q6oSVrnn1Yu50M95DcW8MNvatJEiswMr5cEj1Hb2pNFdbXVLaa8jZLWKdC6EZkX3Ud6w4JUAUBijc/KOhrdt9XiU2UqK0F9DlXuAdzPnoRn7pHSuiMk7M5XFo9I1bR0v9T0/UYNZiOnhcOu4p5R9FHrz0rH0vTpje3uoaeV861KrbFlCs3Y71PXbzkjnmqdjqZvtFm+yW4kuVkPnK/wA7GNjzgDvwOQK0Nctr+JbFdNRXtJCGLYBJDdjnuCK6W1uiEjldStbuXUJZZdskjkyOIl4Bz1A7A9ah24QFWO9RyCMAV1viqR7Odje2ojmgj3QyREByp65H8QzmuTN3pVyqRfvLK4c4Z2YtGRjsK55wVzeE9DX06Gxl06dpYzLP0bZnzoj13Ad1x1rKa5WLgyFR/CysTn8KfY2NrKss76jMJ1BSL7KjOSPRu4z6VkLuhmcI6zE8NImR+AzWbukjRNXZ10D6NHbw2l/dRvI8bSK9tl/LduisuMk+uKx5LkLZtbxxSyT7yweHh3jxyPXGeeabpUd5LJi2iWRV+c74uBjrtbrn6VLqAng+0QxfaftEKjfJK4XbnJAwOpPoa0TbjqY1HZnP3t4IUaLy/LeUYeMAHPcfj71FtMciGQRk43YQZ7dM0jyO7lYthfAMjYCkHPc9Ovao23yAJCZ5VB+bHPOeue30rO/VgvIhlZg5SRsNn5iBgV0fhXRbvWBLMqLFpkB/0i5nlWKNfRdzdSfQAmufa2kS7CNGwbPJlOMfn3rcMUUNpZxSTG8YoZFsYCSI2JwA5/vHqQO2KyZrB9Dc+2PJLJdxxwTbMQxNtLRIBwAinqe9MuYsTRrPJHNJIA0oRtzID0GegY+nYVTa8nSR0vGCbIwuwHAh9lx0/r3qaziEdsqgr5KrvkbHzKT7etZTSZ2QZoNO0KhJmBiRRgRryin6dqNRkthpbsX8+4dlCCMfLjJBPrnoOaqyb2jito0EcZBcAHO8+pPXrT9sf2XfBEC3mBEkBw0hI+Y+4BFZ3NAgRkG8rG0jIoG77qdse/1q5bZa/JgxK8SttR36n+In2HaqdnlfLZ5InbI3JJnHHf8A3R6d6daX0UNzPIFCBwQg2A7uuTnt7VBoWtiyKfNmd4Qf3iqCQFHOc/WmvBPchZrcRrA2UEkhCtjHLey54z3qq0rlAih9vAKjq596rpMbjUZXkYoioMAex6enXtQmJ3aFZ+Zvsjsbfgn0XIG5h6kelW5ZdkRazQeSHCpJIwLEeuOwqsiPMht0UbiSVKryMHJPpnBqqBLauG8td4+Zon+5GD0bPvRuF7IknhjBD/OzSuE2dAx6gkntU2mkC023c7pcoxURq+xQo65P9KqySidMkEzqd3lOc4A5OR2qCCdo3U2wCBzvjSQZwT1Jz6etWZtlm+WVpoyu8RIMlkzkA8YA69KghKvPcPGPJkXJSNDkEE45P6VIZev7oTznPmbm4Un+JQKqzSol3JiUmJdoYjjgdMj2NIE7l+aSW2KiZfJLndnrjtj1FPiuYpG/deU0zKXZpWOSfQehrPuLwX9whlZ5JAfuABQV68kfxGpt26FpJJYlV8H7PGmSQD8q+wppBe5EJGjlMkcJEJ2hsHCgZ6nsT2q1Mg3K6YidvmZ0GA5zjgdKbeTCS0kYRoHGQIeNqKfvcd2wMio9NmX93G26SJF/jyAp57+vSiwrmpCqhh/qcgljwckkcA00Sb7pI5oN5cmQgSc4AwOenU9agjZgu8rI8AyWGcN789xjvVdZ4JLuRyHjhEe2MKoBPPHP4daGrDvc0dPaT+FkYKpAU4wuemB/WmvZJe2NzcPcANaKCTyAOQqqnqSTzUCTYtwfLkRCQEG7AJ+vXP6VRWR0vzkk7UyPRc/zqdhsns5nZngcqgRRuZhy49AfrU8gRkLS3UcTAgCGJSzMvr7CoroQiNZpWAmjG7oRs7fN/Sqti4dzcSmXcxyGXjBxwKdrCbuStIC7tJH97lIzlQR3PP8AKqiZklMjMwUNgFXOUycjPrj1qW8mkkcNNcliOCjA5APA9vWmRljCIw45ZV3g4UD+tOxO5q6OkcniDTUuWa5geZVPlZ3Dng5Heuj1i81251O9um8M2nM5RFex3sF/hJIPzcDrXOWun6fHA73mtNpt0rEbI4WYED7rKV6VJI+mELG/jO/VWAPEUgyPY5pidzndUnnke4kaNYCjlCijbgknjH1/KiqdxEk13O1vcbo43bEz5w/+1j1NFIdz0S9KGZgoJjAydj4Az3FZ11CglieaYOAoR9vY/wB4+voavSLFbI8kkwYcFVQce4FQloRaiXdC7jKmMjkg9DQ3Y23JZUtjHFJCBCZcD5GJyvfj1qMQFjI/nHC8HI5aq1tOE2yyDLRjDJ0J9Mfzq1bp50ayRBZEbIGWwxHeluPZEkqkRWTxuu1sqTjd+OKZFHcAkv5TRjnzFOOCeo96iS3YSqyO5gUgbxwFPv61deSISLFGwQD5mAGRk9QM9BRYLlbVCqRItuz5GX2uNrgA9fxqO1k85FLsFJHzkNz6VZuYftDyExNIG4TBOVH0qnoxVJJbYnMbHq4wVx6mlbUL23NoJEipF5wTccJuwQSeuSOntWbcXLRXcE4C4bMW4dD9cd6c91b28LxOQZFOCBn04xVRzI8UvLRSbQ6qvAYjnNU20F7m0Ed7XbGVkkJ3gY6rnp+FYV5btZXERxtcuDgHI59ParoZpYBI0ZWQgOvIA98CoLmR7lfLdDJyQN3bPI57Gh2E2XGu47l4Q6CK3bKK3occZ+lUbeVHt12IWZS7hcZOM45x2qEkoyW0+5EjbLpKcAP6gjse1WY1MZthHDIuYt428naTzz3pME77i3CywRbwGAZM7gec+/0oglPnH7+5MbcAnnHWp7l5LeyEE0O6LcDFJnkkkZB+vpURlhkWR7YCMeeWyo+VfY9wPSk0VcddnFhOYVfecbwpyuR/EPesR4WSxiklGCy/JIv17+ta16xikaTeAChIOeGGORxWfvSW0VrdWhiwCEYb9/YkcdKdiZMwdWUkMpO48cr3981iTMY2VVAx3NdFeqjhwgVSByvY/wCFYkzboBAyg4bcpPbPY+1a0zlqp7kGNyAgkY65qYyFMkqS54wOlQBMRjPPPJB6fUUK7FMdvY81qjnZtWM+1on+0NbTxN8sikh0759xXQ6frlyltKjzfaIlfzcyqQNx43ZHPJ/CuJhYkH95gDgsRn8qt2NzJbzo6ytuBwecFl9OlbRqNaGEoX2Z1l7ra/a3ligtbknBWbafOQgcjnr36VJpninTxbtFfWcEjK26LzYQ4I6beelN0XStK1MSQvcRRJLgx3D/AHoW/wBvHRexNVG8G3bKXEsflPkIW4DgHqD3FU3O90rlLltZs7TQfEtlexXFla6PGs9yAEZJBGiuMnIc9D6A1V/tnRLeRf7esnkZmDZjVcKehIUdefeuMksRaxJKhjjj25zLLke+Kp6perqF1GLVR8oH7xlIA7c1XPZakWu9Dp/EHiT7TGjaZZCG3RdimMFct3PP58Vyccd5tNw919nVyd8jHmQnrx1NR3MzYKSSyTsuQH6DPoAelVPt8qwCKVmaJSWAZdxB74Pas5TuWoOw154oHlEa+a7nb5k4ztIP3lQcZx608X0jRytJNKPNYZ2YVSAOOB3qgrAspwBzk5HGDSFwpOzLYPGefxrHma2NOVbF5AVlWXKqu4bVY7nY+taFqTaTsyvm6XgfPnZnqSR3H8659JtsobOHPQg8/QVYWQKBCgw2ctnkn0zQ3cErM34JY5JAgRTGmCc9z7n61fjuVZl8tGZzwGZgMv3YdsAVzdo7btpwrH5VX09Sa3NPQSc5KxqvyD+p9zzWUtNjpps03nDzDyP3krDAbHyoO4A7tnvQrCNTHIV+QjODjBI6ZH8qjjg2vLH5cyRw5Zyoy445x71FceXGqRopT5FdwxyTyMY9M1mb3JfO/wBHhhUFQzYkxySOoA9qIXR4wHUpvYj5eSg+nucU1d4uYtqCMDncT3wefrUM2Vsnlh8tQgDfO43EZxkDvyelRYq5bu0ZAFbylaMDIDDGfY96jsXCXrEoDI8YwCM7cnsO/FQyPCtsWMi+bL8qIAWeTJ54/h79aoxzuZblgoi52sQMngAY/KnYnmNW+kkBQ5YeblJHY4GM8fhioLkR+UqxlZcD74BGCfao9qTbVuWjiixu6knaOmcc5p0ZAj8sArsyfMY8EfTqaLAJbMxLMUWaU4ClxlsD+IVlzxXDtOy3QlS3YhpTkFgTx71ekaVXMUaxIzqC5I4RcdKyrwhLhvs+ShwHXs3odvb8fWqIkb4aGOBYEVFmb95vcg7AfVuhqvu8i9LxxxtOoIjdiG5I+8Ox/HpiqlrKCfIvQY0Dl3T+8ccDPap/3UsjJGqRxg8knk57D+VDFYpwXbKWh3thGLKexJ6k+pq/aeYJWMcXmY67j8jN7Y7VVW3ivL5oISBK74jwwA3emTUkBe3UxSDcFOCF5/MUr6losSERQuxLI7/JITg4UnnHpVdvLiZUiLbHO3BHG31z61JJNAIUPDsWAEQGACc+vWoJowsSFpwZCAQA2dp/u0CZptO4jDyvlVU7sv8AfA6DHp7d6q2UsjM80ZXdtKhOygDn6daq3F5I8Eo4ywwcjGMdvqKbZHdaARDnGC5/vH09abYlvc0WkZWjIDuwG1EKkgZ7+9RNdtBdXLSIBIVwAFxg4x+FLb3c0TMrymLjB2tkkAe/Ht7VmNM5hmJw0sjYZ2OcZPTP0pDuX3QlQksjSTSDdtHA6cA+gphHlqlszFGwAzZzxjnGO9Ip+RiNp43Eqcscdse1UFkAG5nI3jt94LRYVy4ku3agZiu05Mg5xngZ9AKSSSeVAqEvKzHBGCPc+3aoHnTbIWKoWwMYIKj0HvUe7zFLxrIyKNrEDavTOC3r7UwudFp3h6+1G3M1jCJYwdjs8qLz379Khu/B+v3EccEdjHjG3cbhP0+bj61Q8PWMeqapY2lxJ5UM8w4QndjGTgfnXT2lt4Unhs7htNvY4ru6a1Ba4z5bLjbux2OR06UIRwhSS0821lhIELFCpPAYHBHHBIoo1yAx6zLA0SI0UjqYQxKpg4xnuRRTuI9D2K8knkIAp4YMfmXHpVREkUskCFuflJTkikuRKbiYxIEAO6NO4z3p0Dxh3NxLIkyAkHoBQzZMS6j+zsjzAeaTtdQc9elWPJ3QfaFjMIR+AOMj296pteLdJ5KQkMeTcc5U+vvUljO0kcgkndggy6A9z0OKWwyxEZJvNjkeXbt+UDpn3Hel0u4iKmGZE3A4Zj/EPr2NRRSSRmTyZfLhxnLH9apyujeY+Q8gbl8dfQ1LZWxsSztJcBY2ZztxIAMFFrH8tVu5B5jmDPGV5bPrV+zZ1gDptZ2HDbuB7H3qldsFuYBLkqFwUxjoc0ITLUkDyOLYSW4hPzgsePpmklQeZuuJmLYwqKvI9hQjII0MLMqckMRyD6H2qJXkCIkGNxO47jzn1z6D1p3FcsI+64MSPIjxxFWYD7wPbHY1CwPmRwB2QAHC+/p71NbBxFJEwbdJlnKsOf8AaqKSV7ZPIilVo5eCQMjP9KGUtCnqt1IDFI5kdyuzzCcjaB8oPuKspcXNsABIPLGAFbkdOoNR3JaUSwsVRmCjaBkHnoPQ8U+OTbbqUYMMnKyIRn2PqKCb6hO8gh8sszHep3BuD3BxTklMdqHltZWK/MSpAVue9VraTdDOrIhgdx+76YYdMelT2PmQKuyfDM2CrcgN/tD+771QrlfULhTBKY4/Lj2EsvfJHY+ntTVV4rWFg5RCo+cDhW9/Q0t8jQ20+0AgrtIU8HJ6j1FEOHiUBtzBRzjB9lP09aQjPvkzLjfuJBySeCfUGsCWJ2Y7FPmY6eorqJCr2Uw8woync6FOvuvv7VlC1lxuiAO1s49x7dqqJEzG2lwFDD1pChBwCFzzwKtzwhZTIYmVM52EdKVgMhjgfrVo5+XuUQNp+XIB7kVdto4nTc0jLgEgf3z6D09zVa4KIcjIbOc/Wo3kAT5XXIG1eOT9a0TMWma739+1wkkWyOQJ5eIAu0R9NuO/PrVrVdcvrryWmPkmNdipHkDgYyPyrmraKTzBkSbzwCOB+dTSSMrlWkddo4y2fpWim0rEuKbJZLiTBwc7zn5uhNOaXEpkbAYryEPT3qh9o6hl57MvJpkp28MWOTwMY6etRcuyLhld8vn5TycnOKgaf+HPJ9ahWcRtgFgcECmhyxBARQo5JOKksk8wuuCS3rUKAsSSSR+WBTiVVcGVWJ7IOn41LNPG0YDBUA/hGc//AF6BMhyI8CP5nbue1T2yM37uIM8rKdoAzn1qEKd5UNEQw+Y5Jx+nFXLC5+ymQwPgFdjOBywz0pollqxt2XajqC0pCccsFHUD3NddaXNqzMJbVjcHaLWOM4BAyHL+pPGD9a5iwKgyXFw+3cdoGMtj27c1O8vm3AZ5GUCPn6dgP61EnY2he51kEpg8M3EzMHutRuBZwxYy0cSENIw9MnaufY1jXcWJ1ZnDSyE7kU/KhHIBNOurpbnyI43/AHFtFsUqMFu5wPUknmkvf3VqIjNk5DCPGAoHqe9YtnRHYScpdBpFZ1jAG5geHf8A2faqLW7KGG3zHA3l1PAHv6VJp264TCIwbeTgEZA7cdqtXzKkcm47UA55BLN2HpS3GmMsniZwXYKsceHkHXPfHvUlnAJ7VyjS4iR5t2PlJ64+uKqLLNFalWVXZufLYctnnJ9s9quWpuMRtG5MufNZCQij3OfahIQ5GExaZoXVUO4semccKew9cVGWSaVt7Dy0OXYHLEnn5RUEs4hh2JIzqDu5Py59AO/1pIPMMZVtu1zuO4cjHYUNjCS4RVOAUQnIXux96YjJghoC1zIpUsvygDrz61PM6DKxRsgByzdzxwAO1VEknWTybd3CsMSPjl/b2FNCYrlYFihhQO2377cqT75pYrZVQEOFY8+ZvyCT7dKmghtoAyzASFuQqNjr657iolZQwyyru4IVRhj7elAh0O5YudvlcnlAf196kvJXYmZsea5yH2/KTj1PWnvcrF5YxGGjGd7p0PoR3qG4f7XOgGBH1cqMr7DA9/Siw276iTESW4aZh5gIBUDAApkJYwysgijw2C2MH25qGST7PFIqMSzZUMDgn2Of5UuZPMAkO35cjzBt4x2BFArkeorsIySspYbgV7deT6ml028BijjJEeAM7hkD1onO2eBx821WysnQGqUgxFB+Rwcbueg/PmgRo3VwUCspDbjgrjcSM/pWZcXKrKI7hmk+beYk4XPv70t/fyNlSMBBtVcAbeR19aqxxhpI239ScnvmmkBpITKfMKqpJx8gPTsM02X95dqm92C/fKnt6CoZ5fK4RjuHIULgE9OaiVysb4YqDkM45LHHYdqQi3PlYxIsfBcgl3zjHOOuTxUTSb5CGYbAc7D09AcdM1BbR+bLliiYGAPb0qSNgoREKL8uT3J560AaWi/b5tXszp6n7Z5qiB8dH7H6Cuk0q/vB4pvtOjOjTSmb7RB5iHyDcDA/dEdCeevGRXNaFe3Flq9lfRWss6xzYjVFOJW7oCOpxnpzW79i0a31GO/j0zxJK6MJIrE2+1AwbIUydSAapIDj7+Wf+1biS5LG4aVml3DkNuOc+9FRalPJc6jdT36lZbiQySoqlSjlsleaKOUjmO+lneK582ZicnAPcikEJvoxmPILEgE4Ue+e/wBKqmMqjPcOQwJLbjyfpTrKRt+5h5cZOBs7D1A9ak6EWmt1tY9ofLKctg5+lNkBLeZCEQryYw3WnMp2FY0LxbtxYDkmnyweYNwP7nGcLg49zQO5GZQyCSYO0fX5ujHtUcDSz2vklQISSzYHSm3shFt9lSYvF/AXGKngj8uBdmzhedp5pMEOtGlihIGG2dVI/wA9qr36FQXjDjeMBW5Iz3HtVh5V85tj4lfG4MMYqjcCTEZYs4DgFsmgGWoS5i+dsx42ld3Bx1JFLtH2pWMioNozG54C9lz2pHJaVUgUEZyVznJ9R7CpIzsDLiOSPPDY4J9aAFadWnVfIaFAFLbXzn15p5kgSSWRi7tkKqDg/X6e9UrFo2aR2dtmecLyP/rVckmVsSJFFLkcxgENj1ppBchvB5RjR4wknJLBs5BH8/eo0mW5tWhLvv8A4JGHBWq+pyAmOK1Z9zpt+9kKWPr7CrMe+K3jy44G1UxnaKLWEV7LbGGUSbDyoXcCGP17VYnkWG3yF2Sq+3JOSPaq85EjkYUY4UHox9aiPmS3kUeEwo43MAWPv/ShICxfljb/ALr5grAMinI98U23JRRIpGQuCpHX6/41WkBjvcAlSnJ28AE+oNPDIrhy0yyg7QFPA47e1OwtSN9rNGN4Vic4z0Gen51Dcn58SbWA6f3j705n3XLsHM8hPDMOw9R2p0+GO4A7VGMjsfemS3cpTorfxlz7nFUmXykJKOyjr6r+HetBbmS3PmwlQ+Cg+UY6YNZ1y5clnwzMciqtoZSZWcjJMbbs/e+XOPwqs8YY+ZlsDjAAFSz4WQk8ORj2FOiitMr9oeRYyP8AlngkfgetaIwejKouXiIKyOCeB82P0pBcMwYbwVY4IapZFiMpEEgEWOXdMH6fWoREmCHOeM5AoErE1vOqfuwYoyDkyn+HjoKgklOCUDYP8RNSR2jBmODwcZxzmnSwguSmUBOdpOaLjUXe5TIIYEMGYjk0EZYkEY/U1eW3ywOztzx1pPLMe5ox1G3JHGPalcrXoUBheXySaUYLZAKgdzVmWPzpDsCoT1CjgCrNraRpzKTtXp8vLUXQ0mVkjOAPLJx2zgD/ABq3bW7yyhADJIOkaLkZ7VfS3DH528vIyBjn/wCt9aktfMWJlgLRRuckKcZ/rU3uOwtvatuBnYRsFO8tztHoBUcrhrjaASoTL5wMKB0qztjdFiVMFefm/iPv6n2qvbbWu5J2Ygg4TK5J7Z9KlmkS7avvYg7VVQA2Bx9OOpqeVo3m3lXYgYAc/wA/8Kp27lU4UgbixOM59/arKmIW/mIZC2fvMMj8Kg1TKcAaN28thk8l+gQYParkUrSTxtasoaPlePlB7GqMJeR9m4nIO72A71LI5t0cR7lhcc8c0CFld/PUsRK+WJJbbkjnNTtIFgWRlV8HJYtkE46H39qoXDKSCcRIEGAOefcVNblvOUnK7QGHy/d9Dg+vvSC452MskiO6qQQxO3v2Ue1WFlCKrQFnlI+868A98fSowxWZXQs287ecEsT3qGWRlkZGym89Dyq/SgaZNFLuLTFvNx03dScdePenWrSTPueRWYdTJ0zQCFjKxJsZ1ID5xgdDgdBRkEFTH58gJyw+VVAHX3p2EEyqY12sCepOeW+lQSt5TLnDTMpbhudvpj1qRJW3AjaSUwd/SP6e9Uo5glxIQo+fAGTjA9aAZeS53IqgM2OQCfzJNUi48wvGGLA8FW6f4mrAHlLKqzFlyC2OE2ntn61lyyHcxUfLuBGDgmiwrlxWMznZOcDHL8tn19sVXuLuVyHm3PN0LFgd2PrThMREkbNtjUjIYZyahcRyGQNuLA/K7cY49KegAbhFmUngBTksueT1pkUwaKNgSFXgE9Mk88VXvDuC5y7sMbycbsegqNbjNqARlhjcV4+gp2JbsOuD5jL5bZHRMDn61YOQqC3iXzMkNKRncfp/hUcIQDz7tnZj/CDjJ9sVJLNI9s6RoFjDAj1GP89aolyTInm+bJ3mYctk87vf0pI9pVCQ5UDJ20O8UkaLGGIDc845xT418tmZiiqvJXrz6c9aRSJZZHhjILAMw5UYz7CoXlLFY1YlcZJ9PYGmygu5TaAinJ3euPakVSpUkbV254GaVgubnh2S5u9S0+wS9uIUNyGTyV5ic8F1GRzjvXUwyQXeqx2cfjrWDM0hjjIjIjLdgDu9e9cHpeoXFjrlpcWmwzQygxxldwY/3ffOcV30mlG0cajbeEphqETects9+kiRMOd3lj5yAecGqQmcn4m0iO2iS/t79763nneKV5E8uWOZTyrDPU9c0VR1HWGu9LtLAQYlW4e6uZnbJnmY8sB/CoHaigm51cke6V3I8zac9TjNNlwhyoKMOfU+9TyTvJbyRLu2IeMd/wAaZJEGiXByzE4/vCszpLQu9yqFfjGGYcD6VLIwmRGeSEsOhQ7c/wCNZsGIv3W9nHQgetXZtrMFaOKMMOCeCPpQBXvY22pGfKkXJIKd+O9LbbJIQY8h1xhB/Q1DfMAYfLA3chj0zVa2luJ38mCMsw6so6D2p2FcunMjs28o6kkvjqfQ1DdyqsMZj8zzGYFmPb/GphtRChaQKTyPQ+tRzyAWzMjI4OCWI6YNILltMbVIZfO6Bjxt4qOaVdgjgBBYYZR3Hc1CbwTRrIVjR89V6k1O5RVaXYVPG+TOSfw7U0guNCNGqopxjkL6fWpJ2WQAxMsTofmx0x7VTgVpnknJyucZLYwPelvbiOSOJRw33E4wD65NCQXIYhvuTKei4HH860PMCqfLCSb/AODOWx9aq+YLeMBkR0J/iGDj2Ipqndu+zjDHqemPb6UIm5KfIeMQyDYSc/O+FAPvVZMSSP8AOiKnChhxxUUhZUeSYq8pH8X3R2FNM0u99+UBG0BKYEwKsC8oLxk54PPtUYlMjNjapU4Dseg+lQSsdh8ssgxgYI6+1IkSrCFUHOcvI3f2osBMHcMWj+YcZbbzj39qZcTP5B2qFDd160s4DICrfvARlTkNj/CmzEIj+WqSMwyDn+lFmK5UklMsQLoCcHBHBqpK3AI++fQVcg+W3UsuBjghe+e9MeExK0yn5m4LLhlANVclq5mumc5BJ9fWoTGy8Yzz1rU8hhGD970x1H1FQOql/LMTGTP3gf0xTTMnEymy5JcKMex5q3CoXCyKoYfMTznHpVlEGCExG4685pywL5Z3uFDEZQ98UNhyjI2MZTMQfdkAknIPrU4VVOZD5bnBxnJNRXCtlCeFXgKOpzU8Q+fcsKqMcjPQ+tK5XKHDsSscjt2zwB9aY6h2CyTJxwQnP5dqlA84EhXwB25yfeiNAq8sW7bcYJ/OhsajYiEKnkJIIQcEtxu9s1KsfmXA8hWAUcBRnH40ybO0FtoG4KFB5B+n9atSOdrRwttUjkbsE/UUX0CxXbzghjM7CNmG456//qqSEsGIVwBHwXLEE+wplufP3MNjYGAW4wKfbsAshGC7MeG+Yn/CpuUlYe4klG6Zk2g/w8DPqT3p7G3trZBEfPlIHCLhQT6mmyJuQrvO7bgKVwM1BIsbIHXzNpxncMAn2oYyW4zFEUJ3SEY2qeFPv7e1SwgIgaaNixGFH3eKrS7Y44wIxkHcSBncfc1YDCNS8kkZ/wBo/MF+gqRiOzJGojw4U/KqjHHrT2k2bs7cqOnUf/rqsqtLcvlWRWU4B67fXFOiGG2qvzLx8q5+vFNgRbtjOUUO7jHPP5U2Ofy5PnBYYH3j1+vvUyxr5khKqq9ye3t70TbfNaSNVQHPzYxj6U1sLqDy+a8ZLYLE4KjnHsO1ORQZOAQit1C5Y/TNVghibMTSCRs5P97PoDU0ryRy7ZNkjgZxnGM/TvSGWrWcJA5SKBpGfbmQ7n9sL0qpNMd255CqjOB3z06CoIJCImZN2VGCQM8/Wm3MoChQqgAAFmOM+v40bgT/ACqAZAc9Bz39T61C0hE0eI1wW43Dr8vemQYZgOrMMnHJA9PrRL985yzHDAKenbmizYXJnWSaQxNvO0dF6n0+mKgwqM6lmJBAJGSAcdKmWParB2VVf7wJ9KruUyyxh/mfBPQU7EcwrSGIejsDgdSB6+1LLPEGTyICg8sFsvksfX2qvvGXVYyCflX5evvUGSGbKsGPHWmkJsind33ZTAY5Dtzge1QK/lSYGQv94/zx61YMRdiZCxA6Dpk04xobcvIp3sMqvoPemJhLuaPC5C9S3Ukf0qaGAhG8xz5eOxwPp71DGSqHc2e+MZx7GrDSlzgFVDEEyLwFoHcZH5cisWBU9FAGOnrTJ3PlBFBA6ZIwSalkUQsuJhyuckfMc9ABVZ0dnG5cN/dHJA9z2osFx0JWOYjPmHtjoR3JNMndi+5c7QCBj5R+Ap8W7znAAHABA9P6027bydxThhjbkdM0E3NfwpdR6X4g066ulLQW8yvI/Uj1b3xn9K37bR/sWvw6vP4l077FFOLlrmOfMrqDnAT7249MVyVjp+o3sCyWtneTQcqXhhZwT3BIFXtA0TUl1/Tmk0a9Ef2qPcWtmxtDDOcimO5narcrfatd3kEYRLmd5Fi7qCxIHtRT9dXb4h1SNEVR9rmwAe288Y9KKdiTtdxMrNnHlnJwcZqQXDt8zxD5jw2OtVFIbkktIeuKmediECrnb3rJo6mxG+WdWjcDI+hzVi4Y3GCP3UW3BB5yfr2qq0gaZTtye9LyUw7KAeSM00K5XKpI0YLFsNjLHgCpId5uU8s7cjbkHFLJO3kqqqgGRgD600ExPsZDkHOCelMllmVSgdi21R1LHr9KpPK9zD8/EA+UY6mrd2qeVujBZm6KxzioULfZtxKqo6D3qWO5Nbtym4rxyCV6025leTGeF/hxzn2qqHDAooIP8RB5+lTwykMuzMci8ZzkAVSEDAIiMcoDgHYev1pzJHcXBEXyCMbRu6Z96ryuZGIRVC5yWY0mch3jbnoSDx9KAuLLLhPLD/OSQMjtUkJ2gIoYkeneq1vKY3LOqNtOAHXirW4Bdo3M5Gc9OaLIV2R3UpaJydoAH3OuKqWpEjASsQiDOAfvc+tTTuDGVZN/GBtHOaqxzNCx8llxjoy9CeoxQMtSOjS4jIBU7QvQZqaT9zGFKsHI6Mcj36daopwPnhVnPVh0WpASFY7QFB4focUCJwxEihtzTdVC8jH41XuBuEpJIYfw4702Jd8hboM8E9TSuSVIjLcnGO4oHcrWrAxGMNIMN8wP3aeVUSHYhbAGNp4xSQAJK6b8bjzxn86sTBUXG1Ci8Eqxyx96VhELR/NkMq46AE5P41C8TtL5jB24B3GrQ2qv7tic8FWGcCoJkjZn8t5CQvJIAFVcQ4ohHCyKOn3h1+tVmBWdUVskc8ckU6zO+MbfmLncM8ECpo4XjHBUgHJ5yfyoBIhnhcK8kzsSGGckGlAjVXjCndjKndxSsA0bBXX534DLgn3pQhEJbBOMryOppAFqpKHM3yn+FV6U9ljwhilWWQnBJUjZikhUyxAMkkh/uJwBSOzRRtF3xzjIwPegLDJkCyqUxIx6Fh1+vtUkj+YAiquerGNPWqyM+wFtw3MPmzkY+lTQBxG6xF8Ekk9z9aAsPaMKwGQuOAxGCKhsJJEjPkuPnY5PT9anlx5DBYwCFO5eTn6mmWoEIIVVxn7w4b8KQIkaZCH3s7ADAJ5B/wDrVDE2QAN0hPzbQDx9KmuJUKsFjGCMDeeT7nFIknloNgZicAdQKBkM86s2SvzEcrjaF6YFLvRgZJZkkfsiLwKWcHKkMmSQGJHT2pIGGzngeoHagB0UpJVw2ZEOVTkEj3PpThKN+4ZTdzhDyM+9KzSRxrubaG6DPJHYVUnyImIJDemaBFxTEC42tjAGT6d+KhkJODtJPGOegx2qOFSWBQhUIwSeM+v40rPmIBGDJ6AYANFirkyDG5vMw4wNzD7g+tLvKhljK+p+X73vzUETxiUiRC7qM4LY/EilllMpDHCgD6Y+lAiONnYIm5tg+fA6Z+lQXLL5jBiSAcE9z/SkJlSJpOQCp+cHnFVZZd0SGHCLxge/enYVy8smwKsIUOw3MC3BPqTSyzSRxqdy8jIYrgYP07VSjnEWUKB05x23H1pbm9ln3tcHdJJ1fpx6D2quhD3sW49zKoZslzg54X86qzzZJhRmIDc44wKhjJ2BNrNgcBR8o+tTeSqtw7PxkBR39zSsAqqW+8xAPAIycilTpI1vGPm43MemPT3qKQiRVABweDgkjPpVhnjjCq7MxAx0xmgZWuDiPYML/Fyen/16nTIVc7eg/Sqc8yM6Y6ZzgjpUkk0jAygle2WGCT7UCFmcKjupAkZhwTndUCSnA8oBTzy3JJ+lJEuCGcFn/hVv51ahULIcjGeTt6U0JlaOOUucH5uhZj8xHrUpZYiu35gOzdD9andh1XbhsEhR+mapTfvbhVL7gPXoKB3LMW/GSAFYE5PaqspM9zGjNkJk81ZbKqzs4ZhyS36CqscTS7ip+Ynk4xj1NCJNa01jUbCAwabqN1b22SdsUmxS3c8daf8A8JNrqNzreoZPO4zHj6Vc8O6DaavY3U9zq5tZrJDI0ItjIfL/AL4wRu9x2pp0fw20gLeKyUPcae/+NMDAjd5JpJWJZ3bc0r8liTnP1NFSzRxxyskUjSwo5VH+7uGeDjt64oouB2UQckkkKDnvz1pxDFMAnANRqUWU8huvBqUM+M8KvU+1Zo6BqKik7QQT1PanRnMvy4xnktTUIdiMssZ7jqajCj7o5A9aLAQs2Z5u6nJAPSngkxpmRncjkHoPanwoSxwB5Y4om4nACqAP7p60WERPujkB3Z9x2p+5GHl7iIGP3iOQaQlTOI/mGecimSQsCAjc/wDjtCsDLarHEP3QL44L1HldvyqQq8ketV5p2Bjif9246Ed6fHk4LuW54IGKoSuRDMs8m7bnP3fSkaR4huAJUHjHrU0TAeYQNu5jz3xVd3ZhuJygOAB296QJDhMWC7g5xyc461PCdqlg2FP97P6VUk2scROScZJNTxM5UAPwo796AHyuPl2jIzyQcZ+lU3bZcM33Rn5e/wBatTSMyhcnaPYVRBbO/kHORxQwLLAAP8zZI6rwDQc7F9AOpqv5jb8OjEHkle1WBdLt2FSq+uM0AOEbkCQtgAcN2FIJyRlz5jejDjA75qM5mGGceUPTgmgKyZVGOw8ZzzQLcaxRpZX8tBk9c9PwqWSZzgp8ijqV6/WoFKBdy7VGeQTnNODDfnacUDsTGPc37t2kc85JA/Oq135iOkbqQSpHJB4qQ5Ee6UYz1qqHzMrDLMTxnsPajqBZhJKqBgbR0Y9fanopQ5HypjkgUyDzGB5OM+nOae5VSeRwP4uuaAILi4YiNQoVecELyec1EQ7lsgtuIKg87aeQI5omjkBYDnjI/WpJJCWBDNuxjOQMUhXRArSCEF5CAegLVXkPnN5SNJg/eb+lPEUjMQqDHQsWq3EiQx7Iz8/Q9zj0pgRhEEe07TzwQcEVIGiO4nKj1Z+D+ApsuI2RcbQTyOp/KllIJGF4H3QQB+dAWuRy3AZFiRZDzg4GAR/WpYiWyoCIv93p+tQbNs252wV5+U+tWGnmliAcK3Q7iAP5UroNUMZVwQCxOemev0pq75pQADiM7cbuM024fZHIXXBxwR0otDHHbKoBZuu5jgf/AF6LDLN3HsCo6DdjKhTnB96qxOpUmSQ5GNoUdKHf5lBPbCqOuahUOk5+8qE5245oA1rS9ltIpltlWMzp5bsYwzY74Jzj6is/YnmJuzs5IC8n6052Y/xMS3HHJpkXRsgDcf4uuPamKw6bp5ikF1wfLA+97+xqvFMWVMEDjA3VOX2DC7mLHA5wKgjEZhUSNuZh8ozwPxoAE2iTGU3HqfSpzIpX5dxJ6FhnA9aoxlopWChgvuM1LNMd5wCEOCQDzQFxskn7oBuhJ2se9V4sGEhsnB+YAfpmllnVikcewjrk8UQ5Qnc42E/e7mmSyPCyfNnaoPAAP3aQDeQEBEYbHPf2qVncKojO4cgE9BSRxhCVYZI5LE8UxD4k2puDDaewPf3p5O6MbdwA5J6c0wybTtj5Y9emAP8AGpEVSAVyEX7xY5yaQDGbMahc7V6E8cnqaMMq5X5f9o9abI56DHB9OAP60m394uXbjkHNACKiCYk72OOM4yTTZPm3vsKqBzzk0smzjZnI4yT1qOVt6bADGvGQe5pkj0ClA7EMxGAgHT6mmzEp5fJJOOMcfWhRzjr6Bj+tRBz5mEYsTwGPb6UICWSY8/NubHOOKjCqShPYZPbNKoTnnc57noKidsqST83QY6UwHSSb5TuUFB0HvUquNv7zaSoyAelVQGbAC8L1J704ld4XPXhsGmBtaNY63cbb3SLO/ZV3KJbZCQDjBGR7Gpk8Ma+zEHRNQLnnmBqd4Z1W8sZZ7Szt7m5tbqNkktYXbcT2dSOVIPOfwqK7TxHZJ516NYhjxzI5kAHvmkMzZi0MrwyKyTo2wrjBUg4OfeiqyESSNI5Lktkk8k85zmigR3AHmEL8oIY4NWGK7WV3AXH51XYyMgL7SATinTuHjARSTjn0qUbEZdVIHOB29adIRwSCuabGgSPzJAcnpSvMAAuN2fWkMcGJYiN8jHIxVe4YqQF4OcZ60NLlgqKFJ4JHpUjqMKARgHrTsIaqqMryTnr3qVTGVKFmVuvPQ0wqwfcGCg0o2qdwXP8AtGlYZHcuXU+Zt2dBxzUNtKyJscFlUnFSeQrtvbJY57/0qB8rKcERgDv1NAE6OfJ+XcpPOAKrW8QcsWjJzk9cYq1bEGIcHZjGAetJACkmMAr7+lMCGSKJUIG7BxnJpFUdFYkHoKlkRizA8x9eKdAFABAOe9IQz93Hj5Sw9SeM0js0ZTGPm4+XmrLlR8hAOOaq3Ei+bGiD5s59qQxkyruDpnG7nJp0zhrc7QAxODxTyhMQPfPXsKhuyfNjkH3lHJ7H8KYiZINqp5mBnpzkU5Eb52ixx6d6aoZwCzIWYZO0dKjuJlUBUOG6AepoFqVpWPmhRtBI5IFT7FAGGzjvu5p8EJVC+07z154qGVwshKxjf3NAxJHDNsJ81SefXPpSJFtkDSj5iegP3RSRMJAS4YAcqAOD9adtJIIUkZw1FgJVwpC4KN785ofG12AOB/EpxSyN+743r82SG7VVmUSrkN8nVs9TTARpWK7mdAzdFxnAoIdjhugPbqatLDCtuHRWVjx8w4H0pBhcn5do745akK5GqnPyjy+xGMVY2g8gknsxNI+SgCscN1BHOahcMFCMCB/eB5IoGM+eS5ctKPlGMgVOQqITu2kDJ3fxfSqtsI0L+YRliSMk5qaWRpQC7uSuApxmiwncFKGMAJhup5NDPHGArqctyAGwDUOGB3Alz1APT8ajuSzFWnU/LwMnIoCxJOBIeVyv90NxTGhkAUxjDgcgc0vmLtAYBl7KoxSliW+XIRuvr+FAyONwGypZnTnFSSy7iGdd2e5bP40yTCrjGz2H9agD4UplWXs2D+VArEpZ0/j5U5Bz1FSKFZPuAcYBPX86qY3tliQV+76ZqztAChiSDyQKBkcjMj7eeBgMvX8aFRAuCfxxTBIXYfLxnOc8j2ps7KqAqCSe/WgTCfKTEJ82B97rTMrjIYt/ez1NOt1MYZmIGerN1xRPsCnJJI+7mmQMRVjkBlA3Y5J5/KppEUgFUVRwMnqapxcSZQZHqeam85QeCcjknH6UwAuMsgbDse/X/wDVSlVibEhDY6gHOaikBZywA29M55pfMCLnPzDgYoC5IoC9Nq5OQD1NEmOA3OeWqo0hWbJwSerdaezYRRnJz070WFcd5ojkAxuGCQM/zp6/MSXZQp6dqqvIi5YZzjpSRys4LlOvAPpRbuIdOfMkG75R1ApdoHJ27+wzniopSZD7npn2pq71k38ZB7imgJWJIIA69STTWZVIycqOMDrSu7fMT940igKuSAAO/rTAAzlOV+QdulMgUMcsCxzxg9KXeWXJ4TqB60xs7BzyaAJWIlXcSc9AopFCr82QPpTlEYhG/gCo2fev7tNqjv60Adp4Zku5/Ck1n4evIrXWWuTJcJ5wilnh2/KEc44BzkZq5otl4u07UYLrUb42dgjA3D3l2rRtHn5gVJO7IyMAVz+mWmkWHh8avrNnNqDXF01tDAkxiVNq5Ziw5zzwKnHh+yvNT0fUNMaS80G6u44JopmzJauTzG+PUdG70WA5+/kt5dVu308GK0ed2iB4whbgfliil1eJLbWdQtoFCQxXMiIueihyAKKdhHaTMpGE4APJ9aijlVItpTBY8sT0p0hAHyryDTHkxlZEG01BvYkndDgKcj9KYxKBSVxntUQdSQqZwaaHw/OSc8Ugv0LCRjlynJ6e1MIIBGTg9vSpUYSSFWkwAP1qMExSEYDE9zQMQjCBsYx371PDIPuqynjPIqrMcA7TuY/w0yLcw5JI7jFCDcuM6s43EADvWeuJJXdwWGeKlncHCjI4p6BgpKkBfUmgQseFiBHHoKTeAcx7WHqaFXbHuByPSoiRuy5xjoMUAWY4pPJJO5FPOabkhtxbKgcnoKQO4wDuwegzTyMocnPsaAFGJHyoAU+oqrIqfaGJbgDHHSpHmYx+XwD6ioYepONyg8k0AWEVVTAyAFyTmqpkE12FDEovB4qaVg2WXcB7Gqts0qNNkZDNuOB2oAuLtQHacD1NQRKJHZ5SQegAFEhJbGMBu5pwaQ/KrYX+9QFyMt5f+zk4x3qHBkY5zsHWnSrvl+c59qazMAqsdoyBxSAliA2AH5R3zzU0pi4wxU/3vemKwyMpn0zxQSXYcjg9cZxQAyWVlUqM4I5YHOaRJFUj94Rn17USDJbOTz2GKFK52sqj0BqgEdy8hVGdyOmakYyIfnJJ7DHFINqqx6EdAOKjLkvz19OwoAmLM33lyfXPFBXawOFOewOagLsGIYA+hNIWLgE4VB29aQEJYrcFRg5zxVmMgjG52PqOlUnGJg0YJ9farecDLMMH9KCXcc79FXJ9ajdSchwpPb2NKZ1AAVBj1pN2AwAG3PYUWEmRDaqkFue4PQU9WV0GCzMO2eBUUvznD44qQDZt3DA9O9Fh3EJCkBup9O9RHAbcUJPYZ4p8pyVGSQOntTUZHJ46dCe9FguK6ZfJYZx+FROxV1QtnPp1qTPl5IxmosYcyOct/KgdxzvlT8hH0quxLzc/L7VMHUoC5xnpUeFwxU5HYY6UENj4my3z5bHb1qN42eRmJ2gDjPanI2Yzj7o/Q0xyCOOT6H0p2C4wqWcheAeOO9C4O1myv9KZubldpwfwprSbDhQSp6c07CuOY7JeCT1GR3p25VAGF+b86gZiT8zcnoB2pgLZOD+PeiwhGJT7hGC2APSpjICg2oNx6nPWq/y7xuycdac3XKHAFMB78DbgHA5FNhDbQFwAO5oLjJU81CHAf9QKAJSCJHywOaeAxTcCSo4zVYuPNORxnmnPJngZ2+lOwh+/nBAJ7VFIxOBnPP5VHyTxnPenhQGBJosBK2RjnPuelQ7yTzye3antncAefaoywz7DtQBJuPc5agn5RliM+lNL8Y7VGHy2MZxQBr2et3Nlpt7p6rDLZXQy0c0YYRvjG9P7re9ReGvEV9oF+bnS5Y/mwJYnAeOQA5AYfyPUVr+GdNhazW/mjt5Z5TL5P2rPkW8cQBkmdR97GQoX1NS6Tcrr9lP/AGulhJDHIkbmC2WCe3VyFWZSoAZQxGVOeKYHM3ly13fT3UoAeeVpWC9AWbJx7c0VFe20tlfTWs+PNglMTEdCQccflRQB3wLDOcHnjNQoRJITJkkcgUOB5/509QATgDpWRuhQcEjGBiq6AuxYHAzxmpJAPLPApYwBCuAKQx+9VUkjmo/MAyzHr+lOCgsuQKeyL9ob5R930oAqAjGSxLnv6CrCSbYshgv9ahKr5bcD8qZgYQY4piHBizFtof3pCcuCQDg9M8VaKhUbaAOOwpjgZXjsKABmcnJxnpgU1s4O5gfbuKkkUY6CoyACcAdaAASKw53bhxUUkjogYnj09alkVcr8o/KoplH2hOB0FADGlPIGA7d6fGSq7cnFPjVcOdozn0pWUbBwKGBEDyNxwuO1KkzKCduR2J9KI1UhsqPyqREU5BUY+lAEfmbxmQf7opgYk5GT9KkjRcn5R+VMtVUl8qPyouBFI4DZKlj7UbclScL3GanCrsPA6+lPiRSrZUdPSgCBpvnVDliecnpUpcqAcDI9OlNRFK5Kg8envTgox0FAhrOxGWcgE5qupPmswBYjpU0iqV5A6+lNgVdjfKPvntTGKSQpJAGetMO1iAhZnPbHWmPznPNP07i+ixxyKcVzNIib5VcnOlX8cYmubKdISMqWXANUJJQ2UVQD7Vv65cTyuqSTSOuMYZiRWaY0Egwi/d9KutTVN2RnTqOauzNfzGYDG0dDjvUwC7AABkHHWrEir5Z4HX0qEquzoOvpWT0NVqI7bVwOGPpzRwcKzEn0qa3VcSHAz9KSRF2E7Vzt9KZJVLK0mCCAO9SZzk46dCaeqIFT5V6elLKqiLgD8qAKU87N8gwOetLEwCAAcepprKPNHA6+lSsABwAOaBNg5JUAVXuGbhR1qywHHA6VWKjngdaAuKTt4Yg4pjnC5BOKGUYk4FLIq+UPlH5U7CIgcJjkJ6etNDlnyRhRzx3p0qj0FIyr5TfKPypgNkl3c42jpio5B8y5GPpUiqpQ5UflTZFGGOBQBCSUztH1pRIRwPzqSNF2n5R09KCi5Hyj8qYEA+9yBn604HjkAU8qvmfdH5UoVdw+Udu1AiANtZjxzxzSPxtx1FPlVfObgflQEXH3R+VAEXRs9c0zJPFWFRc/dH5VGyL/AHR+VMCMMUJ45NJuPPtUrou77o/Km7V2fdH5UDsM3nOR+dIW4/GnbF/uj8qQKOeBQA3NJk5qTav90flS7FyflH5UAdH4Y1WJbNbK4lt4Z4XkaBroEwTRyKBJBIR90HAIbsa0UNjpMTtPBp9jbMyySQ2179snu9jbliBBwiFgCSeeO9cQ6rn7o6HtTVRB0Ve3agB95dS3l9PdXGPNmlMrY6ZY5OKKZIq5X5R27UUAf//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bacillary angiomatous lesions",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 251px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The small papule with a smooth, reddish, glistening and obviously vascular appearance is more typical than the larger lesion, which is hyperkeratotic, drier, and polypoid. Courtesy of Leonard N Slater, MD.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from The Skin and Infection: A Color Atlas and Text. Sanders CV, Nesbitt LT Jr (Eds), Williams and Wilkins, Baltimore 1995.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_22_35177=[""].join("\n");
var outline_f34_22_35177=null;
var title_f34_22_35178="Tonsillectomy and adenoidectomy in children";
var content_f34_22_35178=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Tonsillectomy and adenoidectomy in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/22/35178/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/22/35178/contributors\">",
"     Jack L Paradise, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/22/35178/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/22/35178/contributors\">",
"     Morven S Edwards, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/22/35178/contributors\">",
"     Ellen M Friedman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/22/35178/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/22/35178/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?34/22/35178/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 12, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The surgical removal of the tonsils and adenoids of children has generated considerable controversy among health professionals for many years. The often indiscriminate resort to these operations during the early and middle decades of the 20th century [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/1-3\">",
"     1-3",
"    </a>",
"    ] led many pediatricians to oppose their performance under any and all circumstances. Nonetheless, the operations have retained support throughout the professional and lay communities for a number of reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Many clinicians remained convinced, based on their training, experience, or evidence from clinical trials, that the operations were efficacious in relieving certain recurrent or persistent upper-respiratory and middle-ear disorders.",
"     </li>",
"     <li>",
"      It became clear that extreme hypertrophy of the adenoids, tonsils, or both, could so obstruct the upper airway as to result in alveolar hypoventilation and cor pulmonale, and also that these conditions responded promptly to surgical removal of the offending tissue.",
"     </li>",
"     <li>",
"      Many orthodontists have believed, based on limited evidence, that chronic upper airway obstruction results in abnormal craniofacial and dental growth &mdash; the \"adenoid facies\" &mdash; and that this too can be modified favorably by adenoidectomy or adenotonsillectomy.",
"     </li>",
"     <li>",
"      Many parents of children who underwent surgery reported satisfactory resolution of their children's presenting problems and a decrease in school absence.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An overview of the indications, contraindications, complications, and adverse effects associated with tonsillectomy and adenoidectomy will be presented below. More detailed information regarding the conditions for which these procedures may be indicated is provided separately. (See appropriate topic reviews).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tonsillectomy is among the most commonly performed operations in children. The frequency with which tonsillectomy is performed varies from country to country and region to region [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. The variation appears to be related to differences in the medical practice of general practitioners, pediatricians, and otolaryngologists in the management of recurrent tonsillitis and other conditions affecting the upper airway [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/7\">",
"     7",
"    </a>",
"    ].",
"    <span class=\"nowrap\">",
"     Patient/family",
"    </span>",
"    factors and preferences may also influence the decision [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the United States, the number of tonsillectomies has declined progressively since the 1970s [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. Reports suggest that the decline has mainly involved tonsillectomies performed for infectious indications, while the number of tonsillectomies performed for obstructive indications may have actually increased [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. In 2006, an estimated 530,000 tonsillectomies (with or without adenoidectomy) and 132,000 adenoidectomies (without tonsillectomy) were performed in children younger than 15 years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/10\">",
"     10",
"    </a>",
"    ]. Most of these operations are performed as ambulatory, same-day procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The rates for specific procedures vary depending upon age and sex. Tonsillectomy alone is performed infrequently in children younger than three years of age, whereas adenoidectomy alone is performed infrequently in individuals older than 14 years of age. The rate of adenoidectomy is about 1.5 times as high in boys as in girls, whereas the rate of tonsillectomy is about one-third higher in girls than in boys [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/8,10\">",
"     8,10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     OVERVIEW OF INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tonsil and adenoid surgery may be classified as obligatory (absolute) or elective (conditional), depending upon the nature and severity of the underlying problem(s).",
"   </p>",
"   <p>",
"    Obstruction and infection of the upper respiratory tract form the two major categories of indications for excision of the tonsils",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    adenoids. Obstruction may involve the nasopharyngeal airway, oropharyngeal airway, and the oropharyngeal deglutitory (swallowing) pathway. Infection (recurrent or chronic) may involve the middle ears, mastoid air cells, nose, nasopharynx, adenoids, paranasal sinuses, oropharynx, tonsils, peritonsillar tissues, and cervical lymph nodes.",
"   </p>",
"   <p>",
"    Other, more general complaints, such as poor appetite or slow weight gain in the absence of problematic infection or obstruction, which used to be widely accepted as indications for tonsil and adenoid surgery, may still occasionally be used to justify surgery, but whether and how often this occurs has not been determined.",
"   </p>",
"   <p>",
"    Adenotonsillectomy is often thought of, and most often carried out, as a single, combined operation. However, in assessing indications for surgery, the two components require consideration individually. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'General considerations'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H20\">",
"     'Complications and adverse effects'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     ABSOLUTE INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Absolute indications mandating surgery consist of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Extreme obstruction of the nasopharyngeal or oropharyngeal airways by adenoids, tonsils, or both",
"     </li>",
"     <li>",
"      Tonsillar obstruction of the oropharynx that interferes with swallowing [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/13\">",
"       13",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Malignant tumor of the tonsil (or suspicion of malignancy) (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?10/59/11194?source=see_link&amp;anchor=H39#H39\">",
"       \"The pediatric physical examination: HEENT\", section on 'Tonsillar asymmetry'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Uncontrollable hemorrhage from tonsillar blood vessels",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Nasopharyngeal or oropharyngeal obstruction that is severe enough to prevent, or cause discomfort in, nasal breathing or to result in frequent episodes of apnea during sleep, is an absolute indication for surgery. In extreme cases, obstructive sleep apnea may result in alveolar hypoventilation, pulmonary hypertension, and cor pulmonale. Obstructive sleep apnea also may result in neurocognitive impairment, behavioral problems, and impaired physical growth. Polysomnography is the gold standard for evaluating sleep-disordered breathing and is a useful tool in assessing need for adenoidectomy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    tonsillectomy in patients with suspected sleep apnea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/17/36119?source=see_link\">",
"     \"Cor pulmonale\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/38/44649?source=see_link\">",
"     \"Evaluation of suspected obstructive sleep apnea in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The evaluation and management of children with suspected obstructive sleep apnea are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/38/44649?source=see_link\">",
"     \"Evaluation of suspected obstructive sleep apnea in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/17/40217?source=see_link\">",
"     \"Management of obstructive sleep apnea in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CONDITIONAL INDICATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Tonsillectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conditional indications for tonsillectomy (with or without adenoidectomy) may include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Recurrent acute throat infections.",
"     </li>",
"     <li>",
"      Chronic tonsillitis unresponsive to antimicrobial treatment.",
"     </li>",
"     <li>",
"      Tonsillar obstruction that alters voice quality.",
"     </li>",
"     <li>",
"      Halitosis, refractory to other measures.",
"     </li>",
"     <li>",
"      More than one episode of peritonsillar abscess or peritonsillar abscess in a child with substantial history of recurrent throat infection.",
"     </li>",
"     <li>",
"      Chronic pharyngeal carriage of group A beta-hemolytic Streptococci if the carrier is in close contact with a person who has had rheumatic fever or lives in a household in which infection occurs frequently and eradication has been refractory to other measures.",
"     </li>",
"     <li>",
"      Syndrome of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA syndrome) unresponsive to conservative treatment. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/11/8377?source=see_link\">",
"       \"Periodic fever with aphthous stomatitis, pharyngitis and adenitis (PFAPA syndrome)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Most tonsil-related problems in children tend to decline naturally with increasing age, although not predictably. Decisions regarding elective tonsillectomy in children should be individualized according to the potential benefits and risks of tonsillectomy in comparison with appropriate alternative strategies (eg, watchful waiting, antimicrobial therapy) and the values and preferences of the family and child. The presence of modifying factors (eg, multiple antibiotic",
"    <span class=\"nowrap\">",
"     allergy/intolerance)",
"    </span>",
"    or comorbid conditions (eg, poor school performance) may, in children with conditional indications, tip the balance in favor of tonsillectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'General considerations'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H20\">",
"     'Complications and adverse effects'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Recurrent infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recurrent throat infection (ie, tonsillitis, pharyngitis, tonsillopharyngitis) is a conditional indication for tonsillectomy. When making decisions regarding tonsillectomy in children with recurrent throat infection, there are four main factors to consider:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The frequency of the episodes",
"     </li>",
"     <li>",
"      The clinical features of the episodes",
"     </li>",
"     <li>",
"      The treatment of episodes caused by (or likely caused by) group A beta-hemolytic Streptococcus (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/38/2666?source=see_link\">",
"       \"Treatment and prevention of streptococcal tonsillopharyngitis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      The extent to which the episodes are documented in medical records; an undocumented history of recurrent throat infection tends to be a poor predictor of subsequent experience [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/16\">",
"       16",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A series of clinical trials have assessed the efficacy of tonsillectomy in preventing recurrent throat infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. The potential benefits vary depending upon whether the child is severely or moderately affected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3046050\">",
"    <span class=\"h4\">",
"     Severely affected children",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest tonsillectomy as an option for children with recurrent throat infection who are severely affected, as defined in the clinical trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/17\">",
"     17",
"    </a>",
"    ] described immediately below. In anticipation of the natural decline in tonsil-related problems with increasing age, another option is watchful waiting and the provision of symptomatic care and antimicrobial treatment (as indicated) for recurrent episodes. The decision should be made on a case-by-case basis after weighing the risks and benefits and the values and preferences of the family and child. These recommendation options were incorporated in the American Academy of Otolaryngology-Head Neck Surgery (AAO-HNS) guideline published in 2011 regarding indications for tonsillectomy in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/38/2666?source=see_link\">",
"     \"Treatment and prevention of streptococcal tonsillopharyngitis\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H14\">",
"     'General considerations'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H20\">",
"     'Complications and adverse effects'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/37/27224?source=see_link&amp;anchor=H4#H4\">",
"     \"Symptomatic relief of sore throat in children and adolescents\", section on 'Symptomatic treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The efficacy of tonsillectomy in severely affected children was evaluated in a pair of trials (one randomized and one nonrandomized) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/17\">",
"     17",
"    </a>",
"    ]. Enrolled children met each of the following criteria:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      &ge;3 episodes in each of three years, &ge;5 episodes in each of two years, or &ge;7 episodes in one year.",
"     </li>",
"     <li>",
"      Each qualifying episode characterized by at least ONE of the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Oral temperature &ge;101&ordm;F (38.3&ordm;C)",
"     </li>",
"     <li>",
"      Enlarged (&gt;2 cm) or tender anterior cervical lymph nodes",
"     </li>",
"     <li>",
"      Tonsillar exudate",
"     </li>",
"     <li>",
"      Positive culture for group A beta-hemolytic Streptococcus",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Apparently adequate antibiotic therapy administered for proven or suspected streptococcal episodes.",
"     </li>",
"     <li>",
"      Each qualifying episode confirmed by examination with the clinical features described in a clinical record at the time of occurrence, or if not fully documented, subsequent observance of two episodes of throat infection with patterns of frequency and clinical features consistent with the initial history.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Tonsillectomy was efficacious in reducing the overall number and severity of subsequent episodes of throat infection, as illustrated by the following results:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the first year of follow-up in the randomized trial, the mean number of moderate or severe episodes in the tonsillectomy group was 0.08 compared with 1.17 in the control group, a 14-fold difference. Episodes were rated as mild, moderate, or severe on the basis of a formal scoring system [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In the first and second years of follow-up, 92 and 84 percent of tonsillectomy subjects, respectively, had no episodes of moderate or severe infection, compared with 34 and 41 percent of control subjects.",
"     </li>",
"     <li>",
"      Third-year differences, although in most cases not statistically significant, also consistently favored the surgical groups.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, in each follow-up year, many subjects in the nonsurgical groups had fewer than three episodes of throat infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/17\">",
"     17",
"    </a>",
"    ]. Most episodes among subjects in the nonsurgical groups were mild: among randomized control subjects, 62, 61, and 80 percent of the episodes in the first, second, and third years of follow-up, respectively, were rated as mild; among nonrandomized nonsurgical subjects, corresponding values were 78, 84, and 73 percent.",
"   </p>",
"   <p>",
"    The results described above provide support for both surgical and nonsurgical management of children with recurrent tonsillitis who are severely affected. Treatment decisions for such children are best made on a case-by-case basis. The decision should take into account the potential adverse consequences of surgery, described below, and the values and preferences of the family, and other factors as described below. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'General considerations'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H20\">",
"     'Complications and adverse effects'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3046057\">",
"    <span class=\"h4\">",
"     Moderately affected children",
"    </span>",
"    &nbsp;&mdash;&nbsp;We do not suggest tonsillectomy for children who are mildly or moderately affected [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/18\">",
"     18",
"    </a>",
"    ]. For such children, the benefits of surgery are modest, and outweighed by the potential risks. Episodes of recurrent infection in children with mild or moderate recurrent throat infection should be treated with symptomatic care and antimicrobial treatment (as indicated). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/38/2666?source=see_link\">",
"     \"Treatment and prevention of streptococcal tonsillopharyngitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/37/27224?source=see_link&amp;anchor=H4#H4\">",
"     \"Symptomatic relief of sore throat in children and adolescents\", section on 'Symptomatic treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The efficacy of tonsillectomy in preventing recurrent throat infection in moderately affected children was evaluated in a pair of randomized trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/18\">",
"     18",
"    </a>",
"    ]. These trials also tested whether, in children who met the specified standards regarding throat infection but who had no specific indications for adenoidectomy, the addition of adenoidectomy to tonsillectomy, as is often undertaken in clinical practice, would confer any additional benefit. Thus, in one of the trials, children who had indications for adenoidectomy in addition to indications for tonsillectomy were randomly assigned to one of two groups: adenotonsillectomy or control. In the other trial, children who had no indications for adenoidectomy were randomly assigned to one of three groups: tonsillectomy, adenotonsillectomy, or control.",
"   </p>",
"   <p>",
"    The illness histories of children enrolled in the trials exceeded the minimum criteria for surgery specified in the previous (2000) AAO-HNS guideline for tonsillectomy: \"&ge;3 infections of tonsils",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    adenoids per year despite adequate medical therapy\" [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/9\">",
"     9",
"    </a>",
"    ]. However, the history standards were slightly less stringent than those used in the trials described above for severely affected children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/17\">",
"     17",
"    </a>",
"    ] regarding either frequency, severity, or documentation of previous episodes of throat infection, but not regarding more than one of these parameters [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/18\">",
"     18",
"    </a>",
"    ]. Adequate antibiotic therapy had to have been administered for a previous streptococcal or likely streptococcal episode to be counted [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following results were noted [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/18\">",
"     18",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the first year of follow-up, the mean number of moderate or severe episodes in the combined surgical groups (tonsillectomy and adenotonsillectomy) was 0.14 compared with 0.35 in the combined control groups, a 2.5-fold difference.",
"     </li>",
"     <li>",
"      During each of the three years of follow-up, the incidence of throat infection was significantly lower in the surgical groups than in the corresponding control groups. Results in surgical subjects were similar to those in the trials for severely affected children, described above [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/17\">",
"       17",
"      </a>",
"      ]. However, the proportion of control subjects who developed no moderate or severe episodes of throat infection in a given year ranged from 70 to 84 percent (compared with 34 and 41 percent of control subjects in the first and second years of follow-up in the trials of severely affected children).",
"     </li>",
"     <li>",
"      The outcomes in children who underwent adenotonsillectomy were not more favorable than those in children who underwent tonsillectomy only.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These results indicate that for children who are not severely affected, the benefit of either tonsillectomy or adenotonsillectomy is modest [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/18\">",
"     18",
"    </a>",
"    ]. We suggest that this modest potential benefit does not justify the inherent risks, morbidity, and cost of surgery, a conclusion also incorporated in the 2011 AAO-HNS guideline [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Complications and adverse effects'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     PFAPA syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest tonsillectomy as a treatment option in children with the syndrome of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA syndrome) who have not recovered spontaneously within a reasonable period and who have not responded to conservative treatment. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/11/8377?source=see_link&amp;anchor=H16#H16\">",
"     \"Periodic fever with aphthous stomatitis, pharyngitis and adenitis (PFAPA syndrome)\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Other indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other nonurgent conditions considered to be elective indications for tonsillectomy (with or without adenoidectomy) have not been tested in controlled trials. These conditions include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/9,19,20\">",
"     9,19,20",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chronic (as distinct from recurrent acute) tonsillitis unresponsive to antimicrobial treatment (a condition that is uncommon in adolescents and adults, but rare in young children).",
"     </li>",
"     <li>",
"      Tonsillar obstruction not severe enough to cause dysphagia or sleep apnea but resulting in a muffled or \"hot potato\" voice quality.",
"     </li>",
"     <li>",
"      Halitosis attributed to debris in tonsillar crypts, after conservative measures, such as gargling or pharyngeal douche, have proved ineffective, and when other causes (periodontal disease, sinusitis, intranasal foreign body) have been ruled out. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/32/43527?source=see_link\">",
"       \"Bad breath\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Peritonsillar abscess when the condition has developed more than once, or has developed in a child with a substantial history of recurrent throat infection. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/61/31705?source=see_link\">",
"       \"Peritonsillar cellulitis and abscess\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Chronic pharyngeal carriage of group A beta-hemolytic Streptococci when the carrier is in close contact with a person who has had rheumatic fever or is in a household in which streptococcal infection is occurring frequently, and provided that treatment with",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/56/34688?source=see_link\">",
"       clindamycin",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/26/34214?source=see_link\">",
"       amoxicillin-clavulanate",
"      </a>",
"      , or a combination of penicillin and",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?16/52/17225?source=see_link\">",
"       rifampin",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/21\">",
"       21",
"      </a>",
"      ] has not been successful in eradicating the organism. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/38/6758?source=see_link\">",
"       \"Antibiotic failure in the treatment of streptococcal tonsillopharyngitis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Adenoidectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the nasal obstruction caused by adenoidal hypertrophy, other clinical conditions, namely, rhinosinusitis and Eustachian tube",
"    <span class=\"nowrap\">",
"     dysfunction/otitis",
"    </span>",
"    media, may be initiated or complicated by the presence of adenoidal disease (hypertrophy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    infection). Severe nasal obstruction due to adenoidal hypertrophy is an absolute indication for adenoidectomy. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Absolute indications'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Conditional indications for adenoidectomy in children include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Moderate nasal obstruction caused by adenoidal hypertrophy with persistent symptoms",
"     </li>",
"     <li>",
"      Refractory chronic sinusitis",
"     </li>",
"     <li>",
"      Recurrent acute otitis media (AOM) or chronic otitis media with effusion (OME) in children who have undergone tympanostomy-tube insertion and whose tubes have been extruded",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Decisions regarding elective adenoidectomy should be individualized according to the potential benefits and risks and the values and preferences of the family and child. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'General considerations'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H20\">",
"     'Complications and adverse effects'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Nasal obstruction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nasal obstruction due to adenoidal hypertrophy has a number of clinical effects, including mouth breathing, hyponasal speech, impaired olfaction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/22\">",
"     22",
"    </a>",
"    ], and probably adenoid facies. Nasal obstruction caused by large adenoids must be distinguished from obstruction caused by other conditions, such as allergic or infectious rhinitis or structural nasal disorders. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/30/13801?source=see_link&amp;anchor=H5#H5\">",
"     \"Anatomy and etiology of taste and smell disorders\", section on 'Disorders of olfaction'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/44/16072?source=see_link\">",
"     \"Etiologies of nasal symptoms: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Moderate obstructive symptoms &mdash;We suggest adenoidectomy for children with moderate nasal obstruction caused by adenoidal hypertrophy in whom obstructive symptoms (mouth breathing, hyponasal speech, impaired olfaction) have been present for a substantial period and have not responded to conservative measures. Conservative measures include trial courses of antimicrobial treatment for one month [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/23\">",
"       23",
"      </a>",
"      ] and of nasal glucocorticoids for six weeks (continued for up to six months if prompt initial improvement is realized) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/24-28\">",
"       24-28",
"      </a>",
"      ]. In a few instances, a favorable response to these measures may obviate the need for surgery. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/57/21399?source=see_link&amp;anchor=H11#H11\">",
"       \"Etiology of speech and language disorders in children\", section on 'Resonance disorders'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      For children with adenoidal obstruction who have not improved satisfactorily with conservative measures, results of paired randomized and nonrandomized clinical trials [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/29\">",
"       29",
"      </a>",
"      ] and of a retrospective study [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/30\">",
"       30",
"      </a>",
"      ], as well as results in children with obstructive sleep apnea, indicate that adenoidectomy is effective in reducing obstructive symptoms. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/17/40217?source=see_link\">",
"       \"Management of obstructive sleep apnea in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In a randomized trial of adenoidectomy versus nonsurgical management, children with adenoidal obstruction, most of whom were five or six years old, were followed for up to two years. At both the one-year and two-year follow-up, the children who underwent adenoidectomy had complete or nearly complete resolution of symptoms; in contrast, some of the children in the control group had spontaneous improvement of varying degree, but relatively few had complete resolution. Similar overall differences in outcome were found in the children whose parents refused randomization and instead opted for or against adenoidectomy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a retrospective study, the parents of children aged 2 to 17 years (mean 6.5 years) who underwent adenoidectomy for adenoidal obstruction responded to a questionnaire three to five years after the procedure [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/30\">",
"       30",
"      </a>",
"      ]. The improvement rate for individual symptoms ranged from 74 to 87 percent. In a few cases, failure to improve was attributable to regrowth of adenoid tissue, but in most cases, failure to improve was attributed to nasal mucosal or structural abnormality. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/44/16072?source=see_link\">",
"       \"Etiologies of nasal symptoms: An overview\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Adenoid facies &mdash; Although a relationship has not been established conclusively, some authors have attributed presumably abnormal facial growth patterns (eg, long and narrow face, low tongue placement, narrow upper jaw, steep mandible, open anterior bite) to large adenoids and have advocated adenoidectomy to prevent or ameliorate this process [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/31-34\">",
"       31-34",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Observational studies have described improvement in dentofacial measurements, dental arch morphology, and dental position following adenoidectomy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/31,32,35\">",
"       31,32,35",
"      </a>",
"      ]. However, these studies failed to include control subjects who did not undergo adenoidectomy.",
"      <br/>",
"      <br/>",
"      Nonetheless, adenoidectomy may provide orthodontic benefit to some children, provided there is clear evidence of adenoidal obstruction. Hypertrophy causing dental malocclusion or adversely affecting orofacial growth documented by an orthodontist is included among the earlier-issued (2000) AAO-HNS indications for tonsil or adenoid surgery [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Chronic sinusitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The efficacy of adenoidectomy in children with chronic sinusitis that has not responded adequately to medical management is uncertain. In observational studies, favorable results have been found in some, but not all, children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/36-41\">",
"     36-41",
"    </a>",
"    ], but randomized, controlled trials have not been reported.",
"   </p>",
"   <p>",
"    Adenoidectomy may be indicated for children with refractory chronic sinusitis before considering endoscopic sinus surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/40,42,43\">",
"     40,42,43",
"    </a>",
"    ]. However, before considering surgical intervention of any type, a search should be made for underlying, contributing conditions (eg, allergy, ciliary dysmotility syndromes, and immunodeficiencies) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/37/9817?source=see_link\">",
"     \"Primary ciliary dyskinesia (immotile-cilia syndrome)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/47/30458?source=see_link\">",
"     \"Approach to the child with recurrent infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Otitis media",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recurrent AOM and chronic OME are well-recognized conditional indications for adenoidectomy or adenotonsillectomy in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/9\">",
"     9",
"    </a>",
"    ]. These indications are discussed briefly below, and in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/54/42857?source=see_link&amp;anchor=H25#H25\">",
"     \"Acute otitis media in children: Prevention of recurrence\", section on 'Adenoidectomy or adenotonsillectomy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We suggest adenoidectomy for children who have undergone tympanostomy-tube insertion, whose tubes have been extruded, and who subsequently develop recurrent AOM or chronic OME to a troublesome degree. This particularly applies to children who are about to undergo repeat tube insertion. We do not suggest adenoidectomy for children with recurrent AOM or chronic OME who have not undergone tympanostomy-tube insertion.",
"   </p>",
"   <p>",
"    The cumulative evidence from randomized controlled trials evaluating the effectiveness of adenoidectomy or adenotonsillectomy in children with recurrent AOM or chronic OME suggests that adenoidectomy offers a measure of benefit to at least some of these children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/46-49\">",
"     46-49",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In children who have undergone tympanostomy-tube insertion and who develop troublesome recurrent AOM after extrusion of the tubes, the benefits of adenoidectomy may outweigh the risks, morbidity, and cost of the procedure [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/47\">",
"       47",
"      </a>",
"      ]. For such children the decision should be made on a case-by-case basis, after considering the risks and benefits and the values and preferences of the family and child. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Complications and adverse effects'",
"      </a>",
"      below and",
"      <a class=\"local\" href=\"#H14\">",
"       'General considerations'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      In children with recurrent AOM or chronic OME who have not undergone tympanostomy-tube insertion, the efficacy of adenoidectomy or adenotonsillectomy is, at best, limited and of short duration [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/46,48,49\">",
"       46,48,49",
"      </a>",
"      ]. If surgery is deemed necessary in such children, tympanostomy-tube insertion is the most appropriate initial surgical procedure [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/50\">",
"       50",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?3/56/3978?source=see_link\">",
"       \"Overview of tympanostomy tube placement and medical care of children with tympanostomy tubes\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     General considerations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Decisions regarding tonsillectomy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    adenoidectomy in children with conditional indications for surgery should be made on a case-by-case basis. Factors to be considered in the decision include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The potential benefits and risks of surgery, bearing in mind the natural course of disease",
"     </li>",
"     <li>",
"      Clinical factors related to the disease process (eg, frequency and severity of episodes of recurrent throat infection)",
"     </li>",
"     <li>",
"      The parent's and the child's respective preferences, anxieties, and tolerance of illness",
"     </li>",
"     <li>",
"      The child's tolerance of antimicrobial drugs and other conservative therapies",
"     </li>",
"     <li>",
"      The child's school performance in relation to illness-related absence",
"     </li>",
"     <li>",
"      The accessibility of health care services",
"     </li>",
"     <li>",
"      Out-of-pocket costs",
"     </li>",
"     <li>",
"      The nature of available anesthetic and surgical services and facilities",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Special circumstances",
"    </span>",
"    &nbsp;&mdash;&nbsp;Relaxation of the standards for surgery described above may be appropriate in certain circumstances. As an example, in a child who requires adenoidectomy for unequivocal indications, it would seem reasonable to add tonsillectomy if the tonsils also have been problematic to some degree, even if he or she does not meet the criteria for tonsillectomy described above. By the same token, in a child scheduled for tonsillectomy for unequivocal indications, it would seem reasonable to add adenoidectomy if the child had had more than occasional bouts of otitis media but had not undergone tympanostomy-tube insertion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     CONTRAINDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are three general categories of contraindications to tonsillectomy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    adenoidectomy: velopharyngeal, hematologic, infectious.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Velopharyngeal",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of abnormal conditions that result in or predispose to velopharyngeal insufficiency constitute contraindications to adenoidectomy. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Overt cleft of the palate",
"     </li>",
"     <li>",
"      Submucous (covert) cleft of the palate",
"     </li>",
"     <li>",
"      Neurologic or neuromuscular abnormalities leading to impaired palatal function",
"     </li>",
"     <li>",
"      The unusually capacious pharynx",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In each of these conditions, the characteristic clinical finding is hypernasality, a symptom that the unwary observer may fail to distinguish from hyponasality. Hyponasality can be approximated by saying words or phrases containing the nasal consonants \"m\" and \"n\" (eg, \"my name means money\"), while pinching the nostrils closed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/20\">",
"     20",
"    </a>",
"    ]. Hypernasality results from the inability to seal the soft palate against the posterior pharyngeal wall [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/20\">",
"     20",
"    </a>",
"    ]. Hypernasality is demonstrated by air escape when the child says words or phrases that contain plosive consonants, especially \"b\" and \"p\" (eg, \"puppy\" or \"Bobby\"), or sibilant fricatives such as \"s,\" \"z,\" or \"sh\" (eg, \"sister Suzie sells shells\") [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If adenoidectomy is undertaken to improve the \"nasal\" speech of children with hypernasality, the symptom may worsen markedly, since the adenoids had been serving to help fill the relative velopharyngeal void and thus facilitate normal speech production. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/57/21399?source=see_link&amp;anchor=H11#H11\">",
"     \"Etiology of speech and language disorders in children\", section on 'Resonance disorders'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Examination of the oropharynx for submucous cleft should be performed in all children for whom adenoidectomy is being considered, whether or not hypernasality is present. Submucous cleft of the palate should be suspected when a bifid uvula or widening and attenuation of the median raphe of the soft palate are observed. On examination, palpation of a V-shaped midline notch (rather than the normal rounded curve) along the junction of the hard and soft palates strongly suggests the presence of a submucous cleft.",
"   </p>",
"   <p>",
"    Referral to an individual or a team skilled in cleft palate evaluation and management is warranted if submucous cleft of the palate is detected",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    if hypernasality related to velopharyngeal insufficiency is suspected, even if the oropharyngeal examination is normal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Hematologic",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anemia and disorders of hemostasis are the hematologic contraindications to tonsil and adenoid surgery. Surgery should not be undertaken if the hemoglobin concentration is less than 10",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    or if the hematocrit is less than 30 percent. When surgery is being considered, careful inquiry should be made about a personal and family history of unusual bleeding or bruising; certain hemostatic disorders may not be detectable with readily available tests.",
"   </p>",
"   <p>",
"    Routine preoperative studies may include measurements of the prothrombin time (PT), partial thromboplastin time (PTT), and international normalized ratio (INR), and an estimate of the platelet level, usually from a stained blood smear. Unfortunately, however, the sensitivity and predictive value of these tests in predicting postoperative bleeding are limited [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/52-54\">",
"     52-54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When surgery is deemed appropriate for children with anemia or disorders of hemostasis, consultation with the hematology service is critical for preoperative and postoperative management.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Infectious",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neither tonsillectomy nor adenoidectomy should be undertaken in children with active local infection (ie, pharyngitis, common cold) unless urgent obstructive symptoms are present or prolonged appropriate antimicrobial treatment has been maintained unsuccessfully. An interval of at least three weeks after an episode of acute infection usually is sufficient for general recuperation and to reduce the risk of operative hemorrhage. (See",
"    <a class=\"local\" href=\"#H25\">",
"     'Hemorrhage'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     COMPLICATIONS AND ADVERSE EFFECTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tonsillectomy and adenoidectomy are major operations that require general anesthesia. As such, they are attended by the risk of various complications, not all of which are preventable under even ideal circumstances of care, and some of which are potentially lethal.",
"   </p>",
"   <p>",
"    The incidence of complications varies depending upon surgical technique [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/55-57\">",
"     55-57",
"    </a>",
"    ]. Major complications (eg, delayed bleeding requiring intervention) occur in approximately 3 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/18,58-60\">",
"     18,58-60",
"    </a>",
"    ]. In the randomized trials of tonsillectomy for the prevention of recurrent throat infection described above [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/17,18\">",
"     17,18",
"    </a>",
"    ], the complication rates were 8 and 14 percent. Complications included bleeding; adverse effects of anesthesia; infection, including pharyngitis, otitis media, and bronchitis; severe nausea; and severe or protracted dysphagia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Anesthesia-related",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serious anesthesia-related complications of tonsil and adenoid surgery occur rarely but can be life threatening. Complications related to anesthesia include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Airway-related problems. Problems that may be associated with the induction or conduct of anesthesia include oxygen desaturation, difficult laryngoscopy or failed attempts at laryngoscopy necessitating further attempts, and difficult mask ventilation. In a retrospective cohort of 2170 children undergoing adenotonsillectomy, airway-related problems were more prone to occur in overweight and obese children than in children with normal body mass index (BMI) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/61\">",
"       61",
"      </a>",
"      ]. In another retrospective series of 151 patients who had preoperative polysomnography, adverse respiratory events were associated with higher apnea-hypopnea and hypopnea indexes, lower nadir oxygen saturation, and higher BMI [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/62\">",
"       62",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Nausea and vomiting are common in the period immediately following anesthesia and may contribute to dehydration [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/63\">",
"       63",
"      </a>",
"      ]. The administration of",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?34/33/35344?source=see_link\">",
"       dexamethasone",
"      </a>",
"      after induction of anesthesia appears to reduce the risk of postoperative nausea and vomiting [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/64-69\">",
"       64-69",
"      </a>",
"      ], but there is concern about a possible associated increased risk of postoperative bleeding requiring reoperation. This issue is discussed in detail below. (See",
"      <a class=\"local\" href=\"#H11436020\">",
"       'Intraoperative glucocorticoids'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Endotracheal intubation may result in injuries to teeth or to laryngeal structures.",
"     </li>",
"     <li>",
"      Aspiration may result in bronchopulmonary obstruction or infection.",
"     </li>",
"     <li>",
"      Cardiac arrhythmia. Certain inhalational anesthetic agents may cause prolongation of the QT interval, on occasion resulting in cardiac arrhythmia. This problem is more prone to occur in children with the long QT syndrome, but it may also occur in children with a normal QT interval [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/70,71\">",
"       70,71",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/9/2202?source=see_link\">",
"       \"Clinical features of congenital long QT syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Malignant hyperthermia. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/13/32984?source=see_link\">",
"       \"Malignant hyperthermia: Clinical diagnosis and management of acute crisis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Postoperative",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common postoperative complications are throat pain, otalgia, hemorrhage, and emotional upset [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/63,72\">",
"     63,72",
"    </a>",
"    ]. Less common complications include infection, upper airway obstruction, and velopharyngeal insufficiency.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Throat pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Throat pain, and particularly pain on swallowing, is a virtually inescapable consequence of tonsillectomy. Throat pain may be severe enough for the patient to restrict intake of liquids, resulting in dehydration and, potentially, admission to the hospital [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/55\">",
"     55",
"    </a>",
"    ]. The mean duration of postoperative pain is about five or six days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/17,18,73\">",
"     17,18,73",
"    </a>",
"    ], but some children continue to complain for several weeks.",
"   </p>",
"   <p>",
"    Preoperative anxiety may be associated with postoperative pain. In a prospective study, children who were assessed to be anxious before surgery experienced more pain and slower decline in pain during the first three postoperative days than children who were assessed to be not anxious before surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Throat pain is less of a problem for children undergoing adenoidectomy only. In parallel randomized trials of adenoidectomy and adenotonsillectomy for recurrent acute otitis media, the mean duration of postoperative pain in children undergoing adenoidectomy only was about one day (range zero to seven days), compared with about six days (range 0 to 21 days) in children undergoing adenotonsillectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Otalgia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pain referred from the pharynx to the ear is common following tonsillectomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Hemorrhage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postoperative hemorrhage is the most common serious complication of tonsil and adenoid surgery, although the actual incidence is low. Hemorrhage may require blood transfusion",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    an additional surgical procedure. It may occur after either tonsillectomy or adenoidectomy. Most reports of incidence have concerned tonsillectomy with or without adenoidectomy.",
"   </p>",
"   <p>",
"    Since the 1990s, reported rates of primary hemorrhage (within 24 hours of surgery) have ranged from 0.2 to 2.2 percent, and of secondary hemorrhage (more than 24 hours after surgery) from 0.1 to 3.7 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/75\">",
"     75",
"    </a>",
"    ]. Information about hemorrhage after adenoidectomy without tonsillectomy is limited. One study found a rate of hemorrhage of 0.5 percent (2 out of 429 patients) within the first 12 hours postoperatively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/76\">",
"     76",
"    </a>",
"    ]. In another study, the rate of hemorrhage occurring within 24 hours of the initial procedure that was severe enough to require intervention in the operating room was 0.2 percent (3 out of 1363) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/77\">",
"     77",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Delayed hemorrhage usually occurs between 7 and 10 days after surgery and is caused by premature separation of the eschar (",
"    <a class=\"graphic graphic_picture graphicRef54064 \" href=\"mobipreview.htm?21/63/22518\">",
"     picture 1",
"    </a>",
"    ), which may be precipitated by an underlying infection or dehydration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/63\">",
"     63",
"    </a>",
"    ]. After 10 days, the risk of delayed hemorrhage has resolved in most normal patients. As noted earlier, the administration of",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    after induction of anesthesia (for prevention of postoperative nausea and vomiting) has been associated with an increased risk of postoperative bleeding requiring reoperation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/64\">",
"     64",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Anesthesia-related'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    To anticipate the possibility of hemorrhage, it is important to ask about a family or past history of unusual bleeding or bruising before surgery. Also, to minimize the risk of hemorrhage, surgery should be postponed whenever possible until at least three weeks after an episode of pharyngitis.",
"   </p>",
"   <p>",
"    Whether the use of nonsteroidal antiinflammatory drugs (NSAIDs) before or after adenotonsillectomy increases the risk of hemorrhage because of the drugs&rsquo; adverse effect on platelet function has been a somewhat unsettled issue [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/78,79\">",
"     78,79",
"    </a>",
"    ]. Several studies have suggested that the use of",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/43/34480?source=see_link\">",
"     ketorolac",
"    </a>",
"    increases the risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/80,81\">",
"     80,81",
"    </a>",
"    ], but the use of",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?7/48/7946?source=see_link\">",
"     ibuprofen",
"    </a>",
"    appears not to do so [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/82\">",
"     82",
"    </a>",
"    ]. The 2011 AAO-HNS guideline states &ldquo;data suggest that NSAIDs, ketorolac excluded, can be safely used for the postoperative treatment of pain following tonsillectomy&rdquo; [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/15\">",
"     15",
"    </a>",
"    ]. On the other hand, the use of",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?19/10/19624?source=see_link\">",
"     aspirin",
"    </a>",
"    should be avoided not only postoperatively, but also for two weeks before surgery. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Contraindications'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H32\">",
"     'Medical evaluation'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H35\">",
"     'Pain relief'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The possible association between intraoperative glucocorticoids and postoperative hemorrhage is discussed below. (See",
"    <a class=\"local\" href=\"#H11436020\">",
"     'Intraoperative glucocorticoids'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Emotional upset",
"    </span>",
"    &nbsp;&mdash;&nbsp;During the first few days after tonsil or adenoid surgery, children may exhibit general anxiety and sleep disturbances, including problems falling asleep, problems staying asleep, and crying upon waking up. As with pain, the extent of these problems is related to the degree of anxiety before surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Other complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Less common complications of tonsillectomy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    adenoidectomy include infection, upper airway obstruction",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    central apnea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/61,83,84\">",
"     61,83,84",
"    </a>",
"    ] and velopharyngeal insufficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/85\">",
"     85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infection &mdash; Uncommonly, bronchopulmonary infection may result from aspiration of pharyngeal contents or from extension of preexisting upper respiratory tract infection. Bacterial tracheitis, which may cause life-threatening airway obstruction, has been reported as a rare complication of adenotonsillectomy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/86,87\">",
"       86,87",
"      </a>",
"      ]. Acute otitis media has also been considered a postoperative complication [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/88\">",
"       88",
"      </a>",
"      ]. However, it is not clear that the risk is higher than in comparable patients who have not undergone surgery. (See",
"      <a class=\"local\" href=\"#H39\">",
"       'Antimicrobial prophylaxis'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Upper airway obstruction",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      central apnea &mdash; Upper airway obstruction",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      central apnea may occur as postoperative complications of tonsil and adenoid surgery. Risk factors for postoperative upper airway obstruction",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      central apnea include [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/83,84\">",
"       83,84",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Obstructive sleep apnea (OSA) and, in particular, evidence of severe apnea on polysomnography [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/14\">",
"       14",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Age &lt;3 years",
"     </li>",
"     <li>",
"      Craniofacial anomalies affecting the pharyngeal airway",
"     </li>",
"     <li>",
"      Body mass index greater than normal [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/61\">",
"       61",
"      </a>",
"      ]",
"      <br/>",
"      <br/>",
"      In children without these risk factors, postoperative upper airway obstruction may result from hemorrhage into the pharynx and hypopharynx or from palatal",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      pharyngeal edema [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/83,89\">",
"       83,89",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Velopharyngeal insufficiency &mdash; During speech and in swallowing, the palate serves as a valve to interrupt the continuity between the nasopharynx and the oropharynx. That function of the palate is facilitated by the presence of adenoid tissue, which serves as a cushion against which the palate may make contact.",
"      <br/>",
"      <br/>",
"      Removal of the adenoids, particularly in children with any of the velopharyngeal conditions discussed above, may result in inability of the palate to reach the posterior pharyngeal wall sufficiently to effect complete closure and will result in hypernasal speech and, rarely, in nasopharyngeal regurgitation. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Velopharyngeal'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      Velopharyngeal insufficiency sometimes develops after adenoidectomy in children without predisposing factors [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/85\">",
"       85",
"      </a>",
"      ]. In most children, normal palatal function will be regained spontaneously or with the help of speech therapy, but in others, surgical correction is required.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3046116\">",
"    <span class=\"h4\">",
"     Rare complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rare but serious complications of tonsil and adenoid surgery include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nasopharyngeal stenosis from scar contracture and maturation (may appear months to years after surgery) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/63,90,91\">",
"       63,90,91",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Atlantoaxial subluxation and persistent torticollis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/92\">",
"       92",
"      </a>",
"      ] (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/26/8616?source=see_link&amp;anchor=H3#H3\">",
"       \"Acquired torticollis in children\", section on 'Atlantoaxial rotary subluxation'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Subcutaneous emphysema of the head, neck, and pneumomediastinum [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/93,94\">",
"       93,94",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Carotid artery dissection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/95,96\">",
"       95,96",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Airway fires [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/97\">",
"       97",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Cautery burns and other burn injuries [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/97\">",
"       97",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Immunologic risks",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no evidence that tonsillectomy or adenoidectomy results in immunologic risks to children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/98-101\">",
"     98-101",
"    </a>",
"    ], provided that they have been immunized against poliomyelitis. Decreases in serum levels of immunoglobulin G following tonsillectomy probably reflect a reduction in antigenic stimulation rather than a risk factor for respiratory infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/102\">",
"     102",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anecdotally, deaths as a consequence of tonsillectomy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    adenoidectomy continue to occur. However, actual data on mortality rates are scant and dated, and typically consider tonsillectomy and adenoidectomy as a single entity, rather than as separate procedures. In a series from Austria, one death, from hemorrhage, occurred among 7743 children undergoing these operations between 1979 and 1992 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/103\">",
"     103",
"    </a>",
"    ]. Whether additional deaths occurred from other causes was not stated.",
"   </p>",
"   <p>",
"    In a series from Israel, published in 2008, the posttonsillectomy mortality rate was 1 in 12,000, with hemorrhage and airway obstruction as the principal factors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/89\">",
"     89",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Cost",
"    </span>",
"    &nbsp;&mdash;&nbsp;Costs vary geographically, but in Pittsburgh during the period 2005-2007, costs averaged about $2900 for tonsillectomy with or without adenoidectomy and about $1600 for adenoidectomy alone.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     PREOPERATIVE PREPARATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Medical evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The preoperative evaluation for children who are scheduled to undergo tonsil or adenoid surgery entails evaluation for potential velopharyngeal, hematologic, or infectious contraindications",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    conditions associated with increased risk of complications. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Contraindications'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H20\">",
"     'Complications and adverse effects'",
"    </a>",
"    above.) Important elements include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Examination of the oropharynx (uvula and palate) for submucous cleft",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      pharyngitis. Children in whom submucous cleft of the palate is detected and those in whom velopharyngeal insufficiency is suspected (even if the examination is normal) should be referred to an individual or a team skilled in cleft palate evaluation and management. Acute pharyngitis would ordinarily be an indication to postpone surgery. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Velopharyngeal'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H19\">",
"       'Infectious'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Asking about a family or past history of unusual bleeding or bruising; certain hemostatic disorders may not be detectable with readily available tests. Preoperative coagulation screening tests, namely measurements of prothrombin time (PT), partial thromboplastin time (PTT), international normalized ratio (INR) and an estimate of the platelet level should, because of their extremely low sensitivity and low positive predictive value, be limited to children with a personal or family history suggestive of a hemostatic disorder [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/53,104,105\">",
"       53,104,105",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Hematologic'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Preoperative assessment for risk factors for upper airway obstruction",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      central apnea in the postoperative period; such factors include OSA (particularly evidence of severe apnea on polysomnography), age &lt;three years, obesity or increased body mass index (BMI), and craniofacial anomalies affecting the pharyngeal airway.",
"     </li>",
"     <li>",
"      Assessment of atlantoaxial stability in children who are at increased risk for atlantoaxial instability (eg, children with Down syndrome, achondroplasia, or mucopolysaccharidoses) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/63,106,107\">",
"       63,106,107",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Emotional",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children who are to undergo surgery should be prepared for the experience well in advance. Parents should describe the expected course of events in as much detail and as frankly as possible, commensurate with the child's ability to comprehend. Children should be told that a certain amount of discomfort will be entailed but that every effort will be made to minimize it.",
"   </p>",
"   <p>",
"    Optimally, once in hospital, children should have unlimited access to parents or parent surrogates. One or both parents should remain with the child during the period immediately preceding the trip to the operating room and should be at the bedside when the child returns.",
"   </p>",
"   <p>",
"    Individual health care centers frequently provide patient information handouts regarding tonsillectomy and adenoidectomy. Examples are available at",
"   </p>",
"   <p>",
"    <a class=\"external\" href=\"file://www.dukehealth.org/services/otolaryngology/care_guides/adenoidectomy_patient_information\">",
"     file://www.dukehealth.org/services/otolaryngology/care_guides/adenoidectomy_patient_information",
"    </a>",
"    and",
"    <a class=\"external\" href=\"file://www.dukehealth.org/services/otolaryngology/care_guides/tonsillectomy_instructions\">",
"     file://www.dukehealth.org/services/otolaryngology/care_guides/tonsillectomy_instructions",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11436020\">",
"    <span class=\"h1\">",
"     INTRAOPERATIVE GLUCOCORTICOIDS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Administration of a single, intraoperative dose of intravenous",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    to children undergoing tonsillectomy is strongly recommended in the 2011 AAO-HNS guideline [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/15\">",
"     15",
"    </a>",
"    ]. This recommendation is based upon a series of studies that have shown that the administration of a single intraoperative dose of intravenous dexamethasone in children undergoing tonsillectomy results in decreased nausea and vomiting during the first 24 hours following tonsillectomy, together with decreased time to first oral intake and decreased postoperative pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/64-69\">",
"     64-69",
"    </a>",
"    ]. The administration of dexamethasone after induction of anesthesia for prevention of postoperative nausea and vomiting was associated in one randomized trial with an increased risk of postoperative bleeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/64\">",
"     64",
"    </a>",
"    ], but three subsequent meta-analyses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/108-110\">",
"     108-110",
"    </a>",
"    ], a randomized trial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/111\">",
"     111",
"    </a>",
"    ], and a case series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/112\">",
"     112",
"    </a>",
"    ] have all called into question the existence of any such association. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Anesthesia-related'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In the three meta-analyses of randomized trials of patients undergoing tonsillectomy, there was no significant difference in the pooled relative risk of postoperative bleeding between patients receiving",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    and controls (relative risk [RR], 1.02; 95% confidence interval [CI] 0.65-1.61 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/108\">",
"     108",
"    </a>",
"    ], RR, 1.07; 95% CI 0.58-1.98 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/109\">",
"     109",
"    </a>",
"    ], and RR, 0.96; 95% CI 0.66-1.40 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/110\">",
"     110",
"    </a>",
"    ]). However, the risk of operative reintervention for hemorrhage was higher in those treated with systemic glucocorticoids than placebo (RR, 2.27; 95% CI 1.03-4.99) in the third meta-analysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/110\">",
"     110",
"    </a>",
"    ]. The randomized trial published subsequent to these meta-analyses found no difference between the dexamethasone-treated and placebo groups in the rates of clinically significant level II (required inpatient admission) or level III (required reoperation to control bleeding) postoperative hemorrhage, although a slightly higher rate of level I postoperative bleeding (self-reported or parent-reported) was seen in the dexamethasone-treated group compared with placebo [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/111\">",
"     111",
"    </a>",
"    ]. However, the small number of events in the trial limits the ability to draw firm conclusions.",
"   </p>",
"   <p>",
"    Further investigation is needed to definitively answer whether or not intraoperative systemic glucocorticoids increase the risk of postoperative hemorrhage, because of certain limitations of the existing data. Until then, clinicians should be particularly vigilant for bleeding complications in patients who have received perioperative",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    , even though the risk appears low.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h1\">",
"     POSTOPERATIVE CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most of these procedures are performed in an outpatient setting and children are discharged a few hours after surgery, provided that there are no complications. Children with complicated medical histories, a history of a recent respiratory tract infection, or who are &lt;2 to 3 years of age may be admitted overnight for observation after tonsillectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/15\">",
"     15",
"    </a>",
"    ]. Issues in postoperative care include pain relief, postoperative complications, diet, activity, and the advisability of short-term antimicrobial prophylaxis. During the first postoperative weeks, eschar is visible in the tonsillar fossae in children who have undergone tonsillectomy (",
"    <a class=\"graphic graphic_picture graphicRef54064 \" href=\"mobipreview.htm?21/63/22518\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    A randomized trial of a five-day course of postoperative oral glucocorticoids in 215 children found no effect on postoperative pain, nausea and vomiting, or return to normal function (diet, activity, sleep) in treated children compared with placebo [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/113\">",
"     113",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Pain relief",
"    </span>",
"    &nbsp;&mdash;&nbsp;For postoperative throat pain, pain on swallowing, and otalgia, pain-relieving medication should be offered freely [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/15\">",
"     15",
"    </a>",
"    ].",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?19/15/19705?source=see_link\">",
"     Acetaminophen",
"    </a>",
"    or a nonsteroidal antiinflammatory drug (NSAID) such as",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?7/48/7946?source=see_link\">",
"     ibuprofen",
"    </a>",
"    can be used for analgesia.",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?19/10/19624?source=see_link\">",
"     Aspirin",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/43/34480?source=see_link\">",
"     ketorolac",
"    </a>",
"    are contraindicated because of the risk of hemorrhage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/82\">",
"     82",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Throat pain'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H24\">",
"     'Otalgia'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/30/32230?source=see_link\">",
"     Codeine",
"    </a>",
"    has often been added on in children with inadequate pain relief. However, it is ineffective in a large portion of children due to genetic polymorphisms that affect the metabolism of the drug [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/15\">",
"     15",
"    </a>",
"    ]. In addition, a smaller portion of children may have increased conversion of codeine to",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/30/32233?source=see_link\">",
"     morphine",
"    </a>",
"    (extensive and ultrarapid-metabolizer phenotypes), which can lead to an overdose [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/114\">",
"     114",
"    </a>",
"    ]. This is a potentially greater problem in",
"    <span class=\"nowrap\">",
"     overweight/obese",
"    </span>",
"    children if dosing is based upon total body weight rather than lean mass, since there is a lower distribution of morphine to fatty tissue. Three fatalities and one near-fatal reaction were reported in children with enhanced metabolism of codeine who underwent tonsillectomy for obstructive sleep apnea and were treated with codeine postoperatively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/115,116\">",
"     115,116",
"    </a>",
"    ]. Two of these children were overweight. Determining which children are ultrarapid-metabolizers of codeine is difficult, making routine testing impractical. Thus, the US Food and Drug Administration (FDA) has added a boxed warning and contraindication for the use of codeine for postoperative pain management after tonsillectomy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    adenoidectomy in all children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/117\">",
"     117",
"    </a>",
"    ]. Morphine,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?38/23/39287?source=see_link\">",
"     oxycodone",
"    </a>",
"    , or hydrocodone are alternatives if additional analgesia is required. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/17/40217?source=see_link&amp;anchor=H4#H4\">",
"     \"Management of obstructive sleep apnea in children\", section on 'Adenotonsillectomy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Adequate hydration is also important for pain control [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h2\">",
"     Complications",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Any evidence of hemorrhage, such as the appearance of clots or fresh blood in the nose or throat (beyond slightly blood-tinged sputum or vomitus) should be considered an emergency, and the child should be brought immediately to the hospital for care. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Hemorrhage'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In children with persistent vomiting or refusal to swallow, urine output should be monitored, and evidence of dehydration should prompt consideration of outpatient or inpatient parenteral rehydration. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Throat pain'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Substantial, sustained elevation of temperature should prompt investigation of possible sources of infection, particularly in the upper and lower respiratory tracts. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Other complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hypernasality of speech and transient nasal regurgitation of liquids may result from edema affecting the innervation of the palate. No specific treatment is warranted, but if symptoms persist beyond several months, the possibility of more lasting velopharyngeal insufficiency must be considered. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Velopharyngeal'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h2\">",
"     Diet",
"    </span>",
"    &nbsp;&mdash;&nbsp;Feeding should begin with liquids, including water, grape juice, broth, and oral rehydration solutions, while avoiding acidic liquids such as citrus juices. Soft foods, such as bread, gelatin, mashed potatoes, pudding, apple sauce, soup, and soft-cooked vegetables may then be introduced gradually. In general, warm foods are better tolerated than cold foods; scratchy, hard, or spicy foods should be avoided. Children are themselves the best judges of what they can tolerate, and their wishes should be respected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h2\">",
"     Activity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Activity at home should not be restricted, but children should not participate in sports or strenuous activity for at least two weeks. School-age children who have undergone tonsillectomy should remain away from school for seven to ten days or longer if they have significant symptoms. Three to five days away from school is usually sufficient for children who have undergone adenoidectomy only. For two weeks following surgery, children should be kept away from individuals with respiratory tract infections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h2\">",
"     Antimicrobial prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antimicrobial prophylaxis at the time of, or for short periods following, tonsillectomy has been in common use, but clinical trials of its effectiveness have been few and of variable methodology and quality, and the findings have not been consistent. A Cochrane review updated in 2010 concluded that there is &ldquo;no evidence to support a consistent, clinically important impact of antibiotics in reducing the main morbid outcomes following tonsillectomy (ie pain, need for analgesia and secondary hemorrhage rates),&rdquo; but that antibiotics did appear to reduce postoperative fever [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/118\">",
"     118",
"    </a>",
"    ]. In keeping with that conclusion, the 2011 AAO-HNS guideline recommended strongly that prophylactic antibiotics not be administered or prescribed routinely for children undergoing tonsillectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/15\">",
"     15",
"    </a>",
"    ]. However, the studies reporting negative outcomes had significant limitations, including limited statistical power",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the inclusion only of adults. Moreover, certain seemingly well designed and well conducted studies in children have reported prophylaxis to be moderately effective in hastening recovery from surgery, as measured in terms of postoperative fever, pain, unpleasant mouth odor, return to normal dietary intake, and return to normal activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/22/35178/abstract/119,120\">",
"     119,120",
"    </a>",
"    ]. Accordingly, further study appears necessary to clarify whether or not, or in what circumstances, potential adverse effects of antibiotic use in children undergoing tonsillectomy may be outweighed by potential benefits. In the meantime, for decisions in such children, we suggest that individual clinician judgment is appropriate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?11/1/11282?source=see_link\">",
"       \"Patient information: Tonsillectomy and adenoidectomy in children (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41\">",
"    <span class=\"h2\">",
"     Indications and contraindications",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Obstruction and infection of the upper respiratory tract form the two major categories of indications for excision of the tonsils",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      adenoids. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Overview of indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Absolute indications for tonsillectomy",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      adenoidectomy include obstruction of the nasopharyngeal or oropharyngeal airways, interference with swallowing, malignant tumor of the tonsil or suspicion of malignancy, and uncontrollable hemorrhage from tonsillar blood vessels. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Absolute indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Conditional indications for tonsillectomy (with or without adenoidectomy) include recurrent acute throat infections, chronic tonsillitis, tonsillar obstruction that alters voice quality, the syndrome of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA syndrome), halitosis, peritonsillar abscess, and chronic carriage of group A beta-hemolytic Streptococci. Decisions regarding tonsillectomy",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      adenoidectomy in children with conditional indications should be made on a case-by-case basis. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Tonsillectomy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'General considerations'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/11/8377?source=see_link&amp;anchor=H16#H16\">",
"       \"Periodic fever with aphthous stomatitis, pharyngitis and adenitis (PFAPA syndrome)\", section on 'Treatment'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Tonsillectomy provides moderate benefits for children with recurrent throat infection who are severely affected (as defined above) when compared with symptomatic care and antimicrobial treatment (as indicated). Decisions regarding tonsillectomy in such patients should be made on a case-by-case basis. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Recurrent infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We do not suggest tonsillectomy for children who are mildly or moderately affected (",
"      <a class=\"grade\" href=\"._grade_4?title=Grade 2A\">",
"       Grade 2A",
"      </a>",
"      ). For such children, the benefits of surgery, if any, are modest and outweighed by the potential risks. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Recurrent infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Conditional indications for adenoidectomy in children include moderate nasal obstruction with persistent symptoms; recurrent acute otitis media (AOM) or chronic otitis media with effusion (OME) in children who have undergone tympanostomy-tube insertion and whose tubes have been extruded; and chronic sinusitis that has failed to respond to sustained antimicrobial treatment. Decisions regarding elective adenoidectomy should be individualized according to the potential benefits and risks and the values and preferences of the family and child. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Adenoidectomy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'General considerations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that children with symptoms of moderate nasal obstruction (mouth breathing, hyponasal speech, impaired olfaction) and objective evidence of adenoid hypertrophy be given a trial course of antibiotics for one month and nasal glucocorticoids for up to six months if prompt initial improvement is seen (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). We suggest adenoidectomy for those children with moderate nasal obstruction whose obstructive symptoms have been present for a substantial period and have not responded adequately to conservative measures (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Nasal obstruction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest adenoidectomy for children with recurrent AOM or chronic OME who have previously undergone tympanostomy-tube insertion and whose tubes have been extruded (",
"      <a class=\"grade\" href=\"._grade_4?title=Grade 2A\">",
"       Grade 2A",
"      </a>",
"      ). We do not suggest adenoidectomy for children with recurrent AOM or chronic OME who have not undergone tympanostomy-tube insertion (",
"      <a class=\"grade\" href=\"._grade_4?title=Grade 2A\">",
"       Grade 2A",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Otitis media'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/54/42857?source=see_link&amp;anchor=H25#H25\">",
"       \"Acute otitis media in children: Prevention of recurrence\", section on 'Adenoidectomy or adenotonsillectomy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We suggest adenoidectomy for children with chronic sinusitis that has not responded adequately to vigorous medical treatment (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). The efficacy of adenoidectomy in such children is variable. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Chronic sinusitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are three general categories of contraindications to tonsillectomy",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      adenoidectomy: velopharyngeal, hematologic, infectious. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Contraindications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42\">",
"    <span class=\"h2\">",
"     Complications",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bleeding requiring blood transfusion or additional surgery is the most common serious complication of tonsillectomy",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      adenoidectomy; it occurs in approximately 2 to 4 percent of cases. The need for transfusion is uncommon. Less common serious complications include adverse reactions to anesthesia, velopharyngeal insufficiency, and upper airway obstruction. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Complications and adverse effects'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Postoperative bleeding usually occurs within the first 24 hours following surgery or between 7 and 10 days after surgery. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Hemorrhage'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H43\">",
"    <span class=\"h2\">",
"     Decision-making",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Decisions regarding elective tonsillectomy",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      adenoidectomy should be individualized according to the potential benefits and risks and the values and preferences of the family and child. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Tonsillectomy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H10\">",
"       'Adenoidectomy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'General considerations'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Kaiser AD. Children's tonsils in or out, Lippincott Company, Philadelphia 1932. p.8.",
"    </li>",
"    <li>",
"     TEC Jr. Dr. S. Josephine Baker and the tonsil and adenoid riot at a New York City public school about 1920. file://pediatrics.aappublications.org/content/62/4/559 (Accessed on June 12, 2011).",
"    </li>",
"    <li>",
"     Klass P. A tonsil remedy is fitted for a new century. file://www.nytimes.com/2011/04/12/health/12klass.html?scp=3&amp;sq=tonsillectomy&amp;st=cse (Accessed on June 12, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/4\">",
"      Van Den Akker EH, Hoes AW, Burton MJ, Schilder AG. Large international differences in (adeno)tonsillectomy rates. Clin Otolaryngol Allied Sci 2004; 29:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/5\">",
"      Blair RL, McKerrow WS, Carter NW, Fenton A. The Scottish tonsillectomy audit. Audit Sub-Committee of the Scottish Otolaryngological Society. J Laryngol Otol 1996; 110 Suppl 20:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/6\">",
"      Boss EF, Marsteller JA, Simon AE. Outpatient tonsillectomy in children: demographic and geographic variation in the United States, 2006. J Pediatr 2012; 160:814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/7\">",
"      Capper R, Canter RJ. Is there agreement among general practitioners, paediatricians and otolaryngologists about the management of children with recurrent tonsillitis? Clin Otolaryngol Allied Sci 2001; 26:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/8\">",
"      Lock C, Wilson J, Steen N, et al. Childhood tonsillectomy: who is referred and what treatment choices are made? Baseline findings from the North of England and Scotland Study of Tonsillectomy and Adenotonsillectomy in Children (NESSTAC). Arch Dis Child 2010; 95:203.",
"     </a>",
"    </li>",
"    <li>",
"     2000 Clinical Indicators Compendium. file://www.entlink.net/practice/products/indicators/tonsillectomy.html (Accessed on June 02, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/10\">",
"      Cullen KA, Hall MJ, Golosinskiy A. Ambulatory surgery in the United States, 2006. Natl Health Stat Report 2009; :1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/11\">",
"      Erickson BK, Larson DR, St Sauver JL, et al. Changes in incidence and indications of tonsillectomy and adenotonsillectomy, 1970-2005. Otolaryngol Head Neck Surg 2009; 140:894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/12\">",
"      Bhattacharyya N, Lin HW. Changes and consistencies in the epidemiology of pediatric adenotonsillar surgery, 1996-2006. Otolaryngol Head Neck Surg 2010; 143:680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/13\">",
"      Clayburgh D, Milczuk H, Gorsek S, et al. Efficacy of tonsillectomy for pediatric patients with Dysphagia and tonsillar hypertrophy. Arch Otolaryngol Head Neck Surg 2011; 137:1197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/14\">",
"      Roland PS, Rosenfeld RM, Brooks LJ, et al. Clinical practice guideline: Polysomnography for sleep-disordered breathing prior to tonsillectomy in children. Otolaryngol Head Neck Surg 2011; 145:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/15\">",
"      Baugh RF, Archer SM, Mitchell RB, et al. Clinical practice guideline: tonsillectomy in children. Otolaryngol Head Neck Surg 2011; 144:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/16\">",
"      Paradise JL, Bluestone CD, Bachman RZ, et al. History of recurrent sore throat as an indication for tonsillectomy. Predictive limitations of histories that are undocumented. N Engl J Med 1978; 298:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/17\">",
"      Paradise JL, Bluestone CD, Bachman RZ, et al. Efficacy of tonsillectomy for recurrent throat infection in severely affected children. Results of parallel randomized and nonrandomized clinical trials. N Engl J Med 1984; 310:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/18\">",
"      Paradise JL, Bluestone CD, Colborn DK, et al. Tonsillectomy and adenotonsillectomy for recurrent throat infection in moderately affected children. Pediatrics 2002; 110:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/19\">",
"      Bluestone CD. Current indications for tonsillectomy and adenoidectomy. Ann Otol Rhinol Laryngol Suppl 1992; 155:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/20\">",
"      Deutsch ES. Tonsillectomy and adenoidectomy. Changing indications. Pediatr Clin North Am 1996; 43:1319.",
"     </a>",
"    </li>",
"    <li>",
"     Group A streptococcal infections. In: Red book: 2009 report of the committee on infectious diseases, 28th ed, Pickering LK (Ed), American Academy of Pediatrics, Elk Grove Village 2009. p.616.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/22\">",
"      Ghorbanian SN, Paradise JL, Doty RL. Odor perception in children in relation to nasal obstruction. Pediatrics 1983; 72:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/23\">",
"      Sclafani AP, Ginsburg J, Shah MK, Dolitsky JN. Treatment of symptomatic chronic adenotonsillar hypertrophy with amoxicillin/clavulanate potassium: short- and long-term results. Pediatrics 1998; 101:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/24\">",
"      Demain JG, Goetz DW. Pediatric adenoidal hypertrophy and nasal airway obstruction: reduction with aqueous nasal beclomethasone. Pediatrics 1995; 95:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/25\">",
"      Criscuoli G, D'Amora S, Ripa G, et al. Frequency of surgery among children who have adenotonsillar hypertrophy and improve after treatment with nasal beclomethasone. Pediatrics 2003; 111:e236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/26\">",
"      Ciprandi G, Varricchio A, Capasso M, et al. Intranasal flunisolide treatment in children with adenoidal hypertrophy. Int J Immunopathol Pharmacol 2007; 20:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/27\">",
"      Zhang L, Mendoza-Sassi RA, C&eacute;sar JA, Chadha NK. Intranasal corticosteroids for nasal airway obstruction in children with moderate to severe adenoidal hypertrophy. Cochrane Database Syst Rev 2008; :CD006286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/28\">",
"      Chadha NK, Zhang L, Mendoza-Sassi RA, C&eacute;sar JA. Using nasal steroids to treat nasal obstruction caused by adenoid hypertrophy: does it work? Otolaryngol Head Neck Surg 2009; 140:139.",
"     </a>",
"    </li>",
"    <li>",
"     Paradise JL, Bluestone CD, Carrasco NM. Nasal obstruction due to adenoid hypertrophy two year course with and without adenoidectomy. Abstracts. 18th Annual Meeting of the Ambulatory Pediatric Assoication, New York City, April 25, 1978. p.43.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/30\">",
"      Joshua B, Bahar G, Sulkes J, et al. Adenoidectomy: long-term follow-up. Otolaryngol Head Neck Surg 2006; 135:576.",
"     </a>",
"    </li>",
"    <li>",
"     Solow B. Upper airway obstruction and facial development. In: The biological mechanisms of tooth movement and craniofacial adaptation, Davidovitch Z (Ed), The Ohio State University College of Dentistry, Columbus 1992. p.571.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/32\">",
"      Linder-Aronson S. Adenoids. Their effect on mode of breathing and nasal airflow and their relationship to characteristics of the facial skeleton and the denition. A biometric, rhino-manometric and cephalometro-radiographic study on children with and without adenoids. Acta Otolaryngol Suppl 1970; 265:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/33\">",
"      Linder-Aronson S. Effects of adenoidectomy on dentition and nasopharynx. Trans Eur Orthod Soc 1972; :177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/34\">",
"      Oulis CJ, Vadiakas GP, Ekonomides J, Dratsa J. The effect of hypertrophic adenoids and tonsils on the development of posterior crossbite and oral habits. J Clin Pediatr Dent 1994; 18:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/35\">",
"      Linder-Aronson S, Woodside DG, Hellsing E, Emerson W. Normalization of incisor position after adenoidectomy. Am J Orthod Dentofacial Orthop 1993; 103:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/36\">",
"      Ramadan HH, Tiu J. Failures of adenoidectomy for chronic rhinosinusitis in children: for whom and when do they fail? Laryngoscope 2007; 117:1080.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/37\">",
"      Ramadan HH. Surgical management of chronic sinusitis in children. Laryngoscope 2004; 114:2103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/38\">",
"      Don DM, Yellon RF, Casselbrant ML, Bluestone CD. Efficacy of a stepwise protocol that includes intravenous antibiotic therapy for the management of chronic sinusitis in children and adolescents. Arch Otolaryngol Head Neck Surg 2001; 127:1093.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/39\">",
"      Vandenberg SJ, Heatley DG. Efficacy of adenoidectomy in relieving symptoms of chronic sinusitis in children. Arch Otolaryngol Head Neck Surg 1997; 123:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/40\">",
"      Felisati G, Ramadan H. Rhinosinusitis in children: the role of surgery. Pediatr Allergy Immunol 2007; 18 Suppl 18:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/41\">",
"      Brietzke SE, Brigger MT. Adenoidectomy outcomes in pediatric rhinosinusitis: a meta-analysis. Int J Pediatr Otorhinolaryngol 2008; 72:1541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/42\">",
"      Buchman CA, Yellon RF, Bluestone CD. Alternative to endoscopic sinus surgery in the management of pediatric chronic rhinosinusitis refractory to oral antimicrobial therapy. Otolaryngol Head Neck Surg 1999; 120:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/43\">",
"      Lieser JD, Derkay CS. Pediatric sinusitis: when do we operate? Curr Opin Otolaryngol Head Neck Surg 2005; 13:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/44\">",
"      Cowan MJ, Gladwin MT, Shelhamer JH. Disorders of ciliary motility. Am J Med Sci 2001; 321:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/45\">",
"      Polmar SH. The role of the immunologist in sinus disease. J Allergy Clin Immunol 1992; 90:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/46\">",
"      Gates GA, Avery CA, Prihoda TJ, Cooper JC Jr. Effectiveness of adenoidectomy and tympanostomy tubes in the treatment of chronic otitis media with effusion. N Engl J Med 1987; 317:1444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/47\">",
"      Paradise JL, Bluestone CD, Rogers KD, et al. Efficacy of adenoidectomy for recurrent otitis media in children previously treated with tympanostomy-tube placement. Results of parallel randomized and nonrandomized trials. JAMA 1990; 263:2066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/48\">",
"      Paradise JL, Bluestone CD, Colborn DK, et al. Adenoidectomy and adenotonsillectomy for recurrent acute otitis media: parallel randomized clinical trials in children not previously treated with tympanostomy tubes. JAMA 1999; 282:945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/49\">",
"      Hammar&eacute;n-Malmi S, Saxen H, Tarkkanen J, Mattila PS. Adenoidectomy does not significantly reduce the incidence of otitis media in conjunction with the insertion of tympanostomy tubes in children who are younger than 4 years: a randomized trial. Pediatrics 2005; 116:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/50\">",
"      Rosenfeld RM. Surgical prevention of otitis media. Vaccine 2000; 19 Suppl 1:S134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/51\">",
"      Smith BE, Kuehn DP. Speech evaluation of velopharyngeal dysfunction. J Craniofac Surg 2007; 18:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/52\">",
"      Burk CD, Miller L, Handler SD, Cohen AR. Preoperative history and coagulation screening in children undergoing tonsillectomy. Pediatrics 1992; 89:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/53\">",
"      Asaf T, Reuveni H, Yermiahu T, et al. The need for routine pre-operative coagulation screening tests (prothrombin time PT/partial thromboplastin time PTT) for healthy children undergoing elective tonsillectomy and/or adenoidectomy. Int J Pediatr Otorhinolaryngol 2001; 61:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/54\">",
"      Krishna P, Lee D. Post-tonsillectomy bleeding: a meta-analysis. Laryngoscope 2001; 111:1358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/55\">",
"      Schmidt R, Herzog A, Cook S, et al. Complications of tonsillectomy: a comparison of techniques. Arch Otolaryngol Head Neck Surg 2007; 133:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/56\">",
"      Solares CA, Koempel JA, Hirose K, et al. Safety and efficacy of powered intracapsular tonsillectomy in children: a multi-center retrospective case series. Int J Pediatr Otorhinolaryngol 2005; 69:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/57\">",
"      Ferreira RF, Serapiao CJ, Ferreira AP, et al. Cost and outcomes after cold and mixed adenotonsillectomy in children. Laryngoscope 2010; 120:2301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/58\">",
"      Colclasure JB, Graham SS. Complications of outpatient tonsillectomy and adenoidectomy: a review of 3,340 cases. Ear Nose Throat J 1990; 69:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/59\">",
"      Granell J, Gete P, Villafruela M, et al. Safety of outpatient tonsillectomy in children: a review of 6 years in a tertiary hospital experience. Otolaryngol Head Neck Surg 2004; 131:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/60\">",
"      Liu JH, Anderson KE, Willging JP, et al. Posttonsillectomy hemorrhage: what is it and what should be recorded? Arch Otolaryngol Head Neck Surg 2001; 127:1271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/61\">",
"      Nafiu OO, Green GE, Walton S, et al. Obesity and risk of peri-operative complications in children presenting for adenotonsillectomy. Int J Pediatr Otorhinolaryngol 2009; 73:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/62\">",
"      Jaryszak EM, Shah RK, Vanison CC, et al. Polysomnographic variables predictive of adverse respiratory events after pediatric adenotonsillectomy. Arch Otolaryngol Head Neck Surg 2011; 137:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/63\">",
"      Johnson LB, Elluru RG, Myer CM 3rd. Complications of adenotonsillectomy. Laryngoscope 2002; 112:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/64\">",
"      Czarnetzki C, Elia N, Lysakowski C, et al. Dexamethasone and risk of nausea and vomiting and postoperative bleeding after tonsillectomy in children: a randomized trial. JAMA 2008; 300:2621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/65\">",
"      Splinter WM, Roberts DJ. Dexamethasone decreases vomiting by children after tonsillectomy. Anesth Analg 1996; 83:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/66\">",
"      April MM, Callan ND, Nowak DM, Hausdorff MA. The effect of intravenous dexamethasone in pediatric adenotonsillectomy. Arch Otolaryngol Head Neck Surg 1996; 122:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/67\">",
"      Tom LW, Templeton JJ, Thompson ME, Marsh RR. Dexamethasone in adenotonsillectomy. Int J Pediatr Otorhinolaryngol 1996; 37:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/68\">",
"      Pappas AL, Sukhani R, Hotaling AJ, et al. The effect of preoperative dexamethasone on the immediate and delayed postoperative morbidity in children undergoing adenotonsillectomy. Anesth Analg 1998; 87:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/69\">",
"      Fazel MR, Yegane-Moghaddam A, Forghani Z, et al. The effect of dexamethasone on postoperative vomiting and oral intake after adenotonsillectomy. Int J Pediatr Otorhinolaryngol 2007; 71:1235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/70\">",
"      Michaloudis D, Fraidakis O, Petrou A, et al. Anaesthesia and the QT interval. Effects of isoflurane and halothane in unpremedicated children. Anaesthesia 1998; 53:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/71\">",
"      Aypar E, Karagoz AH, Ozer S, et al. The effects of sevoflurane and desflurane anesthesia on QTc interval and cardiac rhythm in children. Paediatr Anaesth 2007; 17:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/72\">",
"      Randall DA, Hoffer ME. Complications of tonsillectomy and adenoidectomy. Otolaryngol Head Neck Surg 1998; 118:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/73\">",
"      Jones DT, Yoon MJ, Licameli G. Effectiveness of postoperative follow-up telephone interviews for patients who underwent adenotonsillectomy: a retrospective study. Arch Otolaryngol Head Neck Surg 2007; 133:1091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/74\">",
"      Kain ZN, Mayes LC, Caldwell-Andrews AA, et al. Preoperative anxiety, postoperative pain, and behavioral recovery in young children undergoing surgery. Pediatrics 2006; 118:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/75\">",
"      Collison PJ, Mettler B. Factors associated with post-tonsillectomy hemorrhage. Ear Nose Throat J 2000; 79:640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/76\">",
"      Ahmed K, McCormick MS, Baruah AK. Day-case adenoidectomy--is it safe? Clin Otolaryngol Allied Sci 1993; 18:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/77\">",
"      Tomkinson A, Harrison W, Owens D, et al. Postoperative hemorrhage following adenoidectomy. Laryngoscope 2012; 122:1246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/78\">",
"      M&oslash;iniche S, R&oslash;msing J, Dahl JB, Tram&egrave;r MR. Nonsteroidal antiinflammatory drugs and the risk of operative site bleeding after tonsillectomy: a quantitative systematic review. Anesth Analg 2003; 96:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/79\">",
"      Cardwell M, Siviter G, Smith A. Non-steroidal anti-inflammatory drugs and perioperative bleeding in paediatric tonsillectomy. Cochrane Database Syst Rev 2005; :CD003591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/80\">",
"      Judkins JH, Dray TG, Hubbell RN. Intraoperative ketorolac and posttonsillectomy bleeding. Arch Otolaryngol Head Neck Surg 1996; 122:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/81\">",
"      Splinter WM, Rhine EJ, Roberts DW, et al. Preoperative ketorolac increases bleeding after tonsillectomy in children. Can J Anaesth 1996; 43:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/82\">",
"      Jeyakumar A, Brickman TM, Williamson ME, et al. Nonsteroidal anti-inflammatory drugs and postoperative bleeding following adenotonsillectomy in pediatric patients. Arch Otolaryngol Head Neck Surg 2008; 134:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/83\">",
"      Tom LW, DeDio RM, Cohen DE, et al. Is outpatient tonsillectomy appropriate for young children? Laryngoscope 1992; 102:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/84\">",
"      Rosen GM, Muckle RP, Mahowald MW, et al. Postoperative respiratory compromise in children with obstructive sleep apnea syndrome: can it be anticipated? Pediatrics 1994; 93:784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/85\">",
"      Witzel MA, Rich RH, Margar-Bacal F, Cox C. Velopharyngeal insufficiency after adenoidectomy: an 8-year review. Int J Pediatr Otorhinolaryngol 1986; 11:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/86\">",
"      Hopkins A, Lahiri T, Salerno R, Heath B. Changing epidemiology of life-threatening upper airway infections: the reemergence of bacterial tracheitis. Pediatrics 2006; 118:1418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/87\">",
"      Eid NS, Jones VF. Bacterial tracheitis as a complication of tonsillectomy and adenoidectomy. J Pediatr 1994; 125:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/88\">",
"      McKee WJ. The part played by adenoidectomy in the combined operation of tonsillectomy with adenoidectomy. Second part of a controlled study in children. Br J Prev Soc Med 1963; 17:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/89\">",
"      Cohen D, Dor M. Morbidity and mortality of post-tonsillectomy bleeding: analysis of cases. J Laryngol Otol 2008; 122:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/90\">",
"      Cotton RT. Nasopharyngeal stenosis. Arch Otolaryngol 1985; 111:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/91\">",
"      Giannoni C, Sulek M, Friedman EM, Duncan NO 3rd. Acquired nasopharyngeal stenosis: a warning and review. Arch Otolaryngol Head Neck Surg 1998; 124:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/92\">",
"      Derkay CS, Kenna MA, Pang D. Refractory torticollis: an uncommon complication of adenotonsillectomy. Int J Pediatr Otorhinolaryngol 1987; 14:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/93\">",
"      Rowlands JK. Head and neck swelling after tonsillectomy. Anaesth Intensive Care 1985; 13:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/94\">",
"      Yammine NV, Alherabi A, Gerin-Lajoie J. Post-tonsillectomy subcutaneous emphysema and pneumomediastinum. J Otolaryngol 2004; 33:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/95\">",
"      Wraige E, Ganesan V, Pohl KR. Arterial dissection complicating tonsillectomy. Dev Med Child Neurol 2003; 45:638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/96\">",
"      Carvalho KS, Edwards-Brown M, Golomb MR. Carotid dissection and stroke after tonsillectomy and adenoidectomy. Pediatr Neurol 2007; 37:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/97\">",
"      Simonsen AR, Duncavage JA, Becker SS. A review of malpractice cases after tonsillectomy and adenoidectomy. Int J Pediatr Otorhinolaryngol 2010; 74:977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/98\">",
"      Sainz M, Gutierrez F, Moreno PM, et al. Changes in immunologic response in tonsillectomized children. I. Immunosuppression in recurrent tonsillitis. Clin Otolaryngol Allied Sci 1992; 17:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/99\">",
"      van den Akker EH, Sanders EA, van Staaij BK, et al. Long-term effects of pediatric adenotonsillectomy on serum immunoglobulin levels: results of a randomized controlled trial. Ann Allergy Asthma Immunol 2006; 97:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/100\">",
"      Ikincioullari A, Dou F, ikincioullari A, et al. Is immune system influenced by adenotonsillectomy in children? Int J Pediatr Otorhinolaryngol 2002; 66:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/101\">",
"      Paulussen C, Claes J, Claes G, Jorissen M. Adenoids and tonsils, indications for surgery and immunological consequences of surgery. Acta Otorhinolaryngol Belg 2000; 54:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/102\">",
"      Friday GA Jr, Paradise JL, Rabin BS, et al. Serum immunoglobulin changes in relation to tonsil and adenoid surgery. Ann Allergy 1992; 69:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/103\">",
"      Mutz I, Simon H. [Hemorrhagic complications after tonsillectomy and adenoidectomy. Experiences with 7,743 operations in 14 years]. Wien Klin Wochenschr 1993; 105:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/104\">",
"      Manning SC, Beste D, McBride T, Goldberg A. An assessment of preoperative coagulation screening for tonsillectomy and adenoidectomy. Int J Pediatr Otorhinolaryngol 1987; 13:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/105\">",
"      Howells RC 2nd, Wax MK, Ramadan HH. Value of preoperative prothrombin time/partial thromboplastin time as a predictor of postoperative hemorrhage in pediatric patients undergoing tonsillectomy. Otolaryngol Head Neck Surg 1997; 117:628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/106\">",
"      Harley EH, Collins MD. Neurologic sequelae secondary to atlantoaxial instability in Down syndrome. Implications in otolaryngologic surgery. Arch Otolaryngol Head Neck Surg 1994; 120:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/107\">",
"      Onerci M, Ogretmenoglu O, Ozcan OE. Atlantoaxial subluxation after tonsillectomy and adenoidectomy. Otolaryngol Head Neck Surg 1997; 116:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/108\">",
"      Geva A, Brigger MT. Dexamethasone and tonsillectomy bleeding: a meta-analysis. Otolaryngol Head Neck Surg 2011; 144:838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/109\">",
"      Shargorodsky J, Hartnick CJ, Lee GS. Dexamethasone and postoperative bleeding after tonsillectomy and adenotonsillectomy in children: A meta-analysis of prospective studies. Laryngoscope 2012; 122:1158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/110\">",
"      Plante J, Turgeon AF, Zarychanski R, et al. Effect of systemic steroids on post-tonsillectomy bleeding and reinterventions: systematic review and meta-analysis of randomised controlled trials. BMJ 2012; 345:e5389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/111\">",
"      Gallagher TQ, Hill C, Ojha S, et al. Perioperative dexamethasone administration and risk of bleeding following tonsillectomy in children: a randomized controlled trial. JAMA 2012; 308:1221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/112\">",
"      Ahmed KA, Dreher ME, King RF, et al. Dexamethasone and postoperative bleeding risk after adenotonsillectomy in children. Laryngoscope 2011; 121:1060.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/113\">",
"      Macassey E, Dawes P, Taylor B, Gray A. The effect of a postoperative course of oral prednisone on postoperative morbidity following childhood tonsillectomy. Otolaryngol Head Neck Surg 2012; 147:551.",
"     </a>",
"    </li>",
"    <li>",
"     Codeine Use in Certain Children After Tonsillectomy and/or Adenoidectomy: Drug Safety Communication - Risk of Rare, But Life-Threatening Adverse Events or Death file://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm315627.htm (Accessed on August 15, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/115\">",
"      Ciszkowski C, Madadi P, Phillips MS, et al. Codeine, ultrarapid-metabolism genotype, and postoperative death. N Engl J Med 2009; 361:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/116\">",
"      Kelly LE, Rieder M, van den Anker J, et al. More codeine fatalities after tonsillectomy in North American children. Pediatrics 2012; 129:e1343.",
"     </a>",
"    </li>",
"    <li>",
"     FDA Drug Safety Communication: Safety review update of codeine use in children; new Boxed Warning and Contraindication on use after tonsillectomy and/or adenoidectomy. file://www.fda.gov/Drugs/DrugSafety/ucm339112.htm (Accessed on February 27, 2013).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/118\">",
"      Dhiwakar M, Clement WA, Supriya M, McKerrow W. Antibiotics to reduce post-tonsillectomy morbidity. Cochrane Database Syst Rev 2010; :CD005607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/119\">",
"      Telian SA, Handler SD, Fleisher GR, et al. The effect of antibiotic therapy on recovery after tonsillectomy in children. A controlled study. Arch Otolaryngol Head Neck Surg 1986; 112:610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/22/35178/abstract/120\">",
"      Colreavy MP, Nanan D, Benamer M, et al. Antibiotic prophylaxis post-tonsillectomy: is it of benefit? Int J Pediatr Otorhinolaryngol 1999; 50:15.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6296 Version 20.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-61.234.146.186-A1F0AAE071-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_22_35178=[""].join("\n");
var outline_f34_22_35178=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H40\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      OVERVIEW OF INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ABSOLUTE INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CONDITIONAL INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Tonsillectomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Recurrent infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H3046050\">",
"      Severely affected children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H3046057\">",
"      Moderately affected children",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - PFAPA syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Other indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Adenoidectomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Nasal obstruction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Chronic sinusitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Otitis media",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      General considerations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Special circumstances",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      CONTRAINDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Velopharyngeal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Hematologic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Infectious",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      COMPLICATIONS AND ADVERSE EFFECTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Anesthesia-related",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Postoperative",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Throat pain",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Otalgia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Emotional upset",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Other complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H3046116\">",
"      Rare complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Immunologic risks",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Mortality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Cost",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      PREOPERATIVE PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Medical evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Emotional",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11436020\">",
"      INTRAOPERATIVE GLUCOCORTICOIDS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      POSTOPERATIVE CARE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Pain relief",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      Complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      Diet",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      Activity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      Antimicrobial prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H41\">",
"      Indications and contraindications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H42\">",
"      Complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H43\">",
"      Decision-making",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/6296\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/6296|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?21/63/22518\" title=\"picture 1\">",
"      Tonsillectomy post-op",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/26/8616?source=related_link\">",
"      Acquired torticollis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/54/42857?source=related_link\">",
"      Acute otitis media in children: Prevention of recurrence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/30/13801?source=related_link\">",
"      Anatomy and etiology of taste and smell disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/38/6758?source=related_link\">",
"      Antibiotic failure in the treatment of streptococcal tonsillopharyngitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/47/30458?source=related_link\">",
"      Approach to the child with recurrent infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/32/43527?source=related_link\">",
"      Bad breath",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/9/2202?source=related_link\">",
"      Clinical features of congenital long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/17/36119?source=related_link\">",
"      Cor pulmonale",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/44/16072?source=related_link\">",
"      Etiologies of nasal symptoms: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/57/21399?source=related_link\">",
"      Etiology of speech and language disorders in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/38/44649?source=related_link\">",
"      Evaluation of suspected obstructive sleep apnea in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/13/32984?source=related_link\">",
"      Malignant hyperthermia: Clinical diagnosis and management of acute crisis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/17/40217?source=related_link\">",
"      Management of obstructive sleep apnea in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/56/3978?source=related_link\">",
"      Overview of tympanostomy tube placement and medical care of children with tympanostomy tubes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?11/1/11282?source=related_link\">",
"      Patient information: Tonsillectomy and adenoidectomy in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/11/8377?source=related_link\">",
"      Periodic fever with aphthous stomatitis, pharyngitis and adenitis (PFAPA syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/61/31705?source=related_link\">",
"      Peritonsillar cellulitis and abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/37/9817?source=related_link\">",
"      Primary ciliary dyskinesia (immotile-cilia syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/37/27224?source=related_link\">",
"      Symptomatic relief of sore throat in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/59/11194?source=related_link\">",
"      The pediatric physical examination: HEENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/38/2666?source=related_link\">",
"      Treatment and prevention of streptococcal tonsillopharyngitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_22_35179="Clinical predictors of increased perioperative risk among pts";
var content_f34_22_35179=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F69468&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F69468&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical predictors of increased perioperative risk among dialysis patients",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Major clinical predictors of risk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Unstable coronary syndromes (recent myocardial infarction, and unstable or severe angina)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Significant arrhythmias",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Decompensated heart failure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Severe valvular disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Intermediate clinical predictors of risk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mild angina pectoris",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prior myocardial infarction by history or pathological Q waves",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Compensated or prior heart failure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diabetes mellitus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Peripheral vascular disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Minor clinical predictors of risk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Advanced age",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abnormal ECG (left ventricular hypertrophy, left bundle branch block, ST-T wave abnormalities)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rhythm other than sinus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Low functional status",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        History of stroke",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Uncontrolled systolic hypertension",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: ACC/AHA task force guidelines published in Eagle K, Brundage B, Chaitman B, et al, J Am Coll Cardiol 1996; 27:910.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_22_35179=[""].join("\n");
var outline_f34_22_35179=null;
var title_f34_22_35180="Chronic postsurg pain synd";
var content_f34_22_35180=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F70349&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F70349&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Chronic post-surgical pain syndromes in cancer patients",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Syndrome",
"      </td>",
"      <td class=\"subtitle1\">",
"       Characteristics",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"3\">",
"       Post-mastectomy pain syndrome",
"      </td>",
"      <td>",
"       Dull, burning, and aching pain experienced over the axilla, anterior chest wall and medial upper arm, associated with sensory loss and sometimes phantom sensations",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       May be accompanied by dysesthesia, allodynia, and scar sensitivity",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pain can start acutely post-surgery and persist, or onset may occur many months or years after surgery",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"3\">",
"       Post-radical neck dissection pain",
"      </td>",
"      <td>",
"       Often neuropathic and described as a burning or lancinating dysesthesias in the anterolateral neck extending to the shoulder; reflects injury to the cervical plexus",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Often accompanied by sensory loss",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       May experience neck and shoulder pain weeks to months after surgery",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Post-thoracotomy pain",
"      </td>",
"      <td>",
"       Neuropathic pain localized to the region of the thoracotomy scar, experienced months post-surgery; when recurrent rather than persistent, high suspicion for tumor regrowth",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pain described as aching or burning; potentially associated with sensory and autonomic changes; may be accompanied by ipsilateral arm disability",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Postoperative frozen shoulder",
"      </td>",
"      <td>",
"       Limited shoulder range of motion usually caused by untreated thoracotomy pain and inadequate rehabilitation",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Post-surgery pelvic floor pain",
"      </td>",
"      <td>",
"       Resembles the idiopathic syndrome of tension myalgia of the pelvic floor, with pain that occurs on standing",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"3\">",
"       Stump pain",
"      </td>",
"      <td>",
"       Neuropathic pain, described as burning, experienced at the site of a surgical scar several months to years post-amputation",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pain may be exacerbated by movement and is secondary to neuroma formation in the region of amputation",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       May be improved or exacerbated by wearing of a prosthesis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"3\">",
"       Phantom limb pain",
"      </td>",
"      <td>",
"       Site of pain is away from amputation scar and appears to be where the absent limb was located",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pain is dysesthetic, often fluctuating",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       May or may not be associated with phantom sensations, including nonspecific paresthesia and specific sensations of the limb, with or without distortions",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"4\">",
"       Phantom pain",
"      </td>",
"      <td>",
"       Phantom breast pain following mastectomy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Phantom pelvic pain following hemipelvectomy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Phantom rectal pain following rectal cancer surgery",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Phantom eye pain in patients with eye enucleation",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_22_35180=[""].join("\n");
var outline_f34_22_35180=null;
var title_f34_22_35181="Misoprostol-only protocol";
var content_f34_22_35181=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F60845&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F60845&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Misoprostol-only protocol for medical termination of pregnancy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"3\">",
"        Contraindications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        Suspected or confirmed ectopic pregnancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        Gestational trophoblastic disease (GTD)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        High risk of uterine rupture (more than one prior hysterotomy, a prior classical or T-shaped uterine incision, or extensive transfundal uterine surgery [eg, myomectomy])",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        Pregnancy - intrauterine device (IUD; must be removed before misoprostol is administered)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        Allergy to prostaglandins",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        Other contraindications to medical or surgical uterine evacuations (eg, hemodynamically unstable, coagulopathy)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"3\">",
"        Relative contraindications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        Moderate risk of uterine rupture (one prior low transverse or low vertical hysterotomy, multigravidity, or uterine anomaly)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        Breastfeeding (women should be counseled to pump and discard all milk produced within 5 hours after each dose)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"3\">",
"        Pretreatment evaluation and preparation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        Medical history and physical examination",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        Confirmation of pregnancy, gestational age, pregnancy location, and absence of GTD (via history and physical with serum or urine human chorionic gonadotropin testing and/or transvaginal ultrasound)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        Complete blood count",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        Blood group and Rh(D) typing; give anti Rh(D) immune globulin 300 mcg IM, if indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        Remove IUD, if present",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"3\">",
"        Treatment effects and patient counseling",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"3\">",
"        Bleeding - usually commences within 24 hours, lasting 7 to 10 days. Women should be counseled about bleeding and to call or return to the clinic for the following:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"3\">",
"        &bull; 48 hours have passed and bleeding has been less than a normal menstrual period",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"3\">",
"        &bull; Soaks more than 2 pads per hour for 2 consecutive hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"3\">",
"        &bull; Bleeding persists for more than 2 weeks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"3\">",
"        &bull; Heavy bleeding recurs 2 or more weeks after treatment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\" colspan=\"3\">",
"        &bull; Feels dizzy or lightheaded",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        Cramping and pain - symptoms are often more intense than a menstrual period. Non-steroidal inflammatory medications or other analgesia can be used without decreasing treatment effectiveness. Women should be instructed to call if pain greatly exceeds menstrual cramps and/or persists after products of conception have been expelled or &ge;24 hours after last misoprostol dose. Women with severe or persistent pain should be evaluated for uterine rupture, particularly if risk factors are present.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        Chills and fever - common, but generally transient. Women should be instructed to call if a temperature of &ge;100.4&deg;F (&ge;38&deg;C) persists for &ge;24 hours after taking misoprostol.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        Diarrhea, nausea and vomiting - misoprostol may exacerbate pregnancy-related nausea or vomiting and may cause diarrhea; symptoms are generally transient. Anti-emetic or -diarrheal medications can be given. Women should be instructed to call if symptoms persist for 48 hours or more after last dose.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Gestational age, weeks of amenorrhea",
"       </td>",
"       <td class=\"subtitle1\">",
"        Treatment location",
"       </td>",
"       <td class=\"subtitle1\">",
"        Misoprostol regimen",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Clinical regimen",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        &le;9",
"       </td>",
"       <td>",
"        Home or clinic",
"       </td>",
"       <td>",
"        <p>",
"         800 mcg PV every 3 to 12 hours (2 doses, a 3rd dose may be given if complete abortion has not occurred 48 hours after 2nd dose)",
"         <strong>",
"          OR",
"         </strong>",
"        </p>",
"        <p>",
"         800 mcg SL every 3 hours (max 3 doses)",
"         <strong>",
"          OR",
"         </strong>",
"        </p>",
"        <p>",
"         <span style=\"font-family: verdana; font-size: 13px;\">",
"          800 mcg buccally every 3 to 2 hours",
"         </span>",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        10 to 12",
"       </td>",
"       <td>",
"        Clinic advised",
"       </td>",
"       <td>",
"        800 mcg PV every 12 hours (max 3 doses)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        13 to 22",
"       </td>",
"       <td>",
"        Clinic (immediate access to emergency surgery and blood transfusion are required)",
"       </td>",
"       <td>",
"        <p>",
"         400 mcg PV or SL every 3 to 6 hours (max 5 doses)",
"         <strong>",
"          OR",
"         </strong>",
"        </p>",
"        <p>",
"         600 mcg PV every 12 hours",
"        </p>",
"        <p>",
"         Either protocol may be repeated after 24 hours if induction is not complete",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        23 to 26",
"       </td>",
"       <td>",
"        Clinic (immediate access to emergency surgery and blood transfusion are required)",
"       </td>",
"       <td>",
"        No established regimen; it may be prudent to use a lower dose than used at 13 to 22 weeks, due to increased uterine sensitivity to prostaglandins with increasing gestational age",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     PV: per vaginal route; SL: sublingual route; max: maximum.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_22_35181=[""].join("\n");
var outline_f34_22_35181=null;
var title_f34_22_35182="Causes of PALF worldwide";
var content_f34_22_35182=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F83764&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F83764&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Etiology of acute liver failure in children worldwide (final diagnosis as percent of cases in each region)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Etiology",
"       </td>",
"       <td class=\"subtitle1\">",
"        North America and Europe*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Brazil",
"       </td>",
"       <td class=\"subtitle1\">",
"        North Brazil",
"       </td>",
"       <td class=\"subtitle1\">",
"        Argentina",
"       </td>",
"       <td class=\"subtitle1\">",
"        Kolkata",
"       </td>",
"       <td class=\"subtitle1\">",
"        North India",
"       </td>",
"       <td class=\"subtitle1\">",
"        Hong Kong",
"       </td>",
"       <td class=\"subtitle1\">",
"        Chile",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Indeterminate",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #ff0000;\">",
"         48",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        13",
"       </td>",
"       <td class=\"centered\">",
"        4",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #ff0000;\">",
"         32",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"       <td class=\"centered\">",
"        6",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #ff0000;\">",
"         75",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #ff0000;\">",
"         44",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Viral hepatitis",
"       </td>",
"       <td class=\"sublist_other_start_centered\">",
"        6",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td class=\"sublist1_start\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist1_start\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist1_start\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist1_start\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist1_start\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist1_start\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist1_start\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hepatitis A",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        <span style=\"color: #ff0000;\">",
"         80",
"        </span>",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        13",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        <span style=\"color: #ff0000;\">",
"         61",
"        </span>",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        <span style=\"color: #ff0000;\">",
"         43",
"        </span>",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        <span style=\"color: #ff0000;\">",
"         51",
"        </span>",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        <span style=\"color: #ff0000;\">",
"         37",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hepatitis B",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        4",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        <span style=\"color: #ff0000;\">",
"         17",
"        </span>",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        1",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        <span style=\"color: #ff0000;\">",
"         20",
"        </span>",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        7",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hepatitis E",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        <span style=\"color: #ff0000;\">",
"         37",
"        </span>",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        <span style=\"color: #ff0000;\">",
"         25",
"        </span>",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hepatitis A/E",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        10",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hepatitis B/D",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        <span style=\"color: #ff0000;\">",
"         48",
"        </span>",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hepatitis A/C",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        2",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hepatitis A/B",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        4",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hepatitis B/C",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        4",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Autoimmune",
"       </td>",
"       <td class=\"centered\">",
"        7",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        11",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Drugs",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #ff0000;\">",
"         25",
"        </span>",
"       </td>",
"       <td class=\"centered\">",
"        7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Wilson disease",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Yellow fever",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        9",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        APAP",
"       </td>",
"       <td class=\"centered\">",
"        <span style=\"color: #ff0000;\">",
"         12",
"        </span>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Metabolic",
"       </td>",
"       <td class=\"centered\">",
"        10",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Other",
"       </td>",
"       <td class=\"centered\">",
"        11.8",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Causes of acute liver failure in children worldwide, as percent of cases in each country or region. The most common causes in each region are shown in",
"    <span style=\"color: #ff0000;\">",
"     red",
"    </span>",
"    font.",
"    <div class=\"footnotes\">",
"     * Data from the Pediatric Acute Liver Failure Study Group (PALFSG),&nbsp;from 2000 to 2007.",
"     <br>",
"      <font class=\"bullet\">",
"       &bull;",
"      </font>",
"      For the PALFSG data, this category includes all viral causes of acute liver failure. In this population, herpes simplex virus (HSV) was the most common viral cause of acute liver failure in infants; Epstein-Barr virus (EBV) and hepatitis A virus (HAV) were the most common viral causes in older children.",
"      <br>",
"       &Delta; For the PALFSG data, the \"other\" category includes shock/ischemia, gestational alloimmune liver disease (neonatal hemochromatosis), veno-occlusive disease, hemophagocytic syndrome, Budd-Chiari, and \"other diagnosis\".",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Modified with permission from: Squires RH, Alonso EM. Acute liver failure in children. In: Liver Disease in Children, 4th ed, Suchy FJ, Sokol RJ, Balistreri WF (Eds), Cambridge University Press, New York 2012. Copyright &copy; 2012 Cambridge University Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_22_35182=[""].join("\n");
var outline_f34_22_35182=null;
var title_f34_22_35183="Supernumerary nipple";
var content_f34_22_35183=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F86172&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F86172&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Supernumerary nipple",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 405px; height: 540px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAIcAZUDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD1ZVAHIFROxJwKe2SKTHNcp2WItuOaQk4zUjYpVXPUVKQDEBNPAqQKBQCAcYqkrEjQOOlI3FSE/nTSAKokYORzURbninv061EvJpNlJD1yaco5pQuBSEjt1piHNTCaN3FJ14FAkPUH8KXpSqMDFMYHOBTFcC3bFAznikOc0vQcUDH80u6mjJpeKdxDgfTpTlOKaAQKcCD1piHEDrTlINRk5FLk0xDuhPpS54NMJpG4+lAEgbimbqZu4OKTdxjHNFwJgxB56UhOaiL8YNN380XCxKScUK+RTS3GKjDEHmjYRKW5oBGetRFhmg0rjJd3vTXwwxUOTmnh6BiGmMSPpTiw/GmueOKljEJIGabv/vU1mNMZuenFJsokZ+OKap7E801iccU3OT71LYyUnApjHp2pucd6Y+SaLjQ8yENink5XNVnOMGnB/lxTUgYoOTzTJGAGKQtg01iMUXEMxkVBKmOKmLcUyTleKYGfOo39KKdL97miouaI7DBb6UpUYpQQOlL1pkNkYUE0/FGMGnfWkkFxpzjim5x9aUtTeetUTcTvRmgdc01uc4ouG4hXcDSoqp06+tKB2pCD0oHcTdupCD2p6gdKCMcGmSMWLOMmnjgYFOzTRQG4vQcnmkz1NBG7mmYIPtQAE57Uo6GlzgdKReeTQAqnnHSjPYUKM04x9waEIcG45pBxyKTZ0zTzgVQhWOcUFuOaaWyKdj5aYDRQWOMUU3vTELk03Oc5pSw/GmHnpQAZ55pG9qXFNbpSAXJ9aQsAKYW4pu6kFiXd3phbmo8knrSZwxzQFiTdjNNZueKa57imluODQx3JQc96Xdxiq6v6mguQfUUrgTZHOaiY4zjpQXBFRs2KljQ/dwKRumRUbsccc0qt2NIYEEj3pwOBzQp/KmOQSTmntsCYjYpobIpM0zOCaCkDtzmmscinHkZpjcCgAYEAEUzNPzlahbrQNEMud1FK+c0VJZ2AwBzRxTgCBSBTnmmkQxO9B6Up68UwnBoJGtxxTSMmnPzTTnNMB3GOaZkGjk0qrxigBw6cUAc4FO6dKaTimIOFOOppDnPNLjIz3pp+tAWEPWnHAHSmg460vUUrgIMkZ7UjZ420rHaMUYyKACkUDPNMJPSlAJ5qrgS8UqH2pi+9SdBTRLFJzwaaAPekJ9KUUxDTxSjPIpTyccUZ47U0FxpNNz1x1pzYpjcUwuKBnrR0pgyKUmkIWmluMdaQn0ppbHagVyNgT0pM9jT2OeQajJxUjuKSRzUZbPWnE56VCxPTvQNMkLEjrTd3HNRM5BpC5xSbGPc8U0McVG78Z600SDHFIZPvGKjL4NR7/ekyGBx1qRomDcUE88VECfXmjcehpDLAbK1GW9aj3kdKQnuOtAJD8881HITjIpN2etI3SmUPDfJmmlqYH5xSMcHFAWHnGOtRsxxxS9TTZDgcUgRG5JNFMZ+eaKVyzuX9KYW4oOTmkxgVdzIRjTXHSgnJpGOPpQIaxxSck0oGTUgG2hD2GhcDmnYzQcUrHinYQHFMKgnmgHBpc8UBsLx2pCOeKUDvR0oEIw9abjPSnHBHvTcgA0rjGPx70hySM8UueaDz3o3ATHvSj06CkA7daViFXJ6U0AvTrThyOtN+8opRgEZNNCYbSMc07pxSfSimJicZz3prZ6inU3vTENGcc0ZyaVjxjvTORQAjHbxTSwPWlbJ56UzAzQA4nFNJGKAwzikJAPqKdyRpJ7dKjLZp7EEcGq78GpBEgao2YE0wsc0jPQMRz603cM0MwIqImkUhxbORTA2DSE80xsg5FSxjie9IrHNRlvf8KCQe9IZY3g/Wm7uar78GjzPmpATlju4pwbioN2eDShqYyfijNRb8r1phfFK4IkfAPFB6ZqMtTt25eO1BVxC2DSE5ppORSUAQynDUU6TGeaKTZaO7X9KjkbnjpTieODUbAjmrRl1EBoK5PWkCn6VIoxS3BiYAHFKxPpS+lKe1UhXGYwKTqaccZpOCfagBuMnmnY2/SlOD04ozwAOaBCBvWmnr7Up69KafejcaFIz06UxsZ5OaQkim9OTSYxepxSqMcdKaMZzShhjFAmxen1oPPXmjHIJp4ANUkK4mMfSlB9qMY70cDk9aYCYbOaX60iydcimSlycjFMLEhwRmmMaRc4+amt14oEIeaa3HSgnik7daAAnHXrTD/OndTUTkg0hCsR1qItxzS5zTGoEGeOtNJyOtMY000DsKxxUL9acSaa2MUgG549qYx7ig1ExINAhxamlsqaaWGeaa5weKRQ0k5pQ4FGc4qF/Wk0MkyGPpTCSD9Kj3GlD8e9SNMnz8uaaXyARUZbikDUDJlfjPel3ZPNRbs9KQnmkBODk09T1FQK+BT0cE0xjm4PFDNjpSyY+tMY8YoEMk5IopG5NFK5omd2RxRjOM0CnAcVaMRuM0gHrTzxRTGNIyeOlOxgetH06U0HBwKADFIy9s04cZNNY0CEGD0oPAyaDjacVHnOc0DsPJ446U08UYJ70nPejUQ1uenApmCeBTywz7U7d6CkAiJ6mhsA8UoIz0pcU0FwX3FL1NIDjrSk9x0qhDiQBkCo880jE9OlHBFMANNJyKCQD7U1mA96AHfjUbZBpc85FN34zmkAh5HNJxSFxyelMZwe9AhxPFRM2e+RTS1MPHSgBzHAph9jzQTTS3JoEDEEYPWmZwOaHNMPSkMRvamZIpr56ik5xnNA7DWHOaic4NTZGeailHPFAiFuvFR7smpHHpUR75oLH76Y59KhZiG60m/wBaRNhznFR7qcTuqJjzUMaJQ2aM1Ar80pfnrSGWA2KA3PWoA2fpTi3FFwJ93GBTkODzVdHp+7FIdyyXJpM1EHyKeTkU07gNc80U1uTRSKueiDpSnGPehaXHrWqIGkHFA4pfx5pD3z1oACc9OlJgDmjHanHGKQhjGozkt1p7Um3060bjI5M5x2pBnFSlaa2egFMYnTrTDmhs0hOBj1pEsTnk0meaeM446UKoweKpAJnoBSk/nSgdqUrxmmIYBk/MalHA4FJjuOtDEhetNCGsF7nmm7cdKCCRwKQg9M8Ux2EbA5FMxuqUr78VEwx70EiMuOTULE5qc9KYQOnekBWZmPFIOOoqWRAOnWoTuPegod1HApCpxTQxBxzSOx7YoFYQ9SeKY3PWlPTk009KQrDTwOKjLU5j2pjAdjQGw1m7GmtSHOeabmkO4MRimE0jn0qNzxQNCseaikx1oZqYzcGgZFMuRkVBk9DU5bg1A/JoaGhVfHHakdsjNR9/egHjBqRNDWJpd2RSOcUwH25qWguS7sc9qej54qAHNA4PFSMsA8k08NxUGeKep4oAmVsGpQ3y1Xzxmno3FK4CsTmimsOetFDZZ6UBTqWgLkVsZsYc0Yxyac3Wm4556UhgODTMkmpO3oKQAde1FguNxnrSmgjJp2OOaaC5HjJyaY2amYYqNzxQIiA555oI56c05Qc8UEDPegAAx1oz6UMBnpxSrjkAU0AmM9KUHA6UoBHQUoXHNUAmfzo2/nTtvGaB9aBDQcHGKYwBOae3PQU1hTER4A7U0qM9KeOtNk68GkMjcbQeaqu5zVlvm61E8XQ9KAVupACSeeBTwPWjBU89KCxBoE9RHUVCQN3OafIwBweKjJGOCKGNAy8VEVbqOlP39hSEnvSAY3KnNQnrU74PU4qB07qaGAxiKhZjUrKQOaide9ILEbEdQaj3diMGkc4bFNIPXrQFhCeOKjZiDzTmyCcVExoBA/NQSZ/Gns/FQs5PSkNMRiVPNAbIpHYGmbvekDHZz1qJzg08+1Rt0NJiFB704NzUKnBpc1DQycORT1b3qDdT0PPvSGWA2aeDgCoB1qUHK0DRJ1oppbFFIqx6fzinE7V5pQOM00cnFbbGYDnk0EHHFK3GB2pCcjFMBrEdKapycUu3nrSjGcUhjgM0r8EUZA6Co3znmmIRz2FM259zTwM9aUjpiiwXGqmOp4oOM08jjrTGA7GmIQqPWlCY5PAoAp3I5NNIY4Y4owM80zcSeOlL1FMVhxApjcDtTgeOTSMM0wI8gn3pGBPShsc8U0tgGkOwxx+dRknsKczE0wkgcYoCwDOMUxic80u71NMyMnNArAzDn1qBic+lSnbzk1C4GDg5FAyN8EdajIGOOtSgErz0qGTPagBVO3BoPPWojk9+KC2Oh4ouG4jg5xTeg54oLfnTASW6cVI7DnORULEYNSv8owKrk4J4oEkRumRURQgfLVjdxwM00jOcdaAK5HGQPzqCQZPT8Knfg4NQyEYoFYrSg96hYFasuCRUDk0MZCxPbpTQeae59ajKipsDQ5TnjNNPApmcGgMOaGIRqaOlK3vTM4NS0MmVu1PDVACM1Ip71AE4JzUiNg4qEcing9KRSJSc+tFNJ6UUGiR6uScYpeAKjGTyaVjggVtcxAnPSnYwOaVRx700HOc8CmMABTSTnAFObr7UYzQAUw1IRSFaYCKp7il3DOMUDPSgdaEIYc9aU9PanHAFNyc4piQh6+lG3jOacBuIJOKcwBOB0pjuNUcZp2OKOOB6UvQcCmhDNuSe9I3T2p5PFRkcc0ARseeMUwqcdOaeQAfekY4Hv60FXtsQsCaYwp7vxx1qvK7E9aQA5weKjySaazHGSKaXIPpSCwjk9+lQlj1HSnPIpPJpoZD6UaDsMMrYwWNQuzZ4PNWWSPHUVGdpGBj60xldn9TzTVfJwamKAg1XlQr04oAeHAPH40bz2qphkqeNyQOOaQnoPDHvQ21j6GkLr0qMnaeaCRCNp5pjHHOKVn56/nTHbI96QyOUg8VVc4PNWWAB9agYZJ9KYEDtUf8AFzUrqD0qI8DnqKQtiKTB6dahY81K2ckioj8x96RS1GkZFRE4PtUmcetNIBHvSJaEJB6UlRnK0bs/WlYQ5jinK3FRk5GCaRaloaLaNg1KhqqpyKnjOBUDLPYZoqFmzRRoaHrgOKUAk80YyOaeMYrdGbEPTApNtOxk8UpGAeaBDAATRjJpeBRnB6UADcDimoOeaGYnOKVB/eo6gLxupMjsKD1xS4poRG5ycAUnTrTiuenelYDApoBp6YFOyOlIw4pEBqgHAHPNIxAp+Ce9NIHT9aAGMTjNGPU0uN5xnikcAUDG45PpUMuOlOdx0qF5AKQ1EYwx3qF1zx0qO5nOSeABVGe8wnHWolNLctRZbmdIwcnJqjNdBhweRWZPcszfM2RUXn4Hy+neueVa7sjVU7Fqa6KnI5qu18c5B+tVZZDyBzURbKfMMVnzvoaciLzX7t0PHampft/FWeJlDe1Rs+5/QUc77hyo3orvjJqQzhzx+Vc/5pUjbkipYbnY31rRV2tGQ4G98rDng0jgKOKoR3Q7nIFSiYMa3jUTMnAkbHGaGOcd6b1AJqNs7uM1QrDj1welKYzj3ppJxmgMR9KYrDSjY5qPaQeeKsAnFMmJK8UEMqSIQeBVeQd6uM+RyKimwRkCgaZSJ5wartwxINW5BuGaquMtikMjc0hPQ0Pno1IV+XNFhjG71ETtORUu7saiI5qSGG7I4pQ1R9DzRnBpMRZU1MjVTV+asIRtzUMaJi1FQ7j2oqWao9pTJ7UppQcLSelbmYo4FJnPNGcClzn0ouA0dc0dSad2qMn5qGOw4A4o6nApRQo/i7UCExQQTTu5wKd/D700hMiKtjjpTSST14FTHkY9Kj2E1QCE9KNwzxTsZHtQgHNUAuemaaR6mn4pvB6CgEJkqOBUUg4zUpO36VBI5OfSkNIhc4BI61nXMhUnnirV1MsaZJFY11JuDMfwFYznY2hG4y5n+UkEkis6WYsuM4FTM+VIP8qrsoJIxx6muWV3qbJJERU4xjdxUbNgYK1LIdvGDiq7sgGDnA7VIxrE4B6AVGXAHY56VC0oz61G0gbsfamhkzKpbOKR0XGQTxUYb5gx4/rTx8w4BB9KLAMDDd97getBO4gj/wDVT12/dkUjHtVeQfe2nH1qQROHI6H5hV61lGB61kxlmHI4AqaJyrAfpVRdhSibgkJ4/KkBO4YNMtsEAA1O0WG9q7Iu6MHZCff9qCOwpucZzTww24IqiGNB3Aj0pjHOATxUnHJzTCARkUybEDjaT3FQseanPU1GyYOc0CKrg7/Y1DMowD3qy/3qjmUY+tAyjIfl+lMDbl46VLOhA461XAwT2pD6A1MNOLYppIxzSJYx+tJjPSnN096aD2pNEsQdeanifAque+aejVmwTLJINFRb8UVN7GibR7gvNKT+NIo4pcYGa3EJjpmjilGPxoIx2oSAM4WmKuTTvvcU4cUbgJ39qQnPHalcZ4oUYNMBUGBnFBBxx1py9eRxQTz6CmIbg05R+dIMk07B6VRLAr603o3PWpMHFIV796aAQjjrTCMj2oY9utIxAXFAEMo469Kp3EhCnHQVak9c1l3shAIA4qJbFxZRuXL9Tmqci/LyT9BUzn5vambewrmtfc3UiqwKDH+RUb44BHPtVqSNsc9Paq7rtzuPFNpFp3KcpY57L39aoysADyCK05FyPRfpVCWJWJB6etRbsaRRlXDEHPNV/OdT1NakkGWC5zmqNzAqtjnJo9mzVRCO6JGe3TNW4n3chsYrFlDQSZGMetWraYYGO9QRKFjQlYt26fnSOmQCKRTk5Pf9Kk3HJA6YpNGZCFODz83TFKuQcEClY5OQOSKbkgjtUgaFjLtlHatUSZHfHrWFG+HXFa8L8YNdFGXQymuouSSf5UoOQe1DqSaNmSD3Fb6mbA8KQRUQwDjvUkuQBnqKiYA47mmSAODyKCRu+tBGEPpTN3FBLRXnXGKhZcryelWm+YVA4ODTGVJOuc8VXbg81Zcc9KglGcHpSHoQkAZqNhUh5qJsq1AhrnoaZ1NSScAe9M6daLEMD60inBo5FIazkhIlPPvRTQwFFZ3saHu3RfendaQDgZpyrwa3BiEYPvQxzxSt60g5X3NFxeYnAoU5JpGXJp4Uc0RGM3c8D8aeBzTkXJ9hSquTnNFmDFIG0UgQ5pTipF5FWib2GFcfSlUZpWGDgVIvC8VSERkDGKYVJqUKT1pjnigRCeBUZxUp57dKikHpQNIguThcCsi5JDHNas3TnoKzZlLMcdKyqM0iihIB+NAA2g4ANWJIsDjvVcJtchulSlcsbIo28f8A66pTYLgZHNaUqjaMYA7Yqi8Q8wtjNZyVjamUrs4+XPFVCcHoOea0powQAR161TuI8DgE8dqqK1uzpgkZckuH3Jng9KrXMibeevYjtV2aFRgAjkZOKyJ/9YVHQ1bdkdKUXqR3ONp3ryfu0y3TCgHr1qOdi8ygngHj6CrFshkdj/CT+Vcs3fYxmtC7Ep25OQcVZC7kX1HBpqrwOcHtVuKMbQfTk1PkczZSdNp2rnNMbtk5PSrU6YYnIP41EFyvXnripBBbL8/TpW3bgbAcdqybVTuJPSty3UYGOlb0VczqCNyT1BpoHJwelPkOGPrUR+99K6TGwyQgnmkIBXHen7QQQetMYYGT1FBLQ3HynPaoD05qVeRmklAJoBEQGRxULcA1MAcmo5BwaBFJic81E4yDg9KtOmRVcDk+9A2ViCDgjmmTDvU8q856VDKTtpkkRPFMJpwODTSOaQmB5xSUpHHFJjik0SJRSN1orJpXKPe93pTkNIq8UgTD7vwrUoc3PHalY4XijGBSdxQ2IXPFKp46U7aOKZ3pDQoOOlKO1A47cVJGBmrSExu3mpVGOOtOwM05RwP51RNyLacmngcU9hnOKQcD3poBH4FQsMjNTOaYSTTJItvHSopBweKsgCoJBkkUmWjOuBnqcVUZefer1yuBgVRbCnjpXPPc1iRMOevNVnj5LKTkVdYE9AcVG6Db159qE7DKQztx0IqMqSpPerTgDnr2qKR9qkYPPeqauVGRTnX5CAOlUJXYDBBU+taEnPI6/wAqqzEuOcEVk3Y6YSMi5C4ySAT3rIuHG8BBn6Vt3MSPkBBVX7OpyFAUe1ZSkzZTVjFjtT526Xk+laFvEdpPQdhVryQhAUfjT1jIzu49azIlO5Cgy2cYFS+YcYPXofpT0UdB1pHQmQbjj2ovZGe4gxwSMZpmMsApqXyzjHr0qW3jAYgr0otfQNh1tHg8fdPatOEhR0qOCNdnFWFX5M44rqprlMZu5FIRk1CwyfQ1YkTcKiZCOvXtWxAxMhsnrRNguMdO9PHc00gnJxSIZG2M9KidR+VSPncPSmlMgmmBGMDimzgYzSnrk01+V5oFYqMDz71XZSO/NWJODUMtAMryk4qs7fTFWnw3SqsqlTxTFYjYdMUDPU0vGzrzQvIxigQjD0pvanjqaAOKCGREDPOPxopWHNFZu1xnv2MrikIwaO9K/QetUUxp6YpVpo5p4GPrU2AccdKQD0pyp704gAVVguN5JqSNOKVQBilQYznpWgtx2AKcF+XNNxk04c96ZIU0jvTwMGmscUIBhpRjHNMPJ4o6DimFhGIBqFhk8dakbpUYbLYB6daktEFwhIPrWa8eTz2rYl71nzLySaxqLUuLKpBycVG4JA29akJO4jPSoXJxjr6VCZZA2CMng1SlYoTuYn2q3K/GWXGOKquFbqTzT5+gWIHIdSV61WdSxwVwRUsnyPyCT7U0yK3Q1D1NIysVHjHJJwOlMSOMHucdBUxcc85pCwzwT0rJ9zS7IZVJ6YUVFIvOckkVKcnBxn61H5TP93qKlgMC4IPAb2qSNFOSc5PXNNVedp5NWEXnHJpA2JgBgCOexqykQJH86IbfccnNXViCrjritacG9TOTIo1KnBxU6gLyx49KXYFxnFI/AwME10pGbdyKbBPtTH+YgVIFwDk81G2c/SmSMZSBTTwvualH3SSOKj9yKaJZCy8HNMJIHsaezFnPpTHQ5PcUAiKTnHFRuuFNTkZ/CopicGgW5QfOagkPc1acjoRzVWcfMKaKITkN7VDN1x7VZABYe1Qz9T60MkrbfyoXqR3p23B5pv8AHxQDHAUp4pDwDSqMjntQZshPWillB3UVLQHvqjigjjGKkC8ClZePrQirkIXHNOXk05vQUqrgjPShIBQOKRutSMAR70zFVYSHKMinHgYpE64p5GM9zVoYkYy1SkBRUUZwKeMk5NNiY7HHFQt96pWPFMYYGaSJI264FJnC4FKeaayjg5plARTGUZOPxp55+lIV4pMZA/TFU5s1fZaikjyOlZyVyk7GUV+bOailKirlxGVHFZk74JyfyrCXumq1IZmJOOo96qyAgZx9Kmd8jAqEt8uMEVi5JlorFCzN9OaqyxMDlckVfLBQR0x196gLDbyCKOYZTK4HQUm1uQFwamblvloUMTk5wOalspEao2eRQyBVAH6etWVUsM4NAiIYADOaW4XKKRncGOc+tWYELHPr3q4Ic8YFTxxBRnFXGDuJyI4wQo4qZcfSnGPA6cUwg+ldUdDNu4pAbNRsMCpVUkentSuuKohuxXI4+tAT5c4+lSMMDkVGrHoeKBERHtUTjBx2qwF6mmSLkE96EiblTbg5B4pWxg9aV+uKSQbFGPxoKuRsMCopSMHmpX+6CO9VpOaYrFUjkmqzrlqusABzxVfbwfWgbZCq4PFV5eWI71abg9arOPnNMSIHyKjH3qnlXJFREYJoEwJ604dKavTmnA8UyGNYZ70UMOaKQHv6k5xQaTdgHApCcDPakFhDg1Io4GajGS1S4pobDHOBRjmngY60vWqSJuIg68Up4OKcvX3pG5PFMYznNSAHim4yKcOMYNMTAj8qGGV4px4BpgbIzSERMvGKaeBgVMcGmdaY0yPkHnmg+/enPwPWmdqQxr/Wm7iFORSnPpTSMikUincZYHnIrLuYNxz3rYdCc1AYwcisZwuaRdjD8klTxiqzRtkjnNdBJAo6YNVzBzwAawlRL5zC8h93AyKDC2ACDW+ttxnFMFuMnNHsRc5jRWg24YcmrKWQA5HX9a0DEFI705cZzirVJdQcmUPsiqPTIpPICYwDurRcADrVR88jvVcqjsJNlbZ82BUyxAD/AGhSonzbiKnVAoJ7mqihSdittzkE0xY+TxU5GaQ4HSqJuQAYFNJyxJqRh6d6jxz0ouMjIzzUbdcdxUrccDmosZbPekxARg5xUTnJIqVuetRHIJ4yKZJCwwMgVGfmGTTzwKjJOPl/GmirETnaPWq7H5STU7gnAqvPnOPXqKCiJyGHvUbADOKVxgHrxUJY7SDQJoSQgjiqzDnNWGAxmoHFBJA/Jz6Uw9DnvUre1MwGGaYNkZ/Gl7+1I33sU89BQQxjYz0opSAetFAz305NMbkCpBzyKUAE0rBcRF4qVRzSqP0pwwCatITFAzxSYxSjH50uM800iRtIvJIp5HFCrxTC4zbg08d8U0HJPFKuRTBsGyOtISMZFKec1FjGRSEKCDSMV6DrTcHNAXvQUKBnrTGBB9qfTT1pDI2yAMdaifJ6cCp26UzApDTIegxkk1WdcnNWpcLULJkEmpkikyBlLHimOre1SBdrcg0jd+amxQ1Rxkk1C5weKlz8pBqEABuQTSGkNIbHIpo6VaYDbx1qMp696LBcgHzHBphQbj6VYVFPC54prjBNFhXItvvTs4BHU0oB/ComLBqBPUY4OeOnam/XrUjNtXLD8abuyKLEkUhAwT3qIt+tTS89ahLKBmixSGuOmOKYVxUgOOc/nRxyfWmSRNjFV3OTirD8D2quflJJ6U2CQyQA8nrVc5DZxx3qcAkHFRSDqB0oRZEe5HWq0ikyE1aGACPSopMdqB7FOYZ6cZquVx16VblIB6cVXkHPHWgVxkuAMdqrPzzUsvLYqJqCbELYNMJp7DnimEevWgQwqc7qUZIFOb7ooXJwOlMmWpG/B4op7daKAue+x8CnAdwKaMAYNSgg00AgyOaeM4JPelwAKUc1QrjQcCnBu1IQOlOUYpokO9OHXFBpVAFADGGDUZ4zUzjIqIgUxpCbhTWoYc/Sm8dDQKwjE54pc8daNvpUbZz7UhrUcSQO5pCc/hQCCMEUwsRkdqRQM3FN4P4U1ulNBxzzSCwkmSeKRumBTtwxmomGe+KQxjA/gaYBlgKlkI7dKbj5cgYqWi0xsgAyKhYDGAKczcjvSAZJPel1GKnTBprrzzUqsoGDTJFI5FBPUYGAUiomOTTjwcUjLx0pAQnK/Smuw6jrUmwDPHJqMpzTsFxrH5fXNIQNvvQ3tSNyOKBMhk5qu4qzLjp+FQOmDTHFkLdOc5oztGSadsbqaawpDImlJyBUbKSvNT8c8UjLx1o6BdLYiHCYHWq7jGcVO4zwDUYGAaAuV2zUEnJOKsycLVVvv56UxjHGR6VAyjPrirEvPNRHqfWgRWZccnvULDJzViWoCuBQIgeo8c1I3U0m0YyaAYxzx0pFyaVh+VKMA0EMa2M80UPjNFFwPfEHc1KMZ6Um3pilUYOfWrSEPAzSgU4YA4pDwKokQdad1pASTTgMCgLC96DjFA60Z5NMBpOB0pvWnZGaQ8GkNDCvzCmlMmn0hJzwKAZGRio2IzyKlPNROeaQkIxGAe1MPIyDxTsBqUAdBQURImF5JNOIXGO9P2HkdqjIwaQ73GsgxTGT3p7HBFI5yvIpAQhBnnmkKYHHSnDpxTevOaVguQsMdKQKcU8oc+1ISw4GKRSZGV9aY5ww5qQsc4prKDyTzQx3Gn170M2RyKPu9KjckdKQhN2QcDFQg8nNSZx1OKjYYOaY7DMHd7d6bIcDAoZsYxULklqQWHY9elRsfm4FSYOM1EQeTg0XEJIMqPWq8gOeKsgcZqKRh170DTK/8VNJJJzkAU5iCaAMg+lMRAxxwOc1Gcg5zUpU5J9ahfrikUiOQ5OO1V2+8eKsMOOlQOSDQURvwKiYjHv3p75PNR45ouKxEzA9agfr7VYKjdUMijNMlkDrzTTxgU89eKjfg/SgQ0nJoP3qUjIo4oIZHJgmiggUUik0fQQIpV9MU1V569KkAzWxOwL1p1MYc9eKevNMXmKBTiMikHTNKvSgQDimkZzinnmmEc4zQCDAprUPntUZY4x3oKSHE84pGzTVz/FSswPFJgyLBB5OaRhx0p/BNKcCkJkQQ5GaUYU09juAqNs9qBCsT3qNmHQD8aU+ppoYjNIY1hTDzwaccNTGU5BoKGsAMimjGOOalZR+dNKcUguRM4xj0qMsO1SOvWotoFADfm67c+1I3TJGD6VMHyPemMBjnmgdyAg5zzQygj3qVio49aaMdKkLlZ1455prnC8dakkIHaozgmgZFtJPSmvx0xTncg4AqJgTyaTGDDIwKiPy/SngHJzTXUjmgQxmIU461Wcgn5etTuGx71EUKk5/Oi4xmBxnrUcrEfSnM3ftUTEycUMSEL7ufSopBgDPAp5GDTJuaSZRFI/t0qBx3p5ODRIML70wZXkNRZz06VLInHNR4CjFILoifPNR8Y5qV8moyBimiGQ4waifr0qYjnNRkEmmIiPBxRQ/HFC0CZG4waKJDk0VLuB9CYGKdzSgd80N04roRI0DLU5jjim4/OlOKYwBJ+lSY6Y6U0DApwz3oAO/NNY889aceabtzyetIBrZIqNuKmIPamKoU88mmO4xumTTRjnB4qSQ9BimhMdKQANoPvQQDmmtgdetIDzSACAOBTCp281Kq8802THTNFiSuSM4PakfGKXy9pLDqaRhmgYxP0odueOlG05yDxTHODihjFGTzn8KRs44pBwOKYxYVIAygjDVGRxxRl2Pagkjr1pDGjcO1IzZOMUkj57U0N35pAK2BTTig/MfamkqvSgBj8cmmDHcc048im4pLcBu0Z5qMjJ7Yp7nIwKibcKQxHAqJt2fSn54prHjPQ0hET5A5qJz8vNSOzY9qhYkmnYZEy9vWkKgDipDnNRsOuOlO4FeXJPsKifOOassM1DJ0560rDuVm+9TWOT70Oevao8+9DAc4+XioHXpUzcLUDA4pCGEenNQN1NSk4zUZXjk0CZF3zTW4zUp/KomxTJuQnk0gp5o6ZoEyB+DRQ5y1FTcs+h16UvSkQ54FLziukliEc0qgU1gSPSlX5aoB3Qc0ZPpSdaCOetIADZ9qXPrTCc9KFGB1zRYY/6UwjJp2B170hwaEIjZdwoC7RUg4FMZjnGKLBcj6k5FI20USE4Jpg3cEikOxIGAFR4BOe9Lz6CgHJHFADTg96awHQ098Ae9REDqetIQ0lQMCmEDPrQxIPAphJ7CkUDZFRSE1IxOPeomVutIBo3AcUgOetObcRjIxUZYZxQMG9MU0E4ORT9w7VE5+tIQmeDUQyCfSn89gcUjZ9M0gGZ+bnpTGLE+1SYJ6004oYCBccmo3NK7YzULOCMUgBzgCoXbJpzc9BTBnuKVihrZJ9qjc4qVjxUL5PNBIw/SmOCBkU8sMHFN5IpgQtkcCmOOOakPU4qKQnqaQFeQDmqxOTgVZm6VWfg0mUIx4Gajbp7U8nNMYd+KCWyJjmo2NSGoyRzQSyJielMfjinsTUbGgQxjnrSdKDQMd+tMCJxzRQ45oqS0fRCAClBxmgD5aTO3tXUiWhvJNLigcilzTsAKeKU4zxSE4waaWOeKB2FbhsCkIJFKc5FK2eMUAMbgU0KRzUgFRyE9AaWwDue1IfemI3OO9ObIXmi4hCFJ/nTed2McULJ6CkLE9KQwZfU0xjt6UvJHJpjnA4oATdnk1GSckCl3Z6D8aQnBoCwxlweTSYOKGIJPNIzcYPSkMaQCe9NOB0pSeKjO3t1pAKVz3qNsDtT+3NRFu3akG4zfQWGKaQcnPSm9DwKRTQ89OaikbFOJx1IxTSVxnrQSRFmyKQsBTmOTwKaemDSAacMOKr42HnmpnbHTpUTHNDGBOTxUDEg1JnP1psvABIpAQlievFB5FDnKmmK+RgUAMOKYSfWnS4HTvUT9sUgEc8cVG5wKJGGOKiDZ60CsDYqtKo6jpVlyMYqrITz6UCuQs3HHWmMc08jPOajPHSkwGnpiojjNSZ9aaeRkUEkTVEfpUjUzHrQBGxpopTQeaAGPyaKGBzRSZaPohVzjmlbBNIgPOadgCutEjMDtRkZxSYP0oAIpoAkIA+tRqeacQe9AUk57UDQc4pV68mncEcUdO1IBm7cSBTXXFPBU9BQygikwuQhDmpG6U7oKYMk80loF7jGFMKmpSKQjg0wuRYz3pp2gHmlIx3pjAAUgI3Py5/SojuapDjuKTPOBQMbwoxTWyR2pWHqaYSB0pMAKjqxzTWIxxwKU4YU1+mKkY1mB6VE2M07Jz0qJyTxmgaGs2cjNRgbRnrRIQmM96jaQqwwCc0mxj2wVyaQMo4FISWHNIVC8gUEiuwHtmoWOOc8U6QgjLDpUBfd0pCBpN2cdabkk4NG3gkUwsT16UAOZtpAzUcrEjg0M2fwqAPycfrSY0KzjGMc1WZtlSkZfr1qOXk4PakNDCwYD1pH5XrzSyAbAcU0crmgCMqQmajzUjHuTUEh5OOlBLCRxnNQufl60rtke1Qt2FMQH2NRkEEinucHNNbJXPrSYEZ4FMJBzT2xtph6YpCI25qNhxT3zUbc0AMI5pKUikA9elADW60UMOelFK5aPofoMU9R3pgXnmndBXWiGDYxTWOO1KT6UjHFMEhGG4YppOBSj1puOSWNADwQRTGbGc8mhRuNDEDPrQAiEkelPOBzSKeKaRk9akGBYZoY4GRTXyDwM0xlyCCcUXGIzH7xqIybzgHFScAc9KYFUcikNCOcCoy2RzUkhJPHSmADOSOaBjCeaYXHNPYgkgU3Z3xzQBEfm49abwDyKfJwcVGenSpYhGPYVGS2T6Urk54qNzjqaRSFZsCoG6k54pJJQOpqnNcAY2sKlsaVyw/zd6jZtvQ5qsbgeoNSK2cc0Cd0TA+pqNy4fj7tDsRjAzQRkA5oJuIzEjB/GogR0FPZ8dOajGAeOKBiS7sgr+NRl/XrSsSGOelRS45YUh2EOfX6VDu2uQaeHB71HKvIYdaGNBjvmmyfMePxpX+ZR61HuwCD1pWEL22npUQOOvSlGQDTC2UxjrSAZMwOOKhkzwKe+V4PSmMMAU0JkchxULE9amlX5c1E4IX2piI2b5cYoz8tA70BuPpQxEeeaazZz2p5OcmoyeoqQIz09zTCOKe3tTTx9aQiNj2pBTm5pmcUAITk0UjAntRRqWfRAbnFOOBSAgYpc8+1daIYwnA4pu7ccGnkioTndkdKaGSbsnFBHHPSo9vzcGnkZGM0gsNY+lIF45OaXGOBSYKgZ5psQcsPSjGAPWkznvxQwOPl61Ixm59xz07UkgbrS8g/NSEk9+KAGYH8XQ07jH4UjKGpMgcUhjRknjpTG+UcnNK5A5BpnuaAHDaKjZs9KQnikHA4oAa6gnPeoJMgVM+c8moZjlalgVZJSCRVaeU45NSulVp1wOtZSbNYpGfeXBCsdxNc9dXsysTh8etbVxu3EjB+tZl2X2EOVx7CueWu7OunFIpw6mxblsfWt2zvQ6AE1yZj825+RflHetyyiZQMcVNObTFVpxsdHG+4DBp5HPNU7bIFXEI79a60ziasQumGJyabnj3qWbcTjtUGAp5pggCnHNRSD5WHSnF8t7UhORz3oeo9isit3NPcAqOxpQACRSHdmpBu40YIIqELhjUjEryOpppY5JoJImYHIqNhyD0FPOCSabIdw96BkbjLnniol+9605iFOD1qPt15oEB64NQsc/SpCcDJqFuvHSgRG/wB44NNXkYFPdeeKjGVJzTE0DLjrTGI4p7VGw/OpARzUZz+NK2c1G7GkAY9aQjmjnrS8kUCGHrzRQ3HeipbsWj6GU8c0HngGhRxSdOM/jXaiRx4Wo2x1A5pX5xzTGbHNNBYOR+NOXPQ0zeG6GnDuM0thi52g8UmTj5hSgccnmmkn+LpQIUsMdKjZjngcUAjPPNIzCgBCSwODTQB1JpwGQeKYwBNIaBcZOOtNZBnOeaeCAOKjfcTyRSAa7KDtNMY0r/rUcikgYNIaQAYHJprE7fk605Rgc03I7UhjSDjnk1XbOeelSsx3YA4phIPUikFiFh1NU51JHNXJumFIFQOm4c1MlcpGLdRschRWbPZszcjOa6Ly/nIKk+9DouD8vNYOjc2VSxzcViUOcYq9b2+DmtDy+gIFPCgDkVUaSQSqXIkUD0zUgYdM80yQojZJxmmHB5rRGTVx8jHcB1qGTnHOBSGU5K4phyW5NA7CnApuDkk0NgkUMeMA0CYvVTmoTkGnDgHJpqjPBoIYyT7ue9MB+X6088vgjpTSADntSEQkCPg1GzKOTUsh3HJqN0DAe1AyJxuGcVE4xyKmJC/SoyQckDikSyJgce1MZaexpjcgHNAyKTgVGw45NPlwTUJzk96LisBPFIeOaMnHAppBxU3E0MJ6802n470mOvFMRGetLmhhkUgBzxQMY+QaKcwBooKPoQdMk0xwWXg0uaCwIrqTEMUkg5obBFISQKCPlFFxkbKc5FPDELTCSc1GGbNK47XLBb86RmyfWoy2abnA60CsP4BJ9aYpBOec0gJP0pHcKp9qdxIlbkdahA2nJOaZHJuWlZd/fGKTd9SkrbjyQATUQYtzQxC9aD0z1pXHsA4HXNIeRSHpx1qPcV+8aVwtcM460hYH7tMc7+9NxtpFWBiMYJ5quqhM85pxwGIzmmtIBxigdhrYc8k8U13A4pjPtbAFJtVjk9aQWAyAcd6hf5mHpTpGRD7mm/eXIpDsNbgHHXtUSscYfrRh+cniq877Dk55pXGo3JHZWfGORSHHpTA2RkD5jTkLDrigGrDBnPIx6UHG7HenyEIAetRE5BNAhjJ8xOaaxXIJoy2eelEmDye1SKw2UgjA/Omb/enkjFRYXmhk2CTOAV6mozngGlc+WBnmkzuwWNAmrDX44qGQsCAOlSPgMcHioiTu65FMQ2QZAJqNshc9qeXDcdqikYg47VDENY8Y6VE2Sp5p7HKgVG/HAoAjB+Ug0w8Gntg/WomPPPWgY4HikLU0NxkUE80EsRgBTDTt2etMLc0EiE0dqaxNIM0DQ1jg0Uj4z3opFn0KoIBJNI2AcnpTQ2BQRkZrpJEJyCMcUzJHAqQngDtTDj8KYXGKTk5pDjk4p7HjiomIHXrRcpaiZPekOPWg8jrUTElgBxRcqw9yT04qJ2A5PSnOCTwcVGw42nmhsEh6uCOKa0uHxiozhBxxSBt3SkUSFt/XpQzHbheKiYnBApAcL8xoFYFZ1B3mkkw+ATSOw21CGByR1pFJXJW4+7TC+OGqIyHsOaY5OaClEkdlDZ71DKwGCaARkZ602YnHyjJpDsNmk+Tcg59KijkLHng0/kLnvURBLZUUgQ64KgB8ZNCvlPwpHJHBxUTSbe3FILXQ/cFXrmoZSCBkcUFgQcDmkAO3nFBK0Gg9wKaWJ/ClyOcCohwcgmge5IWzURbacYpR94nNNlc8YpMLaiE8Zpj5IxS5JUgiogx6NSCwhJUUDnJprsPutTXfavFANCk7z7VG7cgDqKEc4yKiZssSKGQ0LK24470xmCmmSctnNMY7uPSlcnlHMQM84qIHJyTSSnK4FR84pBYcOpxTWOaF6EE1EfvEg5oZNhvIJ9aaTnOeTQW5qMN83SlcB4bAphPY0mfm5oPU0risBG7pxTCQB70vIPtTCPWi4rC8Y96bz2pB1x2ofgUwGOTmihhmikUe/l8mn9qjTBXNPyeOK6UyBcnHNCnNNcnvTTkDii4xzjioigLZoDMeG4pD14PFK5S0GnjIzzTACBzzTiBu3d6TIIJoLGls8dqY+FyTSBvm4HNKdxHzd6YWIwdw5pmRuxSscHB60uM0XDYjPBxmmHk4NKVJPXFQs3zYBOaVykLK+04pF4XgUxwCRwc+9L0HHNBYDOaidxuwQaUsc8CmyPleBzSGNIG7rSSSBCPekHzHniopcZzjn1pBuxzNuzg4poO0ZBqMktkCmgnByaGwHPIjHJ5pjMo/GmS4A9KZkEDNIdh5ViOODTckDk5pvmEA47VGHOOfypXFYfI+B8vU0xT71G+Tkj8KRGIBBFA+UezEH2phfnnrSOxI46Co2JNAWH7xmoW4l68UmTmo3znNIdrEkp59qjLDHtTZCSvHBqFGYfWhhbQkSbk46VG7YBK0h4JzUD8E88UEtDy29evNRK+088mmlsHI6VDLuLnac1LdibE5cbT2NQrIe9MUljh+lKR82B0qL9SWkPLFie2aYMr0oHD4HIqQnNVczYxxg59ajYYOaczdT6U2RuBSERvjPFCgkZprHJpyttoBhTGPOKcW5prHqTSEMdhkYqNgSOtDc9KTnbnPSmmAjMQeKKjeTB6UVL3GfQcTZGalDA1Qjlx34qwH9K676EEzrkcdab096Ff5eelKSONooGNPJz3pjZxjpUn160zHrQNMjwc0wMCxUDpUsnyjjqaaBz0oLTGEeg5ob7uSMmnH72MUyQ4NArkbLkdMUwg84NSbtwJxScAEdTQFyvtbB3VHs3DOOasHOOlMJ3dBSKTIHXOBmmcYxnpUrg8g1HtCgn1pFJkTkZ4H40nPYVKuCmSKjJPQCi47kLBgSR0qOQcYJzVgjCnPWocKcgGkFyAgE8Gk24XAJqTYFppHGM0guREA++KjccfKKkdducZph+7xQUmQk8A00qHJwafwTzTc/MQopXKuNBYYyOKR1yc5/CnyDIAzg+tRkEc5pXC5GWx16U113j0NSuoYDimdDg0BcrnI75pDkggdamZc52jmowMCgLkYB6sKZt+ct2qZvbgVWlODjpSbsK5HKCvWo9wIIPepJORk9qgkwHBqOYVxpHHqKaRt6CpXIXGOc00nKUEtkOPm5pjctipC+TyPxqIrknBqbiYL8snB4pSxDHBpB0560p5PNNEMaT8uDUbcrQSeSKBgA5oEQ5zS5wSVzSDApVQ4oBgmepokYYNKzYGKgc8/SjYQ3nkd6j3Y4JpjyY79aiZ/zoELJIM9KKryNg9aKNS0j32OTHQ8Vbjk4BrLgYkCrisdtdEWZl7cSOtORj0qrGx21MpPFVcCyPftTXbpUW47utPJwaLhYCRimnjml6kZpD0ouUhhfPXgVHLuJGB8vepG4qN2JwPelcaDnae9MQMeWGKkXv7UN92mIiYHPBpjDFSSngVG5IWgCAsxJG2kKHacjirHVc45qJzkUi7kQwQQAajKhOuamIxmmMMnBpAiCXlCAeT3qFYtg5OferBADVEeSQelIoaUBHXioMHeQO1WmAA4FRlQDxQydiGRMjk4qBkOCKsTGmEDH1oZSKLjHHNABIyKsyqMZxTAMCo5bF30IsFhSHkYqVgB0pmcE07ARKMMcmkxnkU89TTfegCM5zTGUg1K3DcVGxyaBEMmOtQMA2asuBioHUA8VLAiK/JzUBQYz1xVkjKVE4xgDoaloTIXXjOKjbOKnbofao15U57UhELLSKOpxUw601utJIlkQ5HvSNxQ/WlbpTJsRsNnSmEb/pUjfdJ71WLHFOwWuAA5HWml8cUhJCkiom5zmmA6Zxgbaru5pSTtqCVjU7iGyNg8cmoHfA96RmOTzVeQmmhMc0nTjNFVXduOaKltJhc//9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Supernumerary nipple (note that the supernumerary nipple occurs in the \"milk line\").",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: The breast: Examination and lesions. In: Emans, Laufer, Goldstein's Pediatric and Adolescent Gynecology, 6th ed, Emans SJ, Laufer MR (Ed), Lippincott Williams &amp; Wilkins, Philadelphia 2012. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_22_35183=[""].join("\n");
var outline_f34_22_35183=null;
